Interacting selectively and non-covalently with a CCR9 chemokine receptor. [GOC:mah, GOC:nln]|Interacting selectively and not binding with a cell receptor. [GOC:mah, GOC:nln]|1.2888636363636294|32.05250000000001|14.445909090909094|10.155000000000001|16.390128571428573|13.006557142857146|-9.450909090909093|-15.865454545454547|7.6385714285714315|3.937857142857144|54.195869768830164|49.473833993334296|24.018181818181816|20.381818181818183
The chemical reactions and pathways resulting in the formation of 2-deoxyribose 1-phosphate, the phosphorylated sugar 1-phospho-2-deoxyribose. [ISBN:0198506732]|The chemical reactions and pathways resulting in the formation of a molecule of protein, the phosphorylated sugar 1-deoxyribose. [ISBN:0198506732]|68.81926470588238|50.25565789473683|5.772058823529413|8.609736842105267|14.683966666666668|13.180157142857144|14.983529411764707|8.764210526315786|14.322857142857139|11.631428571428572|58.53822981607831|66.37611354998121|19.870588235294118|22.74736842105263
Any process that modulates the rate, frequency, or extent of protein deacetylation, the removal of an acetyl group from a protein amino acid. An acetyl group is CH3CO-, derived from acetic [ethanoic] acid. [GOC:tb]|Any process that modulates the rate, frequency, or extent of protein deacetylation, the removal of an acyl group from a protein amino acid, an enzyme that is soluble in fat globule. [GOC:tb]|41.06107843137258|42.545000000000016|10.347647058823533|11.3|12.786880952380953|12.3747|5.18470588235294|10.899999999999999|7.280476190476186|8.126470588235296|74.48509850970193|85.69119412168324|24.533333333333335|25.150000000000002
The core heterodimer of a condensin complex, a multisubunit protein complex that plays a central role in chromosome condensation. [GOC:elh]|The core heterodimer of a protein complex that helps chromosome condensation. [GOC:elh]|27.485000000000014|31.545000000000016|11.91|10.350000000000001|13.932061904761905|14.134414285714287|5.680000000000003|-11.603333333333325|9.612857142857145|6.6292857142857144|69.96656701596841|54.195869768830164|24.0|22.400000000000002
Abnormally decreased blood carbon dioxide (CO2) level in the cord blood. []|Abnormally decreased carbon dioxide (CO2) level in the cord blood. []|73.84500000000001|70.50704545454548|4.450000000000003|4.791363636363638|11.086572727272728|12.522027272727273|-17.97333333333333|-21.74545454545455|6.582727272727272|4.870000000000001|49.473833993334296|49.473833993334296|19.06666666666667|20.381818181818183
A radiopharmaceutical composed of the dichloride salt of the alpha-emitting isotope radium Ra 223, with antineoplastic activity. Like calcium, radium targets bone tissue and preferentially accumulates in osteoblastic lesions, such as those seen in areas of bone metastases. Radium Ra 223 forms complexes with hydroxyapatite and becomes incorporated into the bone matrix. The radioisotope Ra 223 kills bone cancer cells through local emission of high energy alpha particles, causing DNA double-strand breaks and tumor regression in the skeleton. The short range effects of alpha emission allows for localized DNA damage with limited toxicity to nearby healthy bone tissue.|A radiopharmaceutical composed of the dichloride salt of a protein molecule, with anti-cancer activity. Like calcium, radium targets bone tissue and preferentially accumulates in areas of bone metastases. Radium Ra 223 kills bone cancer cells through localized|26.236258503401388|22.83018018018018|13.657551020408164|13.138918918918922|12.8393|13.188479487179487|16.317551020408164|11.756756756756747|15.087299999999999|11.639230769230771|88.50148473330829|76.64453405168562|26.125170068027213|24.392792792792797
National Early Warning Score 2 (NEWS2) Escalation of care.|Early Warning Score 2 (NEWS2) Escalation of care.|70.66750000000002|86.45000000000002|4.520555555555557|2.1950000000000003|12.855122222222224|12.631922222222224|-33.11111111111111|-42.394999999999996|7.666666666666668|1.7533333333333339|44.250742366654144|38.32226702584281|19.57777777777778|16.6
A ganglioside storage disorder caused by a deficiency of enzymes B and C isoenzymes of beta-galactosidase with resulting accumulation of ganglioside MM1 in the brain and large amounts of keratosulfate-like mucopolysaccharide in the visceral organs. The affected infants appear normal at birth . Locomotor ataxia, the initial symptoms with onset at about one year of life, is followed by strabismus, inability to control hand movements, slurred speech, muscle weakness of the extremities, rapidly progressive psychomotor deterioration, dullness of senses, lethargy, seizures, decerebrate rigidity, and terminal bronchopneumonia at the age of 3 to 10 years and rarely later.|A ganglioside storage disorder caused by a deficit of enzymes B and C isoenzymes of beta-galactosidase, the initial symptoms with onset at about one year of life, is followed by slow eye movement, slurred speech|9.532590206185603|21.447142857142865|17.954097938144333|18.962857142857143|12.668399319727891|12.299808108108108|22.710103092783505|21.44685714285714|21.817619047619047|19.21972972972973|108.39173953766033|117.07645963215661|29.49381443298969|30.0
The process in which the anatomical structures of the neurocranium are generated and organized during the embryonic phase. The neurocranium is the portion of the vertebrate skull surrounding the brain. [GOC:dsf, GOC:jid, PMID:16049113]|The process in which the anatomical structures of the brain are generated and organized during the embryonic phase. The brain's hair-like projections are the result of cellular contacts between two body parts.|44.415454545454566|47.95833333333337|9.796969696969697|9.220000000000002|12.335738095238096|9.771574509803923|9.261818181818175|5.141250000000003|10.644761904761907|8.617843137254905|65.13532912329528|67.59412548439398|20.157575757575756|21.766666666666666
A fusion gene that results from a chromosomal translocation t(5;17)(q33-34;q11.2) which fuses exon 40 of the MYO18A gene to exon 10 of the PDGFRB gene. This rearrangement is associated with eosinophilia associated with atypical myeloproliferative neoplasm.|A gene that results from a chromosomal translocation t(5;17)(q33-34;q11.2) which fuses exon 40 of the MYO18A gene to the PDGFRB gene. This rearrangement is associated with eos|42.60000000000002|75.50000000000003|9.553333333333335|4.964444444444446|14.369505405405405|13.611906896551725|3.2077777777777783|-0.22222222222222143|15.443513513513516|9.694827586206895|58.53822981607831|47.79626449838941|19.15555555555556|13.97037037037037
Cell-surface molecules that exhibit lineage-restricted patterns of expression during EMBRYONIC DEVELOPMENT. The antigens are useful markers in the identification of EMBRYONIC STEM CELLS.|Cell-surface molecules that exhibit lineage-restricted patterns of expression during embryonic development. The antigens are useful markers in the identification of EMBRYONIC STEM CELLS.|-3.2510144927535976|-3.2510144927535976|15.61739130434783|15.61739130434783|12.4673|12.568674358974361|3.318260869565215|3.5739130434782567|14.964000000000006|12.069102564102565|67.59412548439398|67.59412548439398|27.414492753623193|27.414492753623193
<p>Indication of status as incarcerated.</p>|Indication of status as incarcerated.|-15.662499999999966|-15.662499999999966|16.065000000000005|16.065000000000005|16.36401111111111|14.311966666666669|-71.35999999999999|-78.416|4.003333333333334|5.975000000000001|38.32226702584281|38.32226702584281|25.0|25.0
Interacting selectively and non-covalently with a H4 histamine receptor. [GOC:mah, GOC:nln]|Interacting selectively and not binding with a H4 receptor. [GOC:mah, GOC:nln]|1.2888636363636294|39.7434090909091|14.445909090909094|9.08227272727273|16.390128571428573|14.134414285714287|-10.520000000000003|-16.934545454545457|6.965714285714284|3.2650000000000006|54.195869768830164|49.473833993334296|24.018181818181816|20.381818181818183
A disorder characterized by inflammation of the wall of a vein.|A disorder characterized by inflammation of the wall of a vein.|47.434318181818185|47.434318181818185|8.009545454545457|8.009545454545457|9.923918181818184|10.513266666666667|-25.48727272727273|-24.952727272727277|6.335454545454546|2.3725000000000023|38.32226702584281|38.32226702584281|13.109090909090908|13.109090909090908
The maximum blood pressure in the systemic arterial circulation during the cardiac cycle.|The maximum blood pressure in the systemic blood vessels during the heart cycle.|31.037500000000023|63.57596153846157|10.545000000000002|6.006538461538462|12.783607692307694|9.622985714285715|-10.71076923076923|-14.329230769230772|12.605384615384615|4.947142857142854|62.58|54.195869768830164|27.21538461538462|21.06153846153846
Symptomatic; altered GI function (e.g., altered dietary habits, diarrhea, or GI fluid loss); IV fluids indicated <24 hrs|Symptomatic; altered GI function (e.g., changed dietary habits, diarrhea, or fluid loss); IV fluids indicated 24 hrs.|45.64500000000001|53.2271323529412|8.383333333333333|6.8910294117647055|17.875742105263157|16.36401111111111|-15.686666666666667|-34.367058823529405|11.867894736842103|7.666666666666668|54.195869768830164|44.250742366654144|22.400000000000002|20.523529411764706
Human CDKL5 wild-type allele is located in the vicinity of Xp22 and is approximately 228 kb in length. This allele, which encodes cyclin-dependent kinase-like 5 protein, is involved in the mediation of protein phosphorylation. Translocations and mutations involving the gene are associated with X-linked infantile spasm syndrome 2. Rett syndrome also is associated with defects in the gene.|Normal human CDKL5 gene is located in the vicinity of chromosome location, Xp22, and is about 228 kilobases in length. This gene, which encodes cyclin-dependent kinase-like 5 protein, is associated with defects in|44.82306896551725|41.39659090909092|9.889172413793109|11.584393939393944|13.828364516129033|13.740133333333334|8.242068965517245|14.489696969696972|10.857580645161292|10.465833333333332|71.35217810270406|82.78555852321104|22.571034482758623|23.56969696969697
Devices that cover the nose and mouth to maintain aseptic conditions or to administer inhaled anesthetics or other gases. They are typically composed of rubber, plastic or paper products.|Devices that cover the nose and mouth to maintain aseptic conditions or to administer anesthetics or other gases. They are typically composed of rubber, plastic or paper products.|39.49229885057474|43.26880952380955|10.152413793103449|9.542857142857144|10.345010344827585|10.105277011494252|1.6179310344827513|0.4157142857142837|11.156551724137934|7.765402298850574|72.26115969177356|69.96656701596841|25.935632183908048|25.161904761904765
The tendons that connect the muscles and bones that comprise the glenohumeral and acromioclavicular joints and enable abduction of the arm and stabilization of the shoulder.|The tendons that connect the muscles and bones that comprise the glenohumeral and acromioclavicular joints and enable abduction and stabilization of the shoulder.|30.947692307692336|22.2842391304348|12.172307692307694|13.008043478260873|10.391869230769231|10.810866666666666|10.701538461538458|10.307826086956517|18.19961538461539|12.044999999999995|73.38155456243756|73.38155456243756|22.123076923076923|23.730434782608697
<p>Code for Acuity Assessment</p>|Acute lung disease|33.57500000000002|62.79000000000002|9.57|5.246666666666666|17.84955|19.6249|-29.9|-65.34666666666666|0.2325000000000017|0.5874999999999986|44.250742366654144|44.250742366654144|21.6|27.866666666666664
Molecular assay reagents intended to identify deletions or duplications of the carnitine palmitoyltransferase 1A (CPT1A) gene, located at chromosome 11q13.2, which encodes the liver isoform of carnitine O-palmitoyltransferase. Genetic variants at this locus have been associated with carnitine palmitoyltransferase I deficiency.|Molecular assay reagents intended to identify deletions or duplications of a gene, located at chromosome 11q13.2,, which encodes the liver isoform of carnitine palmitoyltransferase I deficit.|2.4702743902439295|9.315256410256438|15.461158536585366|14.113076923076925|14.452861904761905|13.663137037037037|12.42536585365854|3.613846153846147|20.582142857142863|13.754444444444445|75.03078418222748|69.96656701596841|26.539024390243902|26.54358974358974
<p>Lymphocyte Microcytotoxicity Assay</p>|blood clot assay|-162.80999999999995|90.99000000000004|36.71333333333334|1.3133333333333361|19.773699999999998|15.6774|-22.22666666666666|-69.26666666666665|8.311428571428571|-1.7674999999999983|54.195869768830164|31.29|41.2|14.533333333333331
A muscle located at the posterior and medial aspect of the thigh that extends the hip joint, flexes the knee joint and assists in medially rotating the knee. (CDISC)|A muscle located at the back and medial aspect of the thigh that extends the hip joint, flexes and assists in medially rotating the knee. (CDISC)|66.67612068965518|69.99384615384618|7.561551724137935|6.726153846153846|11.978458620689656|11.908692592592592|7.364137931034488|4.595384615384617|7.421034482758621|5.73|69.96656701596841|66.37611354998121|19.593103448275865|19.046153846153846
The division of the peripheral nervous system that comprises the afferent loop of the somatic nervous system, which functions to relay somatosensory perception, including touch, heat, and cold to the spinal cord and CNS.|The division of the peripheral nervous system that comprises the somatosensory representation, including touch, heat, and cold to the spinal cord and CNS.|40.2858823529412|36.997282608695684|11.863529411764706|10.955869565217395|12.75348823529412|11.468783333333334|14.928235294117645|8.262608695652176|20.78235294117647|9.88625|85.69119412168324|66.37611354998121|24.447058823529414|20.252173913043478
Molecular variants of the desired biological product formed during manufacture and/or storage, which are active and have no deleterious effect on the safety and efficacy of the drug substance or drug product. These variants possess properties comparable to the desired product and are not considered impurities.|Molecular variants of the desired biological product formed during manufacture and/or storage, which are active and have no deleterious effect on the safety and efficacy of these substances and are not considered impurities.|33.10644927536234|26.014772727272742|12.450869565217396|13.729848484848485|12.329039130434783|11.445876470588235|14.697391304347828|16.449696969696973|16.99891304347826|13.529117647058818|86.63808689023553|88.50148473330829|26.133333333333333|25.993939393939396
amino sugar derivative of galactose, substituted at the 2 position; occurs in a variety of glycosaminoglycans and complex polysaccharides, such as blood group substances, and is generally acetylated.|Protein building blocks, substituted at the 2 position; occurs in a variety of sugars and complex polysaccharides, such as blood group substances, and is generally acetylated.|-3.767857142857139|24.440000000000026|17.262857142857147|13.080000000000002|12.920300000000001|11.323877777777778|14.977142857142862|11.379999999999992|20.661785714285713|10.788888888888884|82.78555852321104|76.64453405168562|25.6|23.661538461538463
The date (and time) on which the seriousness code was assigned to the adverse event.|The date (and time) on which the seriousness code was assigned to a bad event.|80.78250000000001|86.42250000000001|3.8550000000000004|3.068333333333335|9.643833333333333|8.967675|-12.026666666666664|-13.986666666666672|7.1080000000000005|0.8212499999999991|44.250742366654144|38.32226702584281|13.66666666666667|11.0
An infection of any part of the eye, including the eyelid.|An infection of any part of the eye, including the lid.|78.19795454545455|85.88886363636365|3.7186363636363637|2.6459090909090897|8.488463636363637|7.8816|-28.160000000000007|-29.229090909090914|3.7663636363636357|-1.1600000000000001|44.250742366654144|38.32226702584281|16.745454545454546|13.109090909090908
Low-grade appendiceal mucinous neoplasm confined by the muscularis propria. Acellular mucin or mucinous epithelium may invade into the muscularis propria. T1 and T2 are not applicable to LAMN. Acellular mucin or mucinous epithelium that extends into the subserosa or serosa should be classified as T3 or T4a, respectively. (from AJCC 8th Ed.)|Low-grade appendiceal mucusosal tumor confined by the muscularis propria. Acellular mucin or mucinous epithelium may invade into the subcutaneous tissue surrounding the intestines|36.97294871794875|-14.49836956521736|10.255384615384614|18.138478260869565|13.39792037735849|14.3621|-1.248461538461548|14.653913043478262|8.930754716981134|14.2104|65.13532912329528|91.22524239485473|23.46666666666667|34.165217391304346
Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Been free of worry about your physical health?|Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your health, during the past week how much of the time have you been free of worry about your physical health?|47.72181818181819|52.74250000000002|14.801212121212124|13.852500000000003|8.6777625|8.6777625|19.895757575757575|19.0475|17.825624999999995|16.7953125|98.94766798666859|93.86999999999999|25.321212121212124|24.05
Solid preparation consisting of one or more powders, including freeze-dried powders, intended to be dissolved in the specified liquid to obtain a nebuliser solution.|Solid preparation consisting of one or more powders, including freeze-dried powder, intended to be dissolved in the specified liquid to obtain a nebuliser solution.|25.455000000000013|25.455000000000013|12.690000000000001|12.690000000000001|11.1925|10.961684615384616|10.123333333333335|10.123333333333335|17.069200000000002|10.069230769230767|82.78555852321104|82.78555852321104|28.13333333333334|28.13333333333334
The chemical reactions and pathways involving inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with one or more phosphate groups attached. [GOC:jl]|The chemical reactions and pathways involving a molecule of fat and protein groups attached. [GOC:jl]|58.8663235294118|58.2225|7.160294117647062|7.001666666666669|14.080331578947368|13.346335294117647|10.832941176470591|-4.970666666666666|14.30684210526315|6.092941176470589|62.58|58.53822981607831|22.223529411764705|21.666666666666668
A rare chromosomal anomaly syndrome resulting from a partial deletion of the long arm of chromosome 12 with a highly variable phenotype. The disorder has typical characteristics of developmental delay, learning disability, intrauterine and postnatal growth retardation, and mild facial dysmorphism that changes with age. Nasal speech and hypothyroidism are also associated.|A rare developmental delay, learning disability, intrauterine and postnatal growth retardation, and mild facial anomalies that changes with age. Nasal speech and hypothyroidism are also associated.|16.30538461538464|12.569102564102593|14.214615384615389|13.65923076923077|12.998541025641027|12.855122222222224|13.641538461538463|4.970769230769228|15.858974358974358|12.376666666666672|81.29380465324526|67.59412548439398|25.969230769230776|25.005128205128205
The report describes a non-specific problem with the immune system. Note: Please use "Appropriate Term /Code Not Available" if the report describes a specific problem but the relevant term does not exist.|The report describes a non-specific problem with the immune system. Note: Please use "Appropriate Term /Code Not Available" if the reported problem is specific but the relevant term does not exist.|47.95833333333337|48.978924731182815|9.220000000000002|8.99483870967742|9.923918181818184|10.26600303030303|4.038750000000004|3.2206451612903173|7.905454545454546|5.816818181818181|67.59412548439398|65.13532912329528|21.766666666666666|20.907526881720432
International Physical Activity Questionnaire (August 2002) Long Last 7 Days Self-Administered Format (IPAQ Long Last 7 Days Self-Administered Format Version) How much time did you usually spend on one of those days walking as part of your work?: hours and minutes per day.|International Physical Activity Questionnaire (August 2002) Long Last 7 Days Self-Administered Format) How much time did you usual spend on one of those days walking as part of your work?: hours and minutes per day.|45.32412790697677|53.712500000000034|12.278720930232563|10.115000000000002|9.994722222222222|9.216381081081082|17.82046511627907|13.661714285714286|9.306000000000001|5.472027027027028|82.78555852321104|69.96656701596841|21.62325581395349|18.428571428571427
A species of MITOSPORIC FUNGI commonly found on the body surface. It causes opportunistic infections especially in immunocompromised patients.|A species of MITOSPORIC FUNGI commonly found on the body surface. It causes infections especially in immunocompromised patients.|0.03824561403510529|12.745000000000005|14.827368421052629|12.972222222222225|11.587173684210526|11.430107017543861|-8.362105263157893|-12.746666666666663|13.56315789473684|9.005087719298249|62.58|59.91578840339164|27.796491228070177|26.84444444444445
tear in organ or tissue|tear in organ or tissue surrounding the lungs|83.32000000000004|71.81500000000001|2.879999999999999|5.230000000000004|7.0425|11.100677777777777|-36.855999999999995|-8.334999999999997|-1.032|3.4800000000000004|44.250742366654144|54.195869768830164|18.0|18.2
The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. (LocusLink)|These proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. (LcusLink)|52.09769230769234|0.31571428571430715|9.222307692307695|14.954285714285717|13.087261538461538|12.429833333333335|11.379999999999992|3.0742857142857147|11.246730769230773|14.661999999999999|73.38155456243756|58.53822981607831|22.123076923076923|22.8
Studies using excised tissues.|Studies using excised tissue.|35.60500000000002|35.60500000000002|8.790000000000003|8.790000000000003|11.7299|13.2345|-108.31|-108.31|11.184999999999995|4.312000000000001|38.32226702584281|38.32226702584281|30.8|30.8
Mild increase in subarachnoid space (SAS); mild ventriculomegaly; small (+/- multiple) focal T2 hyperintensities, involving periventricular white matter or <1/3 of susceptible areas of cerebrum|Mild increase in subarachnoid space (SAS); mild ventriculomegaly; small (+/- multiple) focal T2 hyperintensities, involving periventricular white matter or 1/3 of susceptible areas of the brain.|-1.275999999999982|21.18615384615387|19.648|13.533846153846156|15.857638461538462|14.247951851851854|27.908799999999996|15.676923076923078|20.55461538461538|13.231111111111112|108.39173953766033|73.38155456243756|29.200000000000003|22.123076923076923
Interacting selectively and non-covalently with one or more specific sites on a neuromedin U receptor. [GOC:jl, PMID:10899166]|Interacting selectively and not binding with one or more sites on a neuromedin U receptor. [GOC:jl, PMID:10899166]|29.00750000000002|53.889852941176486|11.325000000000003|7.854411764705883|14.080331578947368|12.418226315789473|3.2235294117647086|-0.5811764705882325|9.101052631578948|6.622105263157895|54.195869768830164|49.473833993334296|17.51764705882353|15.164705882352942
Solitary or multiple benign hepatic vascular tumors, usually occurring in women of 20-50 years of age. The nodule, poorly encapsulated, consists of a central stellate fibrous scar and normal liver elements such as HEPATOCYTES, small BILE DUCTS, and KUPFFER CELLS among the intervening fibrous septa. The pale colored central scar represents large blood vessels with hyperplastic fibromuscular layer and narrowing lumen.|Solitary or multiple benign hepatic tumors, usually occurring in women of 20-50 years of age. The nodule, poorly encapsulated, consists of a central scar and normal liver elements such as HEPATOCYTES, small BILE DUCTS, and KU|27.70379098360658|35.815|13.183729508196723|12.735555555555557|13.575276344086022|13.72047894736842|15.195409836065572|14.752222222222223|15.492043010752688|10.876315789473686|91.22524239485473|91.22524239485473|28.395081967213116|26.088888888888892
A gram negative, rod shaped serotype of the bacteria genus Salmonella, species Salmonella enterica, subspecies enterica that causes swine fever in pigs.|A gram negative, rod shaped serotype of the bacteria that causes swine fever in pigs.|11.088181818181852|58.2225|14.445454545454545|7.001666666666669|14.058154545454547|10.941425|8.103636363636358|-11.242666666666668|16.759545454545453|3.1762499999999996|79.77416029015912|54.195869768830164|28.03636363636364|19.0
Surgical removal of the rectum.|Surgical removal of rectum.|35.097500000000025|14.455000000000013|8.985000000000003|11.740000000000002|13.3585|16.392500000000002|-86.648|-111.25|5.562000000000001|2.428000000000001|38.32226702584281|38.32226702584281|25.0|30.8
A cholesteryl ester transfer protein (CETP) inhibitor that can produce an increase in serum HDL-cholesterol levels and a decrease in serum LDL-cholesterol levels. Dalcetrapib is structurally dissimilar from other CETP inhibitors, including torcetrapib, and raises functional HDL by a different mechanism.|A protein building blocks (CETP) inhibitor that can produce an increase in serum HDL-cholesterol levels and a decrease in blood lipid molecule level. Dalcetrapib is structurally dissimilar from other CETP inhibitors, including torcetrasb, and raises|13.446260162601646|22.289642857142866|14.779024390243908|14.497857142857146|13.883132558139534|12.66247837837838|16.202926829268296|19.373714285714286|17.36093023255814|14.552432432432433|90.32644961471695|98.94766798666859|29.856910569105693|29.857142857142858
A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with lysates from an allogeneic glioblastoma (GBM) stem-like cell line, with potential immunostimulatory and antineoplastic activities. Upon administration allogeneic glioblastoma stem-like cell line lysate-pulsed autologous dendritic cell vaccine exposes the immune system to GBM stem cell antigens, which may result in cytotoxic T lymphocyte (CTL) and antibody responses against GBM cells. This leads to GBM cell lysis. GBM stem-like cells contain a specific range of antigens that are essential for the neoplastic growth and survival of GBM cells. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C113296" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C113296" NCI Thesaurus)|A cell-based cancer vaccine composed of autologous dendritic cells pulsed with lysates from an allogeneic glioblastoma (GBM) stem-like cell line, with potential immunostimulatory and anti-cancer activities. Check for "http|35.79307343234328|-3.3376724137930864|10.357846534653465|17.327068965517245|12.854653459119497|12.589142424242425|10.125148514851489|19.124137931034486|20.90654088050315|13.509999999999998|61.26237874911485|88.50148473330829|21.584488448844887|27.868965517241378
Life-threatening consequences; urgent intervention indicated|Life-threatening consequences; urgent intervention indicated|-119.71999999999994|-119.71999999999994|31.200000000000006|31.200000000000006|16.94363333333333|17.344385714285714|6.655999999999999|7.832000000000001|22.46|17.327142857142853|69.96656701596841|69.96656701596841|42.0|42.0
An abnormal endocervical or endometrial cell found in a cervical smear, not further characterized as neoplastic or non-neoplastic. It is often associated with clinically significant uterine lesions.|An abnormal endocervical cell found in a cervical smear, not further characterized as cancer or non-cancer. It is often associated with clinically significant uterine lesions.|6.56666666666672|15.640666666666675|14.57925925925926|13.148000000000003|12.225900000000001|12.493507407407408|4.5688888888888854|0.23040000000000305|13.829999999999998|11.137777777777778|67.59412548439398|65.13532912329528|24.340740740740742|24.133333333333336
Formation of a blood clot (thrombus) in the lumen of the splenic vein or splenic artery.|Formation of a blood clot (thrombus) in the lumen of the splenic vein or artery.|71.81500000000001|75.14250000000001|5.230000000000004|4.641666666666666|12.3251|11.9283|-10.172500000000003|-13.20266666666667|7.17625|1.4100000000000001|54.195869768830164|49.473833993334296|18.2|16.333333333333332
A subjective score of 1 on a scale that ranges from 1: Strongly Disagree to 6: Strongly Agree.|A subjective score of 1 on a scale that ranges from 1: Strongly Disagree to 6: Weakly Agree.|89.60000000000004|89.60000000000004|2.9977777777777774|2.9977777777777774|12.4243|12.418226315789473|-7.735555555555553|-8.062222222222218|6.93333333333333|1.4163157894736855|54.195869768830164|54.195869768830164|16.933333333333334|16.933333333333334
The joining of the lipid bilayer membrane that surround a cell with that of another cell, producing a single cell. [GOC:elh, GOC:mtg_muscle]|The joining of the lipid bilayer membrane that surrounds a cell with that of another cell, producing one cell. [GOC:elh,GOC:mtg_muscle]|61.07909090909095|57.09500000000003|7.472727272727273|7.779999999999998|10.810866666666666|11.468783333333334|4.896363636363631|4.797999999999998|6.550000000000001|6.157499999999999|69.96656701596841|62.58|22.581818181818182|20.0
A small, membrane bound vesicle circulating in the blood that was shed by a cell that expresses the coagulation protein, tissue factor (factor III). The presence of microparticles with tissue factor in the plasma of cancer patients is associated with an increased risk for venous thrombosis.|A small, membrane bound vesicle circulating in the blood that was shed by a cell that expresses the protein complex coagulation protein, tissue factor (factor III). The presence of microparticles with protein and thrombosis.|47.819492753623194|48.525784313725495|10.398695652173913|9.306470588235296|12.329039130434783|11.884595238095239|12.14086956521739|7.087058823529411|14.643913043478257|9.433619047619047|80.79043260188672|69.96656701596841|23.524637681159422|22.180392156862748
A carbohydrate comprised of three to ten monosaccharides joined by ether bridges (covalent bonds centered by an oxygen).|A molecule composed of three to ten monosaccharides joined by ether bridges (covalent bonds centered by an oxygen).|28.50000000000003|37.900000000000034|11.520000000000003|10.208888888888893|10.669855555555555|10.75612105263158|0.7577777777777754|-0.5488888888888894|13.736666666666665|7.1178947368421035|62.58|62.58|21.37777777777778|21.37777777777778
The process whose specific outcome is the progression of the metanephric late distal convoluted tubule over time, from its formation to the mature structure. The metanephric late distal convoluted tubule contains metanephric DCT cells and intercalated (IC) alpha and beta cells and is vasopressin-sensitive. [GOC:mtg_kidney_jan10]|The process whose specific outcome is the progression of the metanephric late distal convoluted tubule over time, from its formation to the mature structure. It is vasopressin-sensitive. [GOC:mtg_kidney_jan10]|28.05000000000001|40.24738095238098|13.073333333333338|9.964285714285715|13.148460283687944|12.298710752688173|17.63733333333333|6.715714285714288|14.1622695035461|10.477311827956992|84.73372056035305|65.13532912329528|25.555555555555557|22.304761904761907
Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for my family to plan activities like vacations.|Pediatric Quality of Life Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you?|65.10263157894738|76.3219230769231|8.898947368421055|9.073076923076925|10.592781081081082|10.999176923076924|9.797894736842107|11.909230769230769|17.43756756756757|9.685384615384617|73.38155456243756|82.78555852321104|19.178947368421053|21.16923076923077
A condition in which an abnormal amount of a single immunoglobulin is present in the serum. This category includes IgM monoclonal gammopathy of undetermined significance and non-IgM monoclonal gammopathy of undetermined significance. Up to 25% of cases of monoclonal gammopathy of undetermined significance progress to a B-cell malignancy or myeloma.|A condition in which an abnormal amount of a single immunoglobulin is present in the serum. This category includes IgM monoclonal gammopathy of undetermined significance and not being able to make blood cells malignancy or myeloma.|1.2595000000000312|20.755000000000024|16.189|13.345555555555556|12.391233333333334|10.222827927927929|11.717599999999997|7.509999999999998|13.956858974358973|9.559639639639641|79.77416029015912|74.48509850970193|25.8|23.68888888888889
Life-threatening consequences (e.g. shock); requiring urgent major care changes.|Life-threatening consequences (e.g. shock); requiring urgent care changes.|7.1512500000000045|3.880000000000024|12.820833333333336|13.215000000000003|12.0275|13.3585|-84.51555555555555|-98.02000000000001|15.127000000000002|10.743000000000002|38.32226702584281|34.983283507984204|27.566666666666663|25.8
<b>Description:</b>This variant includes all attributes and associations present in the R-MIM. Any of non-mandatory and non-required attributes and/or associations may be present or absent, as permitted in the cardinality constraints.|This variant includes all attributes and associations present in the R-MIM. Any of non-mandatory and not-required attributes or/or associations may be present or absent, as permitted by the cardinal constraints.|10.564999999999998|21.845|14.270000000000007|12.696666666666669|13.304952631578947|10.982309523809523|10.580000000000002|6.267999999999997|12.735526315789471|8.08790476190476|72.26115969177356|72.26115969177356|25.333333333333336|25.333333333333336
A collective term for pteroylglutamic acids and their oligoglutamic acid conjugates. As a natural water-soluble substance, folic acid is involved in carbon transfer reactions of amino acid metabolism, in addition to and purine and pyrimidine synthesis, and is essential for hematopoiesis and red blood cell production. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C510" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C510" NCI Thesaurus)|A collective term for pteroylglutamic acids and their oligoglycans. As a natural water-soluble substance, folic acid is involved in carbon transfer reactions of amino acid metabolism, in addition to and purine and pyrimidine synthesis, and|36.123862068965536|12.62107142857144|9.661655172413795|15.846428571428575|13.199794915254238|13.515991891891893|-0.040689655172421624|17.693714285714286|25.06194915254237|13.406756756756756|53.2849499389837|98.94766798666859|22.32|29.857142857142858
A question associated with the FACT-HEP Version 4 questionnaire.|A question associated with the FACT-HEP Version 4 questionnaire.|51.867500000000035|51.867500000000035|7.142777777777777|7.142777777777777|12.0275|12.522027272727273|-29.191111111111105|-28.537777777777777|9.004000000000001|4.870000000000001|49.473833993334296|49.473833993334296|24.022222222222226|24.022222222222226
Reduction inexisting body weight. [HPO:probinson]|Reduction inexisting body weight. [HPO:probinson]|-32.58249999999995|-32.58249999999995|18.425|18.425|16.94363333333333|17.344385714285714|-65.47999999999999|-64.304|12.254999999999995|8.579999999999998|44.250742366654144|44.250742366654144|33.0|33.0
The determination of the amount of calcium sulphate crystals present in a sample.|The determination of the amount of calcium ion crystals present in a sample.|50.56057692307695|57.06826923076926|7.821923076923078|6.91423076923077|10.354376923076924|10.750842857142857|-14.329230769230772|-16.13846153846154|9.706923076923076|3.6014285714285705|58.53822981607831|54.195869768830164|24.13846153846154|21.06153846153846
A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to one second. (NCI)|A unit of both speed (scalar) and velocity, defined as the distance of one centimeter travelled per unit time equal to one second. (NCI)|55.40350000000004|57.18000000000001|8.637|8.265|11.2041|11.2041|4.779199999999996|3.2633333333333354|6.109199999999998|5.167200000000001|73.38155456243756|69.96656701596841|22.6|21.46666666666667
Behavioral responses or sequences associated with eating including modes of feeding, rhythmic patterns of eating, and time intervals.|Behavioral responses or sequences associated with eating including modes of feeding, rhythms of eating, and time intervals.|33.20000000000002|38.960441176470624|10.864444444444448|9.936764705882357|14.178744444444446|13.732344444444447|5.004444444444445|2.5317647058823525|17.13833333333333|10.544999999999998|73.38155456243756|66.37611354998121|28.044444444444448|24.576470588235296
A stratified columnar epithelial cell that surrounds a lumen in a gland such as the breast, pancreas or prostate. These cells are uniform in appearance and have uniformly sized and shaped nuclei.|A stratified columnar skin cell that surrounds a lumen such as the breast, pancreas or prostate. These cells are uniform in appearance and have uniformly sized and shaped nuclei.|58.53333333333336|62.83022988505749|7.745000000000001|6.897241379310348|10.35135|9.922166666666667|2.385000000000005|-0.004137931034481568|10.267187499999999|6.806000000000001|62.58|59.91578840339164|19.266666666666666|19.039080459770116
<p>The relationship that links to a Transportation Act (target) from another Act (source) indicating that the subject of the source Act entered into the source Act by means of the target Transportation act.</p>|The relationship that links to a Transportation Act (target) from another Act(source) indicating that the subject of the source Act entered into the target Transportation act.|54.21477272727276|40.7092307692308|9.796515151515155|10.810769230769232|11.873051351351352|10.154248148148149|13.776969696969694|11.379999999999992|19.21972972972973|10.963333333333331|69.96656701596841|73.38155456243756|18.721212121212123|22.123076923076923
Provides education and support to the patient and designated support person based on their knowledge needs.|Provides education and support to patient and designated support person based on their knowledge needs.|45.377500000000026|41.30250000000001|8.917500000000004|9.361666666666668|11.338225000000001|11.9283|-3.1899999999999977|-4.186666666666667|13.358125000000001|8.769375|62.58|62.58|23.200000000000003|24.333333333333336
A clinical finding about one or more characteristics of lip and oral cavity cancer, following the rules of the TNM AJCC v7 classification system. The assessment of the primary tumor is based on inspection and palpation of the oral cavity and neck. Additional studies may include CT, MRI, or ultrasound. (from AJCC 7th Ed.)|A clinical finding about one or more characteristics of lip and oral cavity cancer, following the rules of the AJCC 7th Ed.)|54.87300000000002|61.07909090909095|8.288666666666668|7.472727272727273|11.908692592592592|11.07211739130435|1.8837037037037057|0.8872727272727268|7.997777777777777|5.003043478260871|64.12541789337516|62.58|19.87555555555556|18.94545454545455
Traumatic injury to the abducens, or sixth, cranial nerve. Injury to this nerve results in lateral rectus muscle weakness or paralysis. The nerve may be damaged by closed or penetrating CRANIOCEREBRAL TRAUMA or by facial trauma involving the orbit.|Traumatic injury to the abducens, or sixth, cranial nerve. Injury to this nerve results in lateral rectus muscle weakness or paralysis. The nerve may be damaged by closed or penetrating CRANIOCEREBRAL TRAUMA or by facial trauma|40.75413461538463|39.55500000000001|9.997115384615388|10.723333333333333|11.568992307692309|11.503098198198199|1.3025641025641086|6.856666666666666|9.827692307692306|8.795855855855855|68.19497397169383|74.48509850970193|23.387179487179488|23.68888888888889
Stage I includes: T1, N0, M0. T1: Solitary tumor without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)|Stage I includes: T1, N0, M0. T1: Tumor with no regional lymph node metastasis. (AJCC 6th and 7th eds.)|80.06750000000002|108.50848684210527|3.2094444444444434|-0.6953947368421041|16.140811111111113|15.727|-35.50666666666666|-35.701052631578946|2.8000000000000007|-0.7964999999999982|40.39521630094336|31.29|16.614814814814817|10.321052631578947
This gene plays a role in the metabolism of a wide variety of carbonyl compounds.|This gene takes part in the metabolism of a wide variety of carbonyl compounds.|63.86250000000001|60.74428571428575|6.215000000000003|6.525714285714287|10.6965|10.3245|-13.20266666666667|-14.145714285714288|6.7940000000000005|3.0440000000000005|44.250742366654144|44.250742366654144|13.66666666666667|14.228571428571428
A gland producing tears in a third eyelid in the corner of each eye, as seen in animals.|A gland producing tears in a third eyelid in the corner of the eye, as seen in animals.|84.90000000000003|84.90000000000003|3.653333333333336|3.653333333333336|7.160966666666667|7.431910526315789|-9.695555555555554|-9.695555555555554|5.625|0.42473684210526486|44.250742366654144|44.250742366654144|12.488888888888889|12.488888888888889
The date that a specific cardiac therapeutic procedure was performed.|The date that a specific heart rhythm procedure was performed.|32.56000000000003|66.40000000000003|9.96|5.240000000000002|12.0275|11.086572727272728|-23.919999999999995|-27.447999999999993|11.359000000000002|4.0136363636363654|49.473833993334296|38.32226702584281|22.0|14.0
A standardized 30-item self-report questionnaire that utilizes a 5-point rating scale for the assessment of the severity of depressive symptoms over the seven day period prior to evaluation. The questionnaire, which was created by Rush, et al. in 1986, originally consisted of 28 items including the nine diagnostic DSM-IV symptom domains used to characterize a major depressive episode, as well as items to address melancholic and atypical features. Two additional items were later added to address leaden paralysis and interpersonal rejection sensitivity.|A standardized 30-item self-report questionnaire that utilizes a 5-point rating scale for the assessment of the severity of depressive symptoms over the seven day period prior to evaluation. The questionnaire, which was created by Rush, et al. in 1986, originally consisted of 28 items including|25.115829268292714|39.33000000000001|13.830390243902439|11.500000000000004|13.320575968992248|13.230067346938775|16.083902439024392|13.194666666666663|18.31542635658915|14.273877551020412|89.6009242139834|80.79043260188672|26.560000000000002|23.77777777777778
A unit of radioactivity equal to one millionth of a curie or 37 kilobecquerels, and corresponding to a radioactivity of 37 000 atomic disintegrations per second.|A unit of radioactivity equal to one millionth of a curie or 37 kilobases, and corresponding to an activity of 37 000 atomic breaks per second.|37.455384615384645|56.97846153846157|11.264615384615386|8.541538461538462|12.8211|11.908692592592592|7.987692307692306|4.143076923076922|15.844615384615388|5.73|69.96656701596841|66.37611354998121|20.58461538461539|19.046153846153846
The condition in which the individual does not see far distances clearly.|The condition in which the individual does not see far distances clear.|52.69500000000002|59.745000000000005|7.400000000000002|6.416666666666668|9.495033333333335|8.817361538461538|-18.953333333333326|-19.443333333333328|8.5125|3.558461538461536|44.250742366654144|38.32226702584281|15.733333333333333|12.4
The process of keeping something within particular limits or bounds.|The process of keeping something within certain limits or bounds.|49.48000000000002|66.40000000000003|7.600000000000001|5.240000000000002|12.0275|11.086572727272728|-24.507999999999996|-25.683999999999997|10.887999999999998|5.298181818181817|54.195869768830164|54.195869768830164|26.0|26.0
A measurement of the herpes simplex virus 2 IgG antibody in a biological specimen.|A measurement of herpes simplex virus 2 IgG antibody in a biological specimen.|36.572857142857174|31.037500000000023|9.89714285714286|10.545000000000002|14.481614285714286|15.262271428571431|-13.305714285714284|-15.233846153846155|8.447142857142854|4.274285714285714|58.53822981607831|58.53822981607831|22.8|24.13846153846154
A programmed cell death characterized morphologically by the presence of smaller than normal mitochondria with condensed mitochondrial membrane densities, reduction or vanishing of mitochondria crista, and outer mitochondrial membrane rupture. Activation of mitochondrial voltage-dependent anion channels and mitogen-activated protein kinases, upregulation of endoplasmic reticulum stress, and inhibition of cystine/glutamate antiporter are involved in the induction of ferroptosis. This process is characterized by the accumulation of lipid peroxidation products and lethal reactive oxygen species (ROS) derived from iron metabolism. Glutathione peroxidase 4 (GPX4), heat shock protein beta-1, and nuclear factor erythroid 2-related factor 2 function as negative regulators of ferroptosis by limiting ROS production and reducing cellular iron uptake, respectively. In contrast, NADPH oxidase and p53 act as positive regulators of ferroptosis by promotion of ROS production and inhibition of expression of SLC7A11 (a specific light-chain subunit of the cystine/glutamate antiporter), respectively. Misregulated ferroptosis has been implicated in multiple physiological and pathological processes. [GOC:mtg_apoptosis, PMID:25236395, PMID:26794443]|A programmed cell death characterized morphologically by the presence of smaller than normal mitochondria with condensed membrane densities, reduction or vanishing of mitochondria crista, and outer mitochondrial membrane rupture. Activation of ferroptosis has been implicated in multiple physiological and|-8.855483870967703|-6.019038461538429|19.995391705069128|18.943205128205125|15.116114109347443|13.707749999999999|28.057806451612905|25.226666666666667|20.959947089947086|19.77375|111.57105673067723|103.77718969022045|31.82488479262673|30.364102564102566
Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: I think our family has a lot of problems.|I think our family has a lot of problems.|69.1602027027027|89.46750000000003|8.208783783783787|1.8983333333333334|9.3696|7.0425|9.585945945945948|-43.56444444444444|17.110833333333332|-3.3870000000000005|73.38155456243756|31.29|19.291891891891893|10.68888888888889
Reduced prothrombin antigen as measured by ELISA assay. Prothrombin is a vitamin K-dependent coagulation factor that is proteolytically cleaved to form thrombin. []|Reduced fibrinogen as measured by ELISA assay. Prothrombin is a vitamin K-dependent protein breakdown factor that is proteolytically cleaved to form blood clot. []|22.49681159420291|36.565|12.026086956521741|10.146666666666668|13.628071014492756|13.523833333333334|-2.306086956521739|-2.4550000000000054|10.458550724637679|8.35906666666667|67.59412548439398|65.13532912329528|27.414492753623193|24.866666666666667
Any treatment designed to lessen the effects of dysphagia. Treatment may include restoration of normal swallow function (rehabilitative), modifications to diet consistency and patient behavior (compensatory), or a combination of these approaches.|Any treatment designed to lessen the effects of dysphagia. Treatment may include restoration of normal swallow function (rehabilitative), modification to diet consistency and patient behavior (compensatory), or a combination of these approaches.|5.65833333333336|5.65833333333336|15.120000000000001|15.120000000000001|13.805412500000001|13.75179696969697|11.756250000000005|11.756250000000005|17.0378125|13.614545454545457|82.78555852321104|82.78555852321104|30.51666666666667|30.51666666666667
Any process that modulates the frequency, rate or extent of striated muscle cell differentiation. [CL:0000737, GOC:ai]|Any process that changes the frequency, rate or extent of striated muscle cell differentiation. [CL:0000737, GOC:ai]|40.09|50.66500000000002|9.655000000000001|8.180000000000003|13.346335294117647|12.855122222222224|0.8524999999999991|0.48499999999999943|9.694705882352942|8.189999999999998|66.37611354998121|66.37611354998121|25.700000000000003|25.700000000000003
International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - How much time did you usually spend doing moderate physical activities on one of those days?: Hours and minutes per day.|International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format - How much time did you usually spend doing moderate physical activities on one of those days? Hours and minutes per day.|48.87821428571431|45.26235294117649|10.789285714285715|11.169411764705881|11.15368787878788|11.024276470588235|14.165714285714287|14.409411764705883|12.225454545454546|7.616764705882353|79.77416029015912|79.77416029015912|21.85714285714286|22.094117647058823
A colloidal mixture of nanoparticles consisting of small interfering RNA (siRNA) targeting the native eukaryotic translation initiation factor 5A (eIF5A), plasmids expressing a pro-apoptotic mutant of elF5A under the control of a B-cell specific promoter (B29), and a synthetic cationic polymer polyethylenimine (PEI) as a delivery vehicle, with potential antineoplastic activity. Upon administration, the siRNA component of SNS01-T suppresses elF5A expression, thereby interfering with translation of eIF5A and reducing levels of hypusinated elF5A in cancer cells. In turn, this inhibits activation of the transcription factor NF-kB and induces apoptosis. In addition, the B-cell specific plasmid component expresses an arginine substituted form of eIF5A, eIF5AK50R, which can not be hypusinated, thus leads to a selective induction of apoptosis in B-cells. The native unhypusinated form of eIF5A is pro-apoptotic and can be modified at the lysine residue, by deoxyhypusine synthase (DHS) and subsequently deoxyhypusine hydroxylase (DHH), to the anti-apoptotic hypusinated form which is associated with tumor cell growth and survival. The delivery vehicle protects the siRNA and plasmid from degradation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C98288" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C98288" NCI Thesaurus)|A colloidal mixture of nanoparticles consisting of small interfering RNA (siRNA) targeting the native eukaryotic translation initiation factor 5A (eIF5A), plasmids expressing a cell cycle protein complex, which can be activated by|26.465000000000003|5.15500000000003|12.762063492063493|20.49|14.12491914893617|15.799966666666668|18.52977777777777|27.5|21.06026595744681|22.759090909090908|77.0994017486517|132.75222709996243|24.03174603174603|35.300000000000004
Life-threatening consequences; urgent intervention indicated|Life-threatening consequences; urgent intervention indicated|-119.71999999999994|-119.71999999999994|31.200000000000006|31.200000000000006|16.94363333333333|17.344385714285714|6.655999999999999|7.832000000000001|22.46|17.327142857142853|69.96656701596841|69.96656701596841|42.0|42.0
This gene plays a role in apoptosis and development.|This gene plays a role in programmed cell death and death.|61.26750000000001|101.27068181818181|5.831666666666667|0.5004545454545486|11.100677777777777|9.197433333333334|-37.0311111111111|-27.625454545454552|5.573333333333334|0.41000000000000014|31.29|22.125371183327072|10.68888888888889|5.836363636363637
A method of ultrasound imaging that uses a linear pattern of beams to produce a standard, two dimensional image.|A method of ultrasound imaging that uses a linear pattern of beams to produce standard, two dimensional image.|45.80302631578948|42.60000000000002|9.230789473684215|9.553333333333335|12.058373684210528|12.418226315789473|-2.067368421052631|-2.1822222222222187|10.876315789473686|6.126315789473683|69.96656701596841|69.96656701596841|24.852631578947367|25.822222222222223
Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you understand how to get dressed?|Disability Rating Scale-Postacute Interview Survivor Version - Do you understand how to get dressed?|30.332941176470626|11.339285714285722|13.251764705882355|15.15571428571429|12.801833333333335|12.801833333333335|15.447058823529414|15.817142857142859|14.958000000000006|12.759999999999998|93.86999999999999|88.50148473330829|27.976470588235294|28.457142857142856
The application of a vacuum across the surface of a wound through a foam dressing cut to fit the wound. This removes wound exudates, reduces build-up of inflammatory mediators, and increases the flow of nutrients to the wound thus promoting healing.|The application of vacuum across the surface of a wound through an elastic bandage dressing cut to fit the wound. This removes wound exudates, reduces build-up of proinflammatory mediators and increases the flow of nutrients to the wounded thus promoting healing.|50.58772357723578|42.334065040650415|9.598536585365853|10.74975609756098|9.189528571428571|9.488363565891472|8.315121951219513|10.46634146341464|11.947142857142858|9.83434108527132|69.96656701596841|76.64453405168562|20.100813008130082|23.027642276422768
Catalysis of the reaction: diolein + mono-olein = triolein + glycerol. Mono-olein, also known as mono-oleoylglycerol, is the monoglyceride formed from oleic acid, 9-octodecenoic acid; diolein is also known as dioleoylglycerol, and triolein as trioleoylglycerol and olein. [GOC:ai, PMID:15364929]|Starting of the reaction: diolein + mono-octadecenoic acid, also known as a molecule of fat and protein. [GOC:ai, PMID:15364929]|28.778461538461556|54.70828947368423|12.474871794871795|7.988684210526319|14.412148484848485|12.794827272727273|15.978461538461534|3.193684210526321|11.70128787878788|6.121363636363636|80.79043260188672|62.58|25.71282051282051|20.642105263157895
percutaneous transabdominal puncture of the uterus during pregnancy to obtain amniotic fluid; it is commonly used for fetal karyotype determination in order to diagnose abnormal fetal conditions.|percutaneous transabdominal puncture of the uterus during pregnancy to obtain amniotic fluid; it is commonly used for fetal kilodal conditions.|1.9991666666667243|10.564999999999998|16.33425925925926|14.270000000000007|14.332737037037038|13.932061904761905|14.878518518518518|7.150000000000002|21.202222222222225|11.407142857142851|93.86999999999999|79.77416029015912|32.06666666666666|30.0
The chemical reactions and pathways resulting in the breakdown of glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues. [ISBN:0198506732]|The chemical reactions and pathways resulting in the breakdown of glycogen, a polydisperse, highly branched molecule composed of chains of D-glucans. [ISBN:0198506732]|44.35380434782613|45.69727272727275|9.929782608695653|9.618181818181817|14.10045|14.10045|13.119999999999997|12.379999999999999|13.222500000000004|12.24125|79.77416029015912|76.64453405168562|27.208695652173915|26.218181818181815
An abnormal decrease of the C-reactive protein level in serum. [PMID:17852082, UCDenver:tjcallahan]|An abnormal decrease of the C-reactive protein level in serum. [PMID:17852082, UCDenver:tjcallahan]|38.595|38.595|9.366666666666667|9.366666666666667|14.134414285714287|14.535166666666669|-6.213333333333331|-5.723333333333329|9.657142857142855|8.381999999999998|58.53822981607831|58.53822981607831|25.733333333333338|25.733333333333338
OBSOLETE. The steps whereby the downstream processes started by a signal are brought to a conclusion. Examples include destruction of cAMP by PDE, or endocytosis resulting from receptor phosphorylation. The termination process ends when the receptor has returned to its inactive state. [GOC:mtg_signal]|OBSOLETE. The steps whereby the downstream processes started by a signal are brought to an conclusion. Examples include destruction of cAMP by PDE, or endocytosis resulting from receptor phosphorylation. This process ends when the receptor has returned to its active state.|34.80832558139534|43.755902439024396|10.540744186046513|9.193365853658538|11.250252727272727|10.820282857142857|1.1348837209302332|-2.538536585365847|9.945454545454545|8.450714285714287|62.58|59.368600792001146|22.0446511627907|20.8409756097561
A taxonomic category above phylum and below subkingdom.|A taxonomic category above phylum and below kingdom.|1.8500000000000227|12.425000000000011|13.995000000000001|12.52|11.9283|10.877477777777777|-38.72|-40.19|10.24125|4.370000000000001|54.195869768830164|54.195869768830164|31.6|31.6
Semiprecision partial denture attachments designed to attach the partial denture to receptacles that are externally connected to the crown contour. These attachments are typically two-component devices that attach to each other with a lesser degree of precision than precision attachments: one component is fixed externally to the abutment tooth and a second component is an integral part of the partial denture base. Rigid and resilient attachments are available that permit a slight vertical, hinging, and/or rotational movement as the patient bites.|These attachments are typically two-component devices that attach to each other with a lesser degree of precision than other attachment types: one component is fixed externally to the base of the crown contour and the other is an integral part of its base.|26.481250000000017|47.2915697674419|14.596388888888892|12.004302325581396|12.502111382113823|9.664944444444444|19.64641975308642|15.632558139534883|18.94581300813008|12.009333333333338|101.39118822659097|88.50148473330829|28.840740740740742|23.48372093023256
Replacement of sperm-specific chromosomal proteins with somatic histones, to allow the paternal genome to acquire a nucleosomal chromatin organization compatible with nuclear activity. [GOC:bf, PMID:11735001]|Replacement of sperm-specific proteins with somatic histones, to allow the paternal genome to acquire an organization compatible with nuclear activity. [GOC:bf, PMID:11735001]|-5.5084999999999695|11.088181818181852|17.133|14.445454545454545|15.417581481481482|14.9937|19.5968|14.51818181818182|16.196666666666665|12.703200000000002|88.50148473330829|79.77416029015912|30.6|28.03636363636364
An agent that prevents damage to the heart, thereby protecting myocardial function.|An agent that prevents damage to the heart, thereby protecting the rhythm.|52.69500000000002|73.84500000000001|7.400000000000002|4.450000000000003|10.810866666666666|10.031976923076924|-14.053333333333327|-17.97333333333333|12.044999999999995|4.283076923076923|58.53822981607831|49.473833993334296|25.733333333333338|19.06666666666667
Life-threatening consequences; widespread areas of mucosal ulceration; urgent intervention indicated|Life-threatening consequences; widespread areas of mucus ulceration; urgent intervention indicated.|-65.57499999999999|-52.039999999999964|24.890000000000004|21.76000000000001|16.82839090909091|16.993233333333333|23.908000000000005|-5.691999999999993|19.0|14.717500000000001|93.86999999999999|66.37611354998121|40.0|38.0
Secretogranin-1 (677 aa, ~78 kDa) is encoded by the human CHGB gene. This protein may play a role in the synthesis of biologically active peptides.|This protein may play a role in the synthesis of biologically active peptides.|79.93666666666668|50.56057692307695|4.18|7.821923076923078|13.7305|11.8787|-6.590399999999995|-15.233846153846155|7.051199999999998|4.274285714285714|47.79626449838941|49.473833993334296|14.533333333333335|17.984615384615388
An emotional state characterized by mild to moderate elevation of mood without relevant effect on functioning.|An emotional state characterized by mild to moderate elevation of mood without relevance to functioning.|18.940000000000026|18.742500000000007|12.605000000000004|12.508333333333336|13.311975|12.915175000000001|-2.0875000000000057|-3.7946666666666715|14.24125|9.063749999999999|62.58|58.53822981607831|23.200000000000003|21.666666666666668
An imaging technology that uses non-ionizing, millimeter-length electromagnetic waves (30GHz to 300GHz) to scan the surface of an object or body. Millimeter-wave imaging (MMW) can image through non-polar and non-metallic materials such as clothing, plastic, and cardboard with relatively little energy loss. Compared to microwaves and radio-frequency waves, MMW can achieve better spatial resolution due to its shorter wavelength. MMW is harmless to humans.|An imaging technology that uses non-ionizing, low-frequency electromagnetic waves (30GHz to 300GHz) to scan the surface of an object or body. Millimeter-wave imaging (MMW) can image through polar materials such as clothing, plastic, and relatively little energy loss. MMW is|27.28675000000004|30.446666666666687|12.633250000000004|12.325000000000003|11.722785714285715|11.90010303030303|13.073749999999997|12.492|12.619428571428571|9.88151515151515|79.15813438933486|78.74477315987392|25.12|24.333333333333336
An active immunizing vaccine used to prevent infection by the bacterium Streptococcus pneumoniae. It consists of a solution of saccharides of the capsular antigens of Streptococcus serotypes individually conjugated to proteins.|An active vaccine used to prevent infection by the bacterium Streptococcus pneumoniae. It consists of a solution of the capsular antigens individually conjugated to proteins.|8.043440860215071|25.792666666666662|14.704516129032257|11.732000000000003|13.573687096774194|13.175982051282052|8.721290322580646|-0.004799999999995919|15.947419354838708|9.895256410256408|76.64453405168562|67.59412548439398|27.35913978494624|25.733333333333338
The series of events required for an organism to detect high environmental humidity, convert this detection into a molecular signal, and recognize and characterize the signal. This is a neurological process. [PMID:18269908]|The series of events required for an organism to detect high environmental humidity, convert this detection into a molecular signal, and recognize and characterize the signal. This is an abnormal process. [PMID:18269908]|32.09583333333336|37.383333333333354|11.432500000000001|10.695|12.554004166666667|12.794827272727273|7.530000000000005|7.162499999999998|11.280208333333334|10.331818181818182|74.48509850970193|74.48509850970193|25.516666666666666|25.516666666666666
This gene is involved in the regulation of microtubule assemblies and chromosome stability.|This gene is involved in the regulation of microtubule assembly and cellular support.|24.529807692307713|37.54519230769233|11.45269230769231|9.637307692307694|12.783607692307694|13.006557142857146|-9.806153846153848|-12.067692307692312|13.329999999999998|6.6292857142857144|54.195869768830164|54.195869768830164|21.06153846153846|21.06153846153846
A surgical procedure in which an opening is made into the mediastinum.|A surgical procedure in which an opening is made into the middle ear.|45.64500000000001|63.57596153846157|8.383333333333333|6.006538461538462|9.495033333333335|8.495128571428573|-20.423333333333325|-19.30461538461539|7.334999999999997|1.24642857142857|49.473833993334296|49.473833993334296|19.06666666666667|17.984615384615388
<p>Injection, hemodialysis port</p>|blood pressure drug|-50.00999999999996|90.99000000000004|20.980000000000008|1.3133333333333361|19.773699999999998|15.6774|-33.986666666666665|-63.386666666666656|3.6014285714285705|1.7650000000000006|44.250742366654144|31.29|27.866666666666664|14.533333333333331
A form of diazoxide-sensitive diffuse hyperinsulinism characterised by hypoglycaemic episodes that are usually mild, escaping detection during infancy, and usually a good clinical response to diazoxide, (but some are diazoxide resistant). Usually has a milder phenotype when compared to that resulting from recessive K+ channel mutations.|A form of diabetes-sensitive diffuse hyperinsulinism characterised by hypoglycaemic episodes that are usually mild, escaping detection during infancy, and usually a good clinical response to diabetes, (but some are diazoxide resistant).|3.6803623188405936|-10.845887096774163|16.55521739130435|18.622741935483877|13.201036170212765|13.067627272727274|18.148695652173917|20.16645161290323|18.880638297872345|15.365454545454547|90.32644961471695|91.22524239485473|27.87246376811594|28.135483870967747
The literal identifier of the vendor or laboratory that performs a morphology examination.|The literal identifier of the vendor or laboratory that performs a morphology examination.|-1.5009615384615245|-1.5009615384615245|15.083461538461542|15.083461538461542|12.783607692307694|13.006557142857146|-10.258461538461539|-9.806153846153848|12.96769230769231|8.311428571428571|58.53822981607831|58.53822981607831|24.13846153846154|24.13846153846154
A CGS unit of area measurement equal to a square measuring one centimeter on each side. One square centimeter is equal to 10E-4 square meter.|A CGS unit of area measurement equal to a square measuring one centimeter on either side of the earth's doorstep.|63.01666666666668|57.09500000000003|6.540000000000003|7.779999999999998|9.3093|8.668728571428572|-8.001599999999996|-1.6699999999999982|6.485999999999997|4.902857142857144|54.195869768830164|62.58|17.733333333333334|20.0
<p>Supernumerary mandibular right second premolar</p>|Mandibular right second premolar/p>|-68.95999999999995|-8.724999999999994|24.120000000000008|15.469999999999999|16.36401111111111|15.262271428571431|-1.5760000000000005|-25.490000000000002|8.713333333333335|3.6014285714285705|62.58|54.195869768830164|34.0|31.6
Neuropsychiatric Inventory - Does the patient pace around the house without apparent purpose?|Neuropsychiatric Inventory - Does the patient pace around the house without apparent purpose?|30.947692307692336|30.947692307692336|12.172307692307694|12.172307692307694|10.810866666666666|11.568992307692309|13.867692307692305|14.319999999999997|15.577499999999993|14.054615384615381|82.78555852321104|82.78555852321104|26.738461538461536|26.738461538461536
Genetic loci in the vertebrate major histocompatibility complex which encode polymorphic characteristics not related to immune responsiveness or complement activity, e.g., B loci (chicken), DLA (dog), GPLA (guinea pig), H-2 (mouse), RT-1 (rat), HLA-A, -B, and -C class I genes of man.|Gene locations in the vertebrate major histocompatibility complex which encode polymorphic characteristics not related to immune responsiveness or complement activity, e.g., loci (chicken), DLA (mouse), RT-1 (rat), HLA-B, and -|39.06321428571431|19.025000000000006|10.419285714285714|13.09|14.949532558139534|15.361196774193548|5.829523809523813|9.404|24.386744186046514|22.178064516129034|66.37611354998121|69.96656701596841|21.34285714285714|24.0
An autosomal recessive condition caused by mutation(s) in the ALOX12B gene, encoding arachidonate 12-lipoxygenase, 12R-type. It is characterized by dry, thickened, scaly skin.|A genetic trait caused by mutation(s) in a gene, used for DNA repair. It is characterized by dry, thickened, scaly skin.|44.56637681159424|66.7871428571429|8.947826086956521|5.682857142857145|13.7305|10.459778787878788|0.5060869565217416|-14.005714285714284|11.949599999999997|2.575303030303033|54.195869768830164|44.250742366654144|18.718840579710143|14.228571428571428
A bluish or purplish discoloration of the skin and mucous membranes resulting from a reduced concentration of oxygenated hemoglobin in the blood.|A bluish or purplish discoloration of the skin and mucous membrane resulting from a reduced concentration of oxygen in the blood.|30.31545454545457|51.1489285714286|11.763636363636365|8.733571428571427|11.904972727272728|11.359372727272728|6.232727272727271|2.609523809523811|15.903181818181814|7.405909090909088|66.37611354998121|62.58|20.763636363636365|19.43809523809524
The chemical reactions and pathways involving a tetrahydromethanopterin. [GOC:mengo_curators]|The chemical reactions and pathways involving a molecule of water. [GOC:mengo_curators]|-60.932499999999976|8.979772727272717|22.87611111111112|13.373181818181823|14.9375|13.675823076923077|-10.24444444444444|-12.123636363636372|19.220999999999997|8.630769230769232|54.195869768830164|58.53822981607831|28.466666666666665|27.654545454545453
A chromosome band present on 12q|A chromosome band present on 12q22.3.|87.94500000000002|92.00500000000002|2.4833333333333343|0.9233333333333356|9.197433333333334|10.577242857142856|-22.873333333333328|-115.66|2.7650000000000006|1.8514285714285705|44.250742366654144|25.548178017228544|15.733333333333333|14.133333333333333
A general term referring to a defect in immunity resulting from impaired antibody production. []|A general term referring to a defect in immunity resulting from impaired antibody production.[]|24.382499999999993|12.401428571428596|11.721666666666671|13.26857142857143|11.8787|12.429833333333335|-7.32266666666667|-7.425714285714285|8.647857142857145|7.439999999999998|62.58|62.58|24.333333333333336|25.65714285714286
The part of the brain located anterior to the parietal lobes at the front of each cerebral hemisphere. (NCI)|The part of the brain located anterior to the parietal lobes at the front of each brain region. (NCI)|63.613552631578955|76.97144736842105|6.746578947368423|4.883421052631579|9.925068421052632|9.659|-3.3052631578947356|-5.1621052631578905|4.886842105263156|2.6454999999999984|54.195869768830164|49.473833993334296|16.431578947368422|14.326315789473682
<p>**Description:**A suffix has a strong association to the immediately preceding name part. A suffix has no implicit leading white space (it has implicit trailing white space though).</p>|p>**Description:**A suffix has a strong association to the immediately preceding name part of the body's immediate prioritization of information about the next step in the process of preparing for an upcoming medical school entrance exam.|47.30000000000004|19.87250000000003|8.89777777777778|14.835|10.889493103448277|10.669855555555555|2.3911111111111154|17.525714285714287|11.806206896551721|14.259999999999998|57.127462747788826|88.50148473330829|18.414814814814815|25.28571428571429
A unit of concentration equal to milligrams per milliliter, divided by meters squared.|A unit of concentration equal to grams per milliliter, divided by meters squared.|24.529807692307713|37.54519230769233|11.45269230769231|9.637307692307694|11.568992307692309|11.8787|-12.067692307692312|-13.876923076923077|11.156153846153849|4.947142857142854|62.58|58.53822981607831|27.21538461538462|24.13846153846154
Absence of the tibia. [HPO:probinson]|Absence of the tibia. [HPO:probinson]|35.097500000000025|35.097500000000025|8.985000000000003|8.985000000000003|14.311966666666669|15.08867142857143|-79.59199999999998|-78.416|2.8349999999999973|0.5057142857142836|38.32226702584281|38.32226702584281|25.0|25.0
A protein encoded by the IL6R gene.|A protein encoded by a gene IL6R.|94.51107142857143|94.51107142857143|0.946428571428573|0.946428571428573|13.006557142857146|13.902050000000001|-60.21142857142857|-61.05142857142857|0.9100000000000001|-0.9450000000000003|31.29|31.29|12.82857142857143|12.82857142857143
The chemical reactions and pathways resulting in the breakdown of nylon, a polymer where the main polymer chain comprises recurring amide groups; these compounds are generally formed from combinations of diamines, diacids and amino acids. [UniProtKB-KW:KW-0549]|The chemical reactions and pathways resulting in the breakdown of nylon, a polymer where the main chain comprises repeated amide groups; these compounds are generally formed from combinations of diamines, diacids and amino acids. [UniProtKB-KW-0549]|35.815|39.20964285714288|12.735555555555557|12.137857142857143|13.72047894736842|13.089235135135135|20.46888888888889|19.373714285714286|15.090526315789468|14.425135135135129|93.86999999999999|91.22524239485473|27.200000000000003|26.42857142857143
<p>Dissolve</p>|Dissolve/p>|-47.97999999999996|-47.97999999999996|20.200000000000006|20.200000000000006|19.674500000000002|19.6249|-207.8|-225.44|-4.800000000000001|-6.477499999999999|31.29|31.29|40.400000000000006|40.400000000000006
Any immunoglobulin that recognizes glutamate carboxypeptidase 2 (folate hydrolase 1).|Any immunoglobulin that recognizes a protein building blocks.|-26.659999999999968|1.8500000000000227|18.220000000000002|13.995000000000001|16.7645|10.877477777777777|-14.512|-33.575|17.952999999999996|9.079999999999998|58.53822981607831|49.473833993334296|30.0|26.6
The transport of substances that occurs outside cells. [GOC:go_curators]|The transport of substances that occur outside cells. [GOC:go_curators]|33.067500000000024|33.067500000000024|9.765|9.765|11.7795|12.522027272727273|-23.96444444444444|-23.96444444444444|9.329999999999998|7.010909090909088|49.473833993334296|49.473833993334296|24.022222222222226|24.022222222222226
A unit of substance content expressed in units of biological activity per 10^12 red blood cells.|A unit of substance content expressed in units of biological activity/1012 red blood cells.|50.66500000000002|60.74428571428575|8.180000000000003|6.525714285714287|14.178744444444446|12.429833333333335|-7.232500000000002|-9.105714285714278|8.503333333333334|6.812000000000001|58.53822981607831|54.195869768830164|20.700000000000003|19.942857142857143
Columbia-Suicide Severity Rating Scale Children's Baseline - Description of active suicidal ideation with some intent to act, without specific plan.|Columbia Suicide Severity Rating Scale Baseline - Description of active suicidal ideation with some intent to act, without specific plan.|23.255000000000024|23.255000000000024|12.499999999999996|12.499999999999996|14.102500000000001|14.396|8.326000000000004|5.385999999999999|18.0075|10.887999999999998|76.64453405168562|76.64453405168562|28.0|28.0
Incomplete maturation or aberrant formation of the male gametes. [HPO:probinson, MP:0001156]|Incomplete maturation or aberrant formation of the male gametes. [HPO:probinson, MP:001156]|16.670681818181833|16.670681818181833|12.300454545454546|12.300454545454546|14.460766666666668|14.890438461538462|-9.985454545454552|-9.985454545454552|11.792499999999997|9.71769230769231|54.195869768830164|54.195869768830164|24.018181818181816|24.018181818181816
Columbia-Suicidality Severity Rating Scale Baseline (C-SSRS Baseline) Most recent actual attempt date.|Columbia Suicide Severity Rating Scale Baseline (C-SSRS Basal) Most recent actual attempt date.|-17.805000000000007|11.514423076923094|17.233333333333338|13.268076923076926|17.517985714285714|17.569166666666668|-4.743333333333332|-7.544615384615383|11.002857142857145|6.189999999999998|62.58|66.37611354998121|29.066666666666663|30.29230769230769
A radioimmunotherapeutic monoclonal antibody (MN-14) directed against tumor-associated carcinoembryonic antigen (CEA) and chelated to the radioisotope yttrium-90 (Y 90). Yttrium 90 monoclonal antibody MN-14 binds to tumor cell expressing CEA, delivering a cytotoxic dose of beta radiation. (NCI04)|A radiotherapeutic monoclonal antibody (MN-14) directed against tumor-associated carcinoembryonic antigen (CEA) and chelated to the radioisotope yttrium-90 (Y 90).|6.967807017543862|-7.628552631578941|15.434210526315791|16.683421052631584|15.617710256410257|15.43587142857143|16.86315789473684|14.025263157894742|15.020769230769226|14.771428571428565|78.74477315987392|69.96656701596841|25.066666666666666|24.852631578947367
fish and shellfish used as food or suitable for food.|fish and shellfish used as food or suitable for food.|91.78000000000003|91.78000000000003|1.7000000000000028|1.7000000000000028|7.2905|8.215663636363637|-33.327999999999996|-32.739999999999995|3.8230000000000004|0.16000000000000014|31.29|31.29|10.0|10.0
A unit of concentration equal to nanomoles per liter, divided by micrograms per day.|A unit of concentration equal to nanomoles per liter, divided by micrograms/day.|36.572857142857174|17.44500000000002|9.89714285714286|12.316666666666666|12.225900000000001|11.8787|-12.465714285714288|-15.033333333333331|8.783571428571431|4.610714285714284|58.53822981607831|58.53822981607831|22.8|25.733333333333338
The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the juxtaglomerulus cells of the kidney as it progresses from its formation to the mature state. [GOC:mtg_kidney_jan10]|The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the juxtaglomerulus cells that progress from its formation to the mature state. [GOC:mtg_kidney_jan10]|24.03875000000002|20.40357142857144|13.881250000000005|13.891428571428573|12.589142424242425|13.328166666666666|21.189999999999998|21.69714285714286|17.078181818181818|17.470000000000006|82.78555852321104|79.77416029015912|23.900000000000002|24.171428571428574
Any process that activates or increases the frequency, rate or extent of tatiopterin metabolic process. [GOC:mengo_curators, GOC:TermGenie]|Any process that activates or increases the frequency, rate or extent of a metabolic process. [GOC:mengo_curators, GOC:TermGenie]|-5.8277941176470165|9.101617647058845|16.183823529411768|14.101470588235298|14.080331578947368|13.6065|7.719999999999999|4.607058823529414|12.07578947368421|8.7685|73.38155456243756|69.96656701596841|29.28235294117647|26.929411764705886
Summary listings or individual subject reports provided by the laboratory or other testing facility. May include but is not limited to results of biochemical testing and histological examination. [Adapted from TMF-RM]|Summary listings or individual subject reports provided by the laboratory or other testing facility. May include but is not limited to results of chemical testing and histology. [Adapted from TMF-RM]|13.501505376344113|27.485000000000014|13.943225806451615|11.91|12.554004166666667|12.554004166666667|6.824516129032258|3.9160000000000004|10.691458333333337|8.336458333333333|72.26115969177356|69.96656701596841|24.778494623655916|24.0
Using homeopathic assessment methods in a detailed, subsequent, 45-minute, out-of-office meeting to assess the health status of an existing homeopathy client to reevaluate and/or develop a homeopathic treatment plan.|Using homeopathic assessment methods in a detailed, subsequent, 45-minute, out-of-office meeting to assess the health status of an existing homeopathy client to reevaluate and/or develop an herbal treatment plan.|28.7519827586207|34.58646551724141|12.851206896551727|12.03741379310345|13.1187|12.589142424242425|17.704827586206893|17.096551724137935|21.2109375|12.225454545454546|88.50148473330829|88.50148473330829|27.868965517241378|27.868965517241378
Catalysis of the reaction: citronellol + NAD+ = citronellal + NADH + H+. [UM-BBD_reactionID:r1155]|Starting of the reaction: citronellol + NADH + H+. [UM-BBD_reactionID:r1155]|78.87285714285717|100.24000000000002|3.997142857142858|0.5199999999999996|17.84955|16.105053846153847|-6.585714285714289|-19.216|5.825624999999999|4.283076923076923|44.250742366654144|31.29|14.228571428571428|10.0
Acquainted with knowledge of a subject.|Acquainted with knowledge of a person.|62.79000000000002|62.79000000000002|5.246666666666666|5.246666666666666|9.197433333333334|10.577242857142856|-65.34666666666666|-65.34666666666666|7.475000000000001|2.524285714285714|38.32226702584281|38.32226702584281|21.200000000000003|21.200000000000003
A retroviral DNA or mutated host gene that encodes a hyperactive form of the proto-oncogene tyrosine-protein kinase Src protein. This oncogene is involved in tyrosine phosphorylation and cellular transformation.|A retroviral DNA or mutated host gene that encodes a hyperactive form of the protein kinase Src protein. This oncogene is involved in cellular transformation.|10.319885057471282|42.71266666666668|14.22137931034483|9.372000000000003|14.083041935483871|13.175982051282052|6.484137931034482|-3.7679999999999936|13.516451612903225|6.996794871794869|67.59412548439398|59.91578840339164|23.177011494252874|20.933333333333337
<p>**Definition:**A patient encounter where the patient and the practitioner(s) are not in the same physical location. Examples include telephone conference, email exchange, robotic surgery, and televideo conference.</p>|A patient encounter where the patient and the practitioner(s) are not in the same physical location. Examples include telephone conference, email exchange, surgery, and televideoconference.|6.56666666666672|19.02466666666666|14.57925925925926|12.676000000000002|13.611906896551725|11.961366666666667|9.36|3.5231999999999957|16.51620689655173|11.887948717948717|74.48509850970193|67.59412548439398|28.785185185185185|25.733333333333338
<p>Swish and swallow, oromucosal</p>|Swish and swallow, oromucosalp>|12.425000000000011|12.425000000000011|12.52|12.52|15.875800000000002|14.460766666666668|-25.490000000000002|-31.369999999999997|1.4100000000000001|3.5500000000000007|44.250742366654144|44.250742366654144|21.6|21.6
A leukemia that originates from a myeloid cell, that is the blood forming cells of the bone marrow. [HPO:probinson]|A leukemia that originates from a myeloid cell, that is the blood forming cells of the bone marrow. [HPO:probinson]|59.16092105263158|59.16092105263158|7.367631578947371|7.367631578947371|8.8695|9.420633333333335|-1.1389473684210465|-0.8294736842105266|5.235999999999997|4.678571428571431|54.195869768830164|54.195869768830164|16.431578947368422|16.431578947368422
The chemical reactions and pathways involving keratan sulfate, a glycosaminoglycan with repeat units consisting of beta-1,4-linked D-galactopyranosyl-beta-(1,4)-N-acetyl-D-glucosamine 6-sulfate and with variable amounts of fucose, sialic acid and mannose units; keratan sulfate chains are covalently linked by a glycosidic attachment through the trisaccharide galactosyl-galactosyl-xylose to peptidyl-threonine or serine residues. [GOC:go_curators]|The chemical reactions and pathways involving keratan sulfate, a sugar molecule with repeat units consisting of beta-1,4-linked D-galactosyl-threonine or serine residues. [GOC:go_curators]|-4.497806122448935|7.242727272727308|19.973163265306116|14.98181818181818|15.914333333333333|15.417581481481482|35.91836734693878|17.99272727272727|23.6355|13.231111111111112|117.07645963215661|85.69119412168324|32.65714285714286|31.672727272727272
Order of dicotyledonous flowering plants consisting of 16 families, 112 genera, and nearly 2,500 species.|Order of plant parts composed of 16 families, 112 genera, and nearly 2,500 species.|41.30250000000001|84.9157142857143|9.361666666666668|3.1542857142857166|12.801833333333335|11.377166666666668|-3.7946666666666715|-12.465714285714288|13.701999999999998|3.6720000000000006|62.58|54.195869768830164|24.333333333333336|19.942857142857143
<p>Concepts representing whether a person does or does not currently have a job or is not currently in the labor pool seeking employment.</p>|A person does or does not currently have a job or is currently in the labor pool seeking employment.|59.066847826086985|72.51881578947369|7.8776086956521745|5.504473684210527|11.408662962962964|8.08|4.68347826086956|-5.4715789473684175|12.82888888888889|2.8810000000000002|66.37611354998121|54.195869768830164|20.252173913043478|16.431578947368422
Middling or intermediate in degree, quality or extent.|Middling or intermediate in degree, quality or extent.|23.00000000000003|23.00000000000003|11.045000000000002|11.045000000000002|13.902050000000001|14.38636666666667|-39.455000000000005|-38.72|9.063749999999999|4.893333333333331|49.473833993334296|49.473833993334296|26.6|26.6
Death|Sudden death|121.22000000000003|77.90500000000002|-3.3999999999999986|2.890000000000004|0.0496|9.048633333333335|-266.6|-112.72|2.620000000000001|-1.0899999999999999|0.0|31.29|0.4|20.8
Uptake of substances into the body via the inner mucosal surface of the cheeks.|Uptake of substances into the body via the inner mucus surface of the cheek.|54.70142857142861|60.74428571428575|7.368571428571428|6.525714285714287|9.970185714285716|10.3245|-14.565714285714286|-15.405714285714286|7.437857142857144|2.1020000000000003|62.58|62.58|25.65714285714286|25.65714285714286
A plasmid encoding the protein antiangiogenic metargidin plasmid (AMEP), the disintegrin domain of ADAM-15 (metargidin), with potential antiangiogenic and antimetastatic activities. Upon intratumoral electrotransfer of plasmid encoding AMEP, AMEP binds to cellular integrin receptors alpha-v-beta-3 (avb3) and alpha-5-beta-1 (a5b1), which are upregulated on activated endothelial cells and a variety of tumor cells. Binding to the integrin receptors may inhibit angiogenesis and may inhibit tumor cell proliferation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C90537" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C90537" NCI Thesaurus)|A plasmid encoding a protein complex, with potential antiangiogenic and antimetastatic activities. Upon intratumoral electrotransfer of the gene, AMEP binds to cellular integrins alpha-v-beta-3 (avb|22.845419580419588|1.2595000000000312|11.834428904428908|16.189|14.381871851851853|15.045542857142859|9.894871794871797|17.479999999999997|25.04777777777778|13.99821428571429|60.408930781646994|82.78555852321104|23.862004662004665|27.400000000000002
The monohydrate bromide salt form of tiotropium, a quaternary ammonium derivative of atropine and a long-acting muscarinic receptor antagonist, with bronchodilating activity. Upon inhalation, tiotropium binds to and blocks mainly muscarinic M3 receptors located on smooth muscle cells, thereby preventing smooth muscle contraction.|The salt form of tiotropium, a molecule of fat and protein, which prevents smooth muscle contraction.|3.41224806201555|66.5275|16.34418604651163|5.967500000000001|13.340427272727274|10.559864705882354|18.867906976744187|-5.027500000000003|19.756818181818183|6.092941176470589|90.32644961471695|54.195869768830164|28.98914728682171|18.2
Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway. [GOC:mtg_apoptosis]|Any process that prevents or reduces cell membrane protein breakdown in a cell undergoin programmed cell death. [GOC:mtg_apoptosis]|-0.44818181818180847|37.900000000000034|16.05454545454546|10.208888888888893|14.10045|12.817|13.98363636363636|4.677777777777784|13.222500000000004|9.7105|82.78555852321104|69.96656701596841|29.854545454545452|25.822222222222223
Human CCNA2 wild-type allele is located within 4q25-q31 and is approximately 6 kb in length. This allele, which encodes cyclin-A2 protein, plays a role in cell cycle G1/S and G2/M transitions.|Normal human CCNA2 gene is located within 4q25-q31 and is about 6 kilobases in length. This gene, which encodes cyclin-A2 protein, plays a role in cell cycle G1/S and G2/M transitions.|84.45634408602152|87.18537634408602|4.046451612903226|3.665806451612905|14.617355555555555|14.617355555555555|2.08258064516129|0.7548387096774185|7.587499999999999|6.802499999999998|59.91578840339164|57.127462747788826|18.32688172043011|17.03655913978495
Stage IV includes: (T3, N1, M0); (T4, N0, M0); (T4, N1, M0); (Any T, Any N, M1). T3: Tumor of any size with local invasion, but not invading adjacent organs. T4: Tumor of any size with invasion of adjacent organs. N1: Metastasis in regional lymph node(s). N0: No regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.)|Stage IV includes: (T3,N1, M0); T4: Tumor of any size with local invasion, but not invading adjacent organs. T1: Metastasis in a specific anatomical area of the muscosal node(s) T3|83.85890681003588|47.79000000000002|3.2740860215053758|10.320000000000004|14.867192668621703|14.083041935483871|-14.61096774193549|10.05866666666666|1.2157624633431112|7.894838709677423|51.09635603445709|82.78555852321104|18.239426523297492|24.666666666666668
Derivatives of ethylene, a simple organic gas of biological origin with many industrial and biological use.|Derivatives of ethylene, a gas of biological origin with many industrial and biological use.|-7.497499999999974|-5.727142857142809|16.292500000000004|15.797142857142859|11.338225000000001|11.377166666666668|-3.1899999999999977|-8.685714285714283|13.063749999999999|6.812000000000001|66.37611354998121|58.53822981607831|25.700000000000003|22.8
An autonomic disorder characterized by excessive sweating of the forehead, upper lip, perioral region, or sternum subsequent to gustatory stimuli. The auriculotemporal syndrome features facial flushing or sweating limited to the distribution of the auriculotemporal nerve and may develop after trauma to the parotid gland, in association with PAROTID NEOPLASMS, or following their surgical removal. (From Ann Neurol 1997 Dec;42(6):973-5)|An autonomic disorder characterized by excessive sweating of the forehead, upper lip, perioral region, or sternum subsequent to gustatory stimuli. The auriculotemporal syndrome features facial flushing limited to the distribution of an ear canal. It may develop after trauma to|8.875000000000028|11.41166666666669|16.99|14.98|13.446016939890713|12.401927642276423|22.244|12.932999999999996|17.15109289617486|12.284796747967476|103.77718969022045|88.50148473330829|30.0|29.333333333333332
Penis tissue expanders designed for the expansion of the penis using constant traction. These expanders are typically a plastic device with a mechanism (e.g., consisting of a base located on the pubis bone and a penis head holder over the glans with expandable metal rods) that provides constant traction to the penis. Traction penis expanders are intended for external placement on the penis, helping to correct penis curvature (i.e., straightening the penis after surgery) and/or possibly resulting in penis enlargement.|These expanders are typically a plastic device that helps to correct penis curvature (i.e., straightening the penistles after surgery) and/or possibly resulting in penile enlargement.|44.405|31.29125000000002|9.55|10.447500000000002|13.248916666666668|13.998223076923077|2.9604999999999997|-9.728000000000002|17.396208333333334|13.329999999999998|73.38155456243756|60.592824451415034|26.0|26.5
Any process that activates or increases the frequency, rate or extent of B cell differentiation. [GOC:go_curators]|Any process that activates or increases the frequency, rate or extent of B cell differentiation. [GOC:go_cursor]|18.940000000000026|24.22750000000002|12.605000000000004|11.867500000000003|12.417511764705882|12.855122222222224|-0.6174999999999997|-0.9849999999999994|8.863529411764706|7.405000000000001|62.58|62.58|23.200000000000003|23.200000000000003
The menstrual cycle process in which one central cavity separating the oocyte/cumulus complex from mural granulosa and theca cells is formed as part of the scattered antral spaces stage of oogenesis. [GOC:dph, GOC:isa_complete]|The menstrual cycle process in which one central cavity separating the ova/cumulus complex from mural granulosa and theca cells is formed as part of the scattered antral spaces stage of oogenesis. [GOC:dph, GOC:iso|26.014772727272742|33.70568181818183|13.729848484848485|12.657121212121215|12.4243|12.66247837837838|16.806060606060612|14.667878787878792|12.166666666666664|10.351621621621625|88.50148473330829|88.50148473330829|25.993939393939396|25.993939393939396
A chromosome band present on 8q|A chromosome band present on 8q21.3|87.94500000000002|90.99000000000004|2.4833333333333343|1.3133333333333361|9.197433333333334|10.750842857142857|-23.85333333333333|-68.28666666666666|1.9800000000000004|2.9285714285714306|44.250742366654144|31.29|15.733333333333333|14.533333333333331
A unique identifier assigned to a study.|A unique identifier assigned to a study.|34.08250000000001|34.08250000000001|9.375|9.375|10.750842857142857|11.7299|-56.011428571428574|-55.17142857142857|4.274285714285714|0.5874999999999986|44.250742366654144|44.250742366654144|24.257142857142856|24.257142857142856
Moderate symptoms; limiting instrumental ADL|Mild symptoms; limiting instrumental ADL|-18.19999999999996|15.640000000000015|17.040000000000003|12.320000000000004|19.674500000000002|19.7241|-12.159999999999997|-15.687999999999995|17.808|9.829999999999998|62.58|54.195869768830164|34.0|26.0
A very rare hereditary neurological dysmorphic syndrome with characteristics of moyamoya disease, short stature of postnatal onset and stereotypical facial dysmorphism. The syndrome is extremely rare and has been reported in three unrelated families to date, with 10 affected individuals in several generations. These families are not from Japan or Asia, whereas in general the incidence of moyamoya disease is highest in Japan and other Asian countries, in comparison with other parts of the world. Affected patients are all male (X-linked inheritance) and have moyamoya angiopathy (progressive stenosis of the terminal portion of the intracranial internal carotid arteries), short stature, hypergonadotropic hypogonadism and other variable manifestations.. The genetic cause appears to involve Xq28 deletions removing MTCP1/CMC4 and BRCC3 (Xq28) .The specific pathophysiological mechanisms underlying this disorder remain obscure, but appear to involve alteration in DNA repair.|A rare genetic disorder with characteristics of moyamoya disease, short stature of postnatal onset and stereotypical facial features. The syndrome is extremely rare and has been reported in three unrelated families to date, with 10 affected individuals in several generations. These families are not from Japan or Asia,|17.26970588235298|26.682500000000005|15.073823529411765|13.5125|12.6723|11.858265986394558|19.12205882352941|14.942499999999995|18.19347826086956|12.49748299319728|94.51962712844353|86.63808689023553|28.270588235294117|25.56666666666667
Trauma Symptom Checklist for Children - Forgetting things, can't remember things.|Trauma Symptom Checklist for Children - Forging things, can't remember things.|62.81613636363636|70.50704545454548|5.864090909090912|4.791363636363638|8.8695|11.086572727272728|-15.865454545454547|-16.934545454545457|15.597999999999999|9.579999999999998|54.195869768830164|54.195869768830164|24.018181818181816|24.018181818181816
the joints that connect the fingers to the hand.|joint that connects the fingers to the hand.|98.8675|97.025|0.5872222222222234|0.7199999999999989|5.837344444444444|7.368588888888889|-39.64444444444443|-46.07|3.4800000000000004|0.18333333333333002|31.29|31.29|10.68888888888889|11.600000000000001
An abnormal concentration of sodium. [HPO:probinson]|An abnormal concentration of sodium. [HPO:probinson]|-21.809999999999945|-21.809999999999945|17.04666666666667|17.04666666666667|15.08867142857143|15.6774|-52.60666666666666|-51.62666666666666|9.252857142857145|6.475000000000001|44.250742366654144|44.250742366654144|27.866666666666664|27.866666666666664
The space enclosed by the double membrane of a cyanelle. [GOC:rph]|The space enclosed by the double membrane of a cyanelle. [GOC:rph]|70.50704545454548|70.50704545454548|4.791363636363638|4.791363636363638|10.513266666666667|11.246592307692307|-23.883636363636366|-23.349090909090915|1.9800000000000004|1.0223076923076917|44.250742366654144|44.250742366654144|16.745454545454546|16.745454545454546
A condition in which a carcinoma has spread extensively throughout the peritoneal cavity.|A condition in which a cancer has spread widely throughout the peritoneal cavity.|18.022115384615404|50.56057692307695|12.360384615384618|7.821923076923078|11.568992307692309|11.8787|-10.71076923076923|-13.876923076923077|12.605384615384615|5.283571428571431|54.195869768830164|54.195869768830164|21.06153846153846|21.06153846153846
An arbitrary unit of substance content expressed in microunit(s) per liter.|A unit of substance content expressed in microunit(s) per liter.|32.05250000000001|49.48000000000002|10.155000000000001|7.600000000000001|15.665736363636366|15.392936363636366|-19.07272727272727|-26.272|11.045454545454547|4.441818181818181|58.53822981607831|54.195869768830164|27.654545454545453|26.0
Adult: Systolic BP 120-139 mm Hg or diastolic BP 80-89 mm Hg; Pediatric: Systolic/diastolic BP >90th percentile but< 95th percentile; Adolescent: BP >= 120/80 even if < 95th percentile|Adult: Systolic BP 120-139 mm Hg or dialysis drug|51.95862068965518|75.50000000000003|13.216551724137933|4.964444444444446|18.48992857142857|18.536645454545457|21.423448275862064|-5.448888888888881|7.23657142857143|1.1972727272727255|98.94766798666859|54.195869768830164|25.393103448275866|16.933333333333334
Human TPMT*V2 allele is a variant form of the TPMT Gene (TPMT Family), located at chromosome 6p22.3, which encodes Thiopurine S-Methyltransferase. Some TPMT alleles contain variable numbers of 17/18 bp tandem repeats (VNTR), within the GC-rich 5'-flanking TPMT promoter region that modulate the level of TPMT enzyme activity (to a smaller extent than ORF-based SNP effects). TPMT*V2 contains 2 VNTR. A decrease in gene expression is seen with increasing repeat numbers.|Human TPMT*V2 gene is a variant form of the protein building blocks gene, located at chromosome 6p22.3, which encodes Thiopurine S-Methyltransferase. Other genes contain variable numbers of 17/18 bp tandem repeat|58.98754694835682|54.43698924731183|7.9714788732394375|8.233548387096778|13.84265890410959|14.02459696969697|8.029859154929582|6.065806451612904|12.406369863013701|12.368181818181817|71.12311754978124|69.96656701596841|22.198122065727702|23.488172043010756
Peroxisomal multifunctional enzyme type 2 (736 aa, ~80 kDa) is encoded by the human HSD17B4 gene. This protein is involved in the peroxisomal beta-oxidation pathway for fatty acids.|Fat cell enzyme type 2 (736 amino acids, 80 kilodaltons) is encoded by a human gene HSD17B4 protein. This protein is involved in the cell's beta-oxidation pathway for fatty acids.|46.290238095238124|64.14500000000001|9.121428571428574|6.79666666666667|15.789837931034484|14.527754166666668|0.6257142857142846|-0.003999999999997783|9.857241379310349|5.245520833333334|62.58|65.13532912329528|20.876190476190477|21.333333333333336
World Health Organization Disability Assessment Schedule 2.0 36-item Version Self-administered (WHODAS 2.0 36-item Version Self-administered) In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]?|World Health Organization Disability Assessment Schedule 2.0 36-item Version Self-administered) In the past 30 days, how much difficulty did you have in walking a long distance such as kilometre [or equivalent]?|43.40855855855855|41.005725806451636|10.268648648648654|11.390483870967746|12.355739024390244|11.445876470588235|11.597837837837833|15.424516129032263|13.289024390243902|11.312647058823536|67.59412548439398|73.38155456243756|20.06846846846847|20.393548387096775
Platelet Activating Factor Degradation consists of conjugation, transport, and/or oxidation of a phospholipid derivative (platelet activating factor) formed by platelets, basophils, neutrophils, monocytes, and macrophages that acts as a potent agent of platelet aggregation, inflammation, neutrophil activity, prostaglandin synthesis, and systemic anaphylaxis: hypotension, thrombocytopenia, neutropenia, and bronchoconstriction.|Platelet Activating Factor Degradation consists of conjugation, transport, and/or oxidation of a molecule (also known as an activator of platelet activation).|-49.21749999999997|-1.2224999999999966|25.962234042553195|16.038333333333334|17.390253191489364|14.230281818181819|35.31999999999999|10.729523809523805|38.74787234042553|12.758181818181818|127.10058084052962|79.77416029015912|37.48510638297872|28.961904761904762
Level 1 Gestational Diabetes Mellitus is defined by three criteria: first, at least one of the following requirements must be met: a) absence of pre-gestational diabetes [pre-gestational diabetes is defined as a) previous diagnosis of diabetes while not pregnant OR b) first trimester hemoglobin A1c level of greater than or equal to 6.5% (47.5 mmol/mol) OR c) first trimester fasting blood glucose greater than or equal to 126 mg/dL (7 mmol/L)]; second, gestational age with level 1 or level 2 certainty, using the GAIA definition for gestational age; third, a diagnosis of gestational diabetes as determined by a positive result from an international standard oral glucose tolerance test using venous blood samples.|Level 1 GDM Mellitus is defined by three criteria: first, at least one of the following requirements must be met: a) absence of pre-gestational diabetes [presence of diabetes while not pregnant OR b) first trimester hemoglobin A1c level of greater than|27.343571428571465|20.780975609756126|16.40142857142857|20.546341463414638|16.997306837606835|12.379067441860466|21.24357142857143|23.32780487804878|60.458974358974366|22.634186046511623|109.51499999999999|125.16|28.700000000000003|32.00975609756098
A diagrammatic method to test visual acuity that utilizes the Sloan optotypes and a 2.5% contrast level.|A diagrammatic method to test visual acuity that utilizes the Sloan optotypes and 25% contrast level.|41.83627450980396|34.80250000000001|8.831764705882357|10.392500000000002|12.839111764705882|13.346335294117647|-21.79764705882353|-5.027500000000003|10.897058823529413|6.370000000000001|51.09635603445709|62.58|21.090196078431372|23.200000000000003
A comprehensive norm-referenced assessment of the adaptive skills of individuals ages 5 to 21 years that is used to evaluate children with intellectual and developmental disabilities. This form is completed by parents or others responsible for the child's primary care.|A comprehensive normative assessment of the adaptive skills of individuals ages 5 to 21 years that is used to evaluate children with intellectual and developmental disabilities. This form is completed by parents or others responsible for the child's primary care.|28.331666666666678|32.561666666666696|12.620000000000001|12.030000000000001|10.815251219512195|10.476317886178862|11.610000000000003|10.874999999999996|14.897317073170733|11.021138211382116|72.26115969177356|72.26115969177356|21.333333333333336|21.333333333333336
<p>Criteria for specifying the entities to be evaluated by a specific quality measure, based on a shared common set of characteristics (within a specific measurement set to which a given measure belongs). The denominator can be the same as the initial population, or it may be a subset of the initial population to further constrain it for the purpose of the eMeasure. Different measures within an eMeasure set may have different denominators. Continuous Variable eMeasures do not have a denominator, but instead define a measure population.</p>|Acute flaccid myelitis|27.06304651162793|6.390000000000015|13.757534883720933|13.113333333333333|10.542166666666667|19.6249|14.241860465116279|-57.50666666666666|13.474666666666671|5.297499999999999|87.38821419390602|54.195869768830164|25.01953488372093|41.2
90-75% of predicted value|90-75% of predicted value|75.87500000000001|75.87500000000001|3.6700000000000017|3.6700000000000017|13.3585|14.460766666666668|-41.660000000000004|-40.19|-0.08999999999999986|-1.9450000000000003|44.250742366654144|44.250742366654144|21.6|21.6
A characteristic of a medicinal product, specifying that its most predominant agreeable savor detected by the unified sensation of taste and olfactory receptors resembles rum.|A characteristic of a medicinal product, specifying that its most predominant agreeable savor detected by the unified sensation of taste and smell.|11.411500000000018|26.470000000000027|14.773000000000003|12.3|13.718900000000001|11.758639130434783|11.8352|7.034545454545448|19.141600000000004|9.917826086956524|79.77416029015912|69.96656701596841|25.8|22.581818181818182
A measurement of the bicarbonate in a biological specimen.|A measurement of the bicarbonate in a biological specimen.|14.267500000000013|14.267500000000013|12.387222222222224|12.387222222222224|11.100677777777777|11.7795|-33.11111111111111|-32.45777777777777|8.713333333333335|4.620000000000001|44.250742366654144|44.250742366654144|19.57777777777778|19.57777777777778
Retroviral-like intracisternal A particles. High copy number family of repeated elements in the mouse with a typical proviral organization. Expressed very early in mouse development (2-8 cell stage) and in transformed cells. Mutant alleles of various genes contain newly-integrated IAP genes.|Retrovirus-like particles. High copy number family of repeated elements in the mouse with a typical proviral organization. Expressed very early in mouse development (2-8 cell stage) and in transformed cells. Mutant alleles of various genes contain newly-integrated IAP genes.|21.05834146341465|25.379538461538488|12.359219512195125|11.657128205128206|11.718236363636365|11.77445534883721|0.042926829268296274|-2.0656410256410282|10.082045454545455|7.953488372093023|64.12541789337516|62.58|23.767804878048782|23.632820512820512
The anterior abdominal wall constitutes a hexagonal area defined superiorly by the costal margins and xiphoid process; and inferiorly by the iliac crests, inguinal ligament, pubis and pubic symphysis. The wall extends posteriorly and incorporates the lateral aspect of the wall until the junction with the posterior abdominal wall approximately at the mid-axillary line. The wall is covered externally by skin and subcutaneous tissue: beneath this lies the superficial fascia (between the dermis and the muscles), which is conventionally divided into a superficial fatty layer (Camper's fascia) and a deep membranous layer (Scarpa's fascia); deep fascia; the rectus abdominis, pyramidalis, external oblique, internal oblique and transversus abdominis; and the extraperitoneal tissue and the parietal peritoneum. These tissues also form the umbilicus and the inguinal canal, which connects the abdominal cavity to the scrotum in males and the labia majora in females.|The front abdominal wall constitutes a hexagonal area defined superiorly by the costal margins and xiphoid process; and lower mid-axillary line. The wall is covered by skin and subcutaneous tissue, which connects the abdomen to the scrotum in male|6.612000000000023|30.85788461538465|19.342751773049645|13.799615384615386|13.181102816901408|11.200373170731707|23.949503546099294|16.482051282051287|22.954718309859153|12.484878048780487|123.5855977045869|93.86999999999999|33.407659574468084|26.261538461538464
POLYCYCLIC AROMATIC HYDROCARBONS composed of three fused BENZENE rings.|POLYCYCLIC AROMATIC HYDROCARBONS composed of three fused rings.|4.867500000000007|1.8500000000000227|13.698333333333334|13.995000000000001|14.60956666666667|14.38636666666667|-24.617777777777775|-32.105000000000004|15.516666666666666|10.126666666666669|54.195869768830164|49.473833993334296|28.466666666666665|26.6
A receptor complex that consists of two identical subunits and binds growth hormone. [GOC:BHF, GOC:mah, GOC:vk, PMID:11445442]|A receptor complex that consists of two identical subunits and binds growth hormone. [GOC:BHF, GOC:mah, PMID:11445442]|63.84279411764709|61.24000000000001|6.466176470588238|6.705000000000002|15.185500000000001|14.911384210526316|3.2235294117647086|1.2199999999999989|7.355499999999999|7.365789473684213|58.53822981607831|58.53822981607831|19.870588235294118|20.700000000000003
Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported Version (PODCI Pediatric Parent-Reported Version) If you answered "no" to Question 52 above, was your child's activity limited by: Doctor or parent instructions?|The pediatric outcome data collection instrument, pediatric parent-reported version (PODCI Pediatric Parent-Reported Version) If you answered "no" to Question 52 above, was your child's activity limited by: Doctor or parent instructions?|-9.734999999999985|-4.74612903225804|22.070000000000004|21.62258064516129|11.338225000000001|11.445876470588235|30.313333333333333|29.90451612903226|15.271562500000002|14.498823529411759|139.93313403193682|139.93313403193682|38.666666666666664|38.20645161290323
The date and time span specifying the best time for an activity or event to begin and end.|The day and time span specifying the best time for an activity or event to begin and end.|80.20000000000003|80.20000000000003|4.308888888888891|4.308888888888891|8.03818888888889|8.262963157894736|-9.042222222222218|-9.042222222222218|6.41|1.1684210526315795|44.250742366654144|44.250742366654144|12.488888888888889|12.488888888888889
refers to one of two parts of the lateral habenula of the rat ( Paxinos-2009b ) and mouse ( Franklin-2008 ). The other is the medial part of the lateral habenula. In this segmentation of the habenula, the medial habenula is not subdivided. \r\nOther authors do not subdivide the lateral habenula in the rat ( Swanson-2004 ) but divide the medial habenula into a dorsal part of the medial habenula and ventral part of the medial habenula. \r\nNeither nucleus of the habenula is subdivided in the human ( Carpenter-1983 ) or the macaque ( Paxinos-2009a ). Functionally the habenula belongs to the central gray of the behavior control column ( Swanson-2004 ).|refers to one of two parts of the lateral habenula of a rat ( Paxinos-2009b ) and mouse ( Franklin-2008 ). The other part is the medial part. rnOrthophore is subdivided in the human|64.45035714285714|90.8257843137255|8.24464285714286|3.4064705882352975|10.779166666666667|9.242581720430108|10.1125|-0.34941176470588076|11.677933333333335|5.463440860215055|74.79740637214636|51.09635603445709|20.685714285714287|13.945098039215686
A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida that are herbaceous or woody vines, shrubs, and trees, mostly of warm regions. Many have tendrils in leaf axils. Leaves are alternate. Flowers have 3-5 sepals, petals and stamens. Nearly all species have seeds that bear a fleshy appendage called an aril.|A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsis. Many have tendrils in leaf axils. Leaves are alternate. Nearly all species have seeds that bear a fleshy appendage called an aril.|62.1899213836478|59.135999999999996|6.779528301886796|6.65066666666667|10.020328148148149|9.546721176470589|-2.223396226415101|-12.953939393939397|7.520000000000003|5.935588235294116|62.58|54.195869768830164|21.64654088050315|20.821818181818184
Any process that modulates the frequency, rate or extent of B cell differentiation. [GOC:go_curators]|Any process that changes the frequency, rate or extent of B cell differentiation. [GOC:go_curators]|18.44428571428574|30.53000000000003|12.425714285714289|10.740000000000002|12.429833333333335|11.9283|-5.325714285714284|-5.7457142857142856|8.381999999999998|6.708749999999998|58.53822981607831|58.53822981607831|22.8|22.8
Telephone surveys are conducted to monitor prevalence of the major behavioral risks among adults associated with premature MORBIDITY and MORTALITY. The data collected is in regard to actual behaviors, rather than on attitudes or knowledge. The Centers for Disease Control and Prevention (CDC) established the Behavioral Risk Factor Surveillance System (BRFSS) in 1984.|Telephone surveys are conducted to monitor prevalence of the major behavioral risks among adults associated with premature MORBIDITY and MORTALITY. The data collected is in regard to actual behaviors, rather than on attitudes or knowledge.|28.97492924528305|18.54190476190476|12.509575471698117|13.571428571428577|13.748427044025156|12.565311111111113|12.718490566037733|9.236571428571423|14.774654088050312|11.12916666666667|85.69119412168324|82.78555852321104|27.941509433962267|28.66666666666667
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating redox state. Redox state refers to the balance of oxidized versus reduced forms of electron donors and acceptors in an organelle, cell or organ; plastoquinone, glutathione (GSH/GSSG), and nicotinamide nucleotides (NAD+/NADH and NADP+/NADPH) are among the most important. [GOC:mah]|Any process that results in a change in state or activity of an organelle or cell (in terms of movement, secretion, enzyme production, etc.); plastoquinone, glutathione (GSH/GSSG), and nicotinamide nucleoside|36.79250000000002|33.690000000000026|12.475000000000001|12.286666666666669|12.283288888888888|12.3251|16.013714285714286|15.546666666666667|14.83958333333333|11.2975|89.87368260508745|79.77416029015912|25.857142857142858|23.333333333333336
An indicator that can be set or unset in order to signal whether a particular condition is true.|An indicator that is set or unset in order to signal whether a particular condition is true.|56.70000000000002|53.889852941176486|7.58666666666667|7.854411764705883|9.792633333333335|10.223455555555555|-7.082222222222221|-8.190588235294115|7.98|2.956666666666667|58.53822981607831|58.53822981607831|19.15555555555556|19.870588235294118
Systems designed to dissolve high levels of oxygen into a solution, such as saline solution. Typically, this system then mixes the supersaturated oxygen solution with autologous blood and delivers the hyperoxemic blood to the patient. This system can be used during therapy to treat damaged cardiac arteries.|Systems designed to dissolve high levels of oxygen into a solution, such as saline solution. Typically, this system mixes the supersaturated oxygen solution with autologous blood and delivers the hyperoxemic blood to the patient. This system can be used during therapy to treat damaged heart|31.108750000000015|29.930000000000007|11.8393085106383|12.811111111111114|11.132715602836878|10.918989855072464|7.586382978723407|12.671999999999997|12.15801418439716|11.220144927536232|78.225|86.63808689023553|25.97659574468085|26.444444444444446
Brief (<24 hrs) episode of ischemia managed medically and without permanent deficit|Brief (24 hrs) episode of ischemia managed medically and without permanent deficit.|25.455000000000013|31.545000000000016|12.690000000000001|10.350000000000001|16.427453846153846|16.427453846153846|10.613333333333337|-13.563333333333333|10.431538461538462|10.431538461538462|82.78555852321104|58.53822981607831|28.13333333333334|25.733333333333338
Stage III includes: T3, N0, M0. T3: Tumor involves one or both both ovaries with microscopically confirmed peritoneal metastasis outside pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)|Stage III includes: T3,N0, M0. T3: Tumor involves one or both both ovarian cancers with microscopically confirmed peritoneal metastasis outside of pelvis. M1: Myeloma. (AJCC 6th and 7|64.44500000000002|60.74428571428575|5.761111111111113|6.525714285714287|15.33798888888889|14.885755172413795|-16.82999999999999|-9.315714285714286|5.905000000000001|6.394655172413795|47.79626449838941|54.195869768830164|17.95555555555556|19.942857142857143
The daily salt intake is deficient.|The salt intake is deficient.|62.79000000000002|68.93750000000003|5.246666666666666|4.265000000000004|9.197433333333334|11.6803|-69.26666666666665|-87.824|4.334999999999997|-0.3049999999999997|38.32226702584281|31.29|21.200000000000003|17.0
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a L-dopa stimulus. [GO_REF:0000071, GOC:TermGenie, PMID:25044243]|Any process that results in a change in state or activity of eukaryotic cell or an organism (in terms of movement, secretion, enzyme production, etc.). [GO_REF:0000071, GOC:2544243]|63.98693693693693|66.10000000000002|7.3983783783783785|6.2755555555555596|12.296264102564102|11.66197142857143|8.260540540540543|1.0844444444444505|11.145384615384614|10.129285714285714|67.59412548439398|57.127462747788826|20.06846846846847|18.414814814814815
Enzymes that catalyze reversibly the formation of an epoxide or arene oxide from a glycol or aromatic diol, respectively.|Enzymes that catalyze reversibly the formation of an epoxide or arene oxide from a sugar or aromatic diol, respectively.|23.53986842105263|23.53986842105263|12.336052631578948|12.336052631578948|13.72047894736842|12.817|0.717894736842112|0.717894736842112|13.107368421052634|7.355499999999999|69.96656701596841|69.96656701596841|24.852631578947367|24.852631578947367
Clinical, therapeutic and diagnostic approaches to optimal disease management based on individual variations in a patient's genetic profile.|Clinical, therapeutic and genetic approaches to optimal disease management based on individual variations in a patient's genetic profile.|0.30000000000001137|0.30000000000001137|15.453333333333337|15.453333333333337|15.055966666666668|14.911384210526316|7.291111111111114|6.637777777777778|19.231666666666662|12.819473684210529|76.64453405168562|76.64453405168562|30.266666666666666|30.266666666666666
Any process that activates or increases the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization. [GO_REF:0000058, GOC:TermGenie, PMID:19737525]|Any process that activates or increases the rate or helps mRNA stabilization. [GO_REF:0000058, GOC:TermGenie, PMID:19737525]|52.00000000000003|52.58250000000001|8.242222222222225|7.7883333333333375|14.080331578947368|13.346335294117647|12.191111111111113|4.045333333333332|15.546315789473681|11.911176470588238|62.58|54.195869768830164|21.37777777777778|19.0
Experimentally induced tumors of the LIVER.|Experimentally induced tumors of the LIVER.|6.390000000000015|6.390000000000015|13.113333333333333|13.113333333333333|11.8291|12.832957142857145|-61.42666666666666|-60.44666666666666|10.615000000000002|5.8885714285714315|44.250742366654144|44.250742366654144|27.866666666666664|27.866666666666664
Wallflower.|a plant.|-47.47249999999997|121.22000000000003|20.005000000000006|-3.3999999999999986|19.476100000000002|8.974233333333334|-527.32|-272.48|26.17|-9.69|22.125371183327072|0.0|40.2|0.4
Reassesses genitourinary status to determine changes from baseline throughout the perioperative phase of care.|Reassesses genital status to determine changes from baseline during the perioperative phase of care.|6.35857142857148|24.487142857142885|14.111428571428572|11.582857142857147|13.353757142857145|12.429833333333335|-1.5457142857142898|-5.325714285714284|17.867142857142852|9.637999999999998|62.58|62.58|25.65714285714286|25.65714285714286
A cell that serves to provide support and protection and perhaps contribute to the nutrition of principal or other cells of the nervous system.|A cell that serves to provide support and protection and may contribute to the nutrition of principal or other cells of the nervous system.|60.70500000000001|64.22999999999999|7.773333333333333|7.28166666666667|10.090233333333334|9.9409|4.733333333333334|3.9983333333333384|13.923749999999998|6.674399999999999|69.96656701596841|66.37611354998121|21.46666666666667|19.8
OBSOLETE. Catalysis of the reaction: Me2+(in) + ATP = Me2+(out) + ADP + phosphate, where Me is Zn2+, Cd2+, Co2+, Ni2+ or Pb2+. [TC:3.A.3.6.2]|OBSOLETE. Catalysis of the reaction: Me2+(in) + adenosine triphosphate. [TC:3.A.3.6.2]|132.85500000000002|44.64500000000004|-4.41952380952381|7.387142857142859|16.519203448275864|16.737457575757574|-57.42333333333334|-161.336|-0.4267241379310356|11.232424242424244|23.653016720917435|26.444876630455283|8.038095238095236|20.571428571428573
Biliary tract carcinoma that is resistant to treatment.|cancer that is resistant to treatment.|33.57500000000002|62.79000000000002|9.57|5.246666666666666|13.902050000000001|12.832957142857145|-38.72|-65.34666666666666|10.24125|2.524285714285714|44.250742366654144|38.32226702584281|21.6|21.200000000000003
A carcinoma that arises from the anterior two-thirds of the tongue. Representative examples include squamous cell carcinoma, adenoid cystic carcinoma, and mucoepidermoid carcinoma.|A cancer that arises from the front two-thirds of the tongue. Representative examples include squamous cell cancer, adenoid cystic carcinoma, and mucusosal cancer.|-3.2510144927535976|29.853333333333353|15.61739130434783|11.000000000000004|12.1267|11.629033333333332|1.7843478260869574|-2.306086956521739|14.596250000000005|8.547466666666669|67.59412548439398|65.13532912329528|27.414492753623193|25.675362318840584
A large vein which returns blood from the head, neck and extremities to the heart.|A large vein which returns blood from the head, neck, extremities to the heart.|92.06250000000001|90.95857142857145|2.2816666666666663|2.3114285714285714|6.485833333333334|7.1665|-12.810666666666673|-14.145714285714288|6.7940000000000005|2.4160000000000004|31.29|31.29|8.333333333333334|8.514285714285714
A neoplasm that arises from mature B-lymphocytes or plasma cells. Representative examples include mature B-cell non-Hodgkin lymphomas, chronic lymphocytic leukemia, hairy cell leukemia, and plasma cell neoplasms.|A blood tumor that arises from mature B-lymphocytes or plasma cells. Representative examples include mature blood cell lymphomas, adult lymph nodes, and plasma cell tumors.|15.966666666666669|42.71266666666668|13.268148148148153|9.372000000000003|14.907166666666669|13.439937037037039|7.617777777777782|-0.47520000000000095|14.015999999999998|8.189999999999998|76.64453405168562|65.13532912329528|30.266666666666666|24.133333333333336
Interacting selectively and non-covalently with phosphatidylinositol-3,5-bisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 3' and 5' positions. [GOC:bf, PMID:18397324]|Interacting selectively and not binding with a molecule of protein that is phosphorylated at the 3' and 5' positions. [GOC:bf, PMID:18397324]|21.563500000000005|55.17750000000001|13.357000000000003|8.171666666666667|13.353757142857145|12.445160869565218|22.419199999999996|5.969523809523807|16.85785714285715|7.870000000000001|62.58|58.53822981607831|17.8|17.53333333333333
This gene is involved in both drug metabolism and bilirubin clearance.|This gene is involved in drug metabolism and bilirubin clearance.|55.12522727272727|49.48000000000002|6.936818181818182|7.600000000000001|12.794827272727273|13.957481818181819|-21.74545454545455|-25.683999999999997|9.332727272727272|5.298181818181817|44.250742366654144|44.250742366654144|16.745454545454546|18.0
An autoimmune disease that causes pain, swelling, and stiffness in the joints, and may cause severe joint damage, loss of function, and disability. The disease may last from months to a lifetime, and symptoms may improve and worsen over time.|An autoimmune disease that causes pain, swelling and rigidity in the joints, and may cause severe joint damage, loss of function and disability. The disease may last from months to a lifetime, but symptoms may improve and worsen over time.|68.51666666666668|64.28666666666669|7.015000000000001|7.605|9.3655|9.320952032520324|7.641000000000002|7.347000000000001|11.53125|7.804552845528452|69.96656701596841|69.96656701596841|20.333333333333336|20.333333333333336
The chemical reactions and pathways involving uracil, 2,4-dioxopyrimidine, one of the pyrimidine bases occurring in RNA, but not in DNA. [GOC:go_curators]|The chemical reactions and pathways involving uracil, 2,4-dioxopyrimidine, one of the bases occurring in RNA, but not in DNA. [GOC:go_curators]|43.09178571428572|52.86500000000001|9.857380952380954|8.370000000000001|13.818204347826088|13.818204347826088|9.329523809523813|7.150000000000002|10.122608695652175|8.279565217391305|66.37611354998121|62.58|21.34285714285714|20.0
Lack of one or more of the normal pulmonary fissures. []|Lack of one or two normal pulmonary fissures. []|78.19795454545455|70.66750000000002|3.7186363636363637|4.520555555555557|10.200500000000002|12.631922222222224|-29.229090909090914|-38.99111111111111|1.3230000000000004|0.706666666666667|38.32226702584281|38.32226702584281|13.109090909090908|15.133333333333333
Any process that activates or increases the frequency, rate or extent of myoblast proliferation. [GOC:BHF]|Any process that activates or increases the frequency, rate or extent of cellular support. [GOC:BHF]|30.022500000000008|41.30250000000001|10.935000000000002|9.361666666666668|12.915175000000001|13.346335294117647|-3.4026666666666685|-5.3626666666666765|8.180625|5.538823529411765|62.58|62.58|24.333333333333336|24.333333333333336
Serology reagents intended to detect antigens to human immunodeficiency virus serotype 1 (HIV-1) and/or serotype 2 (HIV-2). Human immunodeficiency viruses are retroviruses of the genus Lentivirus, family Retroviridae, that may cause acquired immunodeficiency syndrome (AIDS). Tests using these reagents are not widely utilized; these regents may have questionable clinical usefulness, and easier or less expensive tests may be available.|These viruses are retroviruses that are not widely utilized; these regents may have questionable clinical usefulness, and easier or less expensive tests may be available.|9.758665254237314|21.563500000000005|15.562500000000004|13.357000000000003|13.711288700564973|10.961684615384616|17.70372881355932|10.894399999999997|17.62129943502825|11.156153846153849|87.10767345647568|73.38155456243756|26.916949152542372|22.6
Functional Activities Questionnaire-NACC Version (FAQ-NACC Version) Writing checks, paying bills, balancing checkbook.|Functional Activities Questionnaire-NACC Version (FAQ-NAC Version) Writing checks, paying bills, balancing checkbook.|-3.7049999999999557|-3.7049999999999557|15.266666666666666|15.266666666666666|15.60947142857143|15.463833333333334|3.096666666666671|3.096666666666671|19.212857142857146|12.470000000000006|69.96656701596841|69.96656701596841|35.73333333333334|35.73333333333334
Higher intake of phosphorus compared to established reference standards or recommendations based on physiological needs.|Higher intake of phosphorus compared to established reference standards or suggestions based on physiological needs.|18.742500000000007|30.022500000000008|12.508333333333336|10.935000000000002|11.749166666666667|11.9283|2.085333333333324|0.9093333333333291|19.04|12.596250000000005|62.58|62.58|24.333333333333336|24.333333333333336
Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by getting tired very easily?|Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by being tired very easily?|61.45045454545455|57.605000000000004|10.153636363636362|10.690000000000001|9.189528571428571|9.751790909090909|16.479999999999997|16.212727272727278|13.517142857142858|12.691818181818185|93.86999999999999|98.94766798666859|25.163636363636368|26.981818181818184
structural deformities, malformations, or other abnormalities of the cranium, oral and facial bones, muscles, cartilage, etc, that exist at, and usually before, birth regardless of their causation.|structural deformities, malformations, or other abnormalities of the cranium, oral and facial bones, muscles, causation.|20.79916666666668|1.822499999999991|13.712037037037042|14.868333333333336|13.163107407407407|13.902050000000001|15.314074074074071|2.477333333333334|20.15555555555556|12.301875000000003|88.50148473330829|73.38155456243756|29.1037037037037|32.333333333333336
This gene is involved in both nuclear pore formation and nuclear import.|This gene is involved in both nuclearpore formation and nuclear import.|59.745000000000005|55.12522727272727|6.416666666666668|6.936818181818182|13.442533333333335|13.144933333333334|-19.443333333333328|-20.67636363636364|8.120000000000001|5.512499999999999|49.473833993334296|49.473833993334296|19.06666666666667|20.381818181818183
An Ephemerovirus infection of cattle caused by bovine ephemeral fever virus (EPHEMERAL FEVER VIRUS, BOVINE). It is characterized by respiratory symptoms, increased oropharyngeal secretions and lacrimation, joint pains, tremor, and stiffness.|An viral infection of cattle caused by a virus that is characterized by respiratory symptoms, increased oropharyngeal secretions and lacrimation, joint pains, and stiffness.|-0.14365591397850608|21.930000000000035|15.84645161290323|13.181666666666665|13.573687096774194|12.4673|11.376774193548389|12.328333333333333|17.01096774193548|12.514800000000001|80.79043260188672|76.64453405168562|29.939784946236557|24.8
A non-metastasizing neoplasm that arises from the skin. Representative examples include benign melanocytic skin nevus, acanthoma, sebaceous adenoma, sweat gland adenoma, lipoma, hemangioma, fibroma, and benign fibrous histiocytoma.|A non-metastasizing tumor that arises from the skin. Representative examples include benign melanocytic skin nevus, acanthoma, skin cancer, and benign fibrous histiocytoma.|-23.202619047619038|-4.417424242424232|18.81428571428572|15.697272727272729|15.245355172413795|13.902050000000001|11.125714285714292|0.2618181818181853|17.328275862068963|11.222500000000004|78.74477315987392|67.59412548439398|30.876190476190477|28.38787878787879
<p>Stain, Gomori-Wheatly trichrome</p>|Stain, Gomori-Wheatly triadrome/p>|-50.00999999999996|-50.00999999999996|20.980000000000008|20.980000000000008|19.823300000000003|19.773699999999998|-28.106666666666655|-33.986666666666665|2.5874999999999986|2.2557142857142836|44.250742366654144|44.250742366654144|27.866666666666664|27.866666666666664
A species of tick (TICKS) in the family IXODIDAE, distributed throughout the world but abundant in southern Europe. It will feed on a wide variety of MAMMALS, but DOGS are its preferred host. It transmits a large number of diseases including BABESIOSIS; THEILERIASIS; EHRLICHIOSIS; and MEDITERRANEAN SPOTTED FEVER.|A species of tick (TICKS) in the family IXODIDAE, distributed throughout the world but abundant in southern Europe. It will feed on a wide variety of MAMMALS, but DOGS are its preferred host. Viruses include BABESIOSIS; THEILERIASIS|43.08000000000001|47.981531531531516|10.23166666666667|9.63081081081081|10.35135|10.913187719298246|8.040833333333339|7.307027027027026|11.788125|8.453333333333333|71.69439674758411|69.96656701596841|22.3|21.14954954954955
The cascade of processes by which a signal interacts with a receptor, causing a change in the level or activity of a second messenger or other downstream target, and ultimately leading to inhibition of an innate immune response. [GOC:add, ISBN:0781735149, PMID:15771571]|A cascade of processes by which a signal interacts with an innate immune response. [GOC:add, ISBN:0781735149,15771571]|45.71530487804881|66.5275|11.975731707317074|5.967500000000001|11.069290476190476|12.855122222222224|18.546341463414635|1.2199999999999989|13.965714285714284|8.975000000000001|98.94766798666859|62.58|27.712195121951222|23.200000000000003
The component of the endoplasmic reticulum membrane consisting of gene products and protein complexes that are loosely bound to one of its surfaces, but not integrated into the hydrophobic region. [GOC:curators, GOC:dos]|The component of the membrane consisting of gene products and protein complexes loosely bound to one of its surfaces, but not integrated into the hydrophobic region. [GOC:curators, GOC:dos]|24.03875000000002|32.48928571428573|13.881250000000005|12.205714285714286|11.910288235294118|12.045622580645162|16.228749999999998|13.087142857142855|12.28235294117647|10.021935483870969|88.50148473330829|82.78555852321104|26.400000000000002|25.6
Squamous cell carcinoma that affects the renal pelvis.|Cancer that affects the renal pelvis.|44.150000000000006|62.79000000000002|8.094999999999999|5.246666666666666|13.902050000000001|15.08867142857143|-39.455000000000005|-66.32666666666665|9.6525|1.8514285714285705|49.473833993334296|44.250742366654144|26.6|27.866666666666664
This gene is involved in blood coagulation/hemostasis. It also plays a role in embryonic development, tissue remodeling and inflammation.|This gene is involved in blood clotting/hemolysis. It also plays a role in embryonic development, tissue remodeling and inflammation.|22.301403508771955|31.206666666666678|11.722105263157893|10.48|12.0275|12.254652380952383|-9.909473684210525|-10.837894736842102|10.652499999999996|7.189999999999998|51.09635603445709|51.09635603445709|19.37543859649123|19.37543859649123
Visual Functioning Questionnaire 25-Interviewer Administered Format Version 2000 (VFQ25-Interviewer Administered Format) General Heath and Vision: How much of the time do you worry about your eyesight?|Visual Functioning Questionnaire 25-Interviewer Administered Format Version 2000. How much of the time do you worry about your eyes?|30.76807692307696|59.16092105263158|15.426923076923078|7.367631578947371|14.048157142857145|11.50274761904762|28.41846153846153|4.431578947368415|21.166428571428575|7.189999999999998|112.8176994092682|62.58|30.400000000000002|20.642105263157895
A response indicating that an individual doesn't know and/or remember how long it has been since they last smoked a cigarette.|A response indicating an individual doesn't know and/or remember how long it has been since they last smoked a cigarette.|59.20607142857145|57.09500000000003|7.609761904761903|7.779999999999998|7.685719047619047|7.91682380952381|1.4895238095238064|0.6820000000000057|12.619999999999997|6.697142857142854|54.195869768830164|54.195869768830164|15.628571428571428|16.0
An inhibitor of the bromodomain-containing protein 4 (BRD4), with potential antineoplastic activity. Upon administration, the BRD4 inhibitor PLX51107 binds to the acetylated lysine recognition motifs in the bromodomains of the BRD4 protein, thereby preventing the binding of BRD4 to acetylated lysines on histones. This disrupts chromatin remodeling and gene expression. Prevention of the expression of certain growth-promoting genes may lead to an induction of apoptosis and an inhibition of proliferation in BRD4-overexpressing tumor cells. BRD4, a member of the human bromodomain and extra-terminal (BET) family of proteins, is a transcriptional regulator that is overexpressed in certain tumor cells and plays an important role in cellular proliferation.|An inhibitor of the bromodomain-containing protein 4 (BRD4), with potential anti-cancer activity. Upon administration, the BRD4 inhibitor PLX51107 binds to the lysine recognition motif in the DNA of a cell's protein maker. This|20.501446540880522|36.72454545454548|14.78867924528302|10.869696969696971|12.766245454545455|13.442533333333335|19.468301886792446|8.014545454545452|16.759545454545453|9.166666666666668|88.50148473330829|67.59412548439398|25.17987421383648|21.36969696969697
A clinical finding about one or more characteristics of pleural mesothelioma, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.|A clinical finding about one or more characteristics of pleural mesothelioma, following the rules of the classification system for distant metastases.|33.33250000000004|14.891785714285732|11.963888888888892|13.790714285714287|12.578292592592591|11.359372727272728|10.958518518518517|8.48952380952381|18.062222222222225|11.687727272727273|76.64453405168562|73.38155456243756|23.177777777777777|25.152380952380955
Moderate pain; limiting instrumental ADL|Mild pain; limiting instrumental ADL|-1.2799999999999727|32.56000000000003|14.68|9.96|16.5165|17.092433333333332|-16.863999999999997|-20.391999999999996|14.04|6.689999999999998|54.195869768830164|44.250742366654144|26.0|18.0
A semi-quantitative microscopic finding indicating that 5 percent or less of the nucleated cells in a bone marrow sample are immature mononuclear cells of lymphoid origin.|A semi-quantitative microscopy finding indicating that 5 percent or less of the cells in a bone marrow sample are immature mononuclear cells of lymphoid origin.|30.947692307692336|35.099500000000035|12.172307692307694|11.469000000000001|13.163107407407407|12.493507407407408|10.249230769230767|8.5424|17.189999999999998|8.870000000000001|76.64453405168562|73.38155456243756|23.661538461538463|22.6
World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: His or her day-to-day work/school?|World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy- In the past 30 days, how much difficulty your relative had in: His or her day-to-day work/school?|63.75887931034484|58.3991666666667|7.96844827586207|8.467592592592595|10.00820322580645|10.51755806451613|10.608275862068968|10.74074074074074|8.198709677419355|7.894838709677423|66.37611354998121|66.37611354998121|18.21379310344828|18.73333333333333
<p>The urgency for starting a patient encounter.</p><p>*Example:*Routine, urgent, emergency, and elective.</p>|The urgency for starting a patient encounter.p>*Example:*Routine, urgent, emergency, elective.|-12.232121212121172|-16.508333333333297|15.876363636363639|16.390000000000004|14.907166666666669|13.957481818181819|-27.272727272727266|-38.232000000000006|16.528|16.43090909090909|44.250742366654144|44.250742366654144|23.28484848484848|25.333333333333336
Providing and responding to implicit and explicit differences of opinion or disagreement, in a contextually and socially appropriate manner.|Providing and responding to implicit and explicit differences of opinion or disagreement, in a context and socially appropriate manner.|5.729342105263186|14.634605263157908|14.82026315789474|13.578157894736844|12.889426315789473|12.817|6.5978947368421075|5.359999999999999|17.817368421052628|10.887999999999998|73.38155456243756|73.38155456243756|26.957894736842107|26.957894736842107
Human ZNF496 wild-type allele is located in the vicinity of 1q44 and is approximately 31 kb in length. This allele, which encodes zinc finger protein 496, plays a role in the modulation of transcription.|Normal human ZNF496 gene is located in the vicinity of 1q44 and is about 31 kilobases in length. This gene, which encodes zinc finger protein 496, plays a role in modulating transcription.|68.43166666666669|69.10833333333336|6.530000000000005|6.270000000000003|12.62507142857143|12.794827272727273|3.2823529411764696|1.2825000000000024|9.524285714285714|6.050000000000001|62.58|59.91578840339164|18.650980392156864|18.016666666666666
Sounds having similar characteristics and functional properties of natural speech but which are made by means other than natural vocalization mechanisms (e.g., computer-generated speech sounds).|Sounds having similar characteristics and functional properties of natural speech but which are made by means other than natural voice mechanisms (e.g., computer-generated speech sounds).|24.52325000000002|38.05925000000002|11.391500000000004|9.503499999999999|11.606484615384616|10.739062962962963|-7.376000000000005|-8.787200000000006|21.460384615384612|13.056666666666665|49.473833993334296|46.934999999999995|18.5|16.900000000000002
Stage IV includes: Any T, Any N, M1. M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 6th and 7th eds.)|Stage IV includes: Any T, Any N, M1 (excludes peritoneal metastasis). (AJCC 6th and 7th eds.)|63.9821710526316|69.23416666666668|5.5151315789473685|4.927499999999998|16.33788947368421|15.992272549019608|-31.677894736842102|-26.467499999999994|2.7597368421052657|0.7974509803921528|44.250742366654144|44.250742366654144|18.742105263157892|17.133333333333336
A vitamin that can dissolve in water. Water-soluble vitamins are carried to the body's tissues but are not stored in the body. They are found in plant and animal foods or dietary supplements and must be taken in daily. Vitamin C and members of the vitamin B complex are water-soluble.|A vitamin that can dissolve in water. Water-soluble vitamins are carried to the body's tissues but are not stored in the bodies. They are found in plant and animal foods or dietary supplements and must be taken in daily. Vitamin C and members of the vitamin B complex are watersoluble.|57.94100000000003|57.94100000000003|7.662000000000003|7.662000000000003|8.2288|8.403493846153847|-1.9639999999999986|-1.7287999999999961|5.812115384615385|4.783846153846152|60.99543900981449|60.99543900981449|19.200000000000003|19.200000000000003
A malignant epithelial tumor with a glandular organization that originates in the ileum. [HPO:probinson]|A cancerous skin tumor with a glandular organization that originates in the ileum. [HPO:probinson]|-5.727142857142809|12.401428571428596|15.797142857142859|13.26857142857143|13.4825|12.915175000000001|-4.065714285714286|-6.16571428571428|9.637999999999998|6.708749999999998|62.58|58.53822981607831|25.65714285714286|22.8
Any process that modulates the frequency, rate or extent of L-tyrosine import into the cell. [GOC:TermGenie]|Any process that modulates the frequency, rate or extent of L-tyrosine import into the cell. [GOC:TermGenie]|40.09|40.09|9.655000000000001|9.655000000000001|11.9779|12.418226315789473|-2.822499999999998|-2.4550000000000054|5.834999999999997|5.134736842105266|66.37611354998121|66.37611354998121|25.700000000000003|25.700000000000003
Someone from whom an organ is removed for transplantation or other purpose.|Anyone from whom an organ is removed for transplantation or other purpose.|59.745000000000005|52.69500000000002|6.416666666666668|7.400000000000002|6.863366666666667|7.602746153846153|-17.97333333333333|-17.97333333333333|9.2975|4.645384615384614|54.195869768830164|54.195869768830164|22.400000000000002|22.400000000000002
Paced Tapping Test (Paced Tapping) Total number of intertap intervals within the tone-tapping phase of Trial n, that were trimmed before analysis.|Paced Tapping Test) Total number of intertap intervals within the tone-tapping phase of Trial n, that were trimmed before analysis.|34.160909090909115|35.94500000000002|11.22727272727273|10.73|12.445160869565218|11.895233333333334|6.4999999999999964|3.6220000000000034|8.89391304347826|5.5725757575757555|82.78555852321104|76.64453405168562|29.854545454545452|28.0
A sulfur-containing alkyl thionitrite that is one of the NITRIC OXIDE DONORS.|A sulfur-containing alkyl thionitrite that is one of the NOXIDE DONORS.|45.64500000000001|47.434318181818185|8.383333333333333|8.009545454545457|12.783607692307694|12.461207692307694|-16.993333333333332|-20.67636363636364|8.25769230769231|3.558461538461536|54.195869768830164|49.473833993334296|22.400000000000002|20.381818181818183
OBSOLETE. The pathway by which adenine, hypoxanthine and their nucleosides from purine nucleotides breakdown are converted back to purine nucleotides. The salvage pathway is important where there is no de-novo purine nucleotide biosynthesis. [GOC:pz]|OBSOLETE. The pathway by which adenine, hypoxanthine and their DNA fragments are converted back to purine nucleotides. This salvage pathway is important where there is no de-novo DNA synthesis. [GOC:pz]|29.00750000000002|49.76250000000002|11.325000000000003|8.181666666666668|12.855122222222224|12.658427272727273|2.7047058823529397|-5.3626666666666765|10.414166666666667|6.387727272727272|66.37611354998121|56.4088497046341|24.576470588235296|20.333333333333336
Interference or disruption of cognitive processes. This term encompasses a large number of problems and issues associated with intellectual functioning and information processing. 2005|Interference or disruption of mental processes. This term encompasses a large number of problems and issues associated with intellectual functioning and information processing.|18.940000000000026|15.140289855072496|12.605000000000004|13.052173913043479|12.586216666666667|12.586216666666667|2.444999999999993|1.017391304347825|13.77375|12.596250000000005|65.13532912329528|65.13532912329528|24.866666666666667|25.675362318840584
Pan-DR epitope (PADRE) 965.10 is a helper peptide. PADRE peptides have been shown the capacity to deliver help for antibody responses in vivo. They were also found to be able to provide significant helper T-cell activity in vivo. Acts as an adjuvant.|Pan-DR epitope 965.10 is a helper peptide. PADREs have been shown the capacity to deliver help for antibody responses in vivo. They were also found to be able to provide significant help.|56.71571428571431|60.22025000000002|7.08761904761905|6.449750000000005|10.641645454545454|10.095452941176472|-13.025714285714287|-17.401249999999997|5.5861363636363635|4.015000000000001|52.66891825355824|50.453608988852324|18.99047619047619|18.81
A surgical camera and accessories is a device intended to be used to record operative procedures.|A surgical camera and accessory is a device intended to be used to record operative procedures.|24.22750000000002|24.22750000000002|11.867500000000003|11.867500000000003|10.35135|10.559864705882354|-6.864999999999998|-7.232500000000002|10.414375|4.984705882352941|62.58|62.58|23.200000000000003|23.200000000000003
bai dou kou|seizure drug|119.19000000000003|77.90500000000002|-2.619999999999999|2.890000000000004|19.5753|19.5753|-81.02666666666666|-112.72|-5.800000000000001|-1.0899999999999999|0.0|31.29|1.2000000000000002|20.8
The collection of afferent neurons that serve to connect the hair cells of the vestibular sensory end organs with the brain.|The collection of afferent neurons that serve to connect the hair cells of the sensory end organs with the brain.|63.23464285714289|74.01500000000001|7.0478571428571435|5.419999999999998|8.43762380952381|7.91682380952381|0.9295238095238112|-1.6699999999999982|12.17142857142857|4.902857142857144|58.53822981607831|54.195869768830164|17.53333333333333|16.0
Increase in size of the right atrium. [HPO:probinson]|Increased size of the right atrium. [HPO:probinson]|65.30000000000001|58.25392857142859|5.145|6.003571428571426|10.877477777777777|12.631922222222224|-40.19|-45.931428571428576|2.8000000000000007|2.8000000000000007|38.32226702584281|38.32226702584281|16.6|18.54285714285714
A lozenge containing an extract from the Lactobacillus brevis (L. brevis) with potential anti-inflammatory activity. As L. brevis CD2 contains high levels of arginine deiminase, which catalyzes the conversion of arginine to citrulline and ammonia, administration of this lozenge leads to hydrolysis of arginine in the oral cavity. The growth of bacteria, which depends on arginine, is halted, polyamine biosynthesis is reduced and the production of nitric oxide (NO) is reduced. The reduction in NO generation may further prevent inflammation in the oral cavity. Therefore, this agent may be able to reduce chemo- and radiotherapy-induced mucositis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C99229" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C99229" NCI Thesaurus)|A lozenge containing an extract from a bacterial strain with potential anti-inflammatory activity. As L. brevis contains high levels of arginine deiminase, which catalyzes the conversion of the molecule to citrulline and ammonia,|35.810333333333375|21.342727272727302|10.053185185185185|13.015151515151516|12.88511038961039|13.527357142857145|1.791111111111114|8.370909090909091|19.140233766233763|13.426857142857138|59.368600792001146|74.48509850970193|22.880000000000003|25.006060606060608
Leaving vocational training programme in an appropriate manner to enter the next level of school education, work, employment or other domains of adult life.|Leaving vocational training programme in an appropriate manner to enter the next level of school education, work, or other domains of adult life.|39.55500000000001|44.35380434782613|10.723333333333333|9.929782608695653|10.74815|10.15295|7.9183333333333366|5.961739130434779|16.082500000000003|8.31625|79.77416029015912|76.64453405168562|26.466666666666665|25.469565217391306
A series of intracellular molecular signals mediated by TORC1; TOR (target of rapamycin) in complex with at least Raptor (regulatory-associated protein of TOR), or orthologs of, and other signaling components. [GOC:lb]|A series of intracellular molecular signals mediated by TORC1; TOR (target of rapamycin) in complex with at least two other proteins. [GOC:lb]|19.173467741935525|45.69727272727275|14.43564516129032|9.618181818181817|14.02459696969697|13.442533333333335|16.56258064516129|5.698181818181819|11.939999999999998|7.138750000000002|85.69119412168324|69.96656701596841|25.554838709677423|22.581818181818182
A visual estimation of the percent or fraction of the volume of blood ejected from the left ventricle during left ventricular systole.|A visual estimation of the percent or fraction of blood ejected from the left ventricle during left ventricular systole.|45.69727272727275|41.350394736842105|9.618181818181817|9.851842105263156|11.187245454545454|11.238|3.2927272727272765|0.717894736842112|13.548181818181817|7.5909999999999975|69.96656701596841|66.37611354998121|22.581818181818182|22.74736842105263
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an anisomycin stimulus. [GOC:mah]|Any process that results in a change in state or activity of cellular constituents (in terms of movement, secretion, enzyme production, etc.). [GOC:mah]|53.245833333333366|51.92289855072465|8.482500000000002|7.9217391304347835|11.632172727272728|12.4673|1.833750000000002|-5.118260869565219|8.22909090909091|7.616399999999999|65.13532912329528|59.91578840339164|20.516666666666666|22.197101449275365
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism. [GOC:go_curators]|Any process that activates or increases the frequency, rate or extent of chemical reactions and pathways within a cell or an organism. [GOC:go_curators]|36.03|33.31902173913048|11.215|11.468913043478263|11.8357|12.4673|7.9183333333333366|7.7513043478260855|8.935200000000002|8.558399999999999|76.64453405168562|76.64453405168562|24.8|25.469565217391306
Interacting selectively and non-covalently with phosphatidylinositol-3-phosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 3' position. [GOC:bf, PMID:10209156, PMID:11395417, PMID:11557775]|Interacting selectively and not binding with a molecule of protein in which the inositol ring is phosphorylated at the 3' position. [GOC:bf, PMID:10395417,75]|24.94750000000002|44.35380434782613|12.885000000000002|9.929782608695653|13.917685714285716|11.8357|26.4176|9.285217391304343|19.549285714285716|9.500400000000003|62.58|62.58|17.8|18.51304347826087
Automated brachytherapy applicators designed to deliver therapeutic radioactive sources to, retrieve them from, and/or hold them in the uterine cavity. The applicator consists of a hollow metal tube (i.e., tandem), which temporarily holds the radioactive source, and two semioval, cuplike structures (i.e., ovoids) placed on either side of the cervix. The applicator holds the radioactive source during treatment and includes tiny shields to reduce the radiation dose to the rectum and bladder. The tandem is fixed inside a hollow plastic tube (i.e., Smitt sleeve) previously inserted into the uterine cavity. Tandem/ovoid interstitial/intracavitary applicators are used to treat cervical cancer.|The applicator consists of a hollow metal tube (i.e., tandem), which temporarily holds the radioactive source to, retrieve them from, and/or hold them in the uterine cavity.|35.24306818181819|58.983750000000015|10.393156565656568|6.709166666666668|12.924261584158417|11.66197142857143|-0.36121212121211954|-11.620740740740736|15.577623762376234|9.288214285714286|62.58|49.473833993334296|22.693939393939395|17.514814814814816
Orthoses designed to stabilize the hand, provide hand immobilization and/or support while keeping its functional structure and position while permitting the movement of the fingers and thumb. These orthoses typically consist of a device that is placed encircling the distal segment of the forearm and is attached to a rigid component used to support the hand. Hand orthoses are used mainly in patients with severe weakness or complete paralysis of the hand muscles. Static hand orthoses used for therapeutic purposes (e.g., to avoid hyperextension) and/or including attachments intended for functional activities are also available.|Orthoses designed to stabilize the hand, provide hand immobilization and/or support while keeping its functional structure and position while permitting the movement of the fingers and thumb. These orthoses typically consist of a device that is placed encircling the outer ring around the forearm and is attached to|40.20500000000001|37.950000000000045|10.987568389057753|13.928333333333335|12.193163829787235|11.618842857142857|11.673617021276591|20.61916666666667|16.926489361702124|16.484693877551017|80.21128224882081|103.77718969022045|24.945896656534956|27.933333333333334
The determination of the ratio of glutathione-s-transferase compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.|The determination of the ratio of glutathione-s-transferase compared to creatinine present in a sample. The measurement may be expressed as ratio or percentage.|33.04000000000002|29.853333333333353|10.638333333333335|11.000000000000004|10.961684615384616|11.354058974358974|-2.9450000000000003|-3.073043478260871|9.525769230769232|7.359102564102564|59.91578840339164|59.91578840339164|21.53333333333333|22.197101449275365
Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C88089" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C88089" NCI Thesaurus)|Stage 0 includes: Tis, No regional lymph node metastasis. (from AJCC 7th Ed.) Check for "https://www.cancer.gov/about-Cancer/treatment/clinical-trials/intervention/C88089" active|88.87423076923078|93.90164705882354|1.5511111111111155|1.0065882352941173|15.734085714285715|15.486788888888892|-49.558888888888866|-30.680000000000007|24.447261904761902|23.62833333333333|28.782613742434055|27.986626806387367|13.32991452991453|10.771764705882353
A disorder characterized by an abnormal communication between the oral cavity and another organ or anatomic site.|A disorder characterized by an abnormal communication between the mouth and another body part or site.|4.125147058823558|29.515000000000015|14.795588235294119|11.130000000000003|11.910288235294118|9.631041176470589|-1.2729411764705887|-4.660000000000004|13.667647058823526|6.9241176470588215|69.96656701596841|58.53822981607831|26.929411764705886|20.700000000000003
Eighteen-carbon essential fatty acids that contain three double bonds.|Fat acids that contain three double bonds.|33.067500000000024|82.42535714285715|9.765|2.6321428571428562|13.6065|11.7299|-25.271111111111104|-53.49142857142857|11.829999999999998|1.7650000000000006|54.195869768830164|38.32226702584281|28.466666666666665|18.54285714285714
A semi-quantitative microscopic finding indicating that 20 percent or less of the cells in sample are detected following staining using an anti-Ki-67 antibody.|A semi-quantitative microscopic finding indicating that 20 percent or less of the cells in sample are detected following staining with an anti-Ki-67 antibody.|36.997282608695684|36.997282608695684|10.955869565217395|10.955869565217395|13.0873|12.783607692307694|9.285217391304343|9.285217391304343|16.315599999999996|9.344615384615388|69.96656701596841|69.96656701596841|21.991304347826087|21.991304347826087
Wechsler Adult Intelligence Scale, 4th Edition. The subject either names objects presented visually or defines words that are presented visually and orally.|Wechsler Adult Intelligence Scale, 4th Edition. The subject either names objects presented visually or isolating them from being heard.|34.037121212121235|40.11192982456143|10.333636363636366|9.237894736842104|12.0771|11.862166666666667|-4.281818181818181|-10.218947368421055|12.329999999999998|8.985833333333332|65.13532912329528|59.91578840339164|26.56969696969697|25.69122807017544
A response indicating that an individual has or had an occasional cough.|A response indicating an individual has or had an occasional cough.|38.595|32.05250000000001|9.366666666666667|10.155000000000001|9.495033333333335|10.513266666666667|-19.443333333333328|-22.81454545454546|8.120000000000001|3.942499999999999|44.250742366654144|44.250742366654144|15.733333333333333|16.745454545454546
This gene plays a role in the modulation of the phosphorylation of the C-terminal domain (CTD) of DNA-directed RNA polymerase II subunit RPB1 (POLR2A).|This gene plays a role in the modulation of the phosphorylation site on RNA polymerase II subunit RPB1 (POLR2A).|53.655|68.0661842105263|8.756666666666668|6.125526315789475|14.035715384615385|13.6065|6.693333333333335|-1.757894736842104|13.489615384615384|5.235999999999997|58.53822981607831|44.250742366654144|16.46666666666667|12.221052631578948
A appetite depressant considered to produce less central nervous system disturbance than most drugs in this therapeutic category. It is also considered to be among the safest for patients with hypertension. (From AMA Drug Evaluations Annual, 1994, p2290)|A appetite drug considered to produce less central nervous system disturbance than most drugs in this therapeutic category. It is also considered among the safest for patients with high blood pressure. (From AMA Drug Evaluations Annual, 1994, p2290)|40.36254385964915|49.2678070175439|10.776315789473689|9.534210526315793|12.57529298245614|12.783607692307694|10.209473684210526|9.590526315789479|11.056228070175436|10.069230769230767|78.74477315987392|76.64453405168562|25.066666666666666|24.014035087719297
A wheel is a circular component that is intended to rotate on an axial bearing and are used to support and to provide a means of moving the wheelchair. These wheels can be rotated manually by the user or power-assisted with batteries. Wheelchair wheels are typically between 22 to 26 inches (56 to 66 cm) in diameter. Smaller wheels, typically between 3 and 8 inches (7 to 20 cm) in diameter and between 1 and 2 inches (2.5 to 5 cm) in width, are sometimes called casters. Wheelchairs typically have two sets of wheels, 2 larger ones and 2 smaller ones. The wheels can be placed on the front, middle, or rear of the wheelchair, depending upon its design.|A wheel is a circular component that is intended to rotate on an axial bearing and are used to support and to move the wheelchair. These wheels can be rotated manually by the user or power-assisted with batteries. Wheelchair wheels are typically between 22 to 26 inches (56 to 66 cm|80.83267331932774|66.82705882352944|5.680157563025212|8.161568627450979|10.023416666666666|10.471257232704403|6.585546218487391|9.45176470588235|8.86225|7.754088050314465|65.44773057562806|74.48509850970193|17.71470588235294|20.133333333333333
Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta3-adrenergic receptors. [GOC:mah, IUPHAR_GPCR:1274]|Combining with epinephrine or a molecule of fat or protein, with the chemical characteristics of beta3 receptors. [GOC:mah, IUPHAR_GPCR:1274]|11.424615384615407|45.80302631578948|14.895384615384618|9.230789473684215|13.917685714285716|13.180157142857144|18.843076923076918|7.2168421052631615|15.34392857142857|10.285714285714285|76.64453405168562|62.58|23.661538461538463|20.642105263157895
A protein ternary complex that anchors microtubule minus ends to mitotic spindle pole bodies. The founding complex contains a microtubule anchoring protein (Msd1 in fission yeast), A WD-repeat Wdr8 family protein and and a minus end-directed kinesin. [PMID:25987607, PMID:29021344]|A protein complex that anchors microtubule minus ends to mitotic spindle pole bodies. The founding complex contains a protein anchoring protein (Msd1 in fission yeast), A WD-repeat Wdr8 family protein and plus end-directed k|46.132307692307705|45.26235294117649|10.054358974358976|11.169411764705881|13.172171544715447|13.515991891891893|13.867692307692305|15.792941176470588|12.169918699186994|11.497297297297301|84.73372056035305|96.44225707644962|27.764102564102565|29.152941176470588
A unit of magnetic flux density equal to 10(E-9) tesla (one nanotesla) or 10(E-5) oersted, traditionally used in geophysics for measurement of changes in the Earth's magnetic field.|A unit of magnetic flux density equal to 10(E-9) Tela (one nanotesla) or 10 (E-5 oersted, traditionally used in geophysics for measurement of changes in the Earth's magnetic field.|50.61785714285716|55.0071551724138|9.677142857142858|9.189137931034484|12.35637142857143|12.275500000000001|11.197142857142854|10.608275862068968|17.465714285714284|9.149000000000001|76.64453405168562|76.64453405168562|22.742857142857144|22.351724137931036
The hydrochloride salt of the synthetic imidazothiazole derivative levamisole with anthelminthic and immunomodulating activities. In immunosuppressed states, levamisole may restore immune function by: 1) stimulating antibody formation, 2) stimulating T-cell activation and proliferation, 3) potentiating monocyte and macrophage phagocytosis and chemotaxis and 4) increasing neutrophil mobility, adherence, and chemotaxis.|The hydrochloride salt of a drug derivative levamisole with anthelminthic and immunomodulating activities. In immunosuppressed states, it may restore immune function by: 1) stimulating antibody formation, 2) stimulating T-cell activation and proliferation, 3) potentiating|-30.739251700680228|-11.967058823529385|21.604489795918365|19.151764705882353|15.613700000000001|14.617355555555555|26.637551020408164|24.094117647058827|24.982|17.792499999999997|97.28456352371633|91.22524239485473|30.206802721088437|26.8
<p>A container having dimensions that adjust somewhat based on the amount and shape of the material placed within it.</p>|A container having dimensions that adjust somewhat based on the amount and shape of the material placed within it.|63.613552631578955|63.613552631578955|6.746578947368423|6.746578947368423|12.329039130434783|9.659|0.717894736842112|-1.1389473684210465|11.162608695652175|6.178000000000001|58.53822981607831|58.53822981607831|18.53684210526316|18.53684210526316
Human MIR10A wild-type allele is located in the vicinity of 17q21.32 and is 109 bases in length. This allele, which encodes MIR10A pre-miRNA, plays a role in the regulation of gene expression. Alteration in the expression of this gene is associated with development of chronic myeloid leukemia.|Normal human MIR10A gene is located in the vicinity of chromosome location, 17q21.32, and is 109 bases in length. This gene, which encodes a protein complex, but is associated with development of chronic myeloid leukemia.|58.69400000000002|57.7594642857143|7.407914893617022|7.376785714285717|12.825000680272108|13.442533333333335|-0.4629787234042624|-2.244571428571426|9.902176870748299|8.381666666666664|59.368600792001146|60.592824451415034|19.079148936170213|20.642857142857142
A broad class of cell surface proteins that bind specifically to VIRAL SPIKE PROTEINS found on a CORONAVIRUS. The attachment of the virus is the first step of a process that leads to CORONAVIRUS INFECTIONS.|A broad class of cell surface proteins that bind specifically to VIRAL SPIKE PROTEINS found on a CORONAVIRUS. The attachment of the virus is the first step that leads to viral infection.|57.21619047619049|63.820833333333354|8.177142857142858|7.0075|9.015928571428573|8.966948484848485|3.524571428571427|0.9150000000000063|10.197142857142854|6.050000000000001|59.91578840339164|57.127462747788826|17.238095238095237|16.766666666666666
Physiologic monitoring software designed to operate hemodynamic monitors, control/monitor a limited number of their functions, and/or process data obtained while monitoring hemodynamics. This software applies a variety of algorithms to facilitate the operation and analysis of the measurements performed while monitoring hemodynamic parameters such as electrocardiographic data and waveform, blood pressure, cardiac output, central venous pressure, temperature, peripheral venous oxygen saturation, and blood gas analysis. The software usually works with many models of hemodynamic monitors; it may also work with patient information obtained from workstations and remote monitors and interact with hospital information systems. Dedicated hemodynamic software is available to extend the capabilities of the parameters that can be processed [e.g., coronary flow reserve (CFR), first time derivative of pressure (dP/dt)].|This software usually works with many models of hemodynamic monitors; it may also work with patient information obtained from workstations and remote monitoring systems, and/or process the parameters that can be processed [e.g., coronary flow reserve (CFR), first time derivative of pressure (dP/|-4.381074380165273|30.956434108527162|18.16465171192444|12.50232558139535|14.661374796747968|14.431627272727273|21.70347107438016|14.218604651162785|23.660121951219516|27.01022727272727|100.3512511132771|82.78555852321104|30.7159386068477|25.268217054263566
(J0400=9)|(J0400=9)|205.82000000000002|205.82000000000002|-15.2|-15.2|19.476100000000002|19.5257|-243.07999999999998|-237.2|12.04|-1.5899999999999999|0.0|0.0|0.4|0.4
Prostate cancer with tumor involving both lobes. (from AJCC 7th Ed.)|Prostate cancer with tumor involving both lobes. (from AJCC 7th Ed.)|80.0587878787879|80.0587878787879|3.003636363636364|3.003636363636364|15.392936363636366|15.7766|-49.72363636363636|-49.18909090909091|4.441818181818181|3.157499999999999|40.39521630094336|40.39521630094336|19.64848484848485|19.64848484848485
Methods of preparing cells or tissues for examination and study of their origin, structure, function, or pathology. The methods include preservation, fixation, sectioning, staining, replica, or other technique to allow for viewing using a microscope.|Methods of preparing cells or tissues for examination and study of their origin, structure, function, or pathology. The methods include preservation, fixation, sectioning, staining a microscope.|28.210476190476186|22.330641025641057|12.222857142857148|12.297692307692309|11.722785714285715|13.078322222222225|10.916571428571423|4.292307692307688|15.041714285714285|13.579999999999998|82.78555852321104|72.26115969177356|28.66666666666667|28.08205128205128
A nanodispersion containing the benzoquinone ubidecarenone (coenzyme Q10), with potential protective, antioxidant and antineoplastic activities. Upon administration, ubidecarenone nanodispersion BPM31510 modulates tumor cell metabolism and causes an anti-Warburg effect by inducing a shift from lactate dependency towards mitochondrial oxidative phosphorylation, and induces tumor cell apoptosis. This inhibits tumor cell proliferation. BPM 31510 also induces the activation and maturation of T lymphocytes, and changes the surface expression of certain immune checkpoint modulators. In addition, as an antioxidant, ubidecarenone protects against cell damage, by preventing both the peroxidation of lipid membranes and the oxidation of LDL-cholesterol. Ubidecarenone is an essential coenzyme for mitochondrial enzyme complexes involved in oxidative phosphorylation and the production of adenosine triphosphate (ATP). Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C118621" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C118621" NCI Thesaurus)|A nanodispersion containing a molecule of fat and protein, with potential protective, antioxidant and anti-cancer activities. Upon administration, ubidecarenone is an essential coenzyme for cancer drug complexes involved in oxidative phosphorylation, and induce|2.3142857142857736|-15.003409090909088|15.172380952380955|19.45106060606061|13.805412500000001|14.429642857142857|15.597777777777779|23.04242424242424|23.808437499999997|17.464000000000006|71.45012211326164|98.94766798666859|26.774603174603183|30.842424242424244
A monoclonal antibody directed against the cell surface protein claudin 6 (CLDN6), with potential immunostimulating and antineoplastic activities. Upon administration, the anti-CLDN6 monoclonal antibody IMAB027 binds to CLDN-6 and may stimulate the immune system to exert both an antibody-dependent cellular cytotoxicity (ADCC) and a complement-dependent cytotoxicity (CDC)-mediated immune response against CLDN-6-expressing tumor cells. This may inhibit tumor cell growth. CLDN-6, a tight-junction protein and embryonic antigen, is expressed on a variety of tumor cells but is not expressed on normal, healthy adult cells. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C114286" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C114286" NCI Thesaurus)|A monoclonal antibody directed against a protein complex, with potential immunostimulating and anti-cancer activities. Upon administration, the antibody binds to CLDN6 and may stimulate the immune system to exert both an antibody-dependent cellular cytotoxicity (ADCC) and|34.05221491228073|-13.534999999999997|10.476447368421052|19.618888888888893|13.463466666666667|13.510879487179487|10.70273684210526|22.428888888888892|22.275433333333332|16.21769230769231|61.26237874911485|98.94766798666859|22.535087719298247|29.422222222222224
Stage IVA includes: (T4, N0, M0); (Any T, N1, M0). T4: Tumor with periductal invasion. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.)|Stage IVA includes: (T4, N0, M0); (from AJCC 7th Ed.)|82.46970588235294|125.62000000000002|2.963109243697481|-3.0199999999999996|16.850829411764707|16.82839090909091|-30.67647058823529|-32.739999999999995|1.8900000000000006|-3.2654545454545456|40.9682267129052|31.29|16.060504201680672|10.0
The date (and time) on which an adverse event began.|The day (and time) on which an adverse event began.|91.78000000000003|91.78000000000003|1.7000000000000028|1.7000000000000028|7.2905|8.215663636363637|-33.916|-33.916|2.41|-1.5527272727272745|38.32226702584281|38.32226702584281|14.0|14.0
Antibody Degradation consists of conjugation, transport, oxidation, and/or proteolysis of members of a class of cell-surface or secreted B lymphocyte proteins that non-covalently interact through intermolecular physical forces of attraction and spatial complementarity selectively and specifically with foreign substances (antigens), typically as part of an immune response.|Antibody Degradation consists of conjugation, transport, oxidation and/or degradation of proteins that non-covalently interact through intermolecular physical forces of attraction and spatial complementarity selectively and specifically with foreign substances, typically as part of an immune response.|-16.817499999999995|-25.284999999999968|21.443085106382984|21.25777777777778|15.412002040816327|15.382584210526316|28.439148936170213|27.32888888888889|33.733061224489795|20.668157894736844|117.07645963215661|106.1095525859948|33.229787234042554|32.75555555555555
The chemical reactions and pathways performed by an organism resulting in the breakdown of pectin in the cell wall of a second organism, where the two organisms are in a symbiotic interaction. [ISBN:0198547684]|The chemical reactions and pathways performed by an organism resulting in the breakdown of a cell wall protein, where the two organisms are in an beneficial interaction. [ISBN:0198547684]|51.65113636363637|50.61785714285716|10.154090909090915|9.677142857142858|10.675203030303031|11.433975862068966|13.776969696969694|12.66714285714286|11.654545454545449|11.31896551724138|79.77416029015912|73.38155456243756|22.35757575757576|21.314285714285717
A type of junction that attaches one cell to its neighbor. One of a number of differentiated regions which occur, for example, where the cytoplasmic membranes of adjacent epithelial cells are closely apposed. It consists of a circular region of each membrane together with associated intracellular microfilaments and an intercellular material which may include, for example, mucopolysaccharides. (From Glick, Glossary of Biochemistry and Molecular Biology, 1990; Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)|A type of junction that attaches one cell to its neighbor. One of a number of differentiated regions which occur, for example, where the cytoplasmic membranes of adjacent epithelial cells are closely surrounded by cellular microfilaments and an intercellular material which may include|9.306639610389624|25.64970930232562|16.743474025974027|15.022906976744185|12.681663157894738|11.546109090909091|20.20883116883116|19.598139534883718|16.020131578947364|15.367954545454545|93.86999999999999|93.86999999999999|26.4012987012987|25.34418604651163
Mutated forms of genes which encode proteins that are essential for the control and maintenance of normal cellular processes. Inherited or somatic mutations in the wild-type form of these genes alters control of their expression, resulting in a change in control of the cell cycle. Individuals who harbor cancer-predisposing genes require fewer somatic mutations for transformation of a particular cell, thereby predisposing them to the development of cancer.|Mutated forms of proteins that are essential for the control and maintenance of normal cellular processes. Inherited or somatic mutations in the wild-type form of these genes alter their expression, resulting in a change in control of the cell cycle. Individuals who harbor cancer-predispo|30.332941176470626|36.20742424242428|13.251764705882355|11.852727272727272|12.463261904761906|11.804630496453902|16.484705882352944|12.82636363636363|16.141666666666666|10.654822695035463|88.50148473330829|80.79043260188672|25.623529411764707|24.048484848484847
The process in which UDP-glucose is transported across a membrane. [GOC:ai]|The process in which UDP-glucose is transported across a membrane. [GOC]|55.12522727272727|62.81613636363636|6.936818181818182|5.864090909090912|12.461207692307694|12.461207692307694|-19.07272727272727|-20.14181818181818|3.558461538461536|3.1961538461538446|54.195869768830164|49.473833993334296|24.018181818181816|20.381818181818183
Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has the subject engaged in non-suicidal self-injurious behavior. (Past _ Years).|Columbia Suicide Severity Rating Scale Baseline/Screening Version - Has the subject engaged in non-suicidal self-injury. (Past _ Years).|12.745000000000005|17.44500000000002|12.972222222222225|12.316666666666666|15.185500000000001|15.020166666666666|-6.539999999999992|-10.133333333333326|12.0655|8.043833333333332|57.127462747788826|57.127462747788826|24.622222222222224|24.622222222222224
Antibodies reactive with HIV ANTIGENS.|Antibodies reactive with HIV protein.|18.17750000000001|35.097500000000025|11.345000000000006|8.985000000000003|16.5165|16.94363333333333|-78.416|-78.416|12.155999999999999|5.975000000000001|38.32226702584281|38.32226702584281|25.0|25.0
Mild pain not interfering with function|pain not interfering with function|59.745000000000005|49.48000000000002|6.416666666666668|7.600000000000001|11.8291|11.8291|-16.01333333333333|-22.743999999999993|8.260000000000002|5.905000000000001|44.250742366654144|44.250742366654144|15.733333333333333|18.0
Blisters covering >30% BSA; associated with fluid or electrolyte abnormalities; ICU care or burn unit indicated|Blisters covering >30% BSA; associated with fluid abnormalities; ICU care or burn unit indicated.|10.820000000000022|24.487142857142885|15.725000000000005|11.582857142857147|14.69675882352941|14.888925000000002|16.78|-6.585714285714289|12.836470588235294|6.414375|93.86999999999999|62.58|28.900000000000002|25.65714285714286
A corticotroph adenoma composed of faintly basophilic or chromophobic PAS-positive cells with weak or patchy positivity for ACTH, consistent with the scant, small secretory granules seen ultrastructurally. (WHO 2017)|A tumor composed of faintly basophilic or chromosome-positive cells with weak or patchy positivity for ACTH, consistent with the scant, small secretory granules seen ultrastructurally. (WHO 2017)|11.248534482758657|20.79916666666668|15.292586206896551|13.712037037037042|13.328166666666666|13.067424137931035|17.704827586206893|15.096296296296302|14.643999999999998|12.455862068965516|79.77416029015912|73.38155456243756|23.731034482758623|21.696296296296296
The linkage of phosphoribosyl dephospho-coenzyme A to protein via peptidyl-serine, to form O-(phosphoribosyl dephospho-coenzyme A)-L-serine; it is uncertain whether the phosphoribosyl glycosidic attachment to the dephospho-coenzyme A is alpha or beta, and through the 2' or the 3' position. [RESID:AA0167]|The linkage of cellular protein building blocks are alpha or beta, and through the 2' or 3' position. [RESID:AA0167]|10.990000000000009|85.87671052631579|16.695000000000004|3.641315789473687|14.045343478260872|12.428252380952381|24.302000000000007|-0.5199999999999996|15.872608695652175|4.454285714285717|93.86999999999999|58.53822981607831|26.0|18.53684210526316
Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: aching.|Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: aching.|82.39000000000001|82.39000000000001|3.7550000000000026|3.7550000000000026|8.219166666666666|8.835408333333334|-11.275000000000002|-10.907499999999999|3.3580000000000005|1.2541666666666664|44.250742366654144|44.250742366654144|13.200000000000001|13.200000000000001
A peptide vaccine containing five immunogenic peptide epitopes of the human folate receptor alpha (FR alpha or FOLR1), including FR30, FR56, FR76, FR113, and FR238, with potential immunomodulating and antineoplastic activity. Upon administration, the multi-epitope FR alpha peptide vaccine may induce a cytotoxic T-lymphocyte (CTL) response against FR alpha-overexpressing tumor cells. FR alpha is a high-affinity folate-binding protein and a member of the folate receptor family; this receptor is overexpressed in a majority of ovarian cancers and in about 50% of breast cancers. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C101777" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C101777" NCI Thesaurus)|A protein vaccine containing five immunogenic peptide epitopes of the human folate receptor alpha (FRalpha or FOLR1), including a molecule of fat and protein building blocks, with potential immunomodulating and anti-cancer activity. Check for "http://www.|35.102775119617235|23.376190476190516|10.508708133971293|12.897142857142857|14.4183|13.94274864864865|11.157052631578942|11.924571428571419|21.8226|15.061621621621619|65.36267825824541|78.74477315987392|23.665071770334933|26.38095238095238
A substance intended for administration as a solution.|A substance intended for administration as a solution.|23.00000000000003|23.00000000000003|11.045000000000002|11.045000000000002|9.954550000000001|10.877477777777777|-39.455000000000005|-38.72|9.6525|5.416666666666668|44.250742366654144|44.250742366654144|21.6|21.6
Test names of questionnaire questions associated with the Functional Assessment of Multiple Sclerosis (FAMS) for the Clinical Data Interchange Standards Consortium (CDISC) Standard Data Tabulation Model (SDTM).|Test names of questionnaire items associated with the Functional Assessment of Multiple Sclerosis (FAMS) for the Clinical Data Interchange Standards Consortium (CDISC) Standard Data Tabulation Model (SDTM).|20.79916666666668|20.79916666666668|13.712037037037042|13.712037037037042|15.502366666666669|15.60947142857143|18.14518518518519|17.491851851851848|22.946666666666665|14.839285714285715|88.50148473330829|88.50148473330829|29.1037037037037|29.1037037037037
A term that refers to any individual item or entity in a hierarchy or pedigree.|A term that refers to any item or entity in a hierarchy or pedigree.|46.942499999999995|66.7871428571429|8.575000000000003|5.682857142857145|10.6965|10.3245|-13.986666666666672|-18.765714285714285|6.166|-0.41000000000000014|58.53822981607831|54.195869768830164|21.666666666666668|19.942857142857143
Stage IV includes: (T4, N0, M0); (Any T, N1, M0); (Any T, N2, M0); (Any T, Any N, M1). T4: Tumor invades adjacent organs, or through the kidney into the perinephric fat. N0: No regional lymph node metastasis. N1: Metastasis in a single lymph node, 2 cm or less in greatest dimension. N2: Metastasis in a single lymph node, more than 2 cm in greatest dimension; or multiple lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)|Stage IV includes: (T4, N0, M0); T4: Tumor invades adjacent organs, or through the kidney into the tissue surrounding a single lymph node, more than 2 centimeters in greatest measurement; T1: Metastasis. T2: T3|84.66027777777781|70.14470588235295|3.6591666666666676|7.698823529411765|14.033291666666669|14.429642857142857|-5.9580000000000055|13.371764705882352|1.4498333333333342|9.524285714285714|52.15|79.77416029015912|16.055555555555554|22.094117647058823
A complex syndrome resulting from various genetic and epigenetic anomalies of the 11p15.5 chromosomal region, leading to dysregulated expression of imprinted genes. Specific genes involved include CDKN1C, H19, IGF2, and KCNQ1OT1. One of the key genetic anomalies is an imbalance between the paternally expressed IGF2 growth enhancer gene and the maternally expressed H19 growth suppressor gene, leading to fetal and postnatal overgrowth. The condition is typically characterized by macrosomia, macroglossia, umbilical hernia or more severe abdominal wall anomalies such as omphalocele, ear lobe indentations, and hypoglycemia associated with hyperinsulinemia due to pancreatic islet cell hyperplasia. Patients with this syndrome have an increased risk for development of embryonal tumors (particularly Wilms tumor and hepatoblastoma) and adrenal cortex carcinoma.|A complex syndrome resulting from various genetic and epigenetic anomalies of the 11p15.5 chromosome region, leading to dysregulated expression of imprinted genes. Specific genes involved are CDKN1C, H19, and KCNQ1OT1. The condition is typically characterized by|12.716153846153844|33.20000000000002|15.637973137973141|10.864444444444448|14.649020341880343|14.490395495495497|19.832136752136755|4.351111111111109|19.697435897435902|13.123963963963966|91.6077398476788|66.37611354998121|27.198534798534798|23.6
A contraceptive diaphragm is a closely fitting membrane placed between the posterior aspect of the pubic bone and the posterior vaginal fornix. The device covers the cervix completely and is used with a spermicide to prevent pregnancy. This generic type of device may include an introducer.|A contraceptive diaphragm is a closely fitting membrane placed between the back aspect of the pubic bone and the posterior vaginal fornix. The device covers the cervix completely and is used with spermicide to prevent pregnancy. This generic type of device may include|51.71032608695654|54.56573643410857|8.903695652173912|9.209302325581397|11.948772463768117|11.90010303030303|5.5782608695652165|10.389767441860457|11.01536231884058|9.988560606060602|73.38155456243756|80.79043260188672|23.730434782608697|24.337984496124033
Molecular assay reagents intended to identify subtypes of Influenza virus type A (single-stranded RNA viruses of the family Orthomyxoviridae) that affect birds, by detecting the ribonucleic acid (RNA) of the target virus. Influenza A virus subtypes that cause avian influenza usually include the surface glycoproteins H5 or H7 (i.e., subtypes H5N1 and H7N2); these viruses may occasionally cause human influenza, a disease characterized by sudden onset of high fever, myalgia, headache, severe malaise, nonproductive cough, sore throat, and rhinitis.|Molecular assay reagents intended to identify subtypes of Influenza virus type A (single-stranded RNA viruses of the family Orthomyxoviridae) that affect birds, by detecting the ribonucleic acid (RNA) of a|25.881544303797483|-4.09499999999997|13.574531645569625|21.283333333333335|13.841041666666667|14.105575|16.396962025316455|24.825333333333333|18.57370833333333|19.739062499999996|91.76029239273379|125.16|28.092151898734176|33.333333333333336
A rare carcinoma that arises from the cervix. It is characterized by the presence of cystic spaces surrounded by palisaded epithelial cells. The cystic spaces contain eosinophilic hyaline material or mucin. Nuclear pleomorphism, necrotic changes, and a high mitotic rate are also present.|A rare cancer that arises from the cervix. It is characterized by the presence of cystic spaces surrounded by palisaded epithelial cells. The cysts contain eosinophilic hyaline material or mucin. Nuclear pleomorph|28.906000000000006|32.158750000000026|11.364|10.761250000000004|11.146676744186047|12.658427272727273|-0.7795348837209275|-3.373750000000001|10.233372093023256|8.385909090909088|68.55295529734659|64.5059875127883|25.765581395348836|24.450000000000003
Non-payable G-code for reporting functional limitation on physical therapy claim form|Non-payable G-code for functional limitation on physical therapy claim form.|18.77909090909094|24.100000000000023|13.372727272727271|11.14|15.212838461538462|16.105053846153847|13.181818181818176|-19.216|11.518461538461537|5.370000000000001|76.64453405168562|49.473833993334296|26.218181818181815|22.0
An elaboration of the sequence of biological or biochemical events that result in the transport of molecules from one physiological space to another.|An elaboration of the sequence of molecular events that result in the transport of molecules from one physiological space to another.|22.2842391304348|31.00607142857146|13.008043478260873|11.543095238095237|10.955995652173913|10.641645454545454|6.728695652173911|3.7295238095238084|15.872608695652175|8.26227272727273|69.96656701596841|66.37611354998121|21.991304347826087|21.34285714285714
The term 'phyto' originated from a Greek word meaning plant. Phytonutrients are certain organic components of plants, and these components are thought to promote human health. Fruits, vegetables, grains, legumes, nuts and teas are rich sources of phytonutrients. Unlike the traditional nutrients (protein, fat, vitamins, minerals), phytonutrients are not 'essential' for life, so some people prefer the term 'phytochemical'. (USDA Agricultural Research Service)|The term 'phyto' originated from a Greek word meaning plant. Phytochemical substances are certain organic components of plants, and these components are thought to promote human health. Fruits, vegetables, grains, legumes and teas are rich sources of phytonutrients. These nutrients are not|36.93171428571432|49.134642857142865|11.238285714285713|9.014523809523808|10.527333015873015|9.67783953488372|13.747936507936505|6.80952380952381|12.905714285714282|10.342906976744185|75.35629887408219|62.58|23.452698412698414|19.43809523809524
A sac or recess formed by a fold of the peritoneum.|A sac or recessformed by a fold of the peritoneum.|85.88886363636365|66.40000000000003|2.6459090909090897|5.240000000000002|7.053009090909091|9.651118181818184|-31.901818181818186|-34.50399999999999|1.1972727272727255|-1.124545454545455|31.29|31.29|9.472727272727274|10.0
Primary repair of injured organ/structure indicated|Primary repair of injured organ/structure indicated.|-38.954999999999984|-35.90999999999997|20.18333333333334|19.01333333333334|13.006557142857146|13.70365|-4.25333333333333|-51.62666666666666|12.348571428571425|7.6525|69.96656701596841|49.473833993334296|35.73333333333334|34.53333333333334
The 1.0 version of the standard for exchange of nonclinical data (SEND) animal rule implementation guide.|The 1.0 version of a standard for exchange of nonclinical data (SEND) animal rule implementation guide.|53.3716666666667|53.3716666666667|7.140000000000004|7.140000000000004|10.35135|10.559864705882354|-22.424999999999997|-22.79249999999999|12.180625|6.6470588235294095|47.79626449838941|47.79626449838941|19.633333333333336|19.633333333333336
A monoamine compound with positive inotropic activity. Dopamine is a naturally occurring catecholamine formed by decarboxylation of dehydroxyphenylalanine and a precursor of norepinephrine and epinephrine. Dopamine binds to alpha-1 and beta-1 adrenergic receptors. Mediated through myocardial beta-1 adrenergic receptors, dopamine increase heart rate and force, thereby increasing cardiac output. Alpha-1 adrenergic receptor stimulation on vascular smooth muscle, leads to vasoconstriction and results in an increase in systemic vascular resistance. Stimulation of dopaminergic receptors in renal vasculature, leads to renal blood vessel dilation, and an increase in glomerular filtration rate, renal blood flow, sodium excretion, and urine output.|A monoamine compound with positive inotropic activity. Dopamine is a naturally occurring catecholamine formed by decarboxylation of an amino acid, and results in an increase in systemic blood pressure. Alpha-1 and beta-2 receptor stimulation on vascular smooth muscle, leads to blood vessel di|6.126701030927848|25.05410852713183|15.84727540500737|13.325581395348838|13.87980996563574|12.97669393939394|18.162474226804125|13.808372093023252|17.63250859106529|12.450606060606063|86.9067327656494|82.78555852321104|27.81089837997055|25.268217054263566
Cervical carcinoma with measured stromal invasion equal or more than 3 mm and less than 5 mm in depth. (FIGO 2018)|Cancer with measured stromal invasion equal or more than 3 mm and less than 5mm in depth. (FIGO 2018)|79.34892857142859|94.78197368421053|4.800238095238097|2.399210526315791|12.428252380952381|12.254652380952383|-1.8704761904761895|-5.1621052631578905|4.23|0.23714285714285666|58.53822981607831|54.195869768830164|17.53333333333333|16.431578947368422
determination of where in an organism (i.e., organ system) or cell (i.e., organelle) a specific protein may be found.|determination of where in an organism (i.e., organ system) or cell type may be found.|56.68399122807017|73.30875|6.139736842105265|3.965833333333336|11.22732105263158|9.954550000000001|-62.835789473684216|-50.70933333333333|10.876315789473686|2.5874999999999986|33.79706274219699|31.29|16.003508771929823|12.166666666666668
Positive and Negative Syndrome Scale - Uncooperativeness.|Positive and Negative Syndrome Scale - Cooperativeness.|-2.1746428571428282|9.91107142857146|14.432142857142857|12.74642857142857|17.092433333333332|17.344385714285714|-41.731428571428566|-42.57142857142857|20.034999999999997|12.617142857142852|44.250742366654144|44.250742366654144|24.257142857142856|24.257142857142856
Immunohistochemistry test systems (IHC's) are in vitro diagnostic devices consisting of polyclonal or monoclonal antibodies labeled with directions for use and performance claims, which may be packaged with ancillary reagents in kits. Their intended use is to identify, by immunological techniques, antigens in tissues or cytologic specimens. Similar devices intended for use with flow cytometry devices are not considered IHC's.|Immunohistochemistry systems (IHC's) are in vitro diagnostic devices consisting of proteins or monoclonal antibodies labeled with directions for use and performance claims, which may be packaged with ancillary reagents in kits. Their intended use is to identify, by|9.720000000000027|16.123684210526363|15.630000000000003|15.730526315789472|12.260333333333334|11.891392307692307|16.52666666666667|19.855789473684215|16.987000000000002|15.372307692307693|84.2509034076193|91.22524239485473|25.333333333333336|25.494736842105265
The manner in which a particular genetic trait or disorder is passed from one generation to the next.|The manner in which a certain genetic trait or disorder is passed from one generation to the next.|61.400000000000034|70.80000000000003|6.9311111111111146|5.6200000000000045|9.792633333333335|9.094015789473683|-5.448888888888881|-6.10222222222222|9.28833333333333|3.399473684210527|49.473833993334296|49.473833993334296|14.711111111111112|14.711111111111112
AIDS-related Kaposi sarcoma localized on the palate. The lesions are small and flat rather than raised. This stage is associated with good risk of recovery.|HIV-related Kaposi sarcoma localized on the palate. The lesions are small and flat rather than raised. This stage is associated with good risk of recovery.|51.59525000000002|51.59525000000002|7.615500000000001|7.615500000000001|10.139443589743589|10.404262962962964|-16.313599999999997|-16.313599999999997|6.091025641025642|4.273888888888887|46.934999999999995|46.934999999999995|16.900000000000002|16.900000000000002
A type I keratin expressed predominately in gastrointestinal epithelia, MERKEL CELLS, and the TASTE BUDS of the oral mucosa.|A type I keratin expressed predominately in gastrointestinal epithelia, MERKEL CELLS, and the TASTE BUDS of the oral mucous fluid.|23.53986842105263|27.485000000000014|12.336052631578948|11.91|13.72047894736842|14.452861904761905|1.6463157894736824|3.3279999999999994|13.603157894736846|13.517142857142858|62.58|66.37611354998121|20.642105263157895|22.0
For NDAs, ANDAs, and BLAs, this represents an application to modify the current indications or claims for a use for which the application was previously approved/licensed. Efficacy supplements may only be submitted once the original-application has been approved/licensed.|This represents an application to modify the current indications or claims for a use for which the application was previously approved or licensed. Efficacy supplements may only be submitted once the original-application has been approved/licensed.|15.873070175438642|18.54190476190476|14.192105263157895|13.571428571428577|12.355739024390244|11.744240350877194|12.994736842105265|10.74857142857143|14.897317073170733|11.056228070175436|69.96656701596841|69.96656701596841|20.856140350877194|21.80952380952381
Any process that activates or increases the frequency, rate or extent of DNA endoreduplication. [GOC:mah]|Any process that activates or increases the frequency, rate or extent of DNA repair. [GOC:mah]|18.742500000000007|46.942499999999995|12.508333333333336|8.575000000000003|12.915175000000001|12.417511764705882|-3.7946666666666715|-7.714666666666666|7.88625|3.8764705882352963|62.58|62.58|24.333333333333336|24.333333333333336
Death|Sudden death|121.22000000000003|77.90500000000002|-3.3999999999999986|2.890000000000004|0.0496|9.048633333333335|-266.6|-112.72|2.620000000000001|-1.0899999999999999|0.0|31.29|0.4|20.8
DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix.|DNA Topoisomerases that relax the superhelical turns and knotted rings in the DNA helix.|42.0505031446541|42.61571428571432|11.783018867924532|9.054285714285715|12.870700000000001|12.429833333333335|14.531320754716976|-10.365714285714287|16.14333333333333|5.870000000000001|74.48509850970193|49.473833993334296|19.896855345911952|17.085714285714285
An abnormality of the larynx. [HPO:probinson]|An abnormality of the larynx. [HPO:probinson]|6.390000000000015|6.390000000000015|13.113333333333333|13.113333333333333|12.832957142857145|13.70365|-59.466666666666654|-58.48666666666666|4.5428571428571445|2.3537500000000016|38.32226702584281|38.32226702584281|21.200000000000003|21.200000000000003
An indication that MKI67 expression has been detected in a sample.|An indication that MKI67 protein has been detected in a sample.|62.81613636363636|70.50704545454548|5.864090909090912|4.791363636363638|11.359372727272728|11.8291|-23.883636363636366|-24.952727272727277|7.620000000000001|2.3725000000000023|44.250742366654144|44.250742366654144|16.745454545454546|16.745454545454546
Terminology associated with the contact role for clinical study codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).|Terminology associated with the contact role for clinical study codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM)|11.249456521739177|-0.423043478260837|14.547173913043476|19.032173913043476|15.761647826086957|16.011483333333334|12.097391304347823|24.966956521739128|19.353913043478265|18.83|85.69119412168324|121.18564890283007|30.686956521739134|35.286956521739135
Catalysis of the reaction: 3-ADP-2-phosphoglycerate + H(2)O = 3-ADP-glycerate + phosphate. [EC:3.1.3.28, RHEA:15861]|Starts the reaction: 3-ADP-2-phosphoglycerate + hydrogen peroxide + phosphate. [EC:3.1.3.28, RHEA:15861]|132.61138461538462|104.62018181818182|-4.591384615384616|-0.7865454545454522|17.99045294117647|17.517985714285714|-66.80615384615385|-83.76363636363635|9.140588235294118|11.675714285714285|24.23712978056601|27.986626806387367|10.270769230769233|15.42545454545455
A variability of phenotypic features. [HPO:probinson]|A variability of phenotypes. [HPO:probinson]|-50.00999999999996|-49.50249999999997|20.980000000000008|20.785000000000007|15.08867142857143|15.08867142857143|-51.62666666666666|-70.184|9.925714285714285|5.215714285714284|44.250742366654144|38.32226702584281|27.866666666666664|25.0
Subdivision of anterior triangle of neck, each instance of which is bounded by anterior and posterior bellies of some digastric muscle and some; contaims some mylohyoid and hyoglossus muscle, some submandibular gland, segment of some hypoglossal nerve and some segments of lingual and facial arteries.|Subdivision of anterior triangle of neck, each instance of which is bounded by front and back bellies of some digastric muscle and some; contaims some mylohyoid and hyoglossus muscle, some submandible glands, and|31.7175|32.34|14.425|16.94666666666667|13.588055555555556|12.289076470588236|20.425777777777775|23.281212121212114|27.445999999999998|20.089705882352938|101.39118822659097|112.8176994092682|27.666666666666664|28.957575757575757
Actions performed to give fluid rectally|Actions performed to give fluid rectally|31.545000000000016|31.545000000000016|10.350000000000001|10.350000000000001|14.460766666666668|15.262271428571431|-15.033333333333331|-14.053333333333327|9.044999999999998|6.2928571428571445|62.58|62.58|29.066666666666663|29.066666666666663
Group behavior toward others by virtue of their group membership.|Group behavior toward others by virtue of the group membership.|57.940000000000026|57.940000000000026|6.420000000000002|6.420000000000002|8.8695|9.651118181818184|-26.272|-26.86|9.475000000000001|4.441818181818181|49.473833993334296|49.473833993334296|22.0|22.0
Life threatening consequences; disabling|Life threatening consequences; disablement|-29.87499999999997|-51.02499999999998|18.420000000000005|21.370000000000008|15.6774|16.5165|-19.610000000000007|-15.200000000000003|22.96|17.808|54.195869768830164|54.195869768830164|31.6|31.6
Clinical chemistry reagents intended to establish points of reference (i.e., calibrate) in chemical and/or enzymatic assays used in the determination of enzyme (e.g., aldolase, creatine kinase) content in a sample of a body fluid.|Clinical chemistry reagents intended to establish points of reference (i.e., calibrate) in chemical and/or enzymatic assays used in the determination of enzyme content in a sample of fluid.|36.85980392156864|33.5514285714286|9.525882352941178|10.318571428571431|14.611135294117647|13.611906896551725|-18.165882352941175|-8.055714285714288|21.75205882352941|11.643793103448274|55.68096308434328|60.592824451415034|24.619607843137256|24.228571428571428
Reduced intensity of the biceps tendon reflex. []|Reduced intensity of the biceps tendon reflex []|54.72500000000002|50.66500000000002|6.620000000000001|8.180000000000003|15.08867142857143|15.6774|-43.13|-6.130000000000003|6.561428571428571|4.120000000000001|49.473833993334296|69.96656701596841|26.6|28.200000000000003
Any agent that binds to any of the ligands for the receptor programmed cell death protein 1 (PD-1; PD1); programmed death ligand 1 (PD-L1; CD274) and 2 (PD-L2; CD273).|Any agent that binds to any of the ligands for the receptor programmed cell death protein 1 (PD-1; PD1).|98.76577586206898|85.87671052631579|3.0856896551724162|3.641315789473687|14.342487096774192|11.238|7.769655172413792|-4.23368421052632|13.213870967741933|3.116500000000002|66.37611354998121|58.53822981607831|18.21379310344828|18.53684210526316
Monitors designed to display electronic images either in real time as they are obtained using a video camera or from a video or digital versatile disk player, a television system, or from a digital computer or computerized network. These monitors typically include electronic circuitry to process the video signal and a screen (e.g., cathode ray tube, liquid crystal or plasma display, projection sets) to display the image. Video monitors may be used for many purposes, including monitoring patient activity and displaying non-diagnostic images during surgical, endoscopic, and fluoroscopic procedures. Monitors that display images with a higher definition than the standard television monitors (i.e., high-definition video monitors) are also available.|Monitors designed to display electronic images either in real time as they are obtained using a video camera or their use is also possible. These monitors may be used for many purposes, including monitoring patient activity and displaying non-diagnostic images during surgery, endoscopic, and fluoroscopic procedures. Monitor|17.580754332313973|10.933333333333366|13.815902140672783|15.626382978723406|13.974791891891893|12.180510884353742|10.40807339449541|16.136170212765958|19.05013513513513|13.074217687074828|83.43999999999998|95.59252899677882|28.33068297655454|30.09645390070922
Records of sites that are evaluated, but not selected, by a clinical trial.|Record sites that are evaluated, but not selected, by a clinical trial.|63.57596153846157|59.745000000000005|6.006538461538462|6.416666666666668|9.139761538461538|10.031976923076924|-17.043076923076928|-19.443333333333328|6.808461538461536|2.833846153846153|49.473833993334296|49.473833993334296|17.984615384615388|19.06666666666667
Therapeutically inactive ingredient of pharmaceutical dosage form used to improve taste of a drug. Aspartame, fructose, saccharin, sorbitol, and sucrose are the most commonly used sweeteners in the United States.|Theranostically inactive ingredient of pharmaceutical dosage form used to improve taste of a drug. Aspartame, saccharin, sorbitol, and sucrose are the most commonly used sweeteners in the United States.|27.485000000000014|27.823333333333352|11.91|11.780000000000001|12.275500000000001|12.275500000000001|6.267999999999997|4.862068965517238|13.859000000000002|12.759999999999998|67.59412548439398|65.13532912329528|22.666666666666668|21.79770114942529
A type of mechanical ventilation procedure that uses a non-invasive means, such as a face mask or nasal mask, to deliver oxygenated air into the lungs.|A type of ventilatory procedure that uses a non-invasive means to deliver oxygen into the lungs.|43.963076923076954|34.80250000000001|10.356923076923078|10.392500000000002|10.823848148148148|11.9779|5.726153846153842|-6.864999999999998|13.352222222222217|4.003333333333334|66.37611354998121|58.53822981607831|19.046153846153846|20.700000000000003
Human FGF1 wild-type allele is located within 5q31 and is approximately 93 kb in length. This allele, which encodes heparin-binding growth factor 1 protein, is involved in cell migration, proliferation, organogenesis, and angiogenesis.|Normal human FGF1 gene is located within 5q31 and is about 93 kilobases in length. This gene, which encodes a protein complex, involved in cell migration, proliferation, and angiogenesis.|34.160909090909115|51.16126436781613|11.22727272727273|8.524827586206897|14.429642857142857|13.6065|9.261818181818175|1.8206896551724157|13.426857142857138|7.748000000000001|72.26115969177356|65.13532912329528|23.793939393939397|21.79770114942529
Bacteria culture media that are available in ready-to-use tubes specially designed to transport the sample to the clinical laboratory, avoiding contamination and/or leakage.|bacterial media that are available in ready-to-use tubes specially designed to transport the sample to the clinical laboratory, avoiding contamination and/or leakage.|-3.4635869565217092|-0.44818181818180847|16.59934782608696|16.05454545454546|14.3505|13.7305|12.864347826086956|12.112727272727266|18.7648|11.572799999999994|85.69119412168324|82.78555852321104|30.686956521739134|29.854545454545452
Cdh1 is an activator of the anaphase-promoting complex-cyclosome, and is involved in substrate recognition. It associates with the complex in late MITOSIS from anaphase through G1 to regulate activity of CYCLIN-DEPENDENT KINASES and to prevent premature DNA replication.|It associates with the complex in late MITOSIS from anaphase through G1 to regulate activity of CYCLIN-DEPENDENT KINASES and to prevent premature DNA replication.|18.0993859649123|25.455000000000013|13.881578947368421|12.690000000000001|13.51110487804878|13.390915384615385|12.685263157894735|9.633333333333333|14.897317073170733|10.069230769230767|74.48509850970193|73.38155456243756|22.96140350877193|23.133333333333333
Catalysis of the reaction: ATP + nucleoside diphosphate = ADP + nucleoside triphosphate. [EC:2.7.4.6]|Starting of the reaction: ATP + nucleoside diphosphate = ADP + cellular protein. [EC:2.7.4.6]|65.00728571428573|89.17871428571428|4.887714285714285|1.516285714285715|17.40225238095238|16.5165|-68.75428571428571|-71.69428571428571|9.16333333333333|5.248000000000001|34.27647764867329|31.29|18.26285714285714|15.405714285714286
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of glycogen. [GOC:go_curators]|Any process that changes the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a sugar molecule. [GOC:go_curators]|30.31545454545457|39.55500000000001|11.763636363636365|10.723333333333333|12.445160869565218|11.568992307692309|8.370909090909091|8.898333333333333|10.327391304347824|8.982307692307693|76.64453405168562|79.77416029015912|26.218181818181815|26.466666666666665
Operative procedures for the treatment of vascular disorders.|Operative procedures for the treatment of blood disorder.|1.8500000000000227|23.00000000000003|13.995000000000001|11.045000000000002|13.902050000000001|12.631922222222224|-34.31|-36.515|13.77375|6.986666666666665|49.473833993334296|44.250742366654144|26.6|21.6
The gaps formed between myelin sheath segments along axons of certain neurons that serve to facilitate the rapid conduction of nerve impulses.|The gaps formed between myelin sheath segments along axon of certain neurons that serve to facilitate the rapid conduction of nerve impulses.|53.388181818181835|53.388181818181835|8.545454545454547|8.545454545454547|11.904972727272728|11.758639130434783|5.430909090909086|5.430909090909086|15.260909090909088|8.89391304347826|73.38155456243756|73.38155456243756|24.400000000000002|24.400000000000002
Any process that activates or increases the frequency, rate or extent of the addition of telomeric repeats by telomerase. [GOC:mah]|Any process that activates or increases the frequency, rate or extent of the addition of new repeats by telomerase. [GOC:mah]|27.485000000000014|40.17500000000001|11.91|10.140000000000004|11.67634761904762|11.359372727272728|3.3279999999999994|1.8580000000000005|7.818571428571428|5.90727272727273|73.38155456243756|69.96656701596841|26.0|24.0
A bispecific T-cell engager (BiTE) antibody composed of two single-chain variable fragments (scFv), one directed against the tumor-associated antigen (TAA) human B-cell maturation antigen (BCMA; TNFRSF17), fused to one that is directed against the CD3 antigen found on T lymphocytes, with potential immunostimulating and antineoplastic activities. Upon administration of anti-BCMA/CD3 BiTE antibody AMG 701, this bispecific antibody binds to both CD3 on cytotoxic T lymphocytes (CTLs) and BCMA found on BCMA-expressing tumor cells. This activates and redirects CTLs to BCMA-expressing tumor cells, which results in the CTL-mediated cell death of BCMA-expressing tumor cells. BCMA, a member of the tumor necrosis factor receptor superfamily that is specifically overexpressed on malignant plasma cells, plays a key role in promoting plasma cell survival.|A bispecific T-cell engager (BiTE) antibody composed of two single-chain variable fragments (scFv), one directed against the tumor-associated antigen (TAA) human protein complexes found on tumor cells, which results in the CTL-mediated cell death of|15.390000000000015|6.944285714285741|17.075000000000006|20.985714285714284|13.87226923076923|13.515500000000001|23.63266666666667|27.83085714285714|20.253999999999998|22.591|101.87285929039194|129.0119750255766|27.266666666666666|33.42857142857143
A focal seizure characterized at onset by sudden loss or diminution of muscle tone without apparent preceding myoclonic or tonic activity, typically lasting more than 500 ms but less than 2 seconds. It may involve the head, trunk, jaw or limb musculature. [ORCID:0000-0002-1735-8178, PMID:11580774, PMID:28276060, PMID:28276064]|A focal seizure coming from a specific body part or area of the brain that is characterized at onset by sudden loss or diminution of muscle tone without appreciable preceding myoclonic or tonic activity, typically lasting more than 500 ms but less than 2 seconds. It|60.69340579710146|40.03782608695653|8.603043478260872|13.388695652173912|12.180510884353742|10.849334042553192|16.8704347826087|15.507826086956523|12.689727891156465|12.3668085106383|76.64453405168562|98.94766798666859|21.785507246376813|26.59130434782609
A question about how much time an individual spends thinking about the possibility that their breast cancer could recur.|A question about how much time an individual spends thinking about the possibility that their breast cancer can recur.|50.25565789473683|50.25565789473683|8.609736842105267|8.609736842105267|7.90311052631579|8.08|0.4084210526315779|0.0989473684210509|13.107368421052634|7.120000000000001|62.58|62.58|20.642105263157895|20.642105263157895
A product elaborated and marketed by the private Canadian laboratory. 714-X contains trimethylbicyclonitraminoheptane chloride, a nitrogenated camphor-derivative, and mineral salts in ethanol. It is claimed to cure cancer, multiple sclerosis, fibromyalgia, AIDS and other diseases by improving the body's immune function. Few inconclusive animal studies and no human trials were conducted with the product. There is no scientific evidence that 714-X is effective in treating any type of disease. It has not been proven to be safe or effective for any use. 714-X is banned by FDA for use in the USA. In Canada 714-X is legally available on compassionate grounds only through a licensed physician.|A product elaborated and marketed by the private Canadian laboratory. 714-X contains trimethylbicyclonitraminoheptane chloride, a nitrogenated camphor-derivative, and mineral salts in ethanol. It is claimed to cure cancer, multiple|36.05602725366879|-15.935287356321822|11.15616352201258|17.88344827586207|11.437312612612612|13.540879166666668|7.596226415094339|10.742068965517241|9.77885135135135|12.899270833333333|72.26115969177356|72.26115969177356|22.824318658280927|25.935632183908048
A carcinoma that originates usually from cells on the surface of the middle and lower third of the ESOPHAGUS. Tumor cells exhibit typical squamous morphology and form large polypoid lesions. Mutations in RNF6, LZTS1, TGFBR2, DEC1, and WWOX1 genes are associated with this cancer.|A cancer that originates usually from cells in the middle and lower thirds of the ESOPHAGUS. Tumor cells exhibit typical squamous morphology and form large polypoid lesions. Mutations in RNF6, LZTS1, TGFBR2, DEC|57.23363636363638|52.10636363636365|8.009090909090911|8.724242424242426|11.541239393939394|12.093633333333333|4.629090909090905|5.1636363636363605|10.416742424242422|8.4793137254902|64.5059875127883|67.59412548439398|19.854545454545455|21.36969696969697
Electrodes designed to apply electrical stimuli to nerves and/or muscles from external and/or implantable neuromuscular stimulators. These electrodes may be external devices fixed on the skin over the nerves and muscles, electrodes attached to probes appropriate for insertion in the natural cavities of the body, or implantable devices fixed directly on or around the nerves and muscles. Dedicated neuromuscular stimulator electrodes are available for a variety of diagnostic and therapeutic applications, including gait, grasp, muscle strengthening, incontinence, bladder evacuation, swallowing, and ejaculation.|These electrodes are available for a variety of diagnostic and therapeutic applications, including gait, grasp, muscle strengthening, bladder evacuation, and ejaculation.|-4.838353658536562|-5.251071428571407|19.026951219512195|16.6002380952381|13.850038211382113|14.948009090909093|23.780975609756098|14.089523809523811|22.16239837398374|15.113181818181822|108.39173953766033|76.64453405168562|31.614634146341462|27.057142857142857
Severe pain; limiting self care ADL|Severe pain; limiting self care ADL|73.84500000000001|73.84500000000001|4.450000000000003|4.450000000000003|11.8291|12.832957142857145|-19.93333333333333|-18.953333333333326|4.334999999999997|0.5057142857142836|44.250742366654144|44.250742366654144|15.733333333333333|15.733333333333333
Any process that stops, prevents or reduces the frequency, rate or extent of retrograde axon cargo transport. [GOC:obol]|Any process that stops, prevents or reduces axon cargo transport. [GOC:obol]|42.60000000000002|39.7434090909091|9.553333333333335|9.08227272727273|13.24927894736842|14.890438461538462|0.7577777777777754|-18.003636363636367|7.365789473684213|4.283076923076923|73.38155456243756|62.58|28.044444444444448|31.290909090909096
A question about an individual's mouth or throat sores at its worst.|A question about an individual's mouth/ throat sores at its worst.|73.84500000000001|70.50704545454548|4.450000000000003|4.791363636363638|5.547533333333334|7.8816|-21.40333333333333|-23.349090909090915|6.550000000000001|3.5500000000000007|44.250742366654144|44.250742366654144|15.733333333333333|16.745454545454546
Follicular lymphoma grade I, II, III that is resistant to treatment.|Grade I, II, III that is resistant to treatment.|55.12522727272727|89.46750000000003|6.936818181818182|1.8983333333333334|12.794827272727273|11.7795|-22.81454545454546|-38.99111111111111|7.620000000000001|-1.032|44.250742366654144|31.29|16.745454545454546|10.68888888888889
Abrotanum, southernwood, old man.|Abdomen, southernwood, old man.|14.455000000000013|35.60500000000002|11.740000000000002|8.790000000000003|11.7299|13.2345|-103.9|-105.37|12.362500000000004|4.312000000000001|31.29|31.29|20.8|20.8
MALDI-TOF mass spectroscopy of allele-specific primer extension products. Can be used to determine allele dosage ratios at specific loci in samples with heterozygous genotypes. Used rarely, as a validation method.|Mass spectrometry of allele-specific primer extension products. Can be used to determine dosage ratios at specific loci in samples with heterozygous genotypes. Used rarely, as a validation method.|15.922500000000014|18.44428571428574|12.901666666666667|12.425714285714289|14.527754166666668|14.008833333333333|-3.4026666666666685|-6.585714285714289|10.102708333333332|8.225000000000001|66.37611354998121|62.58|27.0|25.65714285714286
A SI derived unit of specific volume, a property of materials defined as the number of cubic meters occupied by one kilogram of a particular substance. Specific volume is inversely proportional to density.|A SI unit of specific volume, a property of materials defined as the number of cubic meters occupied by one kilogram of substance. Specific volume is inversely proportional to density.|26.470000000000027|30.305000000000035|12.3|11.51666666666667|13.546112121212122|13.317420430107527|3.9163636363636343|0.9759999999999991|11.083636363636366|6.982795698924733|78.74477315987392|74.48509850970193|27.430303030303033|26.666666666666664
Virus integrated within host genome but inactive; may be reactivated by stress such as ultraviolet irradiation.|Virus integrated within host genome but active; may be reactivated by stress such as ultraviolet irradiation.|24.22750000000002|29.515000000000015|11.867500000000003|11.130000000000003|13.311975|13.346335294117647|-1.7199999999999989|-2.0875000000000057|14.24125|8.586470588235294|62.58|62.58|23.200000000000003|23.200000000000003
The quantities of sodium chloride (or common salt) taken in and used by the body.|The quantities of chloride (or common salt) taken in and used by the body.|69.5025|78.87285714285717|5.428333333333338|3.997142857142858|8.591166666666666|8.219166666666666|-13.20266666666667|-16.245714285714282|6.166|0.8460000000000001|54.195869768830164|49.473833993334296|19.0|17.085714285714285
Compounds that include the aminobenzene structure.|Compounds that include the aminobenzene structure.|20.490000000000038|20.490000000000038|11.146666666666665|11.146666666666665|14.460766666666668|15.08867142857143|-54.566666666666656|-53.58666666666666|16.11|10.598571428571425|44.250742366654144|44.250742366654144|27.866666666666664|27.866666666666664
The Short Form 36 Health Survey Standard, US Version 2.0 (SF36 v2.0 Standard) Question 4a.|The Short Form 36 Health Survey Standard, US Version 2, (SF36v2.0 Standard) Question 4a.|118.42875000000001|111.45547619047619|-2.327499999999999|-1.1271428571428554|13.8545|13.4825|-49.14133333333334|-31.508571428571425|8.678|4.614000000000001|34.983283507984204|40.39521630094336|14.833333333333332|16.152380952380952
The process of enrolling, enlisting, or adding individuals to a group.|The process of enrolling, enlisted, or adding individuals to a group.|39.7434090909091|39.7434090909091|9.08227272727273|9.08227272727273|9.923918181818184|10.513266666666667|-21.74545454545455|-21.74545454545455|8.476363636363637|3.942499999999999|49.473833993334296|49.473833993334296|20.381818181818183|20.381818181818183
An ependymal tumor affecting the cerebellum, brain stem, and the cervical region of spinal cord.|An neural tumor affecting the cerebellum, brain stem, and the cervical region of spinal cord.|41.30250000000001|52.58250000000001|9.361666666666668|7.7883333333333375|11.749166666666667|11.9283|-7.32266666666667|-8.10666666666667|10.875999999999998|5.236875000000001|58.53822981607831|58.53822981607831|21.666666666666668|21.666666666666668
Stage II: involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C9199" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C9199" NCI Thesaurus)|Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site or its regional Ly nodes with or without this agent. (from PDQ|81.28456223628693|60.15920731707318|3.5572468354430384|9.961097560975613|12.011416455696203|11.445242857142857|-3.8764556962025267|13.52682926829268|20.162974683544306|10.377142857142857|43.319043445117764|76.64453405168562|14.278902953586499|19.90731707317073
A replication incompetent adenoviral vector type 5 (Ad5) encoding the tumor suppressor gene dickkopf-3 (DKK3; reduced expression in immortalized cells; REIC; Dickkopf WNT signaling pathway inhibitor 3), and containing the super gene expression (SGE) system, composed of the triple tandem enhancer sequences of human telomerase reverse transcriptase (hTERT), simian virus 40 (SV40) and cytomegalovirus (CMV), with potential immunostimulating and antineoplastic activities. Upon intratumoral (IT) injection and transfection of Ad5-SGE-REIC/Dkk-3 MTG-201, tumor cells express REIC/DKK3 protein. This may result in the activation of c-Jun-NH2-kinase (JNK) and ultimately lead to apoptosis via B-cell lymphoma-2 (Bcl2) suppression and caspase-3 activation. Increased expression of REIC/DKK3 in cancer cells may lead to an induction of tumor cell apoptosis and a reduction in tumor cell growth, while sparing normal, healthy cells expressing endogenous REIC/DKK3. In addition, the tumor cell killing promotes a cytotoxic T-lymphocyte (CTL)-mediated immune response, thereby further killing any remaining REIC-deficient, untransfected tumor cells. The SGE system, also called C-TSC (CMV promoter driving the triple tandem enhancer sequences of hTERT, SV40 and CMV), enhances gene expression compared to more conventional adenoviral vectors. REIC/DKK3 is expressed by healthy cells, but expression is reduced or absent in many cancer cells due to REIC/DKK3 gene defects. As REIC/DKK3 plays a key role in tumor cell apoptosis, the absence of the REIC protein in tumor cells prevents tumor cell apoptosis.|A viral vector type 5 (Ad5) encoding a tumor suppressor gene dickkopf-3 (DKK3; reduced expression in immortalized cells; REIC; Dickkopf WNT signaling pathway inhibitor 3), and containing the super gene expression system, also called C-TSC|30.890225225225237|31.11571428571429|15.078648648648652|17.614285714285717|15.130125210084035|17.847645945945946|24.39243243243243|25.982857142857142|19.38957983193277|21.892972972972977|108.39173953766033|129.0119750255766|29.326126126126127|33.42857142857143
A condition observed in WOMEN and CHILDREN when there is excess coarse body hair of an adult male distribution pattern, such as facial and chest areas. It is the result of elevated ANDROGENS from the OVARIES, the ADRENAL GLANDS, or exogenous sources. The concept does not include HYPERTRICHOSIS, which is an androgen-independent excessive hair growth.|A condition observed in WOMEN and CHILDREN when there is excess coarse body hair of an adult male distribution pattern, such as facial and chest areas. It is the result of elevated ANDROGENS from the OVARIES, the ADRENAL GOC, or exogenous sources.|43.67511363636365|51.625|10.583409090909093|9.536666666666669|11.329509523809524|11.312667441860466|10.224727272727279|7.837142857142858|12.210297619047623|11.446046511627905|75.03078418222748|76.64453405168562|22.227272727272727|22.742857142857144
An autosomal recessive form of congenital glaucoma caused by mutation(s) in the CYP1B1 gene, encoding cytochrome P450 1B1.|A genetic trait of mental impairment and brittle hair caused by mutation(s) in a gene, used for DNA repair.|52.00000000000003|72.51881578947369|8.242222222222225|5.504473684210527|14.178744444444446|11.238|1.4111111111111114|-3.3052631578947356|14.259999999999998|4.058499999999999|58.53822981607831|54.195869768830164|19.15555555555556|16.431578947368422
The Menstrual Cycle involves regularly recurring hormonal changes and physiologic endometrial changes during the reproductive period in human females, and some primates, and culminates in partial sloughing of the endometrium (menstruation) in the absence of fertilization. For most women, one cycle takes 28 days. (NCI)|The Menstrual Cycle involves regularly recurring hormonal changes and physiologic changes during the reproductive period in human females, and some primates. It culminates in partial sloughing of the endometrium (menstruation) in the absence of fertilization. For most women,|20.53000000000003|13.646754385964925|14.122222222222224|14.50263157894737|12.450944444444445|12.378735897435899|16.199999999999996|13.613684210526312|13.911333333333339|13.209230769230771|90.32644961471695|86.63808689023553|28.222222222222225|29.277192982456143
An accessory for a telephone that is worn on the head and designed to allow hands free conversation.|An accessory phone that is worn on the head and designed to allow hands free conversation.|66.10000000000002|71.81500000000001|6.2755555555555596|5.230000000000004|7.160966666666667|7.773394117647059|-5.775555555555556|-9.07|9.026666666666667|3.5994117647058843|49.473833993334296|44.250742366654144|14.711111111111112|13.200000000000001
Any mixing operation not elsewhere described.|Any mixing operation not elsewhere described.|20.490000000000038|20.490000000000038|11.146666666666665|11.146666666666665|6.565766666666667|8.321528571428573|-59.466666666666654|-58.48666666666666|12.184999999999995|7.234285714285715|49.473833993334296|49.473833993334296|34.53333333333334|34.53333333333334
Candidiasis of the esophagus.|intestinal infection of the esophagus.|-6.694999999999993|-15.662499999999966|14.690000000000001|16.065000000000005|11.7299|14.311966666666669|-109.78|-77.24|10.0075|6.760000000000002|31.29|38.32226702584281|20.8|25.0
The reemergence of lip and/or oral cavity cancer after a period of remission. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C8037" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C8037" NCI Thesaurus)|The reappearance of lip and/or oral cavity cancer after a period of remission. Check for "http://www.cancer.gov/about-Cancer/treatment/clinical-trials/intervention/C8037" active clinical trials using this agent. (http|68.65555555555557|55.03556521739131|4.373333333333335|6.7257391304347856|13.523833333333334|13.244133333333336|-36.70559999999999|-14.239999999999995|37.184266666666666|20.05375|34.59239656340682|46.41057013224466|18.711111111111112|20.9704347826087
Mini-Mental State Examination - What were those three words I asked you to remember: Word 1?|Mini-Mental State Examination - What were those three words I asked you to remember? Word 1?|68.9825|68.9825|7.612500000000001|7.612500000000001|8.377600000000001|8.702217647058824|9.7975|10.165000000000003|8.059375|3.3223529411764687|54.195869768830164|54.195869768830164|13.9|13.9
Any nematode parasite that can be assigned to the species Anisakis simplex.|Any parasitic parasite that can be assigned to the species Anisakis simplex.|31.545000000000016|24.495000000000005|10.350000000000001|11.333333333333336|12.1267|12.461207692307694|-17.97333333333333|-16.993333333333332|9.2975|5.370000000000001|58.53822981607831|58.53822981607831|25.733333333333338|25.733333333333338
Name of the pulse sequence that is used for the acquisition. EXAMPLE(S): OTHER NAME(S): NOTE(S): This is usually a vendor-specific name.|Name of the pulse sequence that is used for the acquisition. It is usually a vendor-specific name.|54.70142857142861|66.71862745098042|7.368571428571428|5.361176470588237|10.641645454545454|9.768001754385967|-9.805714285714288|-23.52705882352941|6.977727272727272|1.5682456140350887|51.09635603445709|36.13057984588678|18.038095238095238|11.67843137254902
The aggregation, arrangement and bonding together of a set of components to form a postsynapse. [GOC:bf, GOC:dos, GOCL:PARL]|The aggregation, arrangement and bonding together a set of components to form an postsynapse. [GOC:bf, GOC:dos, PARL]|47.30000000000004|48.9133823529412|8.89777777777778|8.548529411764708|11.67634761904762|12.0275|2.0644444444444474|0.4564705882352982|5.800000000000001|5.707000000000001|62.58|58.53822981607831|21.37777777777778|19.870588235294118
Delivery of health services via remote telecommunications. This includes interactive consultative and diagnostic services.|Delivery of health services via remote telecommunications. This includes interactive consulting and diagnostic services.|-33.57309523809522|-27.530238095238104|19.101428571428574|18.258571428571432|13.006557142857146|13.3585|-17.648571428571422|-18.068571428571424|18.067857142857143|14.354|57.127462747788826|57.127462747788826|30.438095238095244|30.438095238095244
A traditional unit of volume used for measuring liquids and dry matter. Gallons of various sizes (predominantly in the range of 3.5 - 4.75 liters) have been used in different countries since Roman times.|A traditional unit of volume used for measuring liquids and dry matter. Large volumes (predominantly in the range of 3.5 - 4.75 liters) have been used in different countries since Roman times.|68.05652941176473|70.79525000000001|5.456117647058825|4.974750000000004|9.718233333333334|10.086816666666667|-14.129411764705885|-16.4825|10.370000000000001|7.011770833333333|52.35818446050245|48.47425956113202|19.190588235294115|17.56
Diagnosis of a disease or condition made before DEATH.|Diagnosis of a disease or condition made before AMI.|51.867500000000035|42.46750000000003|7.142777777777777|8.45388888888889|9.346233333333334|11.7795|-35.724444444444444|-36.37777777777777|6.620000000000001|1.7940000000000005|44.250742366654144|49.473833993334296|19.57777777777778|24.022222222222226
A subspecies of facultatively anaerobic, Gram positive, cocci shaped bacteria in the phylum Firmicutes. This subspecies is positive for Lancefield group G, beta hemolysis, arginine deamination, esculin hydrolysis, beta glucuronidase, and growth in 6.5% NaCl and negative for alpha and beta galactosidase, catalase, and pyrrolidonylarylamidase. It can ferment trehalose, and ribose but not sorbitol, or glycogen. S. dysgalactiae subsp. equisimilis is found in the human respiratory tract and vagina and is pathogenic, causing pharyngitis, impetigo, cellulitis, septicemia, glomerulonephritis, and toxic shock.|A subspecies of bacteria that ferment trehalose, and ribose but not sorbitol, or toxic shock. S. dysgalactiae subsp. equisimilis is found in the human respiratory tract and vagina and is path|-0.8418749999999875|46.14294354838711|15.892083333333336|8.748629032258066|14.186933580246915|12.060566666666666|9.094320987654317|-7.465806451612899|16.034814814814816|7.158958333333331|73.38155456243756|54.195869768830164|25.778395061728396|18.583870967741937
An antihistamine with mast-cell stabilizing properties used as eye drops in the treatment of ALLERGIC CONJUNCTIVITIS.|An antibiotic with mast-cell stabilizing properties used as eye drops in the treatment of ALLERGIC CONJUNCTIVITIS.|24.22750000000002|29.515000000000015|11.867500000000003|11.130000000000003|10.052641176470589|10.223455555555555|0.48499999999999943|-0.25|14.775882352941174|8.713333333333335|58.53822981607831|58.53822981607831|20.700000000000003|20.700000000000003
A sulfonamide antibiotic used in the treatment of urinary tract infections.|A sulfur drug used in the treatment of urinary tract infections.|24.36159090909092|62.81613636363636|11.227727272727272|5.864090909090912|12.794827272727273|13.144933333333334|-19.07272727272727|-24.41818181818182|11.473636363636366|2.7650000000000006|49.473833993334296|44.250742366654144|20.381818181818183|16.745454545454546
Administration of a veterinary medicinal product through the shell into an embryonated egg.|Administration of a vet medicinal product through the shell into an embryonated egg.|11.514423076923094|37.54519230769233|13.268076923076926|9.637307692307694|10.354376923076924|10.750842857142857|-9.806153846153848|-12.520000000000003|13.329999999999998|6.2928571428571445|54.195869768830164|49.473833993334296|21.06153846153846|17.984615384615388
Indicates that a toxicity adverse effect has been experienced by a patient, and it is severe enough for the patient to discontinue the treatment.|Indicates that an adverse effect has been experienced by a patient, and it is severe enough for the patient to discontinue the treatment.|46.60500000000002|55.38858695652178|9.740000000000002|8.390652173913043|11.406066666666666|10.810866666666666|5.223333333333336|3.9165217391304346|14.119999999999997|6.942499999999999|73.38155456243756|69.96656701596841|23.133333333333333|21.991304347826087
A device, with a light source, which allows the clear visualization of the structure of the eye at any depth, in order to detect abnormalities within the eye.|A device, with a light source, which allows the clear visualization of the structure of eye at any depth, in order to detect abnormalities within the eye.|62.70357142857142|61.53250000000003|7.991428571428575|8.030555555555559|9.536728571428572|9.406257142857143|6.367142857142859|6.167407407407406|13.933214285714286|6.596785714285716|66.37611354998121|66.37611354998121|18.45714285714286|18.73333333333333
chuan xiong|blood xiong|120.20500000000001|120.20500000000001|-3.01|-3.01|19.5257|14.311966666666669|-118.6|-115.66|3.120000000000001|-2.66|0.0|0.0|0.8|0.8
Air pollutants which affect environmental conditions.|Air pollutants which affect the environment.|6.390000000000015|34.59000000000003|13.113333333333333|9.180000000000003|14.460766666666668|12.832957142857145|-51.62666666666666|-59.466666666666654|18.464999999999996|6.561428571428571|44.250742366654144|38.32226702584281|27.866666666666664|21.200000000000003
Interacting selectively and non-covalently with a 30-bp purine-rich negative regulatory element; the best characterized such element is found in the first intronic region of the rat cardiac alpha-myosin heavy chain gene, and contains two palindromic high-affinity Ets-binding sites (CTTCCCTGGAAG). The presence of this element restricts expression of the gene containing it to cardiac myocytes. [GOC:mah, PMID:9819411]|Interacting selectively and not binding with a DNA element; the best characterized such element is found in the first region of the rat heart alpha-myosin heavy chain gene, and contains two palindromic high-affinity Ets-binding sites. The presence of|21.709761904761933|31.70789473684212|14.868571428571432|13.556842105263158|13.450322222222225|11.069290476190476|22.257857142857148|17.534736842105264|15.012380952380951|12.395714285714284|92.11526583579942|82.78555852321104|26.03809523809524|22.33684210526316
Catalysis of the reaction: alpha-N-peptidyl-L-glutamine + H2O = alpha-N-peptidyl-L-glutamate + NH3. [EC:3.5.1.43, MetaCyc:PEPTIDYL-GLUTAMINASE-RXN]|Starting of the reaction: alpha-N-peptidyl-L-glutamine + hydrogen peroxide + NH3. [EC:3.5.1.43, MetaCyc]|-30.080923076923057|42.248999999999995|18.100923076923085|7.962666666666667|18.70586666666667|17.061629411764706|-52.78461538461537|-77.27333333333334|7.923749999999998|6.370000000000001|31.29|31.29|16.42461538461539|17.62666666666667
Invasive intervention indicated|blood clot that travels|-106.40999999999997|97.025|28.846666666666668|0.7199999999999989|19.5753|13.3585|-41.82666666666667|-43.13|25.599999999999994|0.8520000000000003|54.195869768830164|31.29|41.2|11.600000000000001
Vulvar cancer with tumor of any size with extension to any of the following: upper/proximal 2/3 urethra, upper/proximal 2/3 vagina, bladder mucosa, rectal mucosa, or fixed to pelvic bone. (from AJCC 7th Ed.)|Cancer below vocal cords with tumor of any size with extension to any of the following: upper/proximal 2/3 urine retention time (from AJCC 7th Ed.)|46.97909090909093|58.78750000000002|9.439393939393941|8.165000000000003|12.62507142857143|11.323877777777778|4.272727272727266|5.484799999999996|9.389714285714287|6.078888888888891|72.26115969177356|73.38155456243756|23.793939393939397|22.6
Assistance in promoting continence and maintaining perineal skin integrity|Assistance in promoting continence and maintaining skin integrity.|-9.099999999999994|1.8500000000000227|16.764444444444447|13.995000000000001|14.60956666666667|14.38636666666667|10.231111111111112|-29.9|17.61|11.696666666666665|76.64453405168562|49.473833993334296|30.266666666666666|26.6
The process in which a protrusion or bulge is formed at the site of plant root hair outgrowth. [GOC:jid, PMID:12468740]|The process in which a bulge is formed at the site of plant root hair outgrowth. [GOC:jid, PMID:12468740]|95.165|103.70000000000002|2.4700000000000024|1.0311111111111124|10.172538095238096|10.448500000000001|-0.1999999999999993|-3.8155555555555516|5.127142857142857|3.3520000000000003|44.250742366654144|38.32226702584281|12.0|10.266666666666666
Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: glucose(out) + H(out)+ = glucose(in) + H(in)+, in response to a stimulus by insulin. Symporter activity enables the active transport of a solute across a membrane by a mechanism whereby two or more species are transported together in the same direction in a tightly coupled process not directly linked to a form of energy other than chemiosmotic energy. [GOC:mtg_transport]|Enables the transfer of a solute or two side membranes according to the reaction: glucose(out) + hydrogen peroxide (also known as chemiosmotic energy). [GOC:mtg_transport]|34.890833333333376|25.455000000000013|15.017500000000002|12.690000000000001|11.847674320987656|13.175982051282052|18.741|11.838333333333331|9.754814814814814|8.446025641025642|106.8756964889586|79.77416029015912|28.16666666666667|26.466666666666665
<p>A person becomes eligible for a program based on more than one criterion.</p><i>Examples:</i>In the U.S., a child whose familiy income meets Medicaid financial thresholds and whose age is less than 18 is eligible for the Early and Periodic Screening, Diagnostic, and Treatment program (EPSDT). A person whose family income meets Medicaid financial thresholds and whose age is 65 years or older is eligible for Medicaid and Medicare, and are referred to as dual eligibles.|A person becomes eligible for a program based on more than one criterion./p>i>Examples: A child whose family income meets Medicaid financial thresholds and his age is less than 18 years old. These are referred to as dual eligibles.|47.981531531531516|56.93460526315789|9.63081081081081|7.678157894736845|11.213724691358024|9.488363565891472|7.8632432432432395|-0.9842105263157883|14.922222222222224|6.767364341085273|69.96656701596841|56.4088497046341|21.14954954954955|17.48421052631579
A chromosome band present on 11p|A DNA band present on 11p.|87.94500000000002|119.19000000000003|2.4833333333333343|-2.619999999999999|9.197433333333334|10.577242857142856|-22.873333333333328|-77.10666666666665|2.7650000000000006|-5.550000000000001|44.250742366654144|22.125371183327072|15.733333333333333|7.866666666666666
Columbia-Suicide Severity Rating Scale Baseline - Description of non-specific active suicidal thoughts.|Columbia Suicide Severity Rating Scale Baseline - Description of non-specific active suicide thoughts.|-3.7049999999999557|-1.5009615384615245|15.266666666666666|15.083461538461542|17.64206923076923|17.517985714285714|-4.25333333333333|-4.3784615384615435|16.953076923076928|11.675714285714285|62.58|66.37611354998121|29.066666666666663|30.29230769230769
Any process that modulates the frequency, rate or extent of interleukin-17A biosynthetic process. [GOC:aruk, PMID:27901018]|Any process that modulates the frequency, rate or extent of an IL-17A biosynthetic process. [GOC:aruk, PMID:27901018]|46.942499999999995|50.66500000000002|8.575000000000003|8.180000000000003|13.902050000000001|13.732344444444447|3.261333333333333|0.8524999999999991|12.890625|8.451666666666668|62.58|62.58|24.333333333333336|23.200000000000003
Specifies whether the entity is active.|Specifies whether an entity is active.|34.59000000000003|34.59000000000003|9.180000000000003|9.180000000000003|14.460766666666668|15.08867142857143|-65.34666666666666|-65.34666666666666|7.475000000000001|2.524285714285714|44.250742366654144|44.250742366654144|27.866666666666664|27.866666666666664
An anatomical qualifier that describes the arrangement or apportioning of an entity within a body part, region or organ.|Anatomical qualifier that describes the arrangement or apportioning of a body part, region or organ.|27.992500000000007|24.382499999999993|11.715|11.721666666666671|10.396268421052632|9.954550000000001|0.4084210526315779|-5.3626666666666765|12.859473684210528|7.591875000000002|69.96656701596841|62.58|24.852631578947367|24.333333333333336
<p>Every racial or ethnic group has specific health concerns. Differences in the health of groups can result from</p> <ul> <li>Genetics</li> <li>Environmental factors</li> <li>Access to care</li> <li>Cultural factors</li> </ul> <p>On this page, you'll find links to health issues that affect Latino and Hispanic Americans.</p>|Every race or ethnic group has specific health concerns. Differences in the health of groups can result from/p> ul>|28.988992248062033|72.51881578947369|12.776744186046514|5.504473684210527|15.238143943661973|10.385595652173913|18.184186046511627|-0.8294736842105266|4.37732394366197|3.9791304347826078|78.74477315987392|54.195869768830164|23.4077519379845|16.431578947368422
Therapeutic wrist orthoses designed for external modification of the functional characteristics of the wrist joint. This permits a limited and adjustable limited range of flexion motion of the joint. These orthoses are prefabricated devices typically consisting of semi-rigid articulated devices that include forearm and hand straps, and an adjustable mechanical joint placed at the wrist to regulate the range of the joint flexion. Flexion dynamic therapy wrist orthoses are used to treat patients suffering from hyperextension deformity of the wrist.|These orthoses are prefabricated devices typically consisting of semi-rigid articulated devices that include forearm and hand straps, and an adjustable range of the joint flexion.|24.567500000000024|18.17950000000002|13.807500000000001|13.829000000000004|13.608060493827162|14.332737037037038|16.265499999999996|13.011200000000002|15.85018518518519|18.759999999999998|82.78555852321104|76.64453405168562|23.900000000000002|24.200000000000003
The reported name of an exposure treatment vehicle.|The reported name of a treatment vehicle.|44.150000000000006|58.25392857142859|8.094999999999999|6.003571428571426|11.9283|11.7299|-41.660000000000004|-54.33142857142857|7.88625|1.1762499999999996|44.250742366654144|38.32226702584281|21.6|18.54285714285714
A condition in which the gastrointestinal tract is inflamed over a long period of time. Crohn disease usually affects the small intestine and colon. Symptoms include fever, diarrhea, stomach cramps, vomiting, and weight loss. Crohn disease increases the risk of colorectal cancer and small intestine cancer. It is a type of inflammatory bowel disease (IBD).|A condition in which the gastrointestinal tract is inflamed over a long period of time. Crohn disease usually affects the small intestine and colon. Symptoms include fever, diarrhea, stomach cramps, vomiting, and weight loss.|49.8653787878788|51.40161764705883|8.581363636363637|8.201470588235296|12.794827272727273|12.191071428571428|0.10254545454544939|-1.445882352941176|9.075818181818185|7.9752857142857145|63.87044504307137|62.58|21.848484848484848|22.223529411764705
Any viral organism that can be assigned to the species Rubella virus.|Any viral organism that can be assigned to the family Rubella virus.|45.64500000000001|38.595|8.383333333333333|9.366666666666667|12.1267|11.246592307692307|-20.913333333333334|-20.913333333333334|6.942499999999999|2.471538461538465|58.53822981607831|58.53822981607831|25.733333333333338|25.733333333333338
A neoplasm that arises from the vagina and is characterized by the proliferation of nests of benign melanocytes.|A tumor that arises from the vagina and is characterized by the proliferation of nests of benign melanocytes.|28.50000000000003|28.50000000000003|11.520000000000003|11.520000000000003|9.792633333333335|9.925068421052632|-1.8555555555555578|-2.508888888888883|12.166666666666664|6.126315789473683|58.53822981607831|58.53822981607831|19.15555555555556|19.15555555555556
An imaging agent composed of a heptapeptide targeting human epithelial growth factor receptor type 2 (EGFR2; HER2; ErbB2) conjugated, via a five-amino acid linker, to the near-infrared (NIR) fluorescent dye IRDye800CW, that can potentially be used for the imaging of HER2-expressing tumors. Upon oral administration of the IRDye800CW-labeled heptapeptide KSP-910638G, the peptide moiety targets and binds to HER2 expressed on tumor cells in the gastrointestinal (GI) tract. Upon fluorescence imaging of the fluorophore IRDye800CW, the tumor cells can be detected.|An imaging agent composed of a molecule targeting HER2 expressed on tumor cells in the gastrointestinal tract. Upon oral administration of the IRDye800CW-labeled peptide moiety targets and binds to specific genetic markers.|42.71500000000003|40.027083333333366|12.270000000000003|10.326250000000002|14.701598039215687|14.23234705882353|20.774|7.713750000000001|18.447725490196078|13.390588235294118|92.55706820659348|74.48509850970193|25.5|25.516666666666666
Sheehan Disability Scale (SDS) The symptoms have disrupted your social life/leisure activities.|The symptoms have disrupted your social life/leisure activities.|10.39500000000001|12.425000000000011|13.3|12.52|14.890438461538462|13.3585|-8.173333333333332|-31.369999999999997|10.804615384615381|7.445999999999998|58.53822981607831|49.473833993334296|25.733333333333338|26.6
A partial or complete breakage of the humerus. []|A partial or complete breakage of the humerus. []|80.06750000000002|80.06750000000002|3.2094444444444434|3.2094444444444434|11.7299|12.631922222222224|-38.99111111111111|-38.33777777777777|2.942499999999999|1.2300000000000004|44.250742366654144|44.250742366654144|19.57777777777778|19.57777777777778
Subcutaneous tissue including some tissue of finger AND some additional non finger tissue|Subcutaneous tissue including some tissue of finger AND some additional non finger tissue.|30.947692307692336|37.54519230769233|12.172307692307694|9.637307692307694|12.783607692307694|13.006557142857146|12.05846153846154|-9.806153846153848|12.96769230769231|8.311428571428571|88.50148473330829|62.58|29.81538461538462|27.21538461538462
An enzyme deficiency in the androgen biosynthesis pathway, resulting in the underproduction of one or more androgens by the adrenal glands and/or gonads.|An enzyme deficit in the androgen biosynthesis pathway, resulting in a shortage of one or more steroid hormones by the adrenal glands and/or gonads.|33.31902173913048|46.60500000000002|11.468913043478263|9.740000000000002|13.015560869565219|13.0989|7.7513043478260855|6.203333333333333|16.48695652173913|8.1816|69.96656701596841|73.38155456243756|21.991304347826087|23.133333333333333
Peruvian bark.|a plant.|36.62000000000003|121.22000000000003|8.400000000000002|-3.3999999999999986|11.630700000000001|8.974233333333334|-257.78|-272.48|7.829999999999998|-9.69|22.125371183327072|0.0|20.400000000000002|0.4
A nevus that recurs after incomplete surgical removal, biopsy, or trauma. (WHO 2018)|A skin tumor that recurs after incomplete surgical removal, biopsy, or trauma.|50.56057692307695|38.595|7.821923076923078|9.366666666666667|13.675823076923077|13.675823076923077|-12.972307692307695|-16.01333333333333|6.094615384615388|5.370000000000001|62.58|62.58|27.21538461538462|29.066666666666663
Surgery intended to reduce the risk of ovarian cancer by removing the ovaries before disease develops.|Surgery intended to reduce the risk of ovarian cancer by removing the ovaries before disease begins.|29.515000000000015|34.80250000000001|11.130000000000003|10.392500000000002|12.3251|11.488688235294118|-5.027500000000003|-5.395|11.886249999999997|6.370000000000001|69.96656701596841|69.96656701596841|28.200000000000003|28.200000000000003
Any of various immunohistochemical procedures for visualizing and/or quantitating SOX11 transcription factor expression in a sample. Dysregulation of SOX11 is associated with several types of cancer and has diagnostic and prognostic value.|Any of various immunohistochemical procedures for visualizing and/or quantitating SOX11 transcription factor expression in a sample. Dysregulation is associated with several types of cancer and has diagnostic and prognostic value.|10.945833333333354|2.105000000000018|14.3825|15.45|13.311975|13.317420430107527|10.470000000000002|9.992|16.890625|14.123763440860216|74.48509850970193|74.48509850970193|25.516666666666666|26.666666666666664
An indication of the first year that a particular event or status was noted.|An indication of the first year a particular event or status was noted.|60.74428571428575|57.06826923076926|6.525714285714287|6.91423076923077|8.842328571428572|9.622985714285715|-15.825714285714284|-18.400000000000006|6.428571428571431|1.9192857142857136|49.473833993334296|49.473833993334296|17.085714285714285|17.984615384615388
A disorder characterized by a dysrhythmia with abrupt onset and sudden termination of atrial contractions with a rate of 150-250 beats per minute. The rhythm disturbance originates in the atria.|A disorder characterized by a rhythm disturbance with abrupt onset and sudden termination of irregular heart rhythm with sudden initiation and abrupt removal of the pacemaker. The rhythm disorder originates in the ear canal.|44.405|26.13166666666669|9.55|12.430000000000003|12.045622580645162|11.884595238095239|2.7399999999999984|7.087058823529411|10.93354838709677|9.971904761904764|65.13532912329528|72.26115969177356|21.333333333333336|23.35686274509804
Expanded Disability Rating Scale - Postacute Interview Survivor Version (Expanded DRS-PI Survivor Version) Do you need 24-hour care and are not able to help with your own care at all?|Do you need 24-hour care and are not able to help with your own care at all?|41.025000000000034|104.98000000000002|14.990000000000006|2.84|11.536267741935484|6.241005263157895|20.317333333333334|3.687058823529412|8.806451612903228|2.695789473684208|103.77718969022045|31.29|26.666666666666664|9.15294117647059
An alteration in body temperature outside the normal range.|An alteration in body temperature out of the normal range.|33.067500000000024|49.48000000000002|9.765|7.600000000000001|11.100677777777777|11.086572727272728|-32.45777777777777|-29.799999999999997|9.236666666666665|2.300909090909091|49.473833993334296|44.250742366654144|24.022222222222226|18.0
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a blue light stimulus. Blue light is electromagnetic radiation with a wavelength of between 440 and 500nm. [GOC:ai, GOC:mtg_far_red]|Any process that results in a change in state or activity of eukaryotic cells or an organism (in terms of movement, secretion, enzyme production, etc.). Blue light is an electromagnetic radiation of between 440 and 500nm. [GOC:ai, GOC:|57.095500000000015|56.93460526315789|8.401000000000003|7.678157894736845|11.365030817610062|11.6316837398374|6.543199999999995|-0.36526315789473784|8.998238993710693|6.88552845528455|66.37611354998121|58.53822981607831|19.400000000000002|18.53684210526316
<p>Proposed therapy is outside of the standard practice for an adult patient.</p>|Proposed therapy is outside the standard practice for an adult patient.|52.69500000000002|55.12522727272727|7.400000000000002|6.936818181818182|14.29885|13.144933333333334|-15.033333333333331|-20.67636363636364|7.17625|5.512499999999999|58.53822981607831|58.53822981607831|25.733333333333338|27.654545454545453
A substance formed by chemical union of two or more elements or ingredients in definite proportion by weight.|A substance formed by chemical union of two or more elements or ingredients definite proportion by weight.|56.70000000000002|53.889852941176486|7.58666666666667|7.854411764705883|11.547077777777778|11.9779|-2.8355555555555547|-3.3482352941176465|11.381666666666668|6.620000000000001|58.53822981607831|58.53822981607831|19.15555555555556|19.870588235294118
A congenital birth defect characterized by the absence of a normal vaginal opening.|A genetic birth defect characterized by the absence of a normal vaginal opening.|24.529807692307713|31.037500000000023|11.45269230769231|10.545000000000002|12.783607692307694|13.006557142857146|-13.424615384615386|-14.329230769230772|10.431538461538462|4.947142857142854|58.53822981607831|58.53822981607831|24.13846153846154|24.13846153846154
The cell cycle phase following cytokinesis which begins with G1 phase, proceeds through S phase and G2 phase and ends when prophase of meiosis or mitosis begins. During interphase the cell readies itself for meiosis or mitosis and the replication of its DNA occurs. [GOC:mtg_cell_cycle]|The cell cycle phase following cellular replication which begins with G1 phase, proceeds through G2 phase and ends when prophase of DNA replication begins.|56.25000000000003|64.22999999999999|9.140000000000004|7.28166666666667|11.605511594202898|12.4673|11.888000000000002|7.9183333333333366|10.401014492753625|9.500400000000003|76.64453405168562|66.37611354998121|22.0|19.8
Autologous human T-lymphocytes transduced with a recombinant lentiviral vector encoding a chimeric T-cell receptor (chimeric antigen receptor or CAR) consisting of an anti-CD22 single chain variable fragment (scFv) derived from the monoclonal antibody (moAb) 971 (m971), and the co-stimulatory domain 4-1BB (CD137) coupled to the zeta chain of the TCR/CD3 complex (CD3-zeta), with potential immunostimulating and antineoplastic activities. Autologous peripheral blood lymphocytes (PBLs) from a patient with CD22-positive cancer are transduced with this lentiviral vector that encodes the CAR gene specific for CD22. After expansion in culture and reintroduction into the patient, the anti-CD22-CAR m971-BBz lentiviral vector-transduced autologous T-lymphocytes express anti-CD22-CAR on their cell surfaces and bind to the CD22 antigen on tumor cell surfaces. Subsequently, CD22-expressing tumor cells are lysed. CD22, a B-lineage-restricted, transmembrane phosphoglycoprotein, is expressed on malignant B-cells. m971 binds to a membrane proximal epitope on CD22 and has a higher binding affinity compared to any other anti-CD22 moAb. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C120035" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C120035" NCI Thesaurus)|Autologous human T-cell receptors are transduced with a viral vector that encodes an anti-CD22 protein complex. Subsequently, tumor cells are lysed.|40.18890243902442|42.61571428571432|10.563937282229965|9.054285714285715|14.216973913043478|14.55996666666667|18.401463414634147|-6.16571428571428|19.865869565217388|6.905000000000001|71.93784191925693|62.58|22.734494773519167|25.65714285714286
Palpation of the part of the chest wall that is located anterior to the heart. (ACC-AHA)|Part of the chest wall that is located anterior to the heart. (ACC-AHA)|71.81500000000001|76.59134615384617|5.230000000000004|4.191153846153846|8.702217647058824|9.271833333333333|-10.172500000000003|-18.400000000000006|1.9370588235294122|-0.09600000000000009|44.250742366654144|38.32226702584281|13.200000000000001|11.830769230769231
Autologous human T-lymphocytes transduced with a retroviral vector encoding a T-cell receptor (TCR) specific for the human melanoma antigen A4 (MAGE-A4), with potential immunostimulatory and antineoplastic activities. Upon isolation, transduction, expansion ex vivo, and reintroduction into the patient, MAGE-A4-specific TCR gene-transduced T-lymphocytes TBI-1201 binds to tumor cells expressing MAGE-A4. This may result in both an inhibition of growth and increased cell death for MAGE-A4-expressing tumor cells. The tumor-associated antigen MAGE-A4 is overexpressed by a variety of cancer cell types.|T-cell receptors specific for a human melanoma antigen A4 (MAGE-A4), with potential immunostimulatory and anti-cancer activities. Upon isolation, transduction, expansion ex vivo, and reintroduction into the patient, M|21.598000000000013|-3.767857142857139|14.172|17.262857142857147|15.002372527472529|15.7791625|20.267341772151894|18.96714285714285|15.77236263736264|13.063749999999999|85.1180024436664|91.22524239485473|25.054177215189874|29.885714285714286
A membrane-bounded, cytoplasmic secretory granule found in enzyme-secreting cells and visible by light microscopy. Contain zymogen, an inactive enzyme precursor, often of a digestive enzyme. [GOC:jl, ISBN:0198506732]|A membrane-bounded, cellular secretory granule found in enzyme-secreting cells and visible by light. Contain zymogen, an active enzyme precursor, often of a digestive enzyme. [GOC:jl, ISBN:0198506732]|12.833333333333371|25.584487179487212|13.705185185185186|11.843846153846155|14.132833333333334|14.132833333333334|8.488888888888894|5.649230769230755|11.673000000000002|9.475000000000001|69.96656701596841|67.59412548439398|25.822222222222223|25.005128205128205
Pandrug resistance (PDR) is defined as non-susceptibility to all agents in all epidemiologically significant antimicrobial categories (i.e. no agents tested as susceptible for that organism). Non-susceptibility refers to either a resistant, intermediate or non-susceptible result obtained from in vitro antimicrobial susceptibility testing. (DOI: 10.1111/j.1469-0691.2011.03570.x)|Pandrug resistance (PDR) is defined as non-susceptibility to all agents in all epidemiologically significant antimicrobial categories (i.e. no agents tested as susceptible for that organism). MIC: 10.1111/j.1469-0691.2011.03570|-7.208272727272686|12.276041666666714|15.357818181818182|12.385509259259258|14.758470068027211|14.59239677419355|-22.237272727272725|-43.71259259259258|17.688095238095237|15.643548387096779|48.47425956113202|39.88708014507956|23.578181818181818|20.60925925925926
feces|female feces|36.62000000000003|35.60500000000002|8.400000000000002|8.790000000000003|19.476100000000002|19.5753|-266.6|-112.72|2.620000000000001|-1.0899999999999999|31.29|44.250742366654144|40.400000000000006|40.800000000000004
A primary or metastatic malignant neoplasm that affects the penile urethra.|A primary or metastatic cancer that affects the penile artery.|24.36159090909092|32.56000000000003|11.227727272727272|9.96|14.230281818181819|13.957481818181819|-19.07272727272727|-27.447999999999993|11.473636363636366|4.0136363636363654|58.53822981607831|54.195869768830164|27.654545454545453|26.0
Part of the chromosome bands present on the long (q) arm of chromosome 2.|Part of the DNA strands present on the long arm of chromosome 2.|90.95857142857145|102.62211538461541|2.3114285714285714|0.560384615384617|8.842328571428572|9.622985714285715|-17.085714285714285|-21.56615384615385|4.74642857142857|-0.4357142857142833|38.32226702584281|31.29|11.371428571428572|8.753846153846155
Increased megakaryocyte number, i.e., of platelet precursor cells, present in the bone marrow. [HPO:probinson]|Increased megakaryocyte number, i.e., of platelet precursor cells, present in the bone marrow.|28.039642857142866|40.843942307692316|10.217857142857145|8.369807692307692|12.429833333333335|11.8787|-43.831428571428575|-53.535384615384615|10.579999999999998|8.647857142857145|44.250742366654144|41.39277926160552|24.257142857142856|22.83846153846154
The incorporation of a metal and exogenous sulfur into a metallo-sulfur cluster. [GOC:jl, GOC:mah, GOC:pde, GOC:vw]|The incorporation of metal and exogenous sulfur into a metallo-sulfur cluster. [GOC:mah, GOC:pde, GroupW]|29.515000000000015|18.44428571428574|11.130000000000003|12.425714285714289|14.683966666666668|14.60956666666667|-0.25|-3.2257142857142824|3.7814285714285703|5.311666666666667|62.58|62.58|23.200000000000003|25.65714285714286
<h3>What is stuttering?</h3> <p>Stuttering is a <a href="https://medlineplus.gov/speechandcommunicationdisorders.html">speech disorder</a>. It involves interruptions in the flow of speech. These interruptions are called disfluencies. They may involve</p> <ul> <li>Repeating sounds, syllables, or words</li> <li>Stretching out a sound</li> <li>Suddenly stopping in the middle of a syllable or word</li> </ul> <p>Sometimes, along with the stuttering, there may be nodding, rapid blinking, or trembling lips. The stuttering may be worse when you are stressed, excited, or tired.</p> <p>Stuttering can be frustrating, because you know exactly what you want to say, but you have trouble saying it. It can make it difficult to communicate with people. This can cause problems with school, work, and relationships.</p> <h3>What causes stuttering?</h3> <p>There are two main types of stuttering, and they have different causes:</p> <ul> <li><strong>Developmental stuttering</strong> is the more common type. It starts in young children while they are still learning speech and language skills. Many children stutter when they first start talking. Most of them will outgrow it. But some continue to stutter, and the exact cause is unknown. There are differences in the brains of people who continue to stutter. Genetics may also play a role, since this type of stuttering can run in families.</li> <li><strong>Neurogenic stuttering</strong> can happen after someone has a <a href="https://medlineplus.gov/stroke.html">stroke</a>, <a href="https://medlineplus.gov/headinjuries.html">head trauma</a>, or other type of <a href="https://medlineplus.gov/traumaticbraininjury.html">brain injury</a>. Because of the injury, the brain has trouble coordinating the different parts of the brain involved in speech.</li> </ul> <h3>Who is at risk for stuttering?</h3> <p>Stuttering can affect anyone, but it is much more common in boys than girls. Younger children are most likely to stutter. About 75 percent of children who stutter will get better. For the rest, stuttering can continue their whole lives.</p> <h3>How is stuttering diagnosed?</h3> <p>Stuttering is usually diagnosed by a speech-language pathologist. This is a health professional who is trained to test and treat people with voice, speech, and language disorders. If you or your child stutters, your regular health care provider may give you a referral to a speech-language pathologist. Or in some cases, a child's teacher may make a referral.</p> <p>To make a diagnosis, the speech-language pathologist will</p> <ul> <li>Look at the case history, such as when the stuttering was first noticed, how often it happens, and in what situations it happens</li> <li>Listen to you or your child speak and analyze the stuttering</li> <li>Evaluate you or your child's speech and language abilities, including the ability to understand and use language</li> <li>Ask about the impact of stuttering on you or your child's life</li> <li>Ask whether stuttering runs in the family</li> <li>For a child, consider how likely it is that he or she will outgrow it</li> </ul> <h3>What are the treatments for stuttering?</h3> <p>There are different treatments that can help with stuttering. Some of these may help one person but not another. You need to work with the speech-language pathologist to figure out the best plan for you or your child.</p> <p>The plan should take into account how long the stuttering has been going on and whether there are any other speech or language problems. For a child, the plan should also take into account your child's age and whether he or she is likely to outgrow the stuttering.</p> <p>Younger children may not need therapy right away. Their parents and teachers can learn strategies to help the child practice speaking. That can help some children. As a parent, it's important to be calm and relaxed when your child is speaking. If your child feels pressured, it can make it harder for them to talk. The speech-language pathologist will probably want to evaluate your child regularly, to see whether treatment is needed.</p> <p>Speech therapy can help children and adults minimize stuttering. Some techniques include</p> <ul> <li>Speaking more slowly</li> <li>Controlling breathing</li> <li>Gradually working up from single-syllable responses to longer words and more complex sentences</li> </ul> <p>For adults, self-help groups can help you find resources and support as you face the challenges of stuttering.</p> <p>There are electronic devices to help with fluency, but more research is needed to see whether they really help over the long term. Some people have tried medicines that usually treat other health problems such as epilepsy, anxiety, or depression. But these medicines are not approved for stuttering, and they often have side effects.</p> <p class="">NIH: National Institute on Deafness and Other Communication Disorders</p>|ASD can affect anyone, but it is much more common in boys than girls. These medicines are not approved for stuttering, and they often have side effects.|53.45904289693593|75.50000000000003|9.37028857938719|4.964444444444446|10.566624720179085|8.046933333333333|13.717214484679658|-5.231111111111112|8.797937959705791|3.9270238095238135|70.52407835626069|51.09635603445709|19.89441782729805|15.45185185185185
The small airways branching off the TERTIARY BRONCHI. Terminal bronchioles lead into several orders of respiratory bronchioles which in turn lead into alveolar ducts and then into PULMONARY ALVEOLI.|The small airways branching off the TERTIARY BRONCHI. Terminal bronchioles lead into several orders of respiratory tracts which in turn lead to alveolar ducts and then into PULMONARY ALVEOLI.|30.740574712643706|39.49229885057474|11.373103448275863|10.152413793103449|10.345010344827585|10.448500000000001|3.8482758620689665|2.6317241379310374|13.10551724137931|9.004000000000001|72.26115969177356|67.59412548439398|25.935632183908048|23.177011494252874
Molecular assay reagents intended to identify mutations in genes associated with Diamond-Blackfan anemia, a bone marrow disorder that leads to reduced numbers of red blood cells. Genetic variants at multiple loci have been associated with Diamond-Blackfan anemia. These reagents are intended to detect mutations in multiple Diamond-Blackfan anemia-associated loci simultaneously.|Molecular assay reagents intended to identify mutations in genes associated with Diamond-Blackfan anemia, a bone marrow disorder that leads to reduced numbers of red blood cells. Genetic variants at multiple locations have been associated w i thy disease. These loci are|6.335499999999996|32.01699186991871|15.481000000000005|12.18878048780488|12.716707407407407|12.058828682170544|15.128|11.47024390243902|15.655555555555559|10.601085271317828|84.2509034076193|80.79043260188672|28.200000000000003|24.978861788617888
An orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. Rifaximin binds to the beta-subunit of bacterial DNA-dependent RNA polymerase, inhibiting bacterial RNA synthesis and bacterial cell growth. As rifaximin is not well absorbed, its antibacterial activity is largely localized to the gastrointestinal tract.|An orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. Rifaximin binds to a beta-subunit of bacterial DNA-dependent RNA polymerase, which is largely localized|-17.49124999999998|-35.6008333333333|18.618031914893617|21.578703703703706|14.884566666666666|15.611106451612905|15.5931914893617|20.75851851851852|16.67053333333334|15.035806451612906|78.225|88.50148473330829|25.97659574468085|29.1037037037037
Physicians specializing in the diagnosis, and treatment of diseases of the urinary tract in both sexes, and the genital tract in the male.|Physicians specialized in the diagnosis, and treatment of diseases of the urinary tract in both sexes, as well as the genital tract.|48.032065217391334|45.69727272727275|9.416739130434784|9.618181818181817|11.642517391304349|11.758639130434783|3.9165217391304346|3.0254545454545436|13.210434782608694|6.641304347826086|62.58|62.58|18.51304347826087|18.94545454545455
A coronary vasodilator agent.|blood vessel spasm drug.|-48.994999999999976|99.055|20.590000000000007|-0.0600000000000005|15.6774|13.2345|-109.78|-115.66|10.0075|-0.3979999999999997|38.32226702584281|22.125371183327072|30.8|10.8
A category of juvenile idiopathic arthritis defined by the presence of arthritis affecting five or more separate joints during the first six months of disease, with positive serologic testing for rheumatoid factor.|A category of juvenile joint disease defined by the presence of arthritis affecting five or more separate joints during the first six months of disease, with positive serologic testing for rheumatoid factor.|31.97|42.545000000000016|12.775000000000002|11.3|12.6252625|12.110657575757577|15.126249999999999|14.02375|21.2109375|11.797272727272727|85.69119412168324|82.78555852321104|25.150000000000002|23.900000000000002
A usually aggressive malignant neoplasm arising from the deep soft tissue. It is characterized by the presence of poorly-differentiated spindle-shaped fibroblasts, collagenous stroma formation and increased mitotic activity.|A usually aggressive cancerous tumor arising from the deep soft tissue. It is characterized by the presence of poorly differentiated spindle-shaped fibroblasts, collagenous stroma formation and increased mitotic activity.|-2.0526190476190322|4.485402298850573|15.864285714285717|15.035172413793106|13.328166666666666|13.317420430107527|9.655714285714286|8.71448275862069|16.214000000000006|12.604408602150535|74.48509850970193|76.64453405168562|28.019047619047615|28.694252873563222
Information learned before age 12 and less subject to disruption than intermediate memory.|Information learned before age 12 and less subject to disruption than intermediate memory.|37.54519230769233|37.54519230769233|9.637307692307694|9.637307692307694|10.354376923076924|10.750842857142857|-10.258461538461539|-9.806153846153848|12.96769230769231|8.311428571428571|54.195869768830164|54.195869768830164|21.06153846153846|21.06153846153846
A white blood cell that is derived from a lymphocyte stem cell matured in the thymus and characterized by a CD8 marker on the surface and an antigen-specific T cell receptor which recognizes antigens in the context of MHC class I.|A white blood cell that is derived from a lymphocyte stem cell population matured in the thymus and characterized by an immunoglobulin class I.|51.905548780487806|46.60500000000002|11.112317073170736|9.740000000000002|11.734938095238094|10.5609|12.809756097560975|4.978333333333335|20.765|13.866399999999999|76.64453405168562|58.53822981607831|19.90731707317073|16.46666666666667
Using midwifery assessment methods in a usual, subsequent, 30-minute, out-of-office meeting to assess the health status of an existing midwifery client to develop a midwifery treatment plan.|Using midwifery assessment methods in a usual, followed, 30-minute, out-of-office meeting to assess the health status of an existing midwives treatment plan.|27.06583333333336|38.00636363636366|12.837962962962965|10.690909090909091|12.493166666666667|10.961684615384616|13.78962962962963|9.707272727272727|18.219|8.620000000000001|85.69119412168324|76.64453405168562|27.622222222222224|26.218181818181815
General mental functions of the state of awareness and alertness, including the clarity and continuity of the wakeful state.|General mental functions of the state of awareness and alertness, including the clarity and continuity of this state.|41.350394736842105|47.30000000000004|9.851842105263156|8.89777777777778|11.22732105263158|10.75612105263158|1.6463157894736824|0.10444444444444656|13.851052631578945|7.861578947368422|66.37611354998121|62.58|22.74736842105263|21.37777777777778
A representation of the sequence of biological or biochemical events that are involved in the regulation of the cell cycle.|A sequence of biological or chemical events that are involved in the regulation of the cell cycle.|35.94500000000002|48.9133823529412|10.73|8.548529411764708|10.944500000000001|11.100677777777777|0.9759999999999991|-6.115294117647053|12.826500000000003|4.526666666666667|62.58|58.53822981607831|20.0|19.870588235294118
A unit of spoken language larger than a phoneme.|A unit of spoken language larger than a phoneme.|80.06750000000002|80.06750000000002|3.2094444444444434|3.2094444444444434|9.346233333333334|10.200500000000002|-39.64444444444443|-38.99111111111111|3.4800000000000004|-0.08999999999999986|44.250742366654144|44.250742366654144|19.57777777777778|19.57777777777778
A genetic syndrome caused by mutations in the PTPN11 and RAF1 genes. It is characterized by the following abnormalities: multiple lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonary stenosis, abnormalities in genitalia, growth retardation, and deafness.|A genetic syndrome caused by mutations in the PTPN11 and RAF1 genes. It is characterized by the following abnormalities: multiple lentigines, electrical heart rhythm, pulmonary stenosis, and deafness.|-15.298095238095215|31.183095238095262|18.291428571428572|11.228571428571431|14.429642857142857|12.827690804597701|17.97257142857142|4.825714285714287|20.828285714285713|10.688850574712646|78.74477315987392|62.58|26.38095238095238|20.876190476190477
A finding of no distension of pharyngoesophageal segment opening during swallowing with total obstruction of flow.|A finding of no distension of the pharyngeal segment opening during swallowing with total obstruction of flow.|24.22750000000002|43.93691176470591|11.867500000000003|9.242647058823533|11.338225000000001|11.100677777777777|-0.6174999999999997|-1.9647058823529377|15.418749999999996|7.666666666666668|66.37611354998121|66.37611354998121|25.700000000000003|24.576470588235296
Health insurance plans for employees, and generally including their dependents, usually on a cost-sharing basis with the employer paying a percentage of the premium.|Health insurance plans for employees, and generally including their dependents, usually on a cost-sharing basis with the employer paying % of the premium.|32.504999999999995|40.67554347826092|11.706666666666667|10.442826086956522|11.8241|11.468783333333334|10.123333333333335|8.262608695652176|17.069200000000002|9.689999999999998|76.64453405168562|73.38155456243756|24.8|23.730434782608697
<b>Description:</b>A telephone number served by a fax device \[http://www.ietf.org/rfc/rfc3966.txt and http://www.ietf.org/rfc/rfc2806.txt\]|A telephone number served by a fax device.|82.18545454545456|75.87500000000001|2.1864935064935054|3.6700000000000017|14.178744444444446|9.123033333333336|-118.87272727272725|-47.54|20.801666666666662|-0.8633333333333333|23.653016720917435|38.32226702584281|15.174025974025975|16.6
Used in pharmacokinetics and bioequivalence to indicate maximum plasma concentration for a drug.|Use in pharmacokinetics and bioequivalence to indicate maximum plasma concentration for a drug.|11.514423076923094|11.514423076923094|13.268076923076926|13.268076923076926|12.783607692307694|13.006557142857146|-7.544615384615383|-7.544615384615383|15.141538461538467|9.993571428571428|54.195869768830164|54.195869768830164|21.06153846153846|21.06153846153846
Any process that modulates the frequency, rate or extent of insulin receptor signaling. [GOC:bf]|Any process that modulates the rate or extent of insulin receptor signaling. [GOC:bf]|30.53000000000003|37.54519230769233|10.740000000000002|9.637307692307694|13.4825|13.4825|-7.425714285714285|-12.067692307692312|6.812000000000001|4.300000000000001|62.58|58.53822981607831|25.65714285714286|24.13846153846154
The manifestation of psychotic symptoms, such as hallucinations or delusions, in the presence of a mood disorder.|The manifestation of psychotic symptoms, such as hallucinations or delusions, in the presence of mood disorder.|33.98397058823531|29.515000000000015|10.630882352941178|11.130000000000003|11.910288235294118|12.417511764705882|-1.2729411764705887|-1.3524999999999991|13.11352941176471|8.863529411764706|58.53822981607831|58.53822981607831|19.870588235294118|20.700000000000003
A multi-organ, animal-based dietary supplement used to help strengthen, support and improve the function of the female reproductive system.|A multi-organ, animal-based supplement used to help strengthen, support and improve the function of the female reproductive system.|23.53986842105263|28.50000000000003|12.336052631578948|11.520000000000003|11.445242857142857|10.924442857142857|6.288421052631584|4.677777777777784|15.087142857142858|8.491428571428571|73.38155456243756|69.96656701596841|26.957894736842107|25.822222222222223
A thymic epithelial neoplasm characterized by the presence of a lymphocyte-poor component similar to that seen in type A thymoma and a lymphocyte-rich component which contains neoplastic small polygonal epithelial cells. It may be associated with myasthenia gravis and pure red cell aplasia. The majority of cases occur in the anterior mediastinum as Masaoka stage I tumors. A minority of the cases occur as stage II or stage III tumors. The overall survival is reported to be 80-100% at 5 and 10 years.|A cancerous skin tumor characterized by the presence of a lymphocyte-poor component similar to that seen in type A thymoma. A minority of the cases occur as stage II or stage III tumors. The overall survival is reported to be 80-100% at 5 and 10|41.94115461847392|56.25000000000003|10.845963855421687|9.140000000000004|11.282992093023257|11.338225000000001|8.427469879518068|6.6613333333333316|9.734186046511624|5.900625000000002|73.38155456243756|69.96656701596841|21.43694779116466|19.333333333333332
A propoxyphene test system is a device intended to measure propoxyphene, a pain-relieving drug, in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of propoxyphene use or overdose or in monitoring levels of propoxyphene to ensure appropriate therapy.|A propoxyphene test system is a device intended to measure the drug of choice for the treatment of pain and fever drug, in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment to ensure appropriate therapy.|23.910797101449305|50.630852713178314|13.733478260869568|9.758139534883725|11.857206382978724|10.823512121212122|13.802608695652172|8.748837209302323|15.573617021276597|8.382878787878784|86.63808689023553|76.64453405168562|26.133333333333333|22.477519379844964
An indication that somatostatin receptor type 2 expression has been detected in a sample.|An indication that somatostatin receptor type 2 has been detected in a sample.|36.572857142857174|44.05288461538464|9.89714285714286|8.729615384615386|13.353757142857145|13.006557142857146|-10.365714285714287|-15.233846153846155|10.802142857142854|4.274285714285714|54.195869768830164|49.473833993334296|19.942857142857143|17.984615384615388
This gene is involved in cellular signaling. It is also involved in the immune response and host defense in Leprosy.|This gene is involved cellular signaling. It is also involved in the immune response and host defense in Leprosy.|64.70833333333334|62.37508771929825|5.890000000000004|6.132631578947368|10.448500000000001|11.072666666666667|-15.881999999999998|-17.027368421052632|5.942499999999999|4.040333333333333|54.195869768830164|54.195869768830164|20.666666666666668|21.480701754385965
Cell surface receptors for INTERLEUKIN-18 found on a variety of cell types including MACROPHAGES; NEUTROPHILS; NK CELLS; ENDOTHELIAL CELLS; and SMOOTH MUSCLE CELLS. They are formed as a heterodimer of alpha and beta subunits.|Cell surface receptors for INTERLEUKIN-18 are formed as a heterodimer of alpha and beta subunits.|53.50225490196081|58.2225|8.612352941176475|7.001666666666669|11.445876470588235|10.941425|7.087058823529411|-6.538666666666671|12.836470588235294|7.003125000000001|62.58|54.195869768830164|18.650980392156864|19.0
This gene is involved in signaling.|This gene is involved in signaling.|76.89000000000003|76.89000000000003|3.2800000000000047|3.2800000000000047|11.8291|12.832957142857145|-69.26666666666665|-68.28666666666666|4.334999999999997|0.5057142857142836|31.29|31.29|14.533333333333331|14.533333333333331
The process in which the anatomical structures of a mesonephric nephron tubule are generated and organized. A mesonephric nephron tubule is an epithelial tube that is part of the mesonephric nephron, the functional part of the mesonephros. [GOC:mtg_kidney_jan10]|The process in which the anatomical structures of a renal cell's kidney are generated and organized. A mesonephric nephron tubule is an epithelial tube that is part of the renal pelvis. [GOC:mtg_kid|35.909912280701775|45.31458333333336|11.397368421052636|9.588750000000001|11.973864102564102|12.093633333333333|11.447368421052634|3.120000000000001|11.518461538461537|6.955490196078433|72.26115969177356|67.59412548439398|21.90877192982456|21.766666666666666
The determination of the amount of chenodeoxycholate in a sample.|The determination of the amount of chenodeoxycholate in a sample.|24.100000000000023|24.100000000000023|11.14|11.14|8.8695|9.651118181818184|-26.272|-25.683999999999997|9.475000000000001|5.298181818181817|44.250742366654144|44.250742366654144|18.0|18.0
Any process that modulates the occurrence or rate of mesenchymal stem cell death by apoptotic process that contributes to the shaping of the nephron in the metanephros. [GOC:mtg_apoptosis, GOC:mtg_kidney_jan10]|Any process that modulates the occurrence or rate of mesenchymal stem cells death by programmed cell death that contributes to the shaping of the metanephros. [GOC:mtg_apoptosis, GOC:kidney_jan10]|34.58646551724141|39.59916666666669|12.03741379310345|11.089814814814819|11.536267741935484|11.222833333333334|16.488275862068964|15.314074074074071|13.060645161290324|11.975000000000001|76.64453405168562|69.96656701596841|22.351724137931036|20.214814814814815
A 30-item, self-report questionnaire designed to measure physical and social function along with symptom impact associated with musculoskeletal disorders of the upper limb.|A 30-item, self-report questionnaire designed to measure physical and social function along with symptom impact associated with upper limb disorders.|25.962500000000034|35.94500000000002|12.495000000000001|10.73|12.4557|12.445160869565218|12.608695652173907|8.913999999999998|18.5764|10.327391304347824|82.78555852321104|79.77416029015912|28.947826086956525|30.0
A cytogenetic abnormality that refers to the loss of all or part of the short arm of chromosome 12 (12p).|A DNA abnormality that refers to the loss of all or part of the short arm of chromosome 12 (12p).|74.01500000000001|90.935|5.419999999999998|3.0599999999999987|9.3655|9.420633333333335|-4.3160000000000025|-6.373999999999999|8.116500000000002|0.8657142857142865|44.250742366654144|38.32226702584281|12.0|10.0
Catalysis of the reaction: a hydroxyjasmonate + 3'-phosphoadenosine-5'-phosphosulfate = a hydroxyjasmonate sulfate + adenosine-3',5'-diphosphate. [EC:2.8.2.-, GOC:pmn_curators, MetaCyc:RXN-10451, MetaCyc:RXN-10453, PMID:12637544]|Increasing the rate of the reaction: a hydroxyjasmonate + 3'-phosphoadenosine-5' phosphosulfate is formed. [EC:2.8.2.-, GOC:pmn_curators, MetaCyc:RXN-10|73.85168421052632|60.82450000000003|3.9025263157894763|5.570500000000003|16.7645|13.732344444444447|-12.59578947368422|-41.785000000000004|30.67|17.086666666666666|34.27647764867329|31.29|14.15157894736842|13.780000000000001
Visual field deficit within the central 10 degrees of the visual field in the affected eye|Visual field deficit within the central 10 degrees of visual field in the affected eye.|53.120000000000005|58.2225|9.825|7.001666666666669|12.3251|12.915175000000001|9.0625|-10.45866666666667|8.648125|4.059374999999999|82.78555852321104|58.53822981607831|23.900000000000002|21.666666666666668
Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (typically serum or feces) to determine the serine proteinase trypsin. There are two types of trypsin: trypsin I, which is cationic and is found in serum either as its precursor trypsinogen or in complexed forms, and trypsin II, which is anionic and is only found in healthy people as its precursor trypsinogen II. Trypsin is used as an indicator of the type and severity of pancreatitis. The level of trypsin in feces and duodenal content is used as an aid in the diagnosis of chronic pancreatitis and cystic fibrosis in neonates and children.|Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (typically serum or feces) to determine the protein building blocks used in the diagnosis of pancreatitis and cystic fibrosis. The level of tryp|35.68035514018692|18.857500000000016|13.598990654205611|15.225000000000001|11.603954205607476|12.889426315789473|16.00785046728972|18.008648648648645|15.406962616822433|14.2228947368421|96.94851912226405|101.39118822659097|26.503925233644864|30.102702702702704
This gene plays a role in transcription and proliferation.|This gene has a role in transcription and proliferation.|61.26750000000001|61.26750000000001|5.831666666666667|5.831666666666667|11.100677777777777|11.7795|-33.11111111111111|-33.764444444444436|8.713333333333335|3.678000000000001|31.29|31.29|10.68888888888889|10.68888888888889
Ensuring physical comfort, health and physical and mental well-being, such as by maintaining a balanced diet, and an appropriate level of physical activity, keeping warm or cool, avoiding harms to health, following safe sex practices, including using condoms, getting immunizations and regular physical examinations.|Ensuring physical comfort, health and physical and mental well-being, such as by maintaining a balanced diet, and an appropriate level of physical activity, keeping warm or cool, avoiding harms to health, including condoms and regular physical examinations.|17.227727272727265|23.43047297297298|16.321818181818184|14.587162162162166|12.535388888888889|11.486520512820514|23.028181818181814|19.28|28.59733333333333|14.16461538461538|106.1095525859948|98.94766798666859|29.709090909090914|29.021621621621627
Yellow, white or greyish lesions in the retina that are well-defined/distinct, individual and mostly uniform in size. [UManchester:psergouniotis]|Yellow, white or greyish lesions in the retina that are well-defined/distinct, individual and mostly uniform in size. [UManchester:pserotis]|5.000000000000028|9.700000000000017|14.797777777777782|14.142222222222227|10.172538095238096|10.641645454545454|8.924444444444447|7.617777777777782|10.734285714285711|8.904545454545453|62.58|62.58|21.37777777777778|21.37777777777778
A drug used together with other drugs to treat early breast cancer that has spread to lymph nodes. It is also being studied in the treatment of other types of cancer. Epirubicin is a type of anthracycline antibiotic.|A drug that has spread to lymph nodes. It is also being studied in the treatment of other types of cancer.|65.83986842105264|90.95857142857145|6.436052631578949|2.3114285714285714|9.25108245614035|9.024324242424242|-3.4599999999999973|-17.925714285714285|6.718070175438598|0.4343939393939422|56.4088497046341|44.250742366654144|17.48421052631579|14.228571428571428
This gene is involved in second messenger molecule metabolism.|This gene is involved in second messenger molecule metabolism.|33.067500000000024|33.067500000000024|9.765|9.765|12.855122222222224|13.3585|-30.49777777777777|-29.84444444444444|10.806666666666665|6.504000000000001|49.473833993334296|49.473833993334296|24.022222222222226|24.022222222222226
Cases of harm to a child caused by parents or other caregivers, defined by the Federal government as: any recent act or failure to act on the part of a parent or caretaker which results in death, serious physical or emotional harm, sexual abuse or exploitation; or an act or failure to act which presents an imminent risk of serious harm.|Any recent act or failure to act on the part of a parent or other caregiver which results in death, serious physical or emotional harm, sexual abuse or exploitation; or an act which presents an imminent risk of serious harm.|38.5758606557377|44.83000000000004|15.455819672131149|11.975000000000001|11.06259180327869|10.045007317073171|17.09245901639344|12.542|30.071967213114753|9.727804878048783|106.1095525859948|88.50148473330829|27.281967213114754|24.0
The non-covalent aggregation and arrangement of proteins and lipids in the liver to form a very-low-density lipoprotein particle. [GOC:BHF, GOC:mah]|The non-covalent aggregation and arrangement of proteins and lipids in the liver to form very-low-density lipoprotein particle. [GOC:BHF, GOC:mah]|19.025000000000006|14.634605263157908|13.09|13.578157894736844|12.4673|13.0989|8.326000000000004|8.764210526315786|7.428000000000001|7.428000000000001|69.96656701596841|69.96656701596841|24.0|24.852631578947367
A pharmaceutical preparation of sitagliptin phosphate and metformin hydrochloride that is used in the treatment of TYPE 2 DIABETES.|A pharmaceutical preparation of a drug that treats TYPE 2 DIABETES.|27.992500000000007|47.434318181818185|11.715|8.009545454545457|12.889426315789473|13.144933333333334|3.812631578947368|-22.81454545454546|15.834210526315793|3.942499999999999|62.58|38.32226702584281|20.642105263157895|13.109090909090908
Severe pain; limiting self care ADL|Severe pain; limiting self care ADL|73.84500000000001|73.84500000000001|4.450000000000003|4.450000000000003|11.8291|12.832957142857145|-19.93333333333333|-18.953333333333326|4.334999999999997|0.5057142857142836|44.250742366654144|44.250742366654144|15.733333333333333|15.733333333333333
A lymph node located above the collar bone and between the center of the body and a line drawn through the nipple to the shoulder.|A lymph node located above the collar bone and between the center of the body and a line drawn through the nipple to the shoulder.|79.09150000000001|79.09150000000001|5.333000000000002|5.333000000000002|7.4029|7.317838461538462|1.2512000000000008|1.4863999999999997|10.851999999999997|4.272307692307692|62.58|62.58|17.8|17.8
This gene is involved in G protein-coupled receptor signal transduction and the regulation of growth factor release.|This gene is involved in protein-coupled receptor signal transduction and the regulation of growth factor release.|43.93691176470591|40.09|9.242647058823533|9.655000000000001|15.055966666666668|15.055966666666668|-0.235294117647058|-0.25|13.213333333333331|13.213333333333331|62.58|62.58|22.223529411764705|23.200000000000003
Fountains that spray a controlled stream of water for an extended period of time into the eyes and face. These fountains are usually used for decontamination in emergency situations (e.g., contact with corrosive chemicals or materials). These fountains are usually installed at eye or waist level. They may be wall-mounted hoses with a spray nozzle or consist of a stand-alone sink/basin with one or two nozzles or cups for the eyes and face.|Fountains that spray a controlled stream of water for an extended period of time into the eyes and face. These fountains are usually used for decontamination in emergency situations (e.g., contact with corrosive chemicals or materials). They may be wall-mounted hoses with one or|60.65821917808219|51.775727272727295|7.389471624266147|8.223818181818185|8.734163157894738|9.202685507246377|1.419178082191781|-1.9645454545454477|10.38052631578947|9.889057971014491|60.30359690764722|57.69590921373889|18.418003913894324|18.974545454545456
Bifunctional cross-linking agent that links covalently free amino groups of proteins or polypeptides, including those in cell membranes. It is used as reagent or fixative in immunohistochemistry and is a proposed antisickling agent.|Bifunctional cross-linker that links covalently free amino groups of proteins or polypeptides, including those in cell membranes. It is used as reagent or fixative in immunohistochemistry and is a proposed antisickling agent.|23.906363636363665|24.164583333333354|12.657575757575756|12.53875|11.910288235294118|11.629221568627452|8.727272727272723|8.08125|14.221764705882357|10.69578431372549|69.96656701596841|67.59412548439398|22.581818181818182|21.766666666666666
An insertion of the amino acid histidine between the asparagine at position 771 and the proline at position 772 of the epidermal growth factor receptor protein.|An insertion of protein building blocks between the asparagine and the proline at position 771 of a protein.|40.7092307692308|61.400000000000034|10.810769230769232|6.9311111111111146|14.035715384615385|10.75612105263158|7.761538461538464|-2.8355555555555547|15.844615384615388|5.87842105263158|79.77416029015912|62.58|25.200000000000003|21.37777777777778
A dose calculation unit expressed in milligrams per milliliter, divided by milligram per kilogram.|A dose calculation unit expressed in micrograms per milliliter, divided by millium per kilogram.|12.401428571428596|18.44428571428574|13.26857142857143|12.425714285714289|15.60947142857143|15.587833333333334|-6.585714285714289|-7.005714285714284|13.493571428571428|8.068000000000001|62.58|62.58|25.65714285714286|25.65714285714286
The formation of daughter actin filament branches at an angle on the sides of preexisting mother filaments. [GOC:ascb_2009, GOC:dph, GOC:tb]|The formation of daughter filament branches at an angle on the sides of preexisting mother filaments. [GOC:dph, GOC:tb]|61.32500000000002|56.70000000000002|7.190000000000001|7.58666666666667|12.445160869565218|11.67634761904762|5.974|0.7577777777777754|7.460434782608694|5.575714285714284|66.37611354998121|62.58|22.0|21.37777777777778
The presence of microorganisms that normally reside at an anatomical site and that under normal circumstances do not cause disease.|The presence of microorganisms that normally reside at a body site and that under normal circumstances do not cause disease.|40.17500000000001|52.86500000000001|10.140000000000004|8.370000000000001|11.734|10.924442857142857|3.3279999999999994|1.564|14.710500000000003|7.370000000000001|66.37611354998121|66.37611354998121|22.0|22.0
Any process that modulates the frequency, rate or extent of mesenchymal cell apoptotic process. [GOC:mtg_apoptosis, GOC:obol]|Any process that modulates cell death. [GOC:mtg_apoptosis, GOC:obol]|3.077500000000015|1.8500000000000227|14.817500000000003|13.995000000000001|13.732344444444447|13.957481818181819|3.424999999999997|-28.43|10.021666666666668|5.298181818181817|69.96656701596841|49.473833993334296|28.200000000000003|26.6
An abnormality of a blood vessel of the head, including branches of the arterial and venous systems of the head. [GOC:TermGenie, ORCID:0000-0001-5889-4463]|An abnormality of a blood vessel on the head, including branches of the arterial and venous systems ofthe head. [GOC:TermGenie, ORCID:000-0001-5889-4463]|64.9245454545455|63.23464285714289|6.936363636363637|7.0478571428571435|10.961684615384616|12.1763|8.905454545454543|9.329523809523813|7.714230769230767|7.714230769230767|62.58|62.58|18.94545454545455|19.43809523809524
An array of expression measurement objects.|An array of expression measurement object.|34.59000000000003|34.59000000000003|9.180000000000003|9.180000000000003|14.460766666666668|15.08867142857143|-61.42666666666666|-61.42666666666666|10.615000000000002|5.215714285714284|44.250742366654144|44.250742366654144|27.866666666666664|27.866666666666664
A recombinant form of naturally-occurring GC (group-specific component) protein-derived macrophage-activating factor (GC-MAF). GC is also known as vitamin D binding protein (VDBP). GC-MAF promotes macrophage activation.|A recombinant form of protein-derived macrophage activation factor. GC is also known as vitamin D binding protein (VDBP).|-8.008653846153834|31.545000000000016|15.99115384615385|10.350000000000001|15.514629166666667|13.441166666666666|-1.664615384615388|-15.033333333333331|10.249895833333333|5.453333333333333|58.53822981607831|54.195869768830164|24.13846153846154|22.400000000000002
Derived from a spontaneous mutation in the leptin receptor that appeared in a 13M rat colony bred at the Zucker Laboratory of Comparative Pathology (Stow, MA), genotype leprfa. The Zucker rat may come in four principal color variants, including brown, brown and white, black, and black and white. The mutation causes severe obesity, diabetes, abnormal heart function, hypertriglyceridemia, and hypercholesterolemia. The Zucker rat is utilized in biomedical research to study insulin resistance, glucose intolerance, metabolic syndromes, and obesity.|The Zucker rat is utilized in biomedical research to study insulin resistance, glucose intolerance, and obesity.|16.377923076923082|8.365000000000009|14.85041025641026|14.080000000000002|12.41116329113924|13.346335294117647|16.607179487179483|-0.9849999999999994|15.452974683544305|9.140588235294118|87.38821419390602|69.96656701596841|26.24|28.200000000000003
Faces Pain Scale - Revised test code.|Faces Pain Scale- Revised test code.|106.59678571428573|90.99000000000004|-0.7392857142857139|1.3133333333333361|11.8291|12.832957142857145|-58.53142857142856|-67.30666666666666|4.334999999999997|1.1785714285714306|31.29|31.29|12.82857142857143|14.533333333333331
A fully human monoclonal antibody that targets the neonatal crystallizable fragment receptor (FcRn), with potential immunomodulating activity. Upon administration, nipocalimab targets and binds to FcRn at the immunoglobulin G (IgG) binding site, thereby preventing the interaction between FcRn and the serum protein IgG. By preventing FcRn/IgG binding, nipocalimab blocks the FcRn-mediated rescue of IgG, enables IgG degradation and prevents IgG-mediated inflammation. IgG plays a key role in many autoimmune diseases and is an important factor in inflammatory processes.|A fully human monoclonal antibody that targets a neonatal crystallizable fragment receptor, with potential immunomodulating activity. Upon administration, nipocalimab targets and binds to FcRn at the immunoglobulin G (IgG) binding|8.785615384615397|-19.889999999999986|15.909384615384617|19.76|14.582751851851853|14.59239677419355|18.26564102564102|19.858666666666664|16.547962962962963|16.251290322580644|89.6009242139834|93.86999999999999|27.265641025641028|30.0
Death|Sudden death|121.22000000000003|77.90500000000002|-3.3999999999999986|2.890000000000004|0.0496|9.048633333333335|-266.6|-112.72|2.620000000000001|-1.0899999999999999|0.0|31.29|0.4|20.8
Chemical and/or pharmacological reactions of drugs in combination, including agonistic and antagonistic interactions.|Chemical and/or drug reactions of drugs in combination, including agonistic and antagonistic interactions.|-27.531730769230762|5.006730769230813|18.71423076923077|14.17576923076923|16.427453846153846|16.390128571428573|1.9538461538461505|-2.569230769230778|22.387692307692312|13.35785714285715|62.58|58.53822981607831|27.21538461538462|24.13846153846154
The presenting findings of CHD.|The presenting findings of CHD.|68.93750000000003|68.93750000000003|4.265000000000004|4.265000000000004|10.200500000000002|11.6803|-86.648|-85.472|5.562000000000001|1.2650000000000006|31.29|31.29|17.0|17.0
A pathologic stage that refers to lymphoma involving node regions on both sides of the diaphragm, or an extralymphatic organ or site plus nodes on both sides of the diaphragm (IIIe), or lymph nodes on both sides of the diaphragm plus spleen (IIIs).|A pathologic stage that refers to lymphoma involving node regions on both sides of the diaphragm, or an extralymphatic organ or site or more than one side of a body part.|66.96598837209305|62.837983870967776|9.260116279069766|8.345322580645163|12.746276744186048|9.364474999999999|14.401860465116275|7.647741935483875|21.867441860465114|7.029062499999998|69.96656701596841|66.37611354998121|17.90232558139535|17.81290322580645
A response of 5 on a scale for the subject scoring of upset that ranges from 1: It does not upset me at all to 6: It makes me extremely upset.|A response of 5 on a scale for the subject scoring of upset that ranges from 1: It does not upset me at all to 6: I makes me extremely upset.|90.12830645161293|90.12830645161293|4.538870967741939|4.538870967741939|9.24893870967742|8.8710375|2.1470967741935496|2.1470967741935496|10.630967741935486|2.6134375|62.58|62.58|16.52258064516129|16.52258064516129
An injury to the spinal cord occurring during labor and/or delivery. Injury may include compression, partial or complete disruption of the cord.|An injury to the spinal cord occurring during labor and/or delivery. Injury may include compression, partial or total disruption of the cord.|41.72803030303032|41.72803030303032|9.260909090909092|9.260909090909092|12.794827272727273|12.94154927536232|-7.489090909090912|-8.023636363636363|9.760909090909088|6.567681159420289|62.58|62.58|24.75151515151515|24.75151515151515
A pathologic finding about one or more characteristics of eyelid carcinoma, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes.|A pathologic finding about one or more characteristics of eyelid cancer, following the rules of the cancer staging classification system as they pertain to staging of lymph nodes.|42.150000000000034|41.553571428571445|11.10666666666667|10.941428571428574|12.493166666666667|10.889493103448277|11.430666666666664|10.987142857142853|18.219|10.344482758620689|76.64453405168562|79.77416029015912|22.0|24.171428571428574
Difficulty releasing one's grip associated with prolonged first handgrip relaxation times. [PMID:22987687, UToronto:htrang]|Difficulty releasing one's grip associated with prolonged first handgrip relaxation times. [PMID:22987687, UToronto:htr]|-1.5009615384615245|5.006730769230813|15.083461538461542|14.17576923076923|15.262271428571431|15.587833333333334|4.667692307692306|3.763076923076923|17.731428571428573|14.975999999999999|62.58|62.58|27.21538461538462|27.21538461538462
The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules that contributes to the shaping of the heart. [GOC:dph, GOC:mtg_heart, PMID:16860783]|The attachment of a cell, either to another cell or to an underlying substrate such as the matrix outside of cells. [GOC:dph, GOC:mtg_heart, PMID:16860783]|45.26235294117649|71.28000000000002|11.169411764705881|6.298333333333332|11.108466666666667|10.154248148148149|15.965882352941176|7.9183333333333366|11.64333333333333|7.125555555555557|79.77416029015912|62.58|22.094117647058823|18.133333333333333
A country in Western South America, bordering the Pacific Ocean at the Equator, between Colombia and Peru. (NCI)|A country in Western South America, bordering the Pacific Ocean at the Equator, between Colombia and Peru.|33.20000000000002|29.00750000000002|10.864444444444448|11.325000000000003|10.223455555555555|10.223455555555555|-1.8555555555555578|-3.3482352941176465|6.620000000000001|6.096666666666668|69.96656701596841|69.96656701596841|25.822222222222223|26.929411764705886
<2.5 - 2.0 mg/dL <0.8 - 0.6 mmol/L|2.5-2.0 mg/dL 0.8 -0.6 mmol/L|184.061|171.98000000000002|-12.016|-10.48|19.9225|19.8729|-165.155|-265.424|-5.597000000000001|-4.893333333333334|0.0|0.0|0.6400000000000001|0.4
A collection of logically related observations with a common, specific topic that are normally collected for all subjects in a clinical investigation. NOTE: The logic of the relationship may pertain to the scientific subject matter of the data or to its role in the trial. Example domains include laboratory test results (LB), adverse events (AE), concomitant medications (CM). [After SDTM Implementation Guide version 3.2, CDISC.org] See also general observation class.|A collection of logically related observations with a common, specific topic that are normally collected for all subjects in an clinical investigation. NOTE: The logic of the relationship may pertain to the scientific subject matter or the role in the trial. Example domains include laboratory test results (LB), adverse events (AE),|32.31928571428574|27.015294117647073|11.235714285714284|13.714509803921569|12.451471428571429|12.479953846153846|4.084|15.331764705882353|11.407714285714285|9.888076923076923|70.9590501627523|92.11526583579942|24.57142857142857|27.192156862745094
A neuroendocrine tumor arising from the wall of the appendix, producing glucagon-like peptides. Morphologically, it is characterized by the presence of neoplastic cells forming tubular or trabecular patterns.|A neuroendocrine tumor arising from the wall of the appendix, producing a molecule of protein building blocks. Morphologically, it is characterized by the presence of certain genetic markers.|10.033095238095257|28.16166666666669|14.17857142857143|11.650000000000002|11.433975862068966|10.649759770114944|6.295714285714286|2.935714285714294|14.404827586206899|9.551954022988507|69.96656701596841|67.59412548439398|25.161904761904765|23.733333333333334
Epithelial discoidin domain-containing receptor 1 (913 aa, ~101 kDa) is encoded by the human DDR1 gene. This protein plays a role in tyrosine phosphorylation, extracellular matrix catabolism and signal transduction.|This protein plays a role in tyrosine phosphorylation, matrix chemistry and signal transduction.|33.125|31.037500000000023|11.123333333333338|10.545000000000002|16.12046129032258|14.134414285714287|6.856000000000005|-7.092307692307692|13.516451612903225|9.993571428571428|67.59412548439398|58.53822981607831|22.666666666666668|24.13846153846154
A collection of classification entities in a digital content archive.|A collection of class entities in a digital content archive.|15.640000000000015|49.48000000000002|12.320000000000004|7.600000000000001|13.6065|12.522027272727273|-23.919999999999995|-28.624|11.359000000000002|3.15727272727273|54.195869768830164|49.473833993334296|26.0|22.0
A potency unit for measuring infectious activity of a biologic product or an infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent embryo infective dose.(NCI)|A unit for measuring infectious activity of a biologic product or an infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent embryo infective dose.(NCI)|22.868235294117653|26.014772727272742|14.292941176470588|13.729848484848485|14.146723529411764|14.146723529411764|14.755294117647058|14.133333333333333|21.197941176470586|20.366764705882353|96.44225707644962|93.86999999999999|29.152941176470588|28.418181818181814
Information collected directly from a patient that typically includes subjective feelings regarding symptoms, functions in daily life, physical, mental, emotional, spiritual, and social well being, and satisfaction with his/her health care.|Information collected directly from a patient that typically includes subjective feelings regarding symptoms, functions in daily life, physical, mental, emotional, spiritual, and satisfaction with his/her health care.|10.986370967741976|5.132500000000022|15.577580645161287|15.897222222222226|13.6121375|13.611906896551725|20.735483870967748|19.88740740740741|24.1546875|15.704137931034488|98.94766798666859|93.86999999999999|32.00645161290323|32.06666666666666
The NCI term type designation for the US brand name of a drug. A brand name may be trademarked.|The NCI term type designation for the US brand name of a drug. A brandname may be trademarked.|89.09087719298246|83.24500000000002|2.4063157894736875|3.1388888888888893|9.925068421052632|10.599054385964912|-22.907368421052634|-23.85333333333333|1.912105263157894|0.576666666666668|25.548178017228544|31.29|6.7438596491228076|9.066666666666666
Theoretical representations that simulate the behavior or activity of the neurological system, processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment.|Theoretical representations that simulate the behavior or activity of the brain system, processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment.|-24.367692307692295|-11.352307692307647|19.88769230769231|18.072307692307692|14.035715384615385|13.078322222222225|17.938461538461535|16.58153846153846|23.27192307692308|14.801111111111112|88.50148473330829|85.69119412168324|29.81538461538462|28.276923076923072
Human NR1H4 wild-type allele is located in the vicinity of 12q23.1 and is approximately 91 kb in length. This allele, which encodes bile acid receptor protein, plays a role in both the metabolism of bile acids and ligand-dependent transcriptional regulation.|Normal human NR1H4 gene is located in the vicinity of chromosome location, 12q23.1, and is about 91 kilobases in length. This gene, which encodes bile acid receptor protein, plays a role in both the metabolism of amino acids and|50.75|56.97846153846157|8.665000000000003|8.541538461538462|13.700957142857144|13.313|2.593|6.0276923076923055|12.956428571428567|10.471500000000002|62.58|69.96656701596841|20.0|20.58461538461539
A characterization of the extent of any localized or abnormal change in the structure of part of an organ or tissue. EXAMPLE(S): Typically provided as a set of two measurements (two longest perpendicular measurements) and/or volume measurement. OTHER NAME(S): NOTE(S):|A characterization of the extent of any localized or abnormal change in the structure of part of an organ or tissue. EXAMPLE(S): Typically provided as a set of two measurements (two longest measurements) and/or volume measurement.|28.331666666666678|37.20500000000001|12.620000000000001|11.051111111111112|11.008583333333334|10.649584684684685|11.462999999999997|7.346666666666671|11.023916666666665|8.923153153153155|80.79043260188672|72.26115969177356|25.333333333333336|22.57777777777778
A term coined from a contraction of nutrition and pharmaceutical to mean a component of food that has bioactive effects. It is used in marketing and has no regulatory definition.|A term coined from a contraction of nutrition and pharmaceutical terms that have active effects. It is used in marketing and has no regulatory definition.|55.685|52.864666666666665|7.97666666666667|7.9559999999999995|9.1175|9.532135897435897|-0.39599999999999724|-4.7087999999999965|9.149000000000001|6.272179487179486|57.127462747788826|54.195869768830164|17.333333333333332|17.733333333333334
A question about how often an individual has or had problems with sexual interest or activity.|A question about how often an individual has/had problems with sexual interest or activity.|34.80250000000001|18.44428571428574|10.392500000000002|12.425714285714289|9.364474999999999|9.954550000000001|-7.967500000000001|-9.105714285714278|9.53125|5.236875000000001|62.58|66.37611354998121|23.200000000000003|28.51428571428572
A phenobarbitol test system is a device intended to measure phenobarbital, an antiepileptic and sedative-hypnotic drug, in human specimens. Measurements obtained by this device are used in the diagnosis and treatment of phenobarbital use or overdose and in monitoring levels of phenobarbital to ensure appropriate therapy.|A drug test system is a device intended to measure phenobarbital, an antiepileptic and sedative-hypnotic drug, in human specimens. Measurements obtained by this device are used in the diagnosis and treatment of this drug's use or overdose and in|3.6803623188405936|28.68865384615387|16.55521739130435|14.102179487179487|12.193163829787235|11.58549512195122|16.10347826086956|16.180512820512824|17.577872340425536|12.255121951219515|86.63808689023553|85.69119412168324|26.133333333333333|23.184615384615388
A semi-synthetic, second-generation taxane derived from a compound found in the European yew tree, Taxus baccata. Docetaxel displays potent and broad antineoplastic properties; it binds to and stabilizes tubulin, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and cell death. This agent also inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and displays immunomodulatory and pro-inflammatory properties by inducing various mediators of the inflammatory response. Docetaxel has been studied for use as a radiation-sensitizing agent. (NCI04)|A semi-synthetic, second-generation taxane derived from a compound found in the European yew tree, Taxus baccata. Docetaxel displays potent and broad anti-cancer properties; it binds to and stabilizes tubulin|7.490142857142899|11.248534482758657|16.388190476190477|15.292586206896551|13.827855555555555|13.546112121212122|20.110952380952387|16.285517241379313|14.835666666666661|11.654545454545449|91.76029239273379|85.69119412168324|27.196190476190477|26.48965517241379
A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.|A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It isa mechanism to compensate for reduced sensitivity to insulin.|-8.867017543859646|-20.154999999999973|16.06947368421053|17.561111111111114|12.428252380952381|13.758461904761907|-8.981052631578947|-9.153333333333329|10.061428571428571|8.535714285714285|54.195869768830164|57.127462747788826|21.480701754385965|24.622222222222224
LIM/homeobox protein Lhx2 (406 aa, ~44 kDa) is encoded by the human LHX2 gene. This protein plays a role in both DNA binding and transcriptional regulation.|LIM/homeobox protein Lhx2 (406 amino acids, 44 kilodaltons) is encoded by a human gene LHX2 protein. This protein is involved in both DNA binding and transcription.|77.64602564102567|64.63064102564107|4.582307692307694|6.3976923076923065|14.247951851851854|14.814076190476193|-4.527692307692313|-2.4923076923076977|7.125555555555557|5.777380952380952|51.09635603445709|62.58|15.774358974358975|21.92820512820513
OBSOLETE. (Was not defined before being made obsolete). [GOC:go_curators]|OBSOLETE. (Was not defined before being made obsolete)|15.79000000000002|44.150000000000006|11.802222222222223|8.094999999999999|11.696833333333334|10.877477777777777|-56.199999999999996|-38.72|7.554666666666666|4.370000000000001|44.250742366654144|49.473833993334296|27.866666666666664|26.6
<p>Codes representing a service or product that is being invoiced (billed). The code can represent such concepts as "office visit", "drug X", "wheelchair" and other billable items such as taxes, service charges and discounts.</p>|A service or product that is being invoiced (billed). The code can represent such concepts as "office visit), "drug X", "wheelchair" and other billable items such as taxes, service charges and discounts.|51.01401960784315|58.53333333333336|8.959411764705884|7.745000000000001|12.058373684210528|10.40240303030303|7.778823529411767|4.038750000000004|10.876315789473686|6.906363636363636|78.74477315987392|74.48509850970193|26.886274509803926|25.516666666666666
Any process involved in the transition from the initiation to the elongation phases of transcription by RNA polymerase II, generally including a conformational change from the initiation conformation to the elongation conformation. Promoter clearance often involves breaking contact with transcription factors involved only in the initiation phase and making contacts with elongation specific factors. [GOC:txnOH, PMID:15020047]|Any process involved in the transition from initiation to the elongation phases of transcription by RNA polymerase II, generally including a conformational change from the initial state of the cell's protein maker. Promoter clearance often involves breaking contact with transcription factors involved only in one or two phases|11.134761904761916|22.087500000000034|16.343571428571433|16.140833333333333|13.72047894736842|12.907822448979593|23.307857142857145|22.089166666666667|18.31315789473684|17.638163265306126|103.77718969022045|112.8176994092682|31.03809523809524|31.266666666666666
The anterior portion of a deep fissure or furrow on the medial surface of the cerebral cortex.|The front portion of a deep fissure or furrow on the medial surface of the brain.|63.84279411764709|87.67750000000001|6.466176470588238|3.017500000000002|10.981464705882354|8.702217647058824|-7.844705882352944|-12.377500000000001|8.403529411764705|1.105882352941176|62.58|49.473833993334296|22.223529411764705|15.700000000000001
A preparation of autologous human T-lymphocytes engineered to express a chimeric T-cell receptor (chimeric antigen receptor or CAR) consisting of one or more binding domains targeting the tumor-associated antigens (TAAs) CD19 and CD22 and fused to one or more co-stimulatory TCR-signaling domains, with potential immunostimulating and antineoplastic activities. Upon administration, the autologous CD19/CD22 CAR T-cells bind to CD19 and CD22 on the surface of, and induce selective toxicity against, tumor cells expressing CD19 and CD22. CD19 and CD22, both transmembrane phosphoglycoproteins expressed on the surface of cells in the B lineage, are overexpressed on malignant B-cells.|A preparation of autologous human T-cell receptors engineered to express a chimeric TCR consisting of one or more binding domains targeting the tumor-associated antigens (TAAs) CD19 and CD22 on the surface of, and induce selective toxicity against, tumor|20.325000000000017|5.7439473684210895|16.386666666666667|21.89842105263158|13.858274358974361|14.52790487804878|23.74291666666667|25.943157894736835|21.627179487179482|23.42414634146342|101.39118822659097|136.38994794338765|27.1|35.2
The determination of the amount of factor XII present in a sample.|The determination the amount of factor XII present in a sample.|59.745000000000005|55.12522727272727|6.416666666666668|6.936818181818182|9.495033333333335|10.513266666666667|-22.383333333333333|-24.952727272727277|5.765000000000001|2.3725000000000023|49.473833993334296|49.473833993334296|19.06666666666667|20.381818181818183
The rationale or explanation for why each study endpoint was chosen.|The rationale or explanation why each study endpoint was chosen.|55.12522727272727|49.48000000000002|6.936818181818182|7.600000000000001|8.488463636363637|9.651118181818184|-22.81454545454546|-26.272|8.476363636363637|4.870000000000001|49.473833993334296|49.473833993334296|20.381818181818183|22.0
The point at the base of the skull where the brainstem and cervical spine intersect.|The point at the base of the skull where the brainstem and neck bone intersect.|86.42250000000001|97.7025|3.068333333333335|1.495000000000001|9.643833333333333|7.9808|-12.026666666666664|-13.594666666666669|7.735999999999997|1.7043749999999989|38.32226702584281|31.29|11.0|8.333333333333334
>ULN - 1.5 x ULN|Grade LN - 1.5 x ULN greater than or equal to 12 months of life.|153.53750000000002|122.80000000000003|-7.535|-2.626666666666665|19.674500000000002|10.3245|-104.288|-39.208|-8.568|-2.2940000000000005|0.0|25.548178017228544|1.0|7.333333333333335
A response indicating that an individual is in extreme agreement with something.|A response that an individual is in extreme agreement with something.|31.545000000000016|47.434318181818185|10.350000000000001|8.009545454545457|10.810866666666666|10.513266666666667|-15.523333333333326|-21.74545454545455|11.259999999999998|4.727500000000003|54.195869768830164|49.473833993334296|22.400000000000002|20.381818181818183
A feeling of tension or tightness in one or more muscles.|A sense of tension or tightness in one or more muscles.|85.88886363636365|93.57977272727274|2.6459090909090897|1.5731818181818191|9.923918181818184|9.197433333333334|-28.694545454545462|-29.229090909090914|3.7663636363636357|-0.7674999999999983|44.250742366654144|38.32226702584281|16.745454545454546|13.109090909090908
<p>You can help prevent medical errors by being an active member of your health care team. Research shows that patients who are more involved with their care tend to get better results. To reduce the risk of medical errors, you can</p> <ul> <li>Ask questions if you have doubts or concerns. Take a relative or friend to your doctor appointment to help you ask questions and understand answers.</li> <li>Make sure you understand what will happen if you need surgery</li> <li>Tell your health care providers about all the medicines you take, including over-the-counter drugs and dietary supplements. Tell them if you have any allergies or bad reactions to anesthesia. Make sure you know how to <a href="https://medlineplus.gov/medicationerrors.html">take your medications correctly</a>. </li> <li>Get a second opinion about treatment options</li> <li>Keep a copy of your own <a href="https://medlineplus.gov/personalhealthrecords.html">medical history</a></li> </ul> <p class="">Agency for Healthcare Research and Quality</p>|You can help prevent medical errors by being an active member of your health care team. Research shows that patients who are more involved with their care tend to get better results. To reduce the risk of medical error, you can/p> li>Alkhurma href|43.879443473193504|70.3052713178295|10.099458041958044|7.013953488372092|11.513265524861879|11.009266666666665|11.386573426573428|7.518139534883716|10.233204419889503|6.391249999999999|67.59412548439398|69.96656701596841|20.431002331002333|19.686821705426357
Organized plans for care or training in psychiatric hospitals.|Arrangements for care or training in psychiatric hospitals.|51.867500000000035|33.57500000000002|7.142777777777777|9.57|9.346233333333334|10.877477777777777|-30.49777777777777|-35.045|10.806666666666665|8.033333333333331|44.250742366654144|44.250742366654144|19.57777777777778|21.6
Invasive intervention indicated|blood clot that travels|-106.40999999999997|97.025|28.846666666666668|0.7199999999999989|19.5753|13.3585|-41.82666666666667|-43.13|25.599999999999994|0.8520000000000003|54.195869768830164|31.29|41.2|11.600000000000001
A response indicating that an individual has or had severe pain or discomfort that prevented most activities.|A response that an individual has or had severe pain or discomfort that prevented most activities.|33.98397058823531|45.377500000000026|10.630882352941178|8.917500000000004|10.981464705882354|10.559864705882354|-2.656470588235294|-6.130000000000003|12.559411764705885|5.815882352941177|58.53822981607831|54.195869768830164|19.870588235294118|18.2
A terminology codelist relevant to a comparator against which the study treatment is evaluated.|A vocabulary list relevant to a comparator against which the study treatment is evaluated.|12.401428571428596|24.487142857142885|13.26857142857143|11.582857142857147|11.098042857142858|10.3245|-7.845714285714287|-9.525714285714287|12.820714285714281|6.498000000000001|62.58|58.53822981607831|25.65714285714286|22.8
Abnormal behavioral or physiologic events that are associated with REM sleep, including REM SLEEP BEHAVIOR DISORDER.|Abnormal behavioral or physiological events that are associated with REM sleep, including slow eye movement disorder.|29.515000000000015|29.515000000000015|11.130000000000003|11.130000000000003|14.29885|13.346335294117647|0.11749999999999972|0.8524999999999991|15.713124999999998|10.80294117647059|62.58|62.58|23.200000000000003|23.200000000000003
A group of congenital disorders of lipid metabolism, caused by loss of the normal peroxisomes. Signs and symptoms include developmental delays, mental retardation, facial abnormalities, hepatomegaly, and hypotonia.|A group of genetic disorders of lipid metabolism, caused by loss of the normal cell membranes. Signs and symptoms include developmental delays, mental retardation, facial abnormalities, and hypotonia.|0.96880952380954|25.140238095238118|15.442857142857147|12.071428571428573|13.353757142857145|12.827690804597701|7.555714285714284|4.825714285714287|15.848571428571425|10.688850574712646|72.26115969177356|69.96656701596841|26.59047619047619|25.161904761904765
a kind of antidote for arsenic, mercury, gold, and lead poisoning|antidote for arsenic, mercury, gold, and lead poisoning.|49.54272727272729|33.57500000000002|9.081818181818182|9.57|9.923918181818184|12.631922222222224|2.4909090909090885|-37.25|6.335454545454546|4.893333333333331|62.58|44.250742366654144|18.94545454545455|21.6
A descriptive adjective assigned to the computed amount of blood ejected during a ventricular contraction of the heart.|A descriptive adjective assigned to the computed amount of blood ejected during a heart rhythm.|33.20000000000002|46.942499999999995|10.864444444444448|8.575000000000003|10.669855555555555|10.941425|0.43111111111111455|-7.32266666666667|13.998333333333328|6.414375|66.37611354998121|58.53822981607831|23.6|21.666666666666668
A natural pyrrolizidine alkaloid with antineoplastic properties. Indicine-N-oxide alkylates and crosslinks DNA. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1134" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1134" NCI Thesaurus)|A natural molecule of fat and protein building blocks with anti-cancer properties. Indicine-N-oxide alkylates and crosslinks DNA. Check for "http://ncit.nih.gov/content.jsp?dictionary=NCI%20The|24.624000000000024|38.48166666666668|10.421000000000003|8.720000000000002|15.497746153846155|13.244133333333336|-41.99333333333334|-37.35|39.97038461538462|15.736249999999998|34.27647764867329|38.32226702584281|20.96|19.333333333333336
Carcinoma, Miscellaneous is an NCI Cancer Therapeutic Evaluation Program (CTEP) Simplified Disease Classification (SDC) category used to organize cancer-related disease coding that harmonizes with and supports reporting based on the global standard Medical Dictionary for Drug Regulatory Reporting (MedDRA) terminology.|Cancer Drug Classification (SDC) category used to organize cancer-related disease coding that harmonizes with and supports reporting based on the global standard medical dictionary for drug Regulatory Reporting System (MedDRA) terminology.|-12.274999999999977|5.528306451612963|19.94|16.338870967741936|17.223758536585365|16.756936363636363|26.36|20.735483870967748|30.20195121951219|24.186363636363637|110.62685591663536|96.44225707644962|33.0|30.716129032258063
A radioimmunoconjugate comprised of a recombinant scFv dimer diabody of a monoclonal antibody against human carcinoembryonic antigen (CEA) labeled with iodine I 123 (I-123) with potential radioimmunolocalization applications. The antibody moiety of iodine I 123 anti-CEA recombinant diabody T84.66 binds to cells expressing CEA, selectively delivering I-123 upon cellular internalization and allowing the scintigraphic imaging of CEA-expressing tumor cells. CEA, a tumor associated antigen, is overexpressed in many cancer types, including gastrointestinal, breast, non-small cell lung, and thyroid cancers. Compared to whole monoclonal antibodies, diabody fragments offer the advantages of rapid tumor targeting, rapid blood clearance, more uniform tumor distribution, and a lower potential for eliciting an immune response. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C77911" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C77911" NCI Thesaurus)|A radioimmunoconjugate comprised of a recombinant scFv monoclonal antibody against human carcinoembryonic antigen (CEA) labeled with iodine I 123 after cellular internalization and potential radio|17.00091544818818|-35.115999999999985|13.200330578512396|24.368|14.466647311827957|15.25033076923077|14.412231404958675|28.8496|23.924462365591403|22.54730769230769|71.56296786209171|125.16|26.202415766052134|35.6
An indication as to whether a continuous audio recording is made during the assessment.|An indication as to whether a continuous hearing aid is made during the assessment.|30.53000000000003|48.65857142857146|10.740000000000002|8.211428571428574|11.098042857142858|9.271833333333333|-11.205714285714286|-12.465714285714288|10.129285714285714|4.300000000000001|58.53822981607831|54.195869768830164|22.8|19.942857142857143
A monoclonal antibody targeting the ectoenzyme 5'-ecto-nucleotidase (cluster of differentiation 73; CD73; 5'-NT; ecto-5'-nucleotidase; NT5E), with potential immunomodulating and antineoplastic activities. Upon administration, anti-CD73 monoclonal antibody BMS-986179 targets and binds to CD73, leading to clustering and internalization of CD73. This prevents CD73-mediated conversion of extracellular adenosine monophosphate (AMP) to adenosine and decreases the amount of free adenosine. This prevents adenosine-mediated suppression of lymphocyte activity and increases the activity of CD8-positive effector cells. This also activates macrophages, and reduces the activity of both myeloid-derived suppressor cells (MDSCs) and regulatory T lymphocytes. By abrogating the inhibitory effect on the immune system and enhancing the cytotoxic T-cell-mediated immune response against cancer cells, tumor cell growth is decreased. CD73, a plasma membrane protein belonging to the 5'-nucleotidase (NTase) family, is upregulated on a number of cancer cell types and catalyzes the conversion of extracellular nucleotides, such as AMP, to membrane-permeable nucleosides, such as adenosine; it plays a key role in adenosine-mediated immunosuppression within the tumor microenvironment. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C132266" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C132266" NCI Thesaurus)|A monoclonal antibody targeting a protein building block, which prevents the inhibitory effect on the immune system and enhancing the cellular response against cancer cells. Tumor cell growth is decreased.|20.02651724137931|33.125|13.347793103448279|11.123333333333338|13.839333333333334|12.80806559139785|20.002068965517243|5.092000000000002|22.586666666666666|10.173440860215056|73.15884826868175|74.48509850970193|23.490574712643678|26.666666666666664
an autoimmune diseases affecting multiple endocrine organs|an autoimmune disease affecting multiple body parts.|-17.812857142857126|21.99678571428572|17.482857142857146|11.060714285714287|15.262271428571431|13.70365|1.394285714285715|-45.09142857142857|17.058571428571433|7.6525|76.64453405168562|49.473833993334296|37.08571428571428|29.971428571428575
Suicidal Ideation Questionnaire (SIQ) I thought if I had the chance I would kill myself.|Suicide Severity Rating Scale I thought if I had the chance I would kill myself.|75.14250000000001|75.14250000000001|4.641666666666666|4.641666666666666|8.219166666666666|8.967675|-10.45866666666667|-13.20266666666667|4.614000000000001|1.9987500000000011|44.250742366654144|44.250742366654144|13.66666666666667|13.66666666666667
A standardized 17-item scale that was developed by Elaine Scott and Michelle Eagle in 2011 to measure functional motor ability in ambulant children and adolescents with Duchenne muscular dystrophy. The instrument, which is partly based on the Hammersmith Motor Ability Scale (2003), utilizes a 3-point rating scale to grade activities ranging from standing to running, as well as abilities that are necessary for a patient to remain functionally ambulant and that are known to progressively deteriorate in untreated DMD.|A standardized 17-item scale that was developed by Elaine Scott and Michelle Eagle in 2011 to measure functional motor ability in ambulant children and adolescents with muscle and nerve birth defect. The instrument, which is partly based on the Hammersmith Motor Ability Scale (2003), utilizes a 3-|28.040843881856574|42.58250000000004|15.890126582278484|13.15797872340426|12.663077777777778|12.263332653061225|21.65772151898734|19.056170212765956|23.998148148148147|14.562244897959182|106.8756964889586|98.94766798666859|28.254852320675106|26.42127659574468
A person who has a license that gives them the legal power to witness the signing of documents, to certify that documents are real, and to take statements made under oath.|A person who has a license that gives them the power to witness the signing of documents, to certify that documents are real, and to take statements made under oath.|65.56701612903228|67.53000000000003|7.964677419354839|7.566666666666666|9.758293548387096|8.989493548387095|7.647741935483875|7.1186666666666625|15.03709677419355|6.679354838709678|76.64453405168562|73.38155456243756|21.68387096774194|20.666666666666668
Any factor that lessens or improves the chief complaint.|Any factor that lessens or improves chief complaint.|61.26750000000001|54.72500000000002|5.831666666666667|6.620000000000001|9.346233333333334|10.877477777777777|-34.41777777777777|-40.19|7.666666666666668|4.370000000000001|49.473833993334296|49.473833993334296|24.022222222222226|26.6
A person who determines the significance of a tumor identification assessment.|A person who determines the significance of a tumor identification test.|1.2888636363636294|16.670681818181833|14.445909090909094|12.300454545454546|11.359372727272728|10.513266666666667|-17.46909090909091|-20.14181818181818|12.758181818181818|5.905000000000001|54.195869768830164|49.473833993334296|24.018181818181816|20.381818181818183
A ring-like band of skeletal muscle on the palpebrae, temple, cheeks, and surrounding the orbit, which originates on the frontal bone, medial palpebral ligament, and lacrimal bone with insertion on the lateral palpebral raphe, that functions to close the eyelid.|A ring-like band of muscle on the palpebrae, temple, cheeks, and surrounding the orbit, which originates on a body part, that functions to close the eyelid.|40.60000000000002|63.486153846153854|12.565000000000005|7.633846153846157|12.60229512195122|9.406257142857143|17.981|7.08307692307692|23.653902439024392|6.596785714285716|93.86999999999999|69.96656701596841|26.0|20.58461538461539
Any process involved in the maintenance of an internal steady state of water within an organism or cell. [GOC:dph, GOC:mah, GOC:tb]|Any process involved in the maintenance of an internal steady state of water within an organism or cell. [GOC:dph, GOC:m,tb]|59.20607142857145|61.32500000000002|7.609761904761903|7.190000000000001|12.784616666666667|12.784616666666667|2.8895238095238085|1.564|4.783750000000001|3.998750000000001|69.96656701596841|66.37611354998121|23.247619047619047|22.0
A measurement of the Streptococcus pneumoniae serotype 5 IgG antibody in a biological specimen.|A measurement of the Streptococcus pneumoniae protein complex in a biological specimen.|18.44428571428574|17.44500000000002|12.425714285714289|12.316666666666666|14.481614285714286|13.675823076923077|-7.845714285714287|-11.603333333333325|12.820714285714281|9.355384615384615|58.53822981607831|58.53822981607831|22.8|25.733333333333338
The fifth and smallest finger from the radial side of the hand. (NCI)|The fifth and smallest finger from the base side of the hand. (NCI)|102.62211538461541|109.12980769230771|0.560384615384617|-0.347307692307691|6.388130769230769|6.239414285714286|-19.75692307692308|-20.209230769230775|1.3846153846153868|-0.09928571428571331|31.29|22.125371183327072|8.753846153846155|5.676923076923078
Walking on sloping, uneven, or moving surfaces, such as on grass, gravel or ice and snow, or walking aboard a ship, train or other vehicle.|Walking on sloping, uneven or moving surfaces, such as on grass, gravel or ice and snow, or walking aboard a ship, train or other vehicle.|65.55550000000002|65.55550000000002|7.221|7.221|6.7713|6.710530769230769|3.367999999999995|3.367999999999995|11.417200000000001|4.815769230769231|69.96656701596841|69.96656701596841|21.0|21.0
Any process that stops, prevents or reduces the rate or extent of mast cell proliferation. [GOC:add, GOC:mah]|Any process that stops, prevents or reduces cell proliferation. [GOC:add, GOC:mah]|53.889852941176486|32.05250000000001|7.854411764705883|10.155000000000001|10.75612105263158|13.006557142857146|-2.656470588235294|-14.796363636363644|4.638947368421054|4.274285714285714|62.58|58.53822981607831|22.223529411764705|27.654545454545453
A person having origins in any of the Black racial groups of Africa. Terms such as "Haitian" or "Negro" can be used in addition to "Black or African American". (OMB)|A person having origins in any of the Black racial groups of Africa. Terms such as "Haitian" or "Negro" can be used in addition to "Black or African American" (OMB)|66.965|61.890000000000015|6.4033333333333395|8.353333333333339|8.8695|9.498848387096775|-2.9440000000000026|6.922666666666661|3.3520000000000003|5.6158064516129045|57.127462747788826|69.96656701596841|17.333333333333332|19.333333333333332
A reduced ability to synthesize postvaccination antibodies against a Haemophilus influenzae type b (Hib) antigen, as measured by antibody titer determination following vaccination. []|A reduced ability to synthesize antibodies against a viral protein, as measured by antibody titer determination following vaccination. []|-6.269999999999982|1.2767105263157816|17.115|15.441315789473688|14.504726086956522|13.24927894736842|14.533333333333339|5.9789473684210535|15.856521739130436|12.07578947368421|85.69119412168324|79.77416029015912|29.8|31.16842105263158
Breathing that requires observed effort or an increased amount of energy.|Breathing that requires observed effort or a higher amount of energy.|47.434318181818185|55.12522727272727|8.009545454545457|6.936818181818182|11.359372727272728|10.513266666666667|-20.14181818181818|-21.74545454545455|10.617272727272727|4.727500000000003|58.53822981607831|54.195869768830164|27.654545454545453|24.018181818181816
Prostate cancer limited to one-half or less of one lobe of the prostate gland. (from AJCC 6th and 7th Eds.)|Prostate cancer limited to one-half or less of one lobe of the prostate gland. (from AJCC 6th and 7th Eds.)|94.31833333333333|94.31833333333333|1.7600000000000016|1.7600000000000016|11.67634761904762|12.0771|-18.528|-18.233999999999998|2.435714285714287|2.0536363636363646|40.39521630094336|40.39521630094336|12.666666666666668|12.666666666666668
the joints that connect the fingers to the hand.|joint that connects the fingers to the hand.|98.8675|97.025|0.5872222222222234|0.7199999999999989|5.837344444444444|7.368588888888889|-39.64444444444443|-46.07|3.4800000000000004|0.18333333333333002|31.29|31.29|10.68888888888889|11.600000000000001
A eukaryotically conserved histone deacetylase complex which deacetylates histones across gene coding regions. Composed of a catalytic histone deacetylase subunit, a chromodomain protein, a SIN3 family co-repressor, and a WD repeat protein (Clr6p, Alp13p, Pst2p, and Prw1p respectively in Schizosaccharomyces; Rpd3p, Sin3p, Ume1p, Rco1p and Eaf3 in Saccharomyces; homologs thereof in other species). [GOC:vw, PMID:12773392, PMID:17450151]|A protein complex which deacetylates histones across gene regions. Composed of a catalytically conserved protein modification process that marks genes at risk. [GOC:vw, PMID:12773392]|30.77404761904765|33.04000000000002|13.604285714285716|10.638333333333335|15.757329885057471|14.99790512820513|24.35785714285715|2.444999999999993|17.633563218390805|10.982179487179486|95.59252899677882|62.58|27.46666666666667|23.200000000000003
Problem associated with freezing and becoming nonfunctional of an application program.|Problem associated with freezing and becoming nonfunctional of a program.|8.979772727272717|24.100000000000023|13.373181818181823|11.14|11.359372727272728|11.086572727272728|-13.192727272727275|-20.979999999999997|16.183636363636367|8.723636363636363|58.53822981607831|54.195869768830164|27.654545454545453|26.0
A chromosome band present on 20q|A chromosome band present on 20q21.3.|87.94500000000002|92.00500000000002|2.4833333333333343|0.9233333333333356|9.197433333333334|10.577242857142856|-22.873333333333328|-115.66|2.7650000000000006|1.8514285714285705|44.250742366654144|25.548178017228544|15.733333333333333|14.133333333333333
One of a pair of thick-walled tubes that transports urine from the KIDNEY PELVIS to the URINARY BLADDER.|One of a pair of thick-walled tubes that transport urine from the KIDNEY PELVIS to the URINARY BLADDER.|61.400000000000034|61.400000000000034|6.9311111111111146|6.9311111111111146|11.22732105263158|11.238|-4.468888888888891|-4.468888888888891|9.141052631578948|3.5874999999999986|62.58|62.58|21.37777777777778|21.37777777777778
An observation of the above normal incidence of immature neutrophils, including band neutrophils and neutrophil precursors in a biological specimen.|An observation of the above normal incidence of immature neutrophils, including a normal range of cell types in biological specimens.|10.564999999999998|31.715000000000003|14.270000000000007|11.320000000000004|13.313|13.180157142857144|8.326000000000004|4.210000000000004|18.478499999999997|9.164285714285718|76.64453405168562|69.96656701596841|28.0|24.0
The outermost layer of the renal capsule, which is composed of a single layer of simple squamous epithelium.|The outermost layer of the renal capsule, which is composed of two layers of simple skin cells.|52.00000000000003|73.79573529411766|8.242222222222225|5.077941176470592|11.547077777777778|10.223455555555555|-3.1622222222222227|-7.152941176470584|10.858333333333334|3.4800000000000004|69.96656701596841|58.53822981607831|25.822222222222223|19.870588235294118
A pattern of choosing a course of action for meeting short- and long-term health-related goals, which can be strengthened.|A pattern of choosing a course of action for meeting short- and long-term health goals, which can be strengthened.|72.51881578947369|85.87671052631579|5.504473684210527|3.641315789473687|8.43762380952381|7.91682380952381|1.0273684210526355|-1.1389473684210465|11.49857142857143|4.902857142857144|54.195869768830164|49.473833993334296|16.431578947368422|14.326315789473682
Any cranial somatic dysfunction resulting in abnormal dural membrane tension.|Any brain abnormality resulting in abnormal dural membrane tension.|7.180000000000035|4.867500000000007|13.5|13.698333333333334|16.7645|14.9375|-19.216|-26.57777777777777|15.127000000000002|8.859000000000002|66.37611354998121|58.53822981607831|38.0|32.91111111111112
Life-threatening consequences; urgent operative intervention indicated (e.g., organ resection)|Life-threatening consequences; urgent operative intervention indicated (e.g., organ removal)|-68.80999999999995|-68.80999999999995|23.602222222222228|23.602222222222228|16.7645|17.10119090909091|-42.48|-43.133333333333326|21.720999999999997|18.32454545454545|51.09635603445709|51.09635603445709|36.75555555555555|36.75555555555555
polypeptide hormone secreted by thymic epithelial cells; maintains immune system functions and can restore T cell function in thymectomized animals.|protein hormone secreted by thymic epithelial cells; maintains immune system functions and can restore T cell function.|19.025000000000006|43.93691176470591|13.09|9.242647058823533|14.892000000000001|15.486788888888892|8.326000000000004|1.1482352941176472|18.478499999999997|9.760000000000002|79.77416029015912|73.38155456243756|30.0|29.28235294117647
A therapeutic analogue of the endogenous CXC cytokine macrophage inflammatory protein-2 alpha. Macrophage inflammatory protein-2 alpha attracts and activates neutrophils and may play a role in cell proliferation. In experimental models of acute hepatic injury, macrophage inflammatory protein-2 alpha has been shown to promote liver regeneration by stimulating the proliferation of hepatocytes. (NCI04)|A therapeutic analogue of the protein complex formed by a protein molecule that activates hepatocytes. (NCI04)|6.627759433962268|29.515000000000015|15.62655660377359|11.130000000000003|14.125209433962263|13.346335294117647|16.49056603773585|-1.7199999999999989|15.765566037735852|8.586470588235294|82.78555852321104|62.58|26.432075471698113|23.200000000000003
A disorder characterized by reduced blood flow to the skin.|A disorder characterized by reduced blood flow to the skin.|57.940000000000026|57.940000000000026|6.420000000000002|6.420000000000002|8.8695|9.651118181818184|-29.799999999999997|-29.211999999999996|6.649000000000001|2.7290909090909103|38.32226702584281|38.32226702584281|14.0|14.0
Enables the transfer of short-chain fatty acids from one side of a membrane to the other. Short-chain fatty acids are fatty acids with a chain length of less than C6. [GOC:mah]|Enables the transfer of short-chain fatty acids from one side of a membrane to the other Side of the membrane is the one with the longest chain length of less than C6. [GOC:mah]|76.26924731182795|79.85113636363639|5.188387096774196|6.2207575757575775|9.771574509803923|8.915411111111112|-0.9522580645161263|8.075151515151514|3.4922549019607843|6.017499999999998|65.13532912329528|69.96656701596841|20.907526881720432|18.721212121212123
Seizures that occur while the affected individual is sleeping. [PMID:22334817, PMID:23385697, PMID:25941204]|Seizures that occur while the affected individual is sleeping. [PMID:22334817, PMID =23385697, PMC:25941204]|66.79500000000002|70.08365384615385|5.433333333333334|5.098846153846157|13.144933333333334|14.535166666666669|-1.8033333333333275|-1.664615384615388|17.68|11.208000000000006|49.473833993334296|49.473833993334296|19.06666666666667|17.984615384615388
<p>Values for security metadata observation made about the formal declaration by an authority or neutral third party that validates the technical, security, trust, and business practice conformance of Trust Agents to facilitate security, interoperability, and trust among participants within a security domain or trust framework.</p>|A value for security metadata observation made about the formal declaration by an authority or neutral third party that validates the technical, security, trust, and business practice conformance of Trust Agents to help secure the domain or trust framework.|-7.762499999999989|24.35019230769234|19.93166666666667|14.707307692307694|14.123022448979594|11.33925|24.60711111111111|17.989743589743597|30.36877551020408|14.003999999999998|112.8176994092682|98.94766798666859|32.11111111111111|28.312820512820508
Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: Subscale score.|Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: Subscale score.|18.44428571428574|24.36159090909092|12.425714285714289|11.227727272727272|17.865185714285715|18.40826666666667|2.2342857142857113|-8.381818181818183|19.885714285714286|13.362500000000004|69.96656701596841|62.58|31.371428571428574|31.290909090909096
A terminology subset of the CDISC Study Data Tabulation Model (SDTM) Unit codelist created for Clinical Data Acquisition Standards Harmonization (CDASH) Unit for Duration of Treatment Interruption terminology.|A terminology subset of the CDISC Study Data Tabulation Model (SDTM) Unit codelist created for Clinical Data Acquisition Standards Harmonization (CDASH) unit for duration of treatment interruption terminology.|-6.789285714285711|-6.789285714285711|17.684285714285718|17.684285714285718|16.867800000000003|16.334320689655172|17.077142857142857|17.287142857142857|22.34392857142857|14.729655172413793|96.44225707644962|96.44225707644962|32.74285714285715|32.74285714285715
Simulators designed for training in endoscopic diagnostic and therapeutic procedures performed in the bronchi. These simulators typically include an anatomic model resembling the characteristics of the bronchial tree that is capable of simulating coughing, breathing, and bleeding; the anatomic models are made of plastics, metal, or a combination of these. The equipment simulates the conditions for endoscopic procedures by providing access to entrances in the anatomic model resembling the body natural airways, permitting the use of flexible endoscopes, surgical instruments, cameras as well as the external use of video monitors. The simulator also includes a main control unit with dedicated software that permits both training and recording of the simulated endoscopic procedure in real time. Bronchial endoscopic training simulators may include as integral parts or attached modules and/or accessories intended for training in particular procedures, such as diagnostic, emergency, ultrasonic, and other interventional bronchial procedures.|Simulators designed for training in specific procedures, such as diagnostic, emergency, ultrasonic, and other interventions. These simulators typically include an anatomic model resembling the characteristics of the bronchial tree that is capable of simulating coughing, breathing and bleeding; the an|-0.31347701149422846|2.530000000000058|19.306724137931038|17.875000000000004|13.677727586206897|13.125982926829268|24.36993103448276|23.861000000000004|21.849724137931034|18.228780487804876|117.07645963215661|106.1095525859948|32.839080459770116|31.0
A genus known for fibers obtained from their leaves: sisal from A. sisalana, henequen from A. fourcroyoides and A. cantala, or Manila-Maguey fiber from A. cantala. Some species provide a sap that is fermented to an intoxicating drink, called pulque in Mexico. Some contain agavesides.|A genus known for fibers obtained from their leaves: a sap that is fermented to an intoxicating drink, called pulque in Mexico. Some contain agavesides.|48.84562500000001|56.24866666666668|7.8437500000000036|7.484000000000002|12.635294202898551|10.354376923076924|-21.262222222222228|-5.1791999999999945|9.99144927536232|7.714230769230767|46.934999999999995|51.09635603445709|18.25|16.133333333333336
Transfusion-independent patients: a greater than or equal to 20 g/L increase in hemoglobin level or for transfusion-dependent patients: becoming transfusion-independent (adapted from Revised Response Criteria for Myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report. BLOOD 22 AUGUST 2013 x VOLUME 122 NUMBER 8)|Transfusion-independent patients: a greater than or equal to 20 g/L increase in hemoglobin level or for blood clot disorders: International Working Group-Myelofibrosis Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN|-6.352000000000004|-1.2749999999999773|20.356000000000005|20.890000000000004|15.457978571428571|14.8465|30.613599999999995|29.72533333333333|21.67107142857143|22.04228571428572|119.14877024124084|121.18564890283007|33.2|32.0
Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets hurt accidentally.|Pediatric Quality of Life Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child?|65.79821428571432|69.46206896551725|8.429285714285715|10.775172413793104|10.89584117647059|10.519727586206898|10.133714285714284|14.326896551724138|17.319117647058825|12.234827586206897|73.38155456243756|93.86999999999999|19.571428571428573|24.01379310344828
Evaluating and managing a new client in a comprehensive, prolonged, 150-minute, in-facility meeting. This code may be used by providers of services who are able to diagnose.|Evaluating and managing a new client in an extensive, prolonged, 150-minute, in-facial meeting. This code may be used by providers of services who are able to diagnose.|47.30000000000004|56.70000000000002|8.89777777777778|7.58666666666667|9.800527586206897|9.922166666666667|-0.8755555555555503|-1.7466666666666661|8.55793103448276|4.922000000000001|59.91578840339164|59.91578840339164|19.8962962962963|19.8962962962963
This gene plays a role in the structure of immunoglobulin light chains.|This gene plays a role in the structure of light chains.|73.84500000000001|108.96159090909092|4.450000000000003|-0.5722727272727273|9.495033333333335|9.197433333333334|-19.93333333333333|-28.694545454545462|7.727500000000003|-0.375|31.29|22.125371183327072|9.066666666666666|5.836363636363637
Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)|Inflammation of part or all the uvea, the middle (vascular) tunic of the eye, and commonly involving other organs. (Dorland, 27th ed)|56.25000000000003|57.23363636363638|9.140000000000004|8.009090909090911|11.222833333333334|11.07211739130435|9.078666666666663|3.2927272727272765|7.422000000000001|5.822173913043478|79.77416029015912|69.96656701596841|23.333333333333336|22.581818181818182
A radioimmunoconjugate consisting of the iodine 131-radiolabeled murine IgG1 monoclonal antibody 8H9 directed against the surface immunomodulatory glycoprotein 4Ig-B7-H3 with potential radioimaging and radioimmunotherapeutic uses. Iodine I 131 monoclonal antibody 8H9 binds to 4Ig-B7-H3 (human B7-H3 with 4 Ig-like domains) and may be used to radioimage and/or destroy tumor cells that express tenascin. 4Ig-B7-H3 inhibits T-cell activation and the production of effector cytokines such as interferon-gamma and interleukin-4; it is expressed on the cell membranes of a wide variety of tumors of neuroectodermal, mesenchymal and epithelial origin and is highly expressed on monocyte-derived dendritic cells (mdDCs). In vitro, it has been shown that monoclonal antibody-mediated masking of 4Ig-B7-H3 on neuroblastoma cells resulted in the enhancement of natural killer (NK)-mediated lysis of target cells.|A radioimmunoconjugate consisting of the iodine 131-radiolabeled murine IgG1 monoclonal antibody 8H9 directed against a protein complex. It is expressed on the skin, the deepest mucusosal tissue|12.666000000000025|30.199166666666713|17.604000000000003|12.400925925925925|14.386902898550725|13.067424137931035|25.30308943089431|14.878518518518518|21.55434782608696|12.780689655172417|104.7163689210049|82.78555852321104|28.051382113821138|26.14074074074074
A measurement of the Dermatophagoides farinae antigen IgG antibody in a biological specimen.|A measurement of the Farinae antigen IgG antibody in a biological specimen.|-8.008653846153834|17.44500000000002|15.99115384615385|12.316666666666666|13.998223076923077|13.675823076923077|-9.353846153846156|-17.483333333333327|13.692307692307686|5.007692307692309|58.53822981607831|54.195869768830164|24.13846153846154|22.400000000000002
Problem with all or part of an implanted or invasive device moving from its intended location within the body.|Problem with all or part of a device moving from its intended location within the body.|54.70828947368423|66.5275|7.988684210526319|5.967500000000001|10.396268421052632|9.631041176470589|-2.6863157894736815|-10.172500000000003|10.62842105263158|2.7682352941176482|66.37611354998121|58.53822981607831|22.74736842105263|20.700000000000003
A congenital lymphatic malformation usually arising from the neck and characterized by cystic dilation of the lymphatic vessels.|A congenital lymphatic malformation usually arising from the neck and characterized by cystic dilation of the lymph vessel.|9.700000000000017|19.100000000000023|14.142222222222227|12.831111111111113|11.547077777777778|11.587173684210526|3.3711111111111194|2.0644444444444474|16.35333333333333|9.596842105263157|69.96656701596841|66.37611354998121|25.822222222222223|23.6
An elevated concentration of phosphohydroxylysine in the urine. [HPO:probinson, PMID:23242558]|An elevated concentration of a chemical in the urine. [HPO:probinson, PMID:23242558]|-9.73999999999998|32.05250000000001|15.86|10.155000000000001|13.957481818181819|13.675823076923077|-9.219999999999999|-13.727272727272734|15.57454545454545|7.181538461538462|49.473833993334296|49.473833993334296|22.0|20.381818181818183
A radioactive isotope of cesium with an atomic mass of 139 and potential application in radiotherapy. Cesium Cs 137 is prevalent due to its spontaneous production, which occurs as a result of nuclear fission of other radioactive materials, such as uranium and plutonium. This radionuclide has a relatively long half-life, 30 years, and decays by emitting beta particles. Both Cs 137 and its metastable nuclear isomer, barium-137m, emit gamma radiation of moderate energy and so are used in sterilization procedures in the food industry or in hospital environments. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C68812" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C68812" NCI Thesaurus)|A radioactive isotope of cesium with an atomic mass of 139 atoms and potential application in radiotherapy. Cesium Cs 137 is prevalent due to its spontaneous production, which occurs as a result of nuclear fission of other types of materials. This radionu|46.096666666666664|41.553571428571445|8.900000000000002|10.941428571428574|12.839111764705882|13.160456589147287|6.286800000000007|8.957142857142856|19.07029411764706|8.958062015503877|59.91578840339164|78.74477315987392|20.933333333333337|23.695238095238096
Ureter urothelial carcinoma that has spread to another anatomical site.|Ureter cancer that has spread to another body site.|-1.2799999999999727|61.26750000000001|14.68|5.831666666666667|12.0275|10.200500000000002|-22.743999999999993|-37.0311111111111|12.300999999999995|1.3230000000000004|49.473833993334296|44.250742366654144|22.0|19.57777777777778
An orally administered non-steroidal antiinflammatory agent. Acetylsalicylic acid binds to and acetylates serine residues in cyclooxygenases, resulting in decreased synthesis of prostaglandin, platelet aggregation, and inflammation. This agent exhibits analgesic, antipyretic, and anticoagulant properties.|An orally administered non-steroidal antiinflammatory agent. Acetylsalicylic acid binds to and acylates protein building blocks in cyclooxygenases, resulting in decreased synthesis of prostaglandin, platelet aggregation, and inflammation|-53.10426470588234|-45.000833333333304|22.777941176470588|22.889814814814816|15.493738095238097|14.700872413793105|12.389411764705883|24.242962962962963|19.930190476190475|19.439655172413794|76.64453405168562|93.86999999999999|31.635294117647064|32.06666666666666
Carbetimer (carboxyimamidate) is a low molecular weight derivatized copolymer of ethylene and maleic anhydride. It has demonstrated antitumor activity against several animal models. It has calcium chelation activity but seems to inhibit growth of sensitive cells by disrupting nucleoside uptake and metabolism.|Carbetimer (carboxyimamidate) is a low molecular weight derivatized copolymer of ethylene and maleic anhydride. It has demonstrated antitumor activity against several animal models, it has anticancer potential, and inhibits growth of|-1.2224999999999966|-16.303951612903205|16.038333333333334|19.38403225806452|12.977804761904762|13.311975|9.469523809523807|19.597419354838713|15.175714285714285|15.8603125|76.64453405168562|93.86999999999999|27.057142857142857|29.425806451612903
The chemical reactions and pathways resulting in the breakdown of 2,4-dichlorophenoxyacetic acid, a chlorinated phenoxy compound which functions as a systemic herbicide and is used to control many types of broadleaf weeds. [GOC:ai]|The chemical reactions and pathways resulting in the breakdown of 2,4-dichlorophenoxyacetic acid, a chlorinated molecule used to control many types of broadleaf weeds. [GOC:ai]|49.087500000000006|53.655|10.511666666666667|8.756666666666668|13.076214285714286|13.663137037037037|17.518787878787876|13.06333333333334|13.292285714285718|11.137777777777778|88.50148473330829|76.64453405168562|25.993939393939396|24.8
Benign and malignant neoplasms arising from one or more of the cervical, thoracic, lumbar, sacral, or coccygeal nerve roots. The majority of these tumors are benign. Clinical manifestations may include pain, weakness and loss of sensation along the course of the involved nerve root. Large tumors may cause spinal cord compression.|Benign and malignant neoplasms arising from one or more of the cervical, thoracic, spine and lumbar, sacral, or coccygeal nerve roots. The majority of these tumors are benign. Clinical manifestations may include pain, weakness and|53.82317647058824|45.1304761904762|8.286039215686277|9.862857142857145|10.151449019607844|11.249477777777777|3.3780392156862717|7.72457142857143|10.064999999999998|9.428333333333335|65.6344577184881|72.26115969177356|21.334901960784318|22.952380952380953
Enables the transfer of a negatively charged ion from one side of a membrane to the other. [GOC:dgf, GOC:mtg_transport, ISBN:0815340729]|Enables the transfer of negatively charged ions from one side of a membrane to the other. [GOC:dgf, GOC:mtg_transport, ISBN:0815340729]|69.78500000000001|68.0661842105263|6.010000000000002|6.125526315789475|11.359372727272728|12.0771|4.797999999999998|5.359999999999999|7.620000000000001|7.834090909090911|54.195869768830164|54.195869768830164|16.0|16.431578947368422
Facial ANGIOFIBROMA in tuberous sclerosis|Facial angiofibroma|-35.11999999999995|-91.29499999999996|19.400000000000002|26.490000000000006|16.5165|19.5753|-15.687999999999995|-92.14|15.924|9.899999999999999|62.58|44.250742366654144|34.0|40.800000000000004
Catalysis of the reaction: N5,N10-methenyltetrahydromethanopterin + H2 = N5,N10-methylenetetrahydromethanopterin. [UM-BBD_reactionID:r0353]|Starts the reaction: N5,N10-methenyltetrahydromethanopterin + hydrogen ion. [UM-BBD_reactionID:r0353]|125.62000000000002|107.60000000000001|-3.0199999999999996|-0.754999999999999|17.517985714285714|17.092433333333332|17.240000000000002|-4.175000000000011|23.114285714285714|16.11|31.29|31.29|10.0|11.600000000000001
Hours times nanograms per milliliter per milligram per kilogram.|Hours times nanograms/milliliter per milligram per kilogram.|33.067500000000024|-2.1746428571428282|9.765|14.432142857142857|16.36401111111111|16.140811111111113|-29.191111111111105|-38.371428571428574|11.853333333333332|8.556666666666668|44.250742366654144|38.32226702584281|19.57777777777778|18.54285714285714
A measurement of the cells of nonhematopoietic origin in a biological specimen.|A measurement the cells of nonhematopoietic origin in a biological specimen.|10.39500000000001|1.2888636363636294|13.3|14.445909090909094|10.810866666666666|11.8291|-16.01333333333333|-18.003636363636367|10.8675|7.475000000000001|49.473833993334296|49.473833993334296|19.06666666666667|20.381818181818183
A person who calls for, activates, or starts a process, procedure, or program.|A person who calls for, activates or starts a process, procedure or program.|63.57596153846157|63.57596153846157|6.006538461538462|6.006538461538462|9.139761538461538|9.622985714285715|-15.68615384615385|-16.13846153846154|7.170769230769231|2.9285714285714306|49.473833993334296|49.473833993334296|17.984615384615388|17.984615384615388
Genetically determined classes of human erythrocytes based on specific antigens for which the groups are named.|Genetically determined classes of human blood cells based on specific antigens for which the groups are named.|29.515000000000015|53.889852941176486|11.130000000000003|7.854411764705883|10.35135|9.346233333333334|-1.7199999999999989|-1.9647058823529377|14.535625000000003|7.666666666666668|58.53822981607831|54.195869768830164|20.700000000000003|17.51764705882353
Exocrine pancreatic cancer in which the regional lymph nodes cannot be assessed. (from AJCC 6th Ed.)|Cancer in which the regional lymph node cannot be assessed. (from AJCC 6th Ed.)|69.23416666666668|87.28404761904761|4.927499999999998|2.2442857142857164|13.346335294117647|12.915175000000001|-24.262499999999992|-35.28857142857143|5.261764705882353|1.1156250000000014|44.250742366654144|36.13057984588678|17.133333333333336|13.295238095238094
World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition?|In the past 30 days, not counting the days that you were totally able, for how many days did you cut back or reduce your usual activities or work because of a health condition?|52.39750000000001|55.377941176470614|11.54055555555556|13.981764705882352|10.110654545454546|8.5305|15.721777777777776|16.197647058823527|12.584772727272728|15.044571428571423|85.69119412168324|93.86999999999999|22.333333333333332|24.188235294117646
The volume enclosed by the rhoptry membrane. [GOC:rph, PMID:17997128]|The volume enclosed by the rhoptry membrane. [GOC:rph, PMID:17997128]|80.06750000000002|80.06750000000002|3.2094444444444434|3.2094444444444434|14.9375|15.392936363636366|-25.92444444444444|-25.271111111111104|7.445999999999998|5.7263636363636365|44.250742366654144|44.250742366654144|19.57777777777778|19.57777777777778
Diabetes mellitus in which there are frequent, clinically significant fluctuations in blood glucose levels both above and below levels expected to be achieved by available therapies.|Diabetes mellitus in which there are frequent, clinically significant fluctuations in blood sugar levels both above and below levels expected to be achieved by available therapies.|24.440000000000026|24.440000000000026|13.080000000000002|13.080000000000002|10.999176923076924|10.154248148148149|12.736923076923073|12.510769230769231|19.648846153846158|12.184444444444445|85.69119412168324|85.69119412168324|28.276923076923072|28.276923076923072
Tubes designed to access the esophagus through the mouth or nose for examination, treatment, or other purposes. These devices typically consist of rubber or polymeric flexible tubes with a diameter, length, and other physical characteristics appropriate for reaching the esophagus. Dedicated esophageal tubes are used to facilitate the diagnosis of esophagus diseases, to treat hemorrhage (i.e., tamponade) from esophageal varices, to provide suction of liquids and/or other materials, and to be used as a first step in esophagus reconstruction; they may also be used to assess some stomach diseases. Dedicated tubes intended for patient rewarming may be also available.|Tubes designed to access the esophagus through the mouth or nose for examination, treatment, or other purposes. These devices typically consist of rubber or polymeric flexible tubes with a diameter, length, and other physical characteristics appropriate for reaching the stomach. They are used to facilitate the diagnosis of|21.57090909090911|23.1575|13.764098124098126|14.004166666666666|12.041372727272728|11.213776190476189|13.044040404040409|15.555|17.44469696969697|12.881972789115643|84.45816301577958|88.50148473330829|26.263203463203464|26.400000000000002
Decrease dietary gluten found in wheat, rye, oats, barley and their derivatives. Treatment for celiac disease, dermatitis herpetiformis and gluten sensitivity.|Decreased gluten found in wheat, rye, barley and their derivatives. Treatment for gluten disease, herpetiformis and gluten sensitivity.|18.44428571428574|22.14500000000001|12.425714285714289|11.661111111111111|13.180157142857144|13.092212280701753|-3.36571428571429|-10.459999999999994|13.649999999999999|9.996666666666666|62.58|57.127462747788826|25.65714285714286|24.622222222222224
A molecular genetic abnormality indicating the presence of a mutation in exon 18 of the PDGFRA gene located within 4q11-q13.|A molecular genetic abnormality indicating the presence of a mutation in the gene region 4q11-q13.|40.17500000000001|30.022500000000008|10.140000000000004|10.935000000000002|15.20476666666667|14.275158823529411|1.2699999999999996|-6.146666666666668|12.17142857142857|5.815882352941177|66.37611354998121|58.53822981607831|22.0|21.666666666666668
A standardized 20-item self-report measure, published in 2013, that is used to assess the 20 Diagnostic and Statistical Manual of Mental Disorders (DSM-5) symptoms of post-traumatic stress disorder (PTSD), using a 5-point Likert-type intensity scale, ranging from zero (not at all) to four (extremely).|A standardized 20-item self-report measure, published in 2013, that is used to assess the 20 Diagnostic and Statistical Manual of Mental Disorders (DSM-5) symptoms of post-traumatic stress disorder (PTSD), using a 5-point Likert-type intensity scale, ranging from|44.1459090909091|25.23135135135138|12.567272727272726|18.93189189189189|14.445267346938776|14.949532558139534|21.157272727272726|28.233513513513515|26.235510204081628|23.619999999999997|93.86999999999999|125.16|25.163636363636368|32.097297297297295
A heterotetrameric transcription factor composed of two distinct proteins. Its name refers to the fact it binds to DNA sequences rich in GUANINE and ADENINE. GA-binding protein integrates a variety of SIGNAL TRANSDUCTION PATHWAYS and regulates expression of GENES involved in CELL CYCLE control, PROTEIN BIOSYNTHESIS, and cellular METABOLISM.|A heterotetrameric transcription factor composed of two distinct proteins. Their names refer to the fact that it binds to DNA sequences rich in GUANINE and ADENINE. GA-binding protein integrates a variety of SIGNAL TRANSDUCTION PATHWAYS and|26.927780612244902|37.20500000000001|12.546683673469389|11.051111111111112|13.305566666666667|12.159766666666666|11.116734693877554|8.979999999999997|14.032933333333332|10.064649122807015|79.77416029015912|74.48509850970193|26.124489795918368|23.68888888888889
An abnormal pregnancy in which the conception is implanted in the peritoneal cavity or on the abdominal organs.|An abnormal pregnancy in which the conception is implanted in the peritoneal cavity or on the abdomen.|33.20000000000002|38.960441176470624|10.864444444444448|9.936764705882357|10.669855555555555|11.100677777777777|-2.1822222222222187|-4.731764705882352|11.905000000000001|5.573333333333334|62.58|58.53822981607831|21.37777777777778|19.870588235294118
The number of observable tumor nodules in the lungs.|The number of visible tumor nodules in the lungs.|51.867500000000035|61.26750000000001|7.142777777777777|5.831666666666667|11.100677777777777|11.7795|-37.0311111111111|-38.33777777777777|5.573333333333334|0.3810000000000002|44.250742366654144|44.250742366654144|19.57777777777778|19.57777777777778
A pathologic finding about one or more characteristics of melanoma of the conjunctiva, following the rules of the TNM AJCC v7 classification system. Complete resection of the primary site is indicated. Histopathologic evaluation for negative peripheral and deep margins should be performed. To best judge the depth of penetration of the tumor, sections should be made perpendicular to the epithelial surface. (from AJCC 7th Ed.)|A pathologic finding about one or more characteristics of melanoma of the conjunctiva, following the rules outlined in the classification system of tumor markers for skin tumors. Sections should be made perpendicular to the skin's surface. (from AJCC 7th|35.749935897435904|39.624615384615424|10.96423076923077|10.962051282051284|11.326069230769232|9.824333333333334|5.604923076923075|9.947692307692304|10.793846153846154|10.31741666666667|63.87044504307137|72.26115969177356|19.717948717948723|21.61025641025641
Aspirators designed to provide suction for evacuation of gas, body fluids, or foreign materials that may accumulate between the lung and chest wall (i.e., pleural space). These aspirators typically consist of a powered low-vacuum (> 50 mm Hg) and high-volume (> 20 liter/min) pump; collection canisters; plastic tubes connecting the components each other; an overflow protection and/or bacteria filter; and suction tubing (e.g., tubes, catheters, cannulae). The devices can be line-or battery-powered, mobile or portable. Thoracic aspirators are intended to evacuate gas and body fluids after thoracic surgery, trauma in the chest, or after cardiac bypass surgery. They are used mainly when suction from a central vacuum system is not available or appropriate.|Aspirators are intended to evacuate gas and body fluids after thoracic surgery, trauma in the chest, or when suction from a central vacuum system is not available or appropriate.|37.395588495575225|34.58646551724141|10.850628318584072|12.03741379310345|13.237314237288135|11.222833333333334|7.524247787610616|10.202758620689657|14.997711864406774|9.306000000000001|76.00314592173142|82.78555852321104|25.40495575221239|25.110344827586207
Parental actions to provide an infant a safe, nurturing, and positive physical, emotional, spiritual, and social environment from 28 days to first birthday|Parental actions to provide an infant a safe, nurturing environment from 28 days to first birthday.|21.646521739130463|61.24000000000001|15.953913043478263|6.705000000000002|13.015560869565219|11.488688235294118|21.13217391304348|-5.762499999999999|16.28217391304348|5.815882352941177|108.39173953766033|58.53822981607831|30.0695652173913|20.700000000000003
A campus of the University of California located in Santa Cruz, CA.|A campus of the University of California located in Santa Cruz, CA.|38.595|38.595|9.366666666666667|9.366666666666667|13.442533333333335|13.675823076923077|-21.893333333333324|-21.40333333333333|5.765000000000001|1.7469230769230784|49.473833993334296|49.473833993334296|19.06666666666667|19.06666666666667
Continuing program of rehabilitation designed to reinforce and maintain the effects of treatment and to help clients adjust to their environment after hospital release.|Continuing program of rehabilitation designed to reinforce and maintain the effects of treatment and to help clients adjust to the environment after hospital release.|36.03|36.03|11.215|11.215|12.7219|12.4673|10.858333333333334|10.613333333333337|18.83|11.761199999999995|79.77416029015912|79.77416029015912|26.466666666666665|26.466666666666665
Days times grams per milliliter, divided by grams.|Days times grams per milliliter, divided by gram.|65.30000000000001|65.30000000000001|5.145|5.145|11.9283|12.631922222222224|-42.394999999999996|-42.394999999999996|6.708749999999998|2.2766666666666673|31.29|31.29|11.600000000000001|11.600000000000001
A measurement of the matrix metalloproteinase 1 in a biological specimen.|A measurement of the matrix metalloprotease 1 in a biological specimen.|16.670681818181833|24.36159090909092|12.300454545454546|11.227727272727272|12.794827272727273|13.144933333333334|-20.14181818181818|-20.67636363636364|10.617272727272727|5.512499999999999|49.473833993334296|49.473833993334296|20.381818181818183|20.381818181818183
A mass spectrometric technique that is used for the analysis of large biomolecules. Analyte molecules are embedded in an excess matrix of small organic molecules that show a high resonant absorption at the laser wavelength used. The matrix absorbs the laser energy, thus inducing a soft disintegration of the sample-matrix mixture into free (gas phase) matrix and analyte molecules and molecular ions. In general, only molecular ions of the analyte molecules are produced, and almost no fragmentation occurs. This makes the method well suited for molecular weight determinations and mixture analysis.|A mass spectrometric technique that is used for the analysis of large biomolecules. Analyte molecules are embedded in an excess matrix of small organic molecules that show a high resonant absorption at the wavelength used. The matrix absorbs the laser energy, thus inducing|25.95951465201466|32.92387596899229|13.40631868131868|12.227906976744187|12.44414|12.258966666666668|13.437362637362636|11.07348837209302|13.316630434782603|10.416742424242422|83.76530337794998|78.74477315987392|24.967765567765568|23.4077519379845
Mechanical shields usually made of high-impact transparent plastics attached to or placed on the laboratory benches. These shields are used in clinical laboratories to protect the workers from explosions, flames, spurting liquids, and other physical or chemical reactions.|Mechanical shields usually made of high-impact transparent plastics attached to or placed on the bench top of a clinical laboratory to protect the workers from explosions, flames and other physical or chemical reactions.|31.457280701754428|33.70568181818183|12.018421052631577|12.657121212121215|11.486520512820514|10.820500000000001|12.994736842105265|15.736969696969702|15.976153846153842|12.350285714285711|80.79043260188672|88.50148473330829|26.119298245614033|25.993939393939396
The act of deceiving or the fact of being deceived.|The act of deception or the fact of being deceived.|74.86000000000003|74.86000000000003|4.060000000000002|4.060000000000002|7.2905|8.215663636363637|-34.50399999999999|-33.916|2.8810000000000002|-0.6963636363636354|38.32226702584281|38.32226702584281|14.0|14.0
Syndrome is characterized by hematological anomalies (Fanconi anemia, leukemia and lymphoma) often appearing during childhood. Anomalies of the limbs and hands are also present: bifid or hypoplastic thumbs, cutaneous syndactyly and ulnar and radial defects. The syndrome has been described in several families. Transmission is autosomal dominant.|Syndrome is characterized by hematological anomalies (Fanconi anemia, leukemia and lymphoma) often appearing during childhood. Anomalies of the limbs and hands are also present: bifid or hypoplastic thumbs, cutaneous synd|11.894000000000034|2.670000000000016|13.935574468085107|16.613333333333333|10.938448936170213|11.536267741935484|6.042553191489361|18.09466666666667|13.606914893617024|14.731935483870963|75.35629887408219|93.86999999999999|28.440851063829786|30.0
Optical filter blocking transmission of infrared radiation|Optic filter blocking transmission of infrared radiation|-17.812857142857126|-5.727142857142809|17.482857142857146|15.797142857142859|15.262271428571431|15.875800000000002|1.394285714285715|0.5542857142857187|17.058571428571433|12.596250000000005|76.64453405168562|76.64453405168562|37.08571428571428|37.08571428571428
Catalysis of the reaction: bisphenol A + NADH + H+ + O2 = 1,2-bis(4-hydroxyphenyl)-2-propanol + NAD+ + H2O. [UM-BBD_reactionID:r0860]|Starting of the reaction: bisphenol A + NADH + water = 1,2-bis(4-hydroxyphenyl)-2-propanol + oxygen. [UM-BBD_reactionID:r0860]|125.95039473684211|108.9825|-1.9481578947368412|-0.07833333333333137|18.04795|16.187776190476193|4.431578947368415|4.829333333333331|5.568749999999998|7.145714285714288|38.32226702584281|44.250742366654144|10.115789473684211|13.66666666666667
Paced Tapping Test (Paced Tapping) The median intertap interval within the tone-paced tapping phase across all trials (in milliseconds).|The median intertap interval within the tonal tapping phase across all trials (in milliseconds).|27.992500000000007|36.572857142857174|11.715|9.89714285714286|12.817|13.4825|5.359999999999999|-7.005714285714284|9.945999999999998|7.754000000000001|76.64453405168562|62.58|29.063157894736847|25.65714285714286
A response indicating that something happens or happened a lot of the time.|A response indicating that something happens/ happened a lot of the time.|70.08365384615385|66.79500000000002|5.098846153846157|5.433333333333334|6.710530769230769|8.817361538461538|-17.043076923076928|-18.46333333333333|7.533076923076923|4.283076923076923|49.473833993334296|49.473833993334296|17.984615384615388|19.06666666666667
a substance often found in a person with cancer|A substance often found in a person with cancer|75.50000000000003|75.50000000000003|4.964444444444446|4.964444444444446|7.591788888888889|8.8695|-7.408888888888889|-6.755555555555549|3.4800000000000004|2.41|62.58|62.58|21.37777777777778|21.37777777777778
International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days walking as part of your work?: Hours and minutes per day.|International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format. How much time did you usually spend on one of those days walking as part of your work?: Hours and minutes per day.|64.58722972972974|67.75500000000001|8.846621621621622|6.790000000000003|9.177738095238094|9.346233333333334|12.287567567567567|4.57|7.41504761904762|5.573333333333334|69.96656701596841|57.127462747788826|18.210810810810813|15.911111111111111
Milliliters per hour (flow rate), divided by meters squared (surface area).|Milliliters per hour (flow rate) divided by meters squared (surface area).|39.7434090909091|39.7434090909091|9.08227272727273|9.08227272727273|11.359372727272728|11.8291|-19.07272727272727|-19.07272727272727|9.332727272727272|5.120000000000001|54.195869768830164|54.195869768830164|24.018181818181816|24.018181818181816
Any process that stops, prevents or reduces the frequency, rate or extent of hepatocyte growth factor receptor signaling pathway. [GOC:TermGenie, PMID:18819921]|Any process that stops, prevents or reduces cell growth factor receptor signaling pathway. [GOC:TermGenie, PMID:18819921]|39.06321428571431|46.942499999999995|10.419285714285714|8.575000000000003|14.230281818181819|15.203982352941178|11.009523809523813|2.86933333333333|12.544090909090912|11.079999999999998|76.64453405168562|66.37611354998121|27.057142857142857|27.0
A Developmental Therapist is a person qualified by completion of an approved program in Developmental Therapy and where applicable credentialed by the state and practicing within the scope of the credential, or credentialed by completion of education experiences as approved by the state and practicing within the scope of that credential or, where state credentialing does not exist, certified by the Board of the Developmental Therapy Association. A developmental therapist evaluates children's global development in order to identify areas of developmental delay whether arising from physiological, neurological, or environmental factors, or a combination of factors; and designs, implements, and modifies therapeutic interventions for the child and the family to promote the child's acquisition of skills in a variety of developmental areas, including cognitive processes and social interaction in order to maximize functional independence and developmental homeostasis, and improve the quality of life at home and in the community; and provides consultation for the parents and other professionals working with the family on global development.|A developmental therapist is a person qualified by completion of an approved program in Developmental Therapy and where applicable credentialed by the state and practicing within the scope of the study area. Other factors include functional independence and developmental homeostasis, and improve the quality of life at home and in the|-21.978495934959312|20.046617647058866|29.905609756097565|16.798137254901963|14.732175609756098|11.606484615384616|29.9370731707317|21.366274509803915|47.48536585365853|17.293846153846154|162.58760930649052|108.39173953766033|41.62276422764228|29.02352941176471
The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Losing control of your stools.|The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Loss control of your stools.|71.76785714285715|74.78928571428573|6.727142857142859|6.305714285714288|8.399803703703704|8.610861904761904|5.737142857142857|5.527142857142856|6.776666666666667|3.758809523809525|69.96656701596841|66.37611354998121|19.885714285714286|18.45714285714286
The greening response of plants grown in the dark (etiolated) as a result of chloroplast biogenesis and the accumulation of chlorophyll. [GOC:lr]|The greening response of plants grown in the dark (etiolated) as a result of photosynthesis and the accumulation of chlorophyll. [GOC:lr]|45.69727272727275|47.12035714285716|9.618181818181817|9.29547619047619|10.385595652173913|10.385595652173913|6.232727272727271|4.849523809523809|8.484347826086957|7.255652173913045|62.58|58.53822981607831|18.94545454545455|17.53333333333333
A blood vessel arising from the popliteal artery that supplies blood to the head of the tibia and the knee joint.|A blood vessel arising from the popliteal vein that supplies blood to the head of the tibia and the knee joint.|75.32035714285716|83.37750000000003|5.362142857142857|4.238333333333333|8.43762380952381|8.488463636363637|-2.150476190476187|-2.430476190476192|9.704285714285717|3.5522727272727295|54.195869768830164|49.473833993334296|15.628571428571428|13.723809523809525
The period of time that an action is delayed relative to an original schedule. EXAMPLE(S): If a substance administration is delayed 2 days as a result of an adverse event, then the delayDuration is 2 days. OTHER NAME(S): NOTE(S): Derived from comparing the dates of the scheduled activity with the corresponding performed activity.|The period of time that an action is delayed relative to an original schedule. Note(S): Derived from comparing the dates of the scheduled activity with the performed activity.|43.34096698113211|43.26880952380955|10.505801886792455|9.542857142857144|11.66295534591195|11.194242528735632|8.613584905660382|-0.42428571428571615|11.30880503144654|6.953333333333333|76.64453405168562|65.13532912329528|23.413207547169815|22.304761904761907
Silver Staining or GMS staining is a technique for demonstrating fungi in tissue sections. It is primarily based on staining the polysaccharides in fungal cell wall (From BioGenex).|A technique for demonstrating fungi in tissue sections. It is primarily based on staining the polysaccharides in fungal cell wall.|46.290238095238124|43.55833333333334|9.121428571428574|8.840000000000003|11.66197142857143|11.50274761904762|0.6257142857142846|-11.472000000000001|10.802142857142854|6.741428571428571|65.13532912329528|54.195869768830164|22.304761904761907|20.666666666666668
A series of molecular signals generated as a consequence of a intracellular steroid hormone receptor binding to one of its physiological ligands. [GOC:mah, GOC:signaling]|A series of molecular signals generated as a consequence of an hormone receptor binding to one of its physiological ligands. [GOC:mah, GOC:signaling]|11.355000000000018|22.624545454545483|14.656666666666666|12.836363636363636|13.390915384615385|13.0989|11.348333333333336|7.569090909090907|10.612692307692306|7.993199999999998|82.78555852321104|76.64453405168562|28.13333333333334|26.218181818181815
A plant genus of the family ROSACEAE. Members contain esculetin and QUERCETIN.|A plant genus of the family ROSACEAE. Members contain esculetin and QUERCETIN.|40.625|40.625|8.586666666666666|8.586666666666666|10.513266666666667|11.139125641025641|-41.17|-40.68|7.082500000000003|4.64897435897436|47.79626449838941|47.79626449838941|24.933333333333337|24.933333333333337
Powder (including freeze-dried powder) and solvent intended for the preparation of an intravesical suspension by dispersing the powder in the solvent.|Powder (including freeze-dried powder) and solvent intended for the preparation of an intravesical suspension by dispersing the powder in solution.|26.97750000000002|19.025000000000006|12.105|13.09|9.751790909090909|9.923918181818184|8.209523809523809|8.326000000000004|16.545454545454547|10.83136363636364|76.64453405168562|76.64453405168562|27.057142857142857|28.0
refers to the anterior part of the superior semilunar lobule ( Madigan-1971 ).|refers to the front part of the superior semilunar body ( Madigan-1971 ).|70.08365384615385|83.09903846153848|5.098846153846157|3.283461538461541|12.794827272727273|10.513266666666667|-15.68615384615385|-17.49538461538462|11.045454545454547|4.727500000000003|49.473833993334296|44.250742366654144|17.984615384615388|14.90769230769231
A heterodimer involved in the recognition and repair of base-base and small insertion/deletion mismatches. In human the complex consists of two subunits, MSH2 and MSH6. [PMID:11005803]|A heterodimer involved in the recognition and repair of base-base and small insertion/deletion mismatches. In humans the complex consists of two subunits, MSH2 and MH6. [PMID:11005803]|48.361410256410295|48.361410256410295|8.666923076923077|8.666923076923077|11.430504761904762|11.738725287356322|1.8046153846153743|2.0307692307692236|8.8052380952381|8.252643678160918|59.91578840339164|59.91578840339164|20.38974358974359|20.38974358974359
Transducin beta-like protein 2 (447 aa, ~50 kDa) is encoded by the human TBL2 gene. This protein may be involved in signal transduction.|Transducin beta-like protein 2 (447 amino acids, 50 kilodaltons) is encoded by a human gene TBL2. This protein may be involved in signal transduction.|81.3489855072464|61.24000000000001|3.817391304347826|6.705000000000002|14.758366666666669|14.99790512820513|-9.46434782608696|-5.640000000000001|5.765000000000001|5.004102564102563|54.195869768830164|62.58|18.718840579710143|23.200000000000003
A non-neoplastic disorder that affects the heart and/or vessels. Representative examples include myocardial infarction, endocarditis, arteriosclerosis, thrombosis, and lymphedema.|A disorder that affects the heart and/or vessels. Representative examples include myocardial infarction, heart rhythm, and lymphedema.|-26.67754385964909|26.906862745098067|18.553684210526317|10.914117647058823|15.185500000000001|13.583544444444446|3.088421052631574|-11.075294117647061|19.837000000000003|11.661666666666669|65.13532912329528|54.195869768830164|29.90175438596491|23.443137254901963
Endonucleolytic cleavage between the 5S rRNA and the 4.5S rRNA of an rRNA molecule originally produced as a tetracistronic rRNA transcript that contains the Small Subunit (SSU) rRNA, Large Subunit (LSU) the 4.5S rRNA, and the 5S rRNA in that order from 5' to 3' along the primary transcript. Note that the use of the word tetracistronic refers only to the number of mature rRNA molecules which will be produced from the primary transcript and ignores tRNAs that may also be present within the primary transcript. [GOC:curators]|Endonucleolytic cleavage between the 5S rRNA and the 4.5S subunit of a cell's protein maker. Note that the use of the word tetracistronic refers only to the number of mature RNA molecules that will be produced from|56.92572413793104|61.70045045045046|9.641977011494252|7.717297297297296|12.627569696969697|10.811794736842106|12.794022988505745|4.446486486486478|16.144393939393936|10.132631578947368|77.91147168421348|65.13532912329528|21.212873563218395|18.98738738738739
An acute leukemia characterized by the proliferation of both neutrophil and monocyte precursors. (WHO, 2001)|Acute leukemia characterized by the proliferation of both neutrophil and monocyte precursors. (WHO, 2001)|24.382499999999993|18.44428571428574|11.721666666666671|12.425714285714289|12.429833333333335|13.4825|-2.6186666666666696|-3.2257142857142824|10.579999999999998|10.266000000000002|58.53822981607831|58.53822981607831|21.666666666666668|22.8
Problem associated with any motion of the system or components that was not initiated by the user.|Problem associated with any motion of the system or component that was not initiated by the user.|48.9133823529412|48.9133823529412|8.548529411764708|8.548529411764708|10.981464705882354|11.100677777777777|-6.461176470588235|-6.461176470588235|9.511764705882353|4.265000000000001|62.58|62.58|22.223529411764705|22.223529411764705
Administration of a medicinal product directly into the anterior chamber of the eye|Administration of a medical product directly into the front chamber of the eye.|17.932307692307717|44.05288461538464|13.98769230769231|8.729615384615386|11.568992307692309|10.750842857142857|9.344615384615384|-14.781538461538464|10.793846153846154|4.610714285714284|82.78555852321104|54.195869768830164|26.738461538461536|21.06153846153846
An incision in the uterus, performed through either the abdomen or the vagina.|An incision in the uterus, performed through the abdomen or the vagina.|44.05288461538464|45.64500000000001|8.729615384615386|8.383333333333333|10.354376923076924|11.246592307692307|-15.68615384615385|-19.443333333333328|8.25769230769231|3.1961538461538446|54.195869768830164|49.473833993334296|21.06153846153846|19.06666666666667
A skin spray composed of Evaux thermal spring water, the emulsifier polysorbate 20, the preservatives phenoxyethanol and chlorphenesin, zinc gluconate, and the moisturizer caprylyl glycol with prophylactic and calming activity. Evaux thermal spring water is rich in mineral elements particularly of lithium, strontium and manganese. When sprayed directly onto the skin or scalp, this topical spray may have a calming, moisturizing, healing and nurturing effect. This agent may prevent or decrease skin rashes associated with the administration of EGFR inhibitors or with radiochemotherapy-induced skin reactions.|A skin spray composed of Evaux thermal spring water, the emulsifier polysorbate 20, the preservatives phenoxyethanol and chlorphenesin, zinc gluconate, and the moisturizer caprylyl glycol with prophylactic and calming effect. This|18.389411764705926|16.44443548387102|14.91764705882353|14.816290322580645|13.515923255813954|13.805412500000001|19.113411764705884|19.028387096774196|17.525232558139535|15.418749999999996|90.68703567765351|88.50148473330829|26.56470588235294|26.84516129032258
An estimation as to the cause of the pathology responsible for the cardiac valve regurgitation.|An estimation as to the cause of the disease responsible for the heart valve regurgitation.|35.662499999999994|52.58250000000001|10.148333333333337|7.7883333333333375|10.6965|9.954550000000001|-7.714666666666666|-8.890666666666672|11.189999999999998|5.236875000000001|49.473833993334296|44.250742366654144|16.333333333333332|13.66666666666667
Human UBQLN4 wild-type allele is located in the vicinity of 1q21 and is approximately 18 kb in length. This allele, which encodes ubiquilin-4 protein, may play a role in the regulation of the proteasome.|Normal human UBQLN4 gene is located in the vicinity of 1q21 and is about 18 kilobases in length. This gene, which encodes ubiquilin-4 protein, may play a role in regulation of the proteasome.|70.91990196078433|72.61545454545457|6.182941176470592|5.863636363636363|12.173928571428572|12.093633333333333|3.2823529411764696|1.6000000000000014|9.524285714285714|5.847254901960785|59.91578840339164|57.127462747788826|17.47450980392157|16.521212121212123
GLYCEROL esterified with FATTY ACIDS.|GOCEROL esterified with FATTY ACIDS.|1.2575000000000216|1.2575000000000216|13.705000000000002|13.705000000000002|16.5165|16.94363333333333|-79.59199999999998|-79.59199999999998|11.214000000000006|5.189999999999998|44.250742366654144|44.250742366654144|33.0|33.0
The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration.|The total body clearance for blood injection, calculated using the observed value of the last non-zero concentration.|9.101617647058845|38.960441176470624|14.101470588235298|9.936764705882357|12.4243|11.587173684210526|4.607058823529414|0.4564705882352982|16.615000000000002|7.861578947368422|69.96656701596841|66.37611354998121|26.929411764705886|24.576470588235296
The number of days from the date of initial cancer diagnosis to the date of death.|The number of days from the initial cancer diagnosis to the date of death.|77.1025|72.83000000000003|4.492500000000003|4.840000000000003|7.390725|8.219166666666666|-12.377500000000001|-16.245714285714282|5.998750000000001|1.4740000000000002|44.250742366654144|44.250742366654144|13.200000000000001|14.228571428571428
St. George's Respiratory Questionnaire Past 4 Weeks Version (SGRQ Past 4 Weeks Version) These are questions about your respiratory treatment: My treatment interferes with my life a lot.|These are questions about your respiratory treatment: My treatment interferes with my life a lot.|58.37595238095241|52.58250000000001|7.435714285714287|7.7883333333333375|12.558361904761906|8.835408333333334|1.465714285714295|-6.538666666666671|9.14166666666667|5.375416666666666|59.91578840339164|54.195869768830164|19.44761904761905|19.0
A doctor who specializes in diagnosing and treating eye problems, including injury and disease.|A doctor who specializes in diagnosis and treating eye problems, including injury and disease.|42.61571428571432|36.572857142857174|9.054285714285715|9.89714285714286|11.098042857142858|11.377166666666668|-7.845714285714287|-7.845714285714287|12.484285714285711|7.439999999999998|62.58|62.58|25.65714285714286|25.65714285714286
A route that begins in the regional surrounding a tumor.|A route that begins in the region surrounding a tumor.|66.40000000000003|74.86000000000003|5.240000000000002|4.060000000000002|8.8695|9.651118181818184|-31.563999999999997|-32.152|5.235999999999997|0.5881818181818197|44.250742366654144|44.250742366654144|18.0|18.0
Membrane-associated transporter protein (530 aa, ~58 kDa) is encoded by the human SLC45A2 gene. This protein is involved in the modulation of both melanin synthesis and melanocyte differentiation.|This protein is involved in the modulation of both the middle germ-cell layer synthesis and melanocyte differentiation.|37.22595238095241|29.00750000000002|10.385714285714286|11.325000000000003|14.700872413793105|11.587173684210526|3.7757142857142902|1.1482352941176472|12.293448275862069|8.605263157894736|62.58|66.37611354998121|20.876190476190477|24.576470588235296
Genus in the family FELIDAE comprised of big felines including LIONS; TIGERS; jaguars; and the leopard.|Genus in the family FELIDAE comprised of big felines including LION; TIGERS; jaguars; and the leopard.|50.66500000000002|45.377500000000026|8.180000000000003|8.917500000000004|11.338225000000001|11.488688235294118|-4.660000000000004|-4.660000000000004|11.2975|6.092941176470589|66.37611354998121|69.96656701596841|25.700000000000003|28.200000000000003
Unified Huntington's Disease Rating Scale 1999 Version (UHDRS 1999 Version) Dysarthria.|neurologic disease rating scale 1999 version (UHDRS 1999 Version) Dysarthria.|55.12522727272727|57.940000000000026|6.936818181818182|6.420000000000002|19.972099999999998|19.6993|-12.658181818181824|-18.627999999999993|15.755454545454548|9.579999999999998|58.53822981607831|54.195869768830164|27.654545454545453|26.0
An arbitrary unit of substance concentration expressed in milligrams per a volume of hydrogen peroxide. One Carratelli unit is equal to 0.8mg substance per liter of hydrogen peroxide.|An arbitrary unit of substance concentration expressed in milligrams per a volume of hydrogen peroxide. One Carratelli unit is equal to 0.8mg substance in molar proportions.|33.5514285714286|34.29134615384618|10.318571428571431|10.091153846153848|14.700872413793105|14.25014761904762|-9.525714285714287|-11.841538461538462|10.83172413793104|7.964166666666667|62.58|60.592824451415034|25.65714285714286|25.676923076923075
The chemical reactions and pathways resulting in the formation of oligosaccharides, molecules with between two and (about) 20 monosaccharide residues connected by glycosidic linkages. [ISBN:0198506732]|The chemical reactions and pathways resulting in the formation of oligomers, molecules with between two and (about) 20 monosaccharides connected by glycosidic linkages. [ISBN:0198506732]|8.027500000000003|18.405|15.245000000000005|13.673333333333336|12.4673|12.4673|17.950400000000002|15.513333333333335|17.0364|14.587200000000003|82.78555852321104|79.77416029015912|27.400000000000002|26.466666666666665
A subjective score of 9 on a tiredness scale that ranges from 0: No Tiredness to 10: Worst Possible Tiredness.|A subjective score on a tiredness scale that ranges from 0: No Tiredness to 10: Worst Possible Fatigue.|78.24500000000002|75.50000000000003|4.830000000000002|4.964444444444446|11.734|11.587173684210526|-2.8459999999999965|-4.468888888888891|9.294|4.143157894736845|54.195869768830164|54.195869768830164|16.0|16.933333333333334
The multiplication or reproduction of cells, resulting in the expansion of a cell population. [GOC:mah, GOC:mb]|The multiplication or reproduction of cells, resulting in the expansion of a cell population.|34.80250000000001|30.53000000000003|10.392500000000002|10.740000000000002|11.9779|10.3245|-1.7199999999999989|-8.265714285714282|6.358333333333334|7.126000000000001|54.195869768830164|49.473833993334296|18.2|17.085714285714285
A PEPTIDE of 22 amino acids, derived mainly from cells of VASCULAR ENDOTHELIUM. It is also found in the BRAIN, major endocrine glands, and other tissues. It shares structural homology with ATRIAL NATRIURETIC FACTOR. It has vasorelaxant activity thus is important in the regulation of vascular tone and blood flow. Several high molecular weight forms containing the 22 amino acids have been identified.|A PEPTIDE of 22 amino acids, derived mainly from cells of VASCULAR ENDOTHELIUM. It is also found in the BRAIN, major endocrine glands, and other tissues. This protein has vasorelaxant activity thus is important in|41.74892857142859|47.547619047619065|10.04468253968254|9.525714285714287|11.279237777777777|11.249477777777777|3.4495238095238108|4.868571428571428|9.616190476190479|7.465833333333332|67.59412548439398|72.26115969177356|21.977777777777778|22.952380952380953
Trauma Symptom Checklist for Children - Scary ideas or pictures just pop into my head.|Trauma Symptom Checklist for Children - Scary ideas or pictures just pop into my head.|63.86250000000001|63.86250000000001|6.215000000000003|6.215000000000003|8.842328571428572|9.271833333333333|-11.242666666666668|-10.850666666666672|9.120000000000001|4.614000000000001|62.58|62.58|24.333333333333336|24.333333333333336
Symbol Digit Modalities Test test name.|Symbol Digit Modalities Test name.|48.690000000000026|35.097500000000025|7.213333333333335|8.985000000000003|11.8291|14.311966666666669|-65.34666666666666|-81.94399999999999|7.475000000000001|3.620000000000001|38.32226702584281|38.32226702584281|21.200000000000003|25.0
The developmental process pertaining to the initial formation of a lung lobe from unspecified parts. This process begins with the specific processes that contribute to the appearance of the lobe and ends when the structural rudiment is recognizable. A lung lobe is a projection that extends from the lung. [GOC:dph]|The developmental process pertaining to the initial formation of a lung lobe from unspecified parts. This process begins with the specific processes that contribute to their appearance and ends when the structural rudiment is recognizable.|52.01950000000002|35.461904761904776|9.109000000000002|11.211428571428574|11.699488235294119|11.688088888888888|7.601599999999998|9.236571428571423|8.95676470588235|11.259999999999998|64.5059875127883|69.96656701596841|18.6|21.80952380952381
nutritional condition produced by a deficiency of thiamine in the diet, characterized by anorexia, irritability, and weight loss; later, patients experience weakness, peripheral neuropathy, headache, and tachycardia; in addition to being caused by a poor diet, thiamine deficiency in the United States most commonly occurs as a result of alcoholism, since ethanol interferes with thiamine absorption.|nutrient condition produced by a deficit of thiamine in the diet, characterized by anorexia, nausea, weight loss; later, patients experience weakness, peripheral neuropathy, headache, and rhythm.|-2.870714285714257|11.424615384615407|20.615714285714287|14.895384615384618|14.873028571428572|14.247951851851854|25.653571428571425|15.90307692307692|34.57767857142857|13.579999999999998|123.18885318891476|88.50148473330829|33.34285714285715|29.81538461538462
A standard operating procedure (SOP) that is a collection of activities and the rules that describe when each activity is performed to achieve a specific purpose or objective(s). EXAMPLE(S): Specimen Collection Protocol; Specimen Processing Protocol; Image Acquisition Protocol OTHER NAME(S): NOTE(S): In modeling, often the same term is used to mean different things and a single concept can have more than one name. In the healthcare arena, the term "protocol" is somewhat overloaded and must be qualified to provide semantic context. Therefore during the early years of the BRIDG project, the term "study protocol" was chosen to disambiguate the concept of the detailed plan for a clinical study (the scope of BRIDG at that time) from other kinds of protocols such as are common in life sciences. In BRIDG, the notion of a study protocol is very specific in purpose and includes (but is not limited to) the design, statistical considerations, activities to test a particular hypothesis or answer a particular question that is the basis of the study, characteristics, specifications, objective(s), background, pre-study/study/post-study portions of the plan (including the design, methodology, statistical considerations, organization). For a more complete discussion of the notion of the study protocol see the classes StudyProtocol, StudyProtocolVersion, StudyProtocolDocument, StudyProtocolDocumentVersion, StudyConduct and all their associations. With the addition of life sciences to the scope of the BRIDG model, there came along (with that scope) the need to identify the kind of protocol that represents a more simple or atomic concept, that of a composite activity that serves as a rule that guides how activities should be performed. This concept, represented by the ProcessProtocol class, has a more limited size than the concept of a study protocol does and represents a standardized approach to doing tasks or activities that are not as big as the plan for a whole study. The BRIDG SCC acknowledges that overloaded terms are problematic. The SCC recognizes that many different users within the BRIDG community will have differing opinions on what the meaning of a term is, which term is the best to use for each concept, and how to define them most effectively. Given that the real meat of a concept is in the definition, the BRIDG SCC aims to choose the most unambiguous term to use as the class name, to make the class definition as explicit and clear as possible, to provide sufficient examples and other names to illustrate the range of possible instances that could be represented by the class. So the BRIDG model is maintaining the distinction between a ProcessProtocol and a StudyProtocol because there is a distinction in the domain that we're trying to disambiguate - the concepts, attributes and relationships that describe an SOP-like, atomic, reusable ProcessProtocol are very different than those of a full-blown clinical trial StudyProtocol. Linking the classes because they both contain the same overloaded word would create artificial complexity in the model and not serve the ultimate purpose of interoperability across systems that need to exchange biomedical research data.|A standard operating procedure (SOP) that is a collection of activities and the rules that describe when each activity is performed to achieve specific purpose or objective(s). In the healthcare arena, the term "study protocol" is very specific in purpose and includes (but is not limited to) the design,|18.687831325301232|30.03280612244899|19.489684452094092|15.15683673469388|10.98639392873528|11.5083|23.676305220883535|18.758367346938776|22.59917571494112|14.337400000000002|117.96905039034601|103.77718969022045|30.212507171543315|27.759183673469387
Implantable pacemaker testers designed to perform the assessment/evaluation of pacemaker function via the telephone. These testers include a transmitter that converts the pacemaker signal into a signal appropriate for transmission over the telephone line, a receiver at the monitoring point (e.g., physician's office) that records and decodes the signal, and a testing unit. Transtelephonic pacemaker testers typical transmit a complete electrocardiographic signal depicting the patient's heart activity in addition to the pacemaker performance data.|Implantable pacemakers designed to perform the assessment/evaluation of pacemaker function via the telephone. These testers include a transmitter that converts slow heart rhythm signals from the patient's heart activity in addition to the ratemaker performance data.|10.254504504504496|18.405|14.89297297297298|13.673333333333336|13.718900000000001|13.406345614035088|13.902162162162153|13.226666666666667|20.4604|13.287280701754383|85.69119412168324|80.79043260188672|29.25765765765766|27.022222222222226
Lumpy and sausage-like; indicative of constipation.|Fat and protein-like; indicative of constipation.|-21.809999999999945|6.390000000000015|17.04666666666667|13.113333333333333|10.750842857142857|11.7299|-53.58666666666666|-54.566666666666656|11.002857142857145|5.297499999999999|44.250742366654144|38.32226702584281|27.866666666666664|21.200000000000003
St. George's Respiratory Questionnaire Past 4 Weeks Version (SGRQ Past 4 Weeks Version) We would like to know how your respiratory problems usually affect your daily life: I cannot go out of the house to do the shopping.|We would like to know how your respiratory problems usually affect your daily life: I cannot go out of the house to do the shopping.|69.30464912280705|72.32350000000002|6.739473684210527|6.277000000000001|10.676776923076924|7.230174074074075|4.948421052631577|1.9567999999999977|9.937692307692306|3.9855555555555533|62.58|58.53822981607831|17.698245614035088|16.2
Dietary induced changes in the serum metabolome which serve as biomarkers for physiological status (e.g., relative risk of developing age-related diseases such as cancer).|Dietary induced changes in the serum metabolome which serve as biomarkers for status (e.g., relative risk of developing age-related diseases such as cancer).|20.970000000000027|31.798750000000013|11.825000000000003|10.252500000000001|13.718900000000001|13.0989|-13.073333333333323|-16.709565217391308|18.011199999999995|9.500400000000003|56.4088497046341|54.195869768830164|24.066666666666666|23.169565217391305
This gene is involved in both chromatin structure regulation and tumor suppression.|This gene is involved in both chromatin organization and tumor suppression.|45.64500000000001|39.7434090909091|8.383333333333333|9.08227272727273|13.442533333333335|13.144933333333334|-14.053333333333327|-18.53818181818182|12.4375|7.082500000000003|54.195869768830164|49.473833993334296|22.400000000000002|20.381818181818183
A registered nurse who has additional education and training in how to diagnose and treat disease. Advanced practice nurses are licensed at the state level and certified by national nursing organizations. In cancer care, an advanced practice nurse may manage the primary care of patients and their families, based on a practice agreement with a doctor.|A registered nurse who has additional education and training in how to diagnose and treat disease. Advanced practice nurses are licensed at the state level and certified by national nursing organizations.|49.10714285714286|40.791827956989266|9.887857142857143|10.136774193548387|10.483616666666666|11.073691666666667|10.04214285714286|4.548387096774196|12.46261904761905|9.366770833333334|78.225|69.96656701596841|23.45714285714286|23.488172043010756
that aspect of consciousness devoted to affect or feeling.|that aspect of awareness devoted to affect or feeling.|51.867500000000035|51.867500000000035|7.142777777777777|7.142777777777777|11.100677777777777|11.7795|-33.11111111111111|-35.07111111111111|8.713333333333335|2.735999999999997|49.473833993334296|49.473833993334296|24.022222222222226|24.022222222222226
Enables the transmembrane transfer of a sodium ion by a voltage-gated channel through the plasma membrane of an SA node cardiac muscle cell contributing to the depolarization phase of an action potential. A voltage-gated channel is a channel whose open state is dependent on the voltage across the membrane in which it is embedded. [GOC:BHF, GOC:mtg_cardiac_conduct_nov11]|Enables the transmembrane transfer of a sodium ion from one cell to another cell type. A voltage-gated channel is one whose open state depends on the voltage across the membrane in which it is embedded. [GOC:BHF, GOC:mtg|42.85976190476194|61.70045045045046|11.918571428571429|7.717297297297296|12.260333333333334|10.476317886178862|17.427857142857142|5.399999999999995|12.747999999999998|5.8516260162601625|86.63808689023553|65.13532912329528|23.8952380952381|18.98738738738739
The chemical reactions and pathways resulting in the breakdown of 21U-RNAs, a class of single-stranded RNA molecules of about 21 nucleotides in length characterized by a uridine 5'-monophosphate and a modified 3' end resistant to periodate degradation. 21U-RNAs are derived from distinct, autonomously expressed loci within the genome. [GOC:kmv]|The chemical reactions and pathways resulting in the breakdown of 21U-RNAs, a class of single-stranded RNA molecules of about 21 nucleotides in length characterized by an uridine 5'-monophosphate and an altered 3' end resistant to periodate|40.04850340136059|26.94500000000002|11.731020408163268|18.444444444444446|13.605848717948717|13.4163|17.517551020408167|25.42444444444444|13.141666666666666|22.607368421052634|84.73372056035305|117.07645963215661|24.492517006802725|29.955555555555556
Catalysis of the movement of phosphatidylserine from the cytosolic to the exoplasmic leaftlet of a membrane, using energy from the hydrolysis of ATP. [GOC:ab, PMID:16452632, PMID:20224745, RHEA:38568]|A process that increases the movement of a molecule of protein building blocks from the cytosolic leaflet to the extracellular space. [GOC:ab, PMID:16452632, RHEA:38568]|45.86583333333337|57.18000000000001|10.215740740740742|8.265|12.789828571428572|12.1763|15.967407407407407|11.348333333333336|13.493571428571428|10.612692307692306|69.96656701596841|69.96656701596841|20.214814814814815|21.46666666666667
Life threatening consequences; disabling|Life threatening consequences; disablement|-29.87499999999997|-51.02499999999998|18.420000000000005|21.370000000000008|15.6774|16.5165|-19.610000000000007|-15.200000000000003|22.96|17.808|54.195869768830164|54.195869768830164|31.6|31.6
Powder intended for oral inhalation.|Powder intended for inhalation.|1.2575000000000216|-6.694999999999993|13.705000000000002|14.690000000000001|10.200500000000002|10.0765|-80.768|-105.37|10.272000000000002|6.195999999999998|44.250742366654144|38.32226702584281|33.0|30.8
An injectable radiopharmaceutical formulation containing human serum albumin (HSA) microspheres labeled with technetium-99m (Tc-99m) with diagnostic imaging activity. Technetium Tc 99m-labeled albumin microspheres contain the gamma-emitting Tc99m, a metastable nuclide of molybdenum-99. Upon injection into the hepatic artery, the radionuclide portion allows for SPECT (single photon emission computed tomography) imaging of distribution patterns of the albumin microspheres. This may possibly predict the distribution of other agents with similar particle sizes within the liver and may give a prediction of the tumor response upon administration of such agents. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C92580" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C92580" NCI Thesaurus)|An injectable radiopharmaceutical formulation containing human serum albumin (HSA) microspheres labeled with technetium-99m (Tc 99m) with diagnostic imaging activity. This may possibly predict the distribution of other agents with similar particle sizes within the liver and may give|25.84306818181821|7.218421052631584|11.704267676767678|16.972631578947375|14.516810256410256|14.666470731707317|12.289696969696976|22.641052631578948|23.01455128205128|16.620487804878046|68.19497397169383|103.77718969022045|26.330303030303032|30.757894736842104
This gene is involved in both transcriptional regulation and cell division.|This gene is involved in both gene regulation and cell division.|47.434318181818185|70.50704545454548|8.009545454545457|4.791363636363638|11.359372727272728|11.8291|-19.07272727272727|-24.41818181818182|11.473636363636366|2.7650000000000006|44.250742366654144|38.32226702584281|16.745454545454546|13.109090909090908
Liquid sterile single-dose or multidose preparation consisting of a solution intended for administration by injection. Comment: For infusions, see 'Solution for infusion'.|Fluid sterile single-dose or multidose preparation consisting of a solution intended for administration by injection. Comment: For injections, see 'Solution for infusion'.|7.1189393939393995|7.1189393939393995|14.088181818181823|14.088181818181823|12.94154927536232|13.144933333333334|-0.2727272727272734|-0.005454545454547599|11.687246376811594|9.829999999999998|67.59412548439398|67.59412548439398|28.38787878787879|28.38787878787879
A determination of the amount of pi glutathione-s-transferase being excreted over a defined period of time.|A determination of the amount of sulfur molecule being excreted over a defined period of time.|18.940000000000026|34.80250000000001|12.605000000000004|10.392500000000002|11.547077777777778|10.559864705882354|-3.1899999999999977|-7.600000000000001|10.858333333333334|4.707647058823532|62.58|66.37611354998121|23.200000000000003|25.700000000000003
Urethral catheters designed to infuse a contrast medium in the bladder. These catheters consist of a flexible or semirigid tube with one or more openings at the distal tip; some designed for female use include a balloon at their distal tip that is placed in the bladder and another balloon that remains outside at the proximal end of the urethra. Cystography urethral catheters are used for cystography and/or radiography of the bladder and urethra during micturition voiding (voiding cystouretography), frequently to delineate abnormalities of structure or function of the bladder and urethra, including the detection of vesicoureteral reflux and stress incontinence.|These catheters are used for cystography and/or radiography of the bladder and urethra, including the detection of reflux and urinary problems.|22.895358910891105|35.0346428571429|16.338688118811884|10.981190476190477|12.497851815181518|12.794827272727273|21.3449504950495|6.529523809523809|21.51818481848185|10.189090909090911|109.51499999999999|69.96656701596841|29.505940594059407|23.247619047619047
This gene is involved in the initiation of DNA replication and sister-chromatid cohesion.|This gene is involved in the initiation of DNA replication and sister DNA repair.|31.037500000000023|60.74428571428575|10.545000000000002|6.525714285714287|12.225900000000001|11.377166666666668|-10.71076923076923|-13.305714285714284|10.802142857142854|3.6720000000000006|49.473833993334296|49.473833993334296|17.984615384615388|17.085714285714285
Echovirus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to echovirus in serum. Additionally, some of these reagents consist of echovirus antisera conjugated with a fluorescent dye used to identify echoviruses from clinical specimens or from tissue culture isolates derived from clinical specimens. The identification aids in the diagnosis of echovirus infections and provides epidemiological information on diseases caused by these viruses. Echoviruses cause illnesses such as meningitis (inflammation of the brain and spinal cord membranes), febrile illnesses (accompanied by fever) with or without rash, and the common cold.|Echoviruses cause illnesses such as meningitis (inflammation of the brain and spinal cord membranes), fever (accompanied by fever) with or without rash, and the cold.|-1.250836734693877|38.48350000000002|18.302979591836735|10.997000000000003|12.907822448979593|9.747069230769231|21.077959183673464|9.953599999999994|19.272244897959183|9.706923076923076|98.94766798666859|69.96656701596841|28.248163265306125|21.0
Ozone in the lower troposphere, just above the surface of the Earth.|Ozone in the lower troposphere, just above the surface of the Earth.|73.84500000000001|73.84500000000001|4.450000000000003|4.450000000000003|6.863366666666667|7.602746153846153|-21.40333333333333|-20.913333333333334|6.157499999999999|2.10923076923077|49.473833993334296|49.473833993334296|19.06666666666667|19.06666666666667
The diameter of the region within which the data is collected.|The size of the region within which the data is collected.|55.12522727272727|78.19795454545455|6.936818181818182|3.7186363636363637|11.359372727272728|10.513266666666667|-26.021818181818183|-27.625454545454552|5.90727272727273|0.41000000000000014|49.473833993334296|44.250742366654144|20.381818181818183|16.745454545454546
Any process that activates or increases the frequency, rate or extent of Schwann cell chemotaxis. [GO_REF:0000058, GOC:TermGenie, PMID:16203995]|Any process that activates or increases the frequency, rate or extent of Schwann cell chemotaxis. [GO_REF:0000058, GOC:PMID:16203995]|52.00000000000003|58.8663235294118|8.242222222222225|7.160294117647062|13.24927894736842|13.24927894736842|8.597777777777779|5.990588235294119|13.067368421052628|11.084210526315793|62.58|58.53822981607831|21.37777777777778|19.870588235294118
HLA class II histocompatibility antigen, DQ beta 1 chain (261 aa, ~30 kDa) is encoded by the human HLA-DQB1 gene. This transmembrane protein is involved in the presentation of peptide antigens on the cell surface.|This protein is involved in the presentation of peptide antigens on the cell surface.|62.05047619047622|60.74428571428575|7.502857142857145|6.525714285714287|14.178744444444446|10.3245|4.7005714285714255|-11.625714285714288|10.073333333333334|4.928000000000001|62.58|54.195869768830164|18.38095238095238|19.942857142857143
<h3>What is lupus?</h3> <p>Lupus is an <a href="https://medlineplus.gov/autoimmunediseases.html">autoimmune disease</a>. This means that your immune system attacks healthy cells and tissues by mistake. This can damage many parts of the body, including the joints, skin, kidneys, heart, lungs, blood vessels, and brain.</p> <p>There are several kinds of lupus</p> <ul> <li>Systemic lupus erythematosus (SLE) is the most common type. It can be mild or severe and can affect many parts of the body.</li> <li>Discoid lupus causes a red rash that doesn't go away</li> <li>Subacute cutaneous lupus causes sores after being out in the sun</li> <li>Drug-induced lupus is caused by certain medicines. It usually goes away when you stop taking the medicine.</li> <li>Neonatal lupus, which is rare, affects newborns. It is probably caused by certain antibodies from the mother.</li> </ul> <h3>What causes lupus?</h3> <p>The cause of lupus is unknown.</p> <h3>Who is at risk for lupus?</h3> <p>Anyone can get lupus, but women are most at risk. Lupus is two to three times more common in African American women than in white women. It's also more common in Hispanic, Asian, and Native American women. African American and Hispanic women are more likely to have severe forms of lupus.</p> <h3>What are the symptoms of lupus?</h3> <p>Lupus can have many symptoms, and they differ from person to person. Some of the more common ones are</p> <ul> <li>Pain or swelling in joints</li> <li>Muscle pain</li> <li><a href="https://medlineplus.gov/fever.html">Fever</a> with no known cause</li> <li>Red <a href="https://medlineplus.gov/rashes.html">rashes</a>, most often on the face (also called the "butterfly rash")</li> <li>Chest pain when taking a deep breath</li> <li>Hair loss</li> <li>Pale or purple fingers or toes</li> <li>Sensitivity to the sun</li> <li>Swelling in legs or around eyes</li> <li>Mouth ulcers</li> <li>Swollen glands</li> <li><a href="https://medlineplus.gov/fatigue.html">Feeling very tired</a></li> </ul> <p>Symptoms may come and go. When you are having symptoms, it is called a flare. Flares can range from mild to severe. New symptoms may appear at any time.</p> <h3>How is lupus diagnosed?</h3> <p>There is no specific test for lupus, and it's often mistaken for other diseases. So it may take months or years for a doctor to diagnose it. Your doctor may use many tools to make a diagnosis:</p> <ul> <li>Medical history</li> <li>Complete exam</li> <li>Blood tests</li> <li>Skin biopsy (looking at skin samples under a microscope)</li> <li>Kidney biopsy (looking at tissue from your kidney under a microscope)</li> </ul> <h3>What are the treatments for lupus?</h3> <p>There is no cure for lupus, but medicines and lifestyle changes can help control it.</p> <p>People with lupus often need to see different doctors. You will have a primary care doctor and a rheumatologist (a doctor who specializes in the diseases of joints and muscles). Which other specialists you see depends on how lupus affects your body. For example, if lupus damages your heart or blood vessels, you would see a cardiologist.</p> <p>Your primary care doctor should coordinate care between your different health care providers and treat other problems as they come up. Your doctor will develop a treatment plan to fit your needs. You and your doctor should review the plan often to be sure it is working. You should report new symptoms to your doctor right away so that your treatment plan can be changed if needed.</p> <p>The goals of the treatment plan are to</p> <ul> <li>Prevent flares</li> <li>Treat flares when they occur</li> <li>Reduce organ damage and other problems</li> </ul> <p>Treatments may include drugs to</p> <ul> <li>Reduce swelling and pain</li> <li>Prevent or reduce flares</li> <li>Help the immune system</li> <li>Reduce or prevent damage to joints</li> <li>Balance the hormones</li> </ul> <p>Besides taking medicines for lupus, you may need to take medicines for problems that are related to lupus such as high cholesterol, high blood pressure, or infection.</p> <p>Alternative treatments are those that are not part of standard treatment. At this time, no research shows that alternative medicine can treat lupus. Some alternative or complementary approaches may help you cope or reduce some of the stress associated with living with a chronic illness. You should talk to your doctor before trying any alternative treatments.</p> <h3>How can I cope with lupus?</h3> <p>It is important to take an active role in your treatment. It helps to learn more about lupus - being able to spot the warning signs of a flare can help you prevent the flare or make the symptoms less severe.</p> <p>It is also important to find ways to cope with the stress of having lupus. Exercising and finding ways to relax may make it easier for you to cope. A good support system can also help.</p> <p class="">NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases</p>|This means that your immune system attacks healthy cells and tissues by mistake. This can damage many parts of the body, including the joints, skin, heart, lungs, and brain.|53.79608571428574|83.2509195402299|9.558321088435374|4.048965517241381|12.051600882589845|7.816833333333333|13.706933333333335|-1.0179310344827606|6.720021250706928|5.393000000000001|77.5516015308517|57.127462747788826|22.175782312925172|17.65977011494253
A rare chromosomal anomaly syndrome resulting from the partial duplication of the short arm of chromosome 8 with a highly variable phenotype. Principle characteristics are mild to moderate developmental delay, intellectual disability, mild facial dysmorphism (including prominent forehead, arched eyebrows, broad nasal bridge, upturned nares, cleft lip and/or palate) and congenital cardiac anomalies (atrioventricular septal defect). Other reported features include macrocephaly, attention deficit disorder, seizures, hypotonia and ocular and digital anomalies (poly or syndactyly).|A rare genetic abnormality resulting from the partial duplication of the short arm of chromosome 8 with a highly variable phenotype. Principle characteristics are mild to moderate developmental delay, intellectual disability, mild facial abnormalities (including prominent forehead, broad nasal bridge, upturned nares|-10.866824324324313|-3.822857142857117|19.37094594594595|19.00952380952381|15.528885585585586|14.98476046511628|24.524324324324326|24.684761904761906|22.218468468468465|19.00395348837209|109.51499999999999|108.39173953766033|33.88648648648648|31.257142857142856
A component of the MRN complex along with Rad50 and Nibrin. Together, these perform a critical function in the repair of DOUBLE-STRANDED DNA BREAKS; RECOMBINATIONAL DNA REPAIR; maintenance of TELOMERE integrity and MEIOSIS. MRE11, which contains a poly(ADP)-ribose binding motif and associates with PARP1, possesses single-strand endonuclease activity and double-strand-specific 3'-5' exonuclease activity. Mutations in the MRE11 gene are associated with ATAXIA-TELANGIECTASIA-like disorder 1.|A component of the MRN complex along with Rad50 and Nibrinol. Together, these perform a critical function in the repair of DOUBLE-STRANDED DNA BREAKS; RECOMBINATIONAL DNA REPAIR; maintenance of TELOMERE integrity and MEIO|18.03362500000003|33.70568181818183|13.923875000000002|12.657121212121215|13.416882608695653|12.62507142857143|16.38125|15.915151515151514|15.454999999999998|12.215714285714284|79.15813438933486|85.69119412168324|25.12|24.78181818181818
Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: unbearable.|Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: unbearable.|71.81500000000001|71.81500000000001|5.230000000000004|5.230000000000004|9.271833333333333|9.822283333333335|-9.805000000000003|-9.4375|4.614000000000001|2.4316666666666684|44.250742366654144|44.250742366654144|13.200000000000001|13.200000000000001
A procedure in which water or a medicated solution is used to clean the vagina and cervix.|A procedure in which water or a medical solution is used to clean the vagina and cervix.|58.8663235294118|63.84279411764709|7.160294117647062|6.466176470588238|9.123817647058823|9.346233333333334|-9.228235294117649|-9.57411764705882|7.295294117647057|1.9100000000000001|54.195869768830164|54.195869768830164|17.51764705882353|17.51764705882353
A tumor component characterized by the presence of a diffuse, homogeneous population of tumor cells (oligodendroglial cells) with round nuclei and clear cytoplasm. The infiltrate has a honeycomb appearance. An oligodendroglial component can be seen in central nervous system tumors including glioblastomas and mixed gliomas.|A tumor component characterized by the presence of a diffuse, homogeneous population of tumor cells (oligodendroglial cells) with round nuclei and clear cytoplasm. The tumor components are glioblastomas and mixed tumors.|24.336250000000035|27.146666666666675|12.659722222222221|12.040000000000003|12.801833333333335|12.554004166666667|10.275555555555552|7.583225806451612|14.748666666666665|11.280208333333334|75.03078418222748|69.96656701596841|24.944444444444443|23.488172043010756
The presence of a teratoma. [HPO:probinson]|The presence of a tumor. [HPO:probinson]|20.490000000000038|48.690000000000026|11.146666666666665|7.213333333333335|12.832957142857145|13.70365|-61.42666666666666|-63.386666666666656|3.197142857142854|-0.5899999999999999|38.32226702584281|38.32226702584281|21.200000000000003|21.200000000000003
The regulated release of corticotropin by a cell. Corticotropin hormone is a polypeptide hormone synthesized and secreted from corticotropes in the anterior lobe of the pituitary gland in response to corticotropin-releasing hormone (CRH) released by the hypothalamus. [GOC:cjm, PMID:11027914]|The regulated release of a hormone in the front lobe of the pituitary gland in response to an agonist hormone released by the hypothalamus. [GOC:cjm, PMID:11027914]|13.593846153846187|56.97846153846157|14.592820512820516|8.541538461538462|13.55729349593496|12.789828571428572|15.526153846153843|8.892307692307693|13.548455284552844|8.278928571428569|74.48509850970193|66.37611354998121|22.635897435897437|19.046153846153846
Truncus arteriosus (single great artery leaving the base of the heart, giving rise to the coronary, pulmonary, and systemic arteries) with a short pulmonary trunk arises from the truncus arteriosus, giving rise to both pulmonary arteries. [DDD:dbrown, HPO:probinson]|Truncus arteriosus (single great artery leaving the base of the heart, giving rise to the coronary vessels, and systemic arteries). [DDD:dbrown, HPO:probinson]|25.028947368421086|38.00636363636366|14.48842105263158|10.690909090909091|10.944500000000001|11.2041|19.855789473684215|10.241818181818179|14.121749999999999|9.1236|88.50148473330829|69.96656701596841|24.442105263157895|22.581818181818182
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a catecholamine stimulus. A catecholamine is any of a group of biogenic amines that includes 4-(2-aminoethyl)pyrocatechol [4-(2-aminoethyl)benzene-1,2-diol] and derivatives formed by substitution. [GOC:BHF, GOC:mah]|Any process that results in a change in state or activity of cellular or an organism (in terms of movement, secretion, enzyme production, etc.). A catecholamine is an amine that includes 4-(2-aminoethyl)pyrocatechol [4-(|46.75147727272727|57.23363636363638|10.154318181818184|8.009090909090911|12.012333333333334|11.884595238095239|14.287272727272729|6.767272727272729|10.875999999999998|8.491619047619043|71.69439674758411|65.13532912329528|20.772727272727277|20.157575757575756
Physical location of ANGPT1_Gene|Location of ANGPT1 gene.|54.72500000000002|99.055|6.620000000000001|-0.0600000000000005|15.6774|16.392500000000002|-31.369999999999997|-115.66|14.717500000000001|-0.3979999999999997|44.250742366654144|22.125371183327072|21.6|10.8
A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.|A molecule of protein that stimulates mucous action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.|15.41500000000002|33.04000000000002|13.096666666666668|10.638333333333335|11.468783333333334|11.629033333333332|-2.4550000000000054|-4.660000000000004|11.848750000000003|7.228666666666669|57.127462747788826|57.127462747788826|19.86666666666667|19.86666666666667
Any process that increases the rate, frequency, or extent of the appearance of any platelet-derived growth factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. [GOC:BHF]|Any process that increases the rate, frequency, or extent of the appearance of any platelet growth factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. [GOC:BHF]|14.284527027027053|21.14398648648651|15.862837837837837|14.906081081081084|12.296264102564102|12.296264102564102|19.28|18.167567567567566|14.16461538461538|13.439999999999998|96.44225707644962|96.44225707644962|27.940540540540542|27.940540540540542
An autosomal dominant hereditary neoplastic syndrome. Mutations in the SMAD4 or BMPR1A genes have been identified in the majority of patients. It is characterized by the presence of multiple juvenile polyps in the gastrointestinal tract.|A genetic trait of mental impairment and brittle hair caused by mutations in SMAD4 or BMPR1A genes have been identified in the majority of patients. It is characterized by the presence of multiple juvenile polyps along the gastrointestinal tract.|33.58803571428575|48.301538461538485|10.748214285714287|9.751794871794871|12.786880952380953|12.192833333333335|0.27542857142857|8.741538461538454|11.317619047619047|9.610916666666668|60.592824451415034|69.96656701596841|20.642857142857142|20.58461538461539
The anatomic site from which a biospecimen was obtained.|The body site from which a biospecimen was obtained.|42.46750000000003|61.26750000000001|8.45388888888889|5.831666666666667|11.100677777777777|10.200500000000002|-34.41777777777777|-36.37777777777777|7.666666666666668|1.7940000000000005|38.32226702584281|38.32226702584281|15.133333333333333|15.133333333333333
The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Feeling distant or cut off from other people?|The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Feeling distant or cut off from others?|80.25000000000004|84.17695652173914|8.028333333333332|7.232173913043479|6.952986956521739|7.639508695652174|12.90166666666667|12.439999999999994|4.5934782608695635|3.774347826086956|76.64453405168562|69.96656701596841|19.6|17.895652173913046
A Fab fragment of a recombinant, humanized monoclonal antibody directed against the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha), with anti-inflammatory activity. Upon administration, certolizumab binds to TNF-alpha, preventing the interaction of this cytokine with endogenous cell surface receptors, thereby rendering TNF-alpha inactive and inhibiting TNF-mediated inflammatory responses. TNF-alpha is a protein involved in inflammation, cell survival, and apoptosis.|A protein complex involved in inflammation, cell survival, and apoptosis.|-22.29974137931032|24.100000000000023|19.97189655172414|11.14|15.156858974358977|13.957481818181819|23.280689655172413|-20.979999999999997|19.25748717948718|7.867272727272727|97.70299368494294|54.195869768830164|32.69655172413793|26.0
A measure of the range of values in a set of values that describe the diameter of an entity.|A measure of the range of values that describe the diameter of an entity.|72.51881578947369|66.7871428571429|5.504473684210527|5.682857142857145|7.072057894736842|8.219166666666666|-8.256842105263157|-16.665714285714287|6.1663157894736855|1.1600000000000001|54.195869768830164|49.473833993334296|16.431578947368422|17.085714285714285
Human APC2 wild-type allele is located in the vicinity of 19p13.3 and is approximately 23 kb in length. This allele, which encodes adenomatous polyposis coli protein 2, plays a role in the potentiation of the Wnt protein signaling pathway.|Normal human APC2 gene is located in the vicinity of gene region 19p13.3 and is about 23 kilobases in length. This gene, which encodes a protein complex that increases the Wnt protein signaling pathway.|55.93875|66.33102941176472|7.879166666666666|6.119117647058825|13.707749999999999|13.689166666666667|-0.05435897435896919|-5.423529411764704|11.649000000000001|6.876761904761903|62.58|58.53822981607831|20.31025641025641|19.870588235294118
1. Checking data for correctness and/or compliance with applicable standards, rules, and conventions. 2. Process used to determine if data are inaccurate, incomplete, or unreasonable. The process may include format checks, completeness checks, check key tests, reasonableness checks, and limit checks. [1. FDA. 2. ISO]|1. Checking data for correctness and/or compliance with applicable standards, rules, and conventions. 2. Process used to determine if data are inaccurate, incomplete, or unreasonable. The process may include format checks, completeness checks and limit checks. [1. FDA.2. ISO]|55.12000000000003|54.92897435897436|6.813333333333336|6.674358974358977|12.656722222222223|13.393928571428571|-23.39733333333333|-32.273846153846165|7.864666666666668|7.9208928571428565|46.64437801064561|45.46331598112923|19.77777777777778|21.220512820512823
Claudin-6 (220 aa, ~23 kDa) is encoded by the human CLDN6 gene. This protein is involved in the formation of tight junctions.|This protein is involved in the formation of tight junctions.|99.4098484848485|74.86000000000003|1.2154545454545485|4.060000000000002|13.512554545454547|11.086572727272728|-12.567272727272723|-28.035999999999998|5.265000000000001|3.585454545454546|44.250742366654144|44.250742366654144|13.842424242424242|18.0
An X-ray radiation therapy system is a device intended to produce and control X-rays used for radiation therapy. This generic type of device may include signal analysis and display equipment, patient and equipment supports, treatment planning computer programs, component parts, and accessories.|An X-ray radiation therapy system is a device intended to produce and control high doses used for radiotherapy. This generic type of device may include signal analysis and display equipment, patient and equipment supports, treatment planning computer programs, and accessories.|25.439285714285717|26.21666666666667|13.18904761904762|12.915000000000003|14.417018181818184|14.105661904761906|14.417142857142853|12.932999999999996|15.903181818181814|11.699285714285715|90.32644961471695|88.50148473330829|29.409523809523808|29.333333333333332
The chemical reactions and pathways resulting in the formation of GDP, guanosine 5'-diphosphate. [GOC:ai]|The chemical reactions and pathways resulting in the formation of GDP, adenine 5'-diphosphate. [GOC:ai]|54.70142857142861|54.70142857142861|7.368571428571428|7.368571428571428|14.134414285714287|14.535166666666669|-3.6457142857142912|-4.065714285714286|11.339285714285715|9.324000000000002|58.53822981607831|58.53822981607831|22.8|22.8
The distal interphalangeal joint and/or the proximal interphalangeal joint of the fingers cannot be extended to 180 degrees by either active or passive extension. [HPO:sdoelken, PMID:19125433]|The joint between the two ends of the fingers can be extended to 180 degrees by either active or passive extension. [HPO:sdoelken, PMID:19125433]|40.7092307692308|73.77989130434786|10.810769230769232|5.825434782608696|13.353757142857145|11.2041|14.998461538461537|5.961739130434779|12.820714285714281|7.239599999999999|79.77416029015912|66.37611354998121|25.200000000000003|20.252173913043478
A coded value specifying the highest level of education completed. EXAMPLE(S): Less than High School Diploma, High School Diploma, Some College|A coded value specifying the highest level of education completed. EXAMPLE(S): Less than high school diploma, High School Diploma, Some College|43.09178571428572|43.09178571428572|9.857380952380954|9.857380952380954|9.420633333333335|9.923918181818184|6.249523809523808|6.529523809523809|10.285714285714285|9.546818181818182|69.96656701596841|69.96656701596841|23.247619047619047|23.247619047619047
Nonphysical abuse as defined as a pattern of behavior in which one person deliberately and repeatedly subjects another to nonphysical acts that are detrimental to behavioral and affective functioning and overall mental well-being. (APA Dictionary of Psychology, accessed 4/21/2020),|Nonphysical abuse as defined as a pattern of behavior in which one person deliberately and repeatedly subjects another person to acts that are detrimental to behavioral and affective functioning and overall mental well-being. (APA Dictionary of Psychology, accessed 4/21/2020),|13.5040384615385|17.84250000000003|16.220128205128205|15.615000000000002|12.12875|11.970617073170732|21.608205128205128|21.00512820512821|16.594500000000004|15.70146341463414|103.77718969022045|103.77718969022045|30.364102564102566|30.364102564102566
A question about an individual's knowledge of the most common complication after surgery for prostate cancer.|A question about an individual's knowledge of the most common complication after surgery for prostate cancer.|34.80250000000001|34.80250000000001|10.392500000000002|10.392500000000002|11.338225000000001|11.488688235294118|-2.4550000000000054|-2.0875000000000057|13.946874999999999|8.863529411764706|69.96656701596841|69.96656701596841|28.200000000000003|28.200000000000003
A bradyarrhythmia adverse event in a newborn characterized by life-threatening consequences (e.g. shock); requiring urgent major care changes.|A rhythm abnormal event in a newborn characterized by life-threatening consequences (e.g. shock); requiring urgent major care changes.|14.267500000000013|23.667500000000018|12.387222222222224|11.07611111111111|12.889426315789473|12.817|-24.944444444444436|-27.23111111111111|17.817368421052628|10.181500000000003|51.88859484511023|49.473833993334296|26.244444444444447|24.022222222222226
Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Young Child Report (PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report) Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to breathe.|The Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Young Child Report (PedsQL-NCM). Please listen carefully to each sentence and tell me how much of a problem this is for you. It is hard to breathe.|76.12057142857144|80.42670270270271|5.424428571428571|3.879783783783786|9.536728571428572|8.978561538461538|1.6064285714285695|-11.235675675675676|14.606071428571433|4.5796153846153835|59.368600792001146|46.41057013224466|17.337142857142858|14.851891891891894
An event in the personal medical history of peripheral vascular disease as evidenced by: 1. Claudication either with exertion or at rest; 2. Amputation for arterial vascular insufficiency; 3. Aorto-iliac occlusive disease reconstruction, peripheral vascular bypass surgery, angioplasty or stent; or percutaneous intervention to the extremities; 4. Documented abdominal aortic aneurysm (AAA) repair or stent; 5. Positive non-invasive/invasive test. It does not include procedures such as vein stripping, carotid disease, or procedures originating above the diaphragm. (from NIH Roadmap Cardiovascular Data Standards Working Group)|An event in the personal medical history of peripheral vascular disease as evidenced by: 1. Claudication either with exertion or rest; 2. Amputation for blood vessel insufficiency; 3. Aorto-iliac occlusive disease reconstruction, peripheral vessel bypass surgery, angi|9.856071428571425|12.240844594594648|14.49309523809524|13.849932432432436|14.339578160919542|13.837023076923076|10.029523809523809|5.028108108108107|12.267499999999998|10.497307692307693|76.64453405168562|75.03078418222748|27.057142857142857|28.564864864864866
<p>Provision of diagnosis and treatment of diseases and disorders affecting children.</p>|Provisional diagnosis and treatment of diseases and disorders affecting children.|16.670681818181833|-1.2799999999999727|12.300454545454546|14.68|15.959833333333334|13.957481818181819|-11.589090909090913|-16.276000000000003|10.875999999999998|12.149090909090908|58.53822981607831|58.53822981607831|27.654545454545453|30.0
<b>Description:</b>AU: If this item exists, update it with these values. If it does not exist, create it with these values. If the item is part of the collection, update each item that matches this item, and if no items match, add a new item to the collection.|b>Description:|72.50874999999999|-47.97999999999996|6.064840425531916|20.200000000000006|10.26565641025641|19.6249|1.5812765957446828|-207.8|5.804935897435897|-2.9450000000000003|64.5059875127883|31.29|19.168085106382982|40.400000000000006
A chemotherapy regimen consisting of doxorubicin, prednisone, and vincristine that may be used in the treatment of Hodgkin lymphoma (HL).|A chemotherapy regimen consisting of doxorubicin, prednisone, and vincristine that may be used in the treatment of Hodgkin lymphoma.|27.485000000000014|23.53986842105263|11.91|12.336052631578948|12.5235|12.0275|5.092000000000002|4.431578947368415|15.181500000000007|9.945999999999998|66.37611354998121|66.37611354998121|22.0|22.74736842105263
Asymptomatic or mild symptoms; additional medical intervention over baseline not indicated|Asymptomatic or mild symptoms; additional medical intervention over baseline not indicated.|-35.057272727272675|-29.474772727272693|20.88181818181818|18.736818181818183|15.665736363636366|15.7766|15.854545454545448|-9.985454545454552|17.89636363636364|12.970000000000006|88.50148473330829|62.58|33.49090909090909|31.290909090909096
A human infant born before 37 weeks of GESTATION.|A human infant born before 37 weeks of GOC.|80.06750000000002|98.8675|3.2094444444444434|0.5872222222222234|11.100677777777777|11.7795|-38.99111111111111|-42.257777777777775|4.003333333333334|-2.4450000000000003|44.250742366654144|38.32226702584281|19.57777777777778|15.133333333333333
Use of reflected ultrasound in the diagnosis of intracranial pathologic processes.|Use of reflected ultrasound in the diagnosis of intracranial pathologies.|1.2888636363636294|7.180000000000035|14.445909090909094|13.5|12.794827272727273|12.522027272727273|-15.330909090909088|-20.979999999999997|14.470909090909089|8.723636363636363|54.195869768830164|49.473833993334296|24.018181818181816|22.0
Derived by Curtiss and Dunning (1920) at Columbia University and disseminated to Heston (1949) and then to the NIH (1951). The Fischer 344 rat has an albino coat and genotype c.|Derived by Curtiss and Dunning (1920) at Columbia University and disseminated to Heston (1949) and then to the NIH (1951).|68.08215053763442|61.32500000000002|6.330322580645163|7.190000000000001|12.55497741935484|13.180157142857144|-0.7625806451612895|0.9759999999999991|7.590967741935486|5.575714285714284|57.127462747788826|58.53822981607831|17.03655913978495|18.0
A bispecific antibody that simultaneously binds to two different and as of yet undisclosed antigens, with potential immunomodulating and antineoplastic activities. Upon administration, AMG 509 targets and binds to the two antigens. This may modulate the tumor microenvironment (TME) and may enhance an immune-mediated antitumor response.|A bispecific antibody that simultaneously binds to two different and as of yet undisclosed antigens, with potential immunomodulating and anticancer activities. Upon administration, AMG 509 targets a tumor microenvironment (TME) and may enhance an immune-mediated antit|7.571195652173941|-8.835000000000008|15.060217391304349|18.963333333333335|12.140587943262412|13.304952631578947|11.586086956521733|21.775555555555556|14.86375886524823|16.33|71.69439674758411|93.86999999999999|22.860869565217392|27.200000000000003
Two muscles located in the upper extremity, the triceps brachii and anconeus, that allow for straightening of the arm at the elbow joint.|Muscles located in the upper extremity, the triceps brachii and anconeus, that allow for straightening of the arm at the elbow joint.|55.38858695652178|53.388181818181835|8.390652173913043|8.545454545454547|10.269473913043479|10.385595652173913|3.6608695652173893|3.2927272727272765|13.005652173913042|6.846086956521738|69.96656701596841|69.96656701596841|21.991304347826087|22.581818181818182
The specification of the characteristic structures of the maxillary segment following establishment of segment boundaries. Identity is considered to be the aggregate of characteristics by which a structure is recognized. [ISBN:0878932437]|The specification of the characteristic structures following establishment of segment boundaries. Identity is considered to be the aggregate of characteristics by which a structure is recognized. [ISBN:0878932437]|16.23053763440862|15.966666666666669|13.56258064516129|13.268148148148153|11.789355913978495|11.994433333333333|10.807741935483872|8.053333333333335|14.731505376344089|14.188095238095237|69.96656701596841|65.13532912329528|23.488172043010756|22.85925925925926
Set of organs located in the thoracic cavity. Examples: There is only one set of thoracic viscera.|Set of organs located in the thoracic cavity. Examples: There is only one set of chest muscles.|46.812745098039244|61.742156862745134|8.137647058823532|6.055294117647062|9.631041176470589|9.346233333333334|-23.87294117647059|-24.56470588235294|4.707647058823532|3.2183333333333337|51.09635603445709|47.79626449838941|21.090196078431372|18.73725490196078
Catalysis of the reaction: dihydroneopterin monophosphate = dihydroneopterin + phosphate. [MetaCyc:DIHYDRONEOPTERIN-MONO-P-DEPHOS-RXN]|Starting of the reaction: dihydroneopterin monophosphate = a new molecule of water. [MetaCyc:DIHYDRONEOPTERIN-MONO-P-DEPHOS-RXN]|-106.38386363636363|-40.54711538461535|29.464090909090917|20.529615384615386|17.717283333333334|14.080331578947368|12.465454545454541|7.381538461538462|15.089791666666663|10.092631578947369|58.53822981607831|54.195869768830164|27.654545454545453|21.06153846153846
<p>The lingual aspect of the tooth.</p>|The lingual aspect of the tooth.|90.99000000000004|90.99000000000004|1.3133333333333361|1.3133333333333361|15.185500000000001|10.577242857142856|-65.34666666666666|-71.22666666666666|-0.41600000000000037|-1.5128571428571433|31.29|31.29|14.533333333333331|14.533333333333331
An Eastern Polynesian language spoken by the Maori people of New Zealand.|An East Polynesian language spoken by the Maori people of New Zealand.|52.69500000000002|59.745000000000005|7.400000000000002|6.416666666666668|8.1792|8.817361538461538|-18.953333333333326|-19.93333333333333|8.5125|3.1961538461538446|58.53822981607831|54.195869768830164|25.733333333333338|22.400000000000002
Hematology analyzers that require minimal involvement of technicians, with complete automation of sampling and dilution, cell counting, and red blood cell index determination; some include closed-tube sampling to automatically extract the blood sample from the phlebotomy tube. Most of these analyzers are based on fluorescence quantification and cytometry techniques or on electrical impedance (Coulter) techniques. Some automated hematology analyzers perform a three-part white blood cell differential count, while most provide a five-part count, differentiating all five types of normal white blood cells. Automated cell-counting hematology analyzers may include reticulocyte analysis capabilities.|Hematology analyzers that require minimal involvement of technicians, with complete automation of sampling and dilution, cell counting, and red blood cell index determination; some include closed-tube sampling to automatically extract the blood sample from the phlebotomy tube, while others are based on|2.427934065934096|-2.9807142857142708|17.44206593406594|24.10904761904762|12.792605263157895|14.072763636363636|23.216263736263734|29.772380952380953|19.94447368421053|28.080681818181823|95.93332340745836|143.38879349516822|27.93934065934066|36.800000000000004
Death|Sudden death|121.22000000000003|77.90500000000002|-3.3999999999999986|2.890000000000004|0.0496|9.048633333333335|-266.6|-112.72|2.620000000000001|-1.0899999999999999|0.0|31.29|0.4|20.8
Isoenzymes that are generated by different alleles of the same gene.|Enzymes that are generated by different alleles of the same gene.|39.7434090909091|47.434318181818185|9.08227272727273|8.009545454545457|9.923918181818184|10.513266666666667|-22.81454545454546|-23.883636363636366|8.476363636363637|3.157499999999999|44.250742366654144|44.250742366654144|16.745454545454546|16.745454545454546
Used generally to describe the process whereby thoughts, attitudes, emotions, or a coordinated set of activities becomes separated from one's personality or mental processes. Compare DISSOCIATIVE DISORDERS.|Used generally to describe the process whereby thoughts, attitudes, emotions, or a coordinated set of activities becomes separated from one's personality or mental processes.|-2.833333333333286|0.7800000000000296|15.890370370370373|16.131666666666668|11.908692592592592|11.8357|6.311111111111117|12.57333333333333|15.847777777777779|12.703200000000002|74.48509850970193|82.78555852321104|28.785185185185185|28.13333333333334
A hole or opening made through a membrane or other tissue.|A hole or opening made through a membrane or other tissue.|78.19795454545455|78.19795454545455|3.7186363636363637|3.7186363636363637|8.488463636363637|9.197433333333334|-28.160000000000007|-27.625454545454552|4.194545454545455|0.41000000000000014|44.250742366654144|44.250742366654144|16.745454545454546|16.745454545454546
Human CYP21A2 wild-type allele is located in the vicinity of 6p21.3 and is approximately 3 kb in length. This allele, which encodes cytochrome P450 21 protein, plays a role in the 21-hydroxylation of steroids. Gene conversion events involving the CYP21A2 gene and a nearby pseudogene putatively account for many cases of steroid 21-hydroxylase deficiency. CYP21A2 gene dysfunction causes congenital adrenal hyperplasia.|Normal human CYP21A2 gene is located in the vicinity of gene region 6p21.3 and is about 3 kilobases in length. This gene, which encodes cytochrome P450 21 protein, and serves as a precursor for many cases of steroid 21-|57.827308743169425|74.33230769230771|7.719262295081968|6.121025641025643|13.805412500000001|12.918250000000002|5.490491803278687|4.670769230769235|12.3278125|9.64725|66.37611354998121|67.59412548439398|21.771584699453552|19.55897435897436
An expression that conveys significant information about the type of measurement of observation.|An expression that conveys significant information about the type of measurement of observation.|18.022115384615404|18.022115384615404|12.360384615384618|12.360384615384618|12.783607692307694|13.006557142857146|-7.544615384615383|-7.092307692307692|15.141538461538467|10.329999999999998|58.53822981607831|58.53822981607831|24.13846153846154|24.13846153846154
A question about how useful an individual finds or found tables and graphs that accompany a newspaper story or other text.|A question about how useful an individual finds or found tables and graphs that accompany a newspaper story or other text.|51.1489285714286|51.1489285714286|8.733571428571427|8.733571428571427|7.685719047619047|7.770736363636364|0.36952380952380537|0.6495238095238101|11.722857142857144|5.90727272727273|66.37611354998121|66.37611354998121|21.34285714285714|21.34285714285714
Clone positive. Note: A T-cell clone is defined by PCR or Southern blot analysis of the T-cell receptor gene. (from AJCC 7th Ed.)|A T-cell clone is defined by PCR or Southern blot analysis of a gene. (from AJCC 7th Ed.)|86.97266304347826|97.345|2.5568478260869583|1.1722222222222243|12.260633333333335|12.0275|-24.123478260869565|-25.48666666666666|1.3882666666666665|-0.41600000000000037|34.983283507984204|31.29|10.995652173913044|9.066666666666666
The sodium salt form of sanfetrinem, an orally available tricyclic beta-lactam (trinem) antibiotic, with broad-spectrum activity against gram-positive and gram-negative bacteria. Sanfetrinem has high stability to many beta-lactamases.|The sodium salt form of sanfetrinem, an orally available beta-lactam antibiotic, with broad-spectrum activity against gram-positive and Gram-negative bacteria.|-26.22404761904758|-25.439078947368415|19.235714285714284|19.167631578947375|14.02459696969697|14.10045|11.755714285714294|12.787368421052633|14.79454545454545|11.063749999999999|76.64453405168562|76.64453405168562|29.44761904761905|29.063157894736847
Expressing something as negative, undesired or adverse.|Expressing something as negative, unired or bad.|9.91107142857146|34.08250000000001|12.74642857142857|9.375|13.006557142857146|11.7299|-43.41142857142857|-48.451428571428565|13.69428571428572|4.708749999999998|49.473833993334296|44.250742366654144|29.971428571428575|24.257142857142856
Heat shock protein HSP 90-beta (724 aa, ~83 kDa) is encoded by the human HSP90AB1 gene. This protein plays a role in the modulation of both interferon signaling and protein folding.|Human heat shock protein 90-beta (724 amino acids, 83 kilodaltons) is encoded by a human gene HSP90AB1. This protein is involved in the modulation of both interferon signaling and protein folding.|81.727311827957|59.89505376344087|4.427096774193547|7.472258064516129|13.805412500000001|14.230281818181819|-0.0038709677419390687|3.0309677419354806|7.912187500000002|7.049090909090911|54.195869768830164|67.59412548439398|15.746236559139787|22.197849462365593
Death|Sudden death|121.22000000000003|77.90500000000002|-3.3999999999999986|2.890000000000004|0.0496|9.048633333333335|-266.6|-112.72|2.620000000000001|-1.0899999999999999|0.0|31.29|0.4|20.8
An indication that the chief complaint was worsened by another factor other than those listed.|An indication that the chief complaint was worsened by another factor other than those listed.|52.58250000000001|52.58250000000001|7.7883333333333375|7.7883333333333375|8.591166666666666|8.967675|-8.10666666666667|-7.714666666666666|10.875999999999998|6.120000000000001|58.53822981607831|58.53822981607831|21.666666666666668|21.666666666666668
An electrocardiogram (ECG) lead placement that allows monitoring and recording of cardiac electrical activity. A V1-type lead is used whose positive electrode is localized in the 4th intercostal space, 2.5cm from the sternum. Its negative electrode is placed below the left clavicle. An addition of lead V5 and aVF can be made to facilitate interpretation.|An electrocardiogram (ECG) lead placement that allows monitoring and recording of cardiac electrical activity. A V1-type lead is used whose positive electrode is localized in the 4th intercostal space, 2.5cm from the sternum. Its negative equivalent is placed below the left|48.327196969696985|43.73856707317074|8.795909090909092|9.705060975609758|11.545756140350878|11.90010303030303|-0.004363636363635237|4.824390243902435|9.988684210526316|10.416742424242422|57.127462747788826|62.58|18.212121212121215|19.709756097560977
The approximate intake in one day of cider that contains alcohol.|The approximate intake in one day of cider containing alcohol.|55.12522727272727|41.02000000000004|6.936818181818182|8.780000000000001|11.359372727272728|12.522027272727273|-24.41818181818182|-27.447999999999993|7.191818181818181|4.0136363636363654|49.473833993334296|49.473833993334296|20.381818181818183|22.0
A measurement of the carbon monoxide in a biological specimen.|A measurement of the carbon monoxide in a biological specimen.|24.100000000000023|24.100000000000023|11.14|11.14|12.0275|12.522027272727273|-28.035999999999998|-27.447999999999993|8.062000000000001|4.0136363636363654|49.473833993334296|49.473833993334296|22.0|22.0
A malignant plasma cell tumor growing within soft tissue or within the skeleton. [HPO:sdoelken]|A cancerous plasma cell tumor growing within soft tissue or within the skeleton. [HPO:sdoelken]|42.61571428571432|42.61571428571432|9.054285714285715|9.054285714285715|13.4825|13.902050000000001|-7.845714285714287|-7.425714285714285|6.812000000000001|5.825624999999999|66.37611354998121|66.37611354998121|28.51428571428572|28.51428571428572
A chronic respiratory disease caused by obstruction of the bronchi and small airways, and characterized by wheezing and shortness of breath.|A chronic lung disease caused by blockage of the bronchi and small airways, and characterized by wheezing and breathlessness.|47.12035714285716|59.16092105263158|9.29547619047619|7.367631578947371|11.445242857142857|12.0275|5.409523809523812|2.2652631578947364|15.535714285714285|8.532999999999998|66.37611354998121|62.58|21.34285714285714|20.642105263157895
An abnormality of the pupil. [HPO:probinson]|An abnormality of the pupil. [HPO:probinson]|6.390000000000015|6.390000000000015|13.113333333333333|13.113333333333333|10.577242857142856|11.7299|-60.44666666666666|-59.466666666666654|3.870000000000001|1.7650000000000006|38.32226702584281|38.32226702584281|21.200000000000003|21.200000000000003
A human monoclonal antibody directed against the human epidermal growth factor receptor HER3 (ErbB3) with potential antineoplastic activity. Anti-HER3 monoclonal antibody LJM716 possesses a novel mechanism of action; LJM716 binds to and locks HER3 in the inactive conformation and does not interfere with its interaction with neuregulin (NRG). The inactivated form of HER3 blocks the PI3K/Akt signaling pathway, thereby inhibiting cellular proliferation in HER2 or NRG expressing tumor cells. HER3, a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases, is frequently overexpressed in tumors; it has no active kinase domain but is activated through heterodimerization with other members of the EGFR receptor family, such as HER2. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C101895" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C101895" NCI Thesaurus)|A human monoclonal antibody directed against the human epidermal growth factor receptor HER3 (ErbB3) with potential anti-cancer activity. The antibody targets a human skin cell growth protein, which is frequently overexpressed in tumors; it has no active kinase|39.61173780487806|18.350000000000023|10.280670731707318|15.420000000000002|13.764873333333334|14.49725|13.811707317073171|19.23684210526316|21.692906666666666|14.35725|67.59412548439398|101.39118822659097|22.31138211382114|29.70526315789474
Tooth not emerged.|Toothnot emerged.|64.3125|-5.679999999999978|4.661666666666669|14.3|9.048633333333335|19.5009|-165.9733333333333|-246.02|3.620000000000001|4.439999999999998|22.125371183327072|31.29|13.933333333333332|40.400000000000006
Catalysis of the reaction: N-formimidoyl-L-aspartate + H2O = N-formyl-L-aspartate + NH3. [EC:3.5.3.5, MetaCyc:FORMIMINOASPARTATE-DEIMINASE-RXN]|Increasing the rate of the reaction: N-formimidoyl-aspartate + water = a new molecule of fat and protein that is soluble in fat.|-23.573230769230776|57.23363636363638|17.193230769230777|8.009090909090911|18.35477878787879|11.2041|-54.593846153846144|1.9563636363636334|7.285303030303034|4.413600000000002|31.29|58.53822981607831|16.42461538461539|17.127272727272725
Any process that modulates the frequency, rate or extent of glucosylceramidase activity. [GO_REF:0000059, GOC:bf, GOC:PARL, GOC:TermGenie, PMID:24334770]|Any process that modulates the frequency, rate or extent of a sugar molecule. [GO_REF:0000059, GroupGenie, PMID:24334770]|24.031029411764735|61.24000000000001|12.019117647058824|6.705000000000002|15.185500000000001|12.417511764705882|12.56235294117647|2.322499999999998|13.243000000000002|10.80294117647059|66.37611354998121|62.58|24.576470588235296|23.200000000000003
Human FALEC wild-type allele is located in the vicinity of 1q21.3 and is approximately 2 kb in length. This allele, which encodes focally amplified long non-coding RNA in epithelial cancer, may play a role in tumorigenesis.|Normal human FALEC gene is located in the vicinity of 1q21.3 and is about 2 kilobases in length. This gene, which encodes focally amplified long non-coding RNA in cancer, may play a role in tumorigenesis.|47.30000000000004|55.34232142857144|8.89777777777778|7.713928571428575|13.304952631578947|12.783368468468469|-2.1822222222222187|-5.100571428571417|10.62842105263158|5.86801801801802|60.592824451415034|56.4088497046341|20.26666666666667|18.357142857142858
<p>Insertion, cervical (uterine)</p>|Insertion, cervical (uterine)|-78.20999999999998|-50.00999999999996|24.913333333333338|20.980000000000008|19.773699999999998|19.6249|-32.02666666666666|-43.78666666666665|3.6014285714285705|10.0075|54.195869768830164|54.195869768830164|41.2|41.2
A type of Congenital cataract in which the opacities occupy the subcapsular cortex at the anterior or posterior pole of the lens. [HPO:probinson]|A type of Congenital cataract in which the opacities occupy the outer lining of the lens. [HPO:probinson]|33.31902173913048|38.960441176470624|11.468913043478263|9.936764705882357|12.1267|13.24927894736842|5.706086956521737|-3.6941176470588246|7.923749999999998|4.638947368421054|66.37611354998121|58.53822981607831|20.252173913043478|19.870588235294118
The process in which tRNA genes, which are not linearly connected on the chromosome, are transported in three dimensions to, and maintained together in, the nucleolus. This clustered positioning leads to transcriptional silencing of nearby RNA polymerase II promoters (termed tRNA gene mediated (tgm) silencing) in S. cerevisiae. [GOC:jh, GOC:mah, PMID:18708579]|The process in which tRNA genes, which are not linearly connected on the chromosome, are transported in three dimensions to, and maintained together in, the nucleolus. This clustered positioning leads to the silencing of nearby genes. [GOC:jh, G|42.94080882352944|53.72043859649125|10.437401960784317|8.913157894736845|12.854653459119497|11.008583333333334|12.756078431372547|8.971578947368418|13.708238993710694|8.786666666666669|71.69439674758411|65.13532912329528|21.570588235294117|18.750877192982454
The sodium salt of a semisynthetic heparin-like glucosaminoglycan. Although its mechanism of action is unknown, pentosan polysulfate may act as a buffer to control cell permeability by preventing irritating solutes from reaching cells coated with it. Administered orally, excreted pentosan polysulfate adheres to the urinary bladder wall, preventing irritants from entering bladder cells and the development or progression of interstitial cystitis (IC), a complication of some chemotherapies. This agent also exhibits anticoagulant and fibrinolytic properties. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C946" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C946" NCI Thesaurus)|The sodium salt of a molecule that blocks cell permeability by preventing irritating solutes from reaching cells coated with it. Administered orally, this agent also exhibits anticoagulant and fibrinolytic properties. ("http://www.cancer.gov/about-can|16.66245689655176|1.3226451612903247|12.736350574712645|14.61509677419355|12.617830303030303|11.567129166666668|7.564137931034487|-5.6335483870967735|23.262196969696973|15.843020833333334|61.26237874911485|57.69590921373889|24.049425287356325|24.415483870967744
CD99 antigen (185 aa, ~19 kDa) is encoded by the human CD99 gene. This protein plays a role in cell adhesion.|CD99 antigen (185 amino acids, 19 kilodaltons) is encoded by a human gene whose product is involved in cell adhesion.|99.01571428571431|61.32500000000002|1.187619047619048|7.190000000000001|13.932061904761905|14.683966666666668|-17.365714285714283|-0.4939999999999998|2.66|5.127142857142857|40.39521630094336|66.37611354998121|12.323809523809523|22.0
Fibroma that occurs in a rabbit.|Fibroma that occurs in a rabbit.|62.79000000000002|62.79000000000002|5.246666666666666|5.246666666666666|9.197433333333334|10.577242857142856|-72.20666666666665|-71.22666666666666|1.9800000000000004|-1.5128571428571433|38.32226702584281|38.32226702584281|21.200000000000003|21.200000000000003
Identically shaped visual field defect in the same location in both eyes.|Identical shaped visual field defect in the same location in both eyes.|45.64500000000001|52.69500000000002|8.383333333333333|7.400000000000002|9.495033333333335|10.031976923076924|-18.953333333333326|-19.443333333333328|8.5125|3.558461538461536|49.473833993334296|49.473833993334296|19.06666666666667|19.06666666666667
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving isoprenoid. [GOC:go_curators]|Any process that stops, prevents, or reduces the frequency, rate or extent of chemical reactions and pathways involving isoprenoid. [GOC:go_curators]|26.97750000000002|23.255000000000024|12.105|12.499999999999996|12.794827272727273|13.512554545454547|9.049523809523805|8.913999999999998|11.045454545454547|10.617272727272727|76.64453405168562|76.64453405168562|27.057142857142857|28.0
A disorder of large arteries, in particular the aorta, characterized by an accumulation of basophilic ground substance in the media with cyst-like lesions associated with degenerative changes of collagen, elastin and the vascular smooth muscle cells. [HPO:probinson]|A disorder of large blood vessels, in particular the aorta, characterized by an accumulation of basophilic ground substance in the media with cyst-like lesions associated with degenerative changes of collagen and elastin and the smooth muscle cells.|7.425067567567595|21.14398648648651|16.819594594594594|14.906081081081084|12.296264102564102|11.081648717948719|20.551351351351343|18.008648648648645|15.130769230769232|13.681538461538459|96.44225707644962|91.22524239485473|27.940540540540542|25.77837837837838
The process by which a person is tested and approved to practice in the specialty field of clinical genetics.|The process by which a person is tested and approved to practice in the specialty field of genetics.|63.613552631578955|70.80000000000003|6.746578947368423|5.6200000000000045|9.565215789473683|9.094015789473683|-2.9957894736842086|-5.448888888888881|10.38052631578947|3.8952631578947354|62.58|58.53822981607831|20.642105263157895|19.15555555555556
A plant genus of the family ERICACEAE.|A plant genus of the family ERICACEAE.|58.25392857142859|58.25392857142859|6.003571428571426|6.003571428571426|8.495128571428573|9.756150000000002|-57.691428571428574|-56.85142857142857|2.9285714285714306|-0.5899999999999999|38.32226702584281|38.32226702584281|18.54285714285714|18.54285714285714
Lower intake of iodine compared to established reference standards or recommendations based on physiological needs(Source: International Dietetics and Nutrition Terminology (IDNT) Reference Manual, edition 4; ISBN #978-0-88091-467-3)|Lower intake of iodine compared to established reference standards or recommendations based on physiological needs(Source: International Dietetics and Nutrition Terminology) Reference Manual, edition 4; ISBN #978-0-88091-467-3)|-11.70333333333329|-14.785769230769176|21.59925925925926|21.780769230769227|16.88926129032258|16.88926129032258|34.117037037037036|34.52461538461538|23.84935483870968|23.39354838709678|129.0119750255766|129.0119750255766|35.98518518518519|36.55384615384616
Liquid preparation consisting of a solution intended for spot-on use for the prevention and treatment of ectoparasitic and/or endoparasitic infestations of animals. Spot-on-solutions are applied in volumes that are usually less than 10 mL.|Liquid preparation consisting of a solution intended for spot-on use for the prevention and treatment of parasitic and/or endoparasitis in volumes that are usually less than 10 mL.|18.666960784313744|32.48928571428573|13.47117647058824|12.205714285714286|11.38220810810811|12.493166666666667|9.508235294117647|11.197142857142854|13.53405405405406|17.591|72.26115969177356|76.64453405168562|23.35686274509804|22.742857142857144
Venoms from snakes of the subfamily Crotalinae or pit vipers, found mostly in the Americas. They include the rattlesnake, cottonmouth, fer-de-lance, bushmaster, and American copperhead. Their venoms contain nontoxic proteins, cardio-, hemo-, cyto-, and neurotoxins, and many enzymes, especially phospholipases A. Many of the toxins have been characterized.|Venoms from snakes of the subfamily Crotalinae or pit vipers, found mostly in the Americas. They include the rattlesnake, cottonmouth, fer-de-lance, bushmaster, and American copperhead. Their proteins, cardio-, hemo-|19.07850000000002|27.823333333333352|12.983166666666666|11.780000000000001|13.305566666666667|13.047441666666668|7.0191666666666634|7.700689655172411|14.503933333333336|10.102708333333332|75.35629887408219|74.48509850970193|28.006666666666668|27.314942528735628
<p>Relates a place entity (player) as the region over which the scoper (typically an Organization) has certain authority (jurisdiction). For example, the Calgary Regional Health Authority (scoper) has authority over the territory "Region 4 of Alberta" (player) in matters of health.</p>|A place entity (player) as the region over which the scoper (typically an Organization) has certain authority (jurisdiction). For example, the Calgary Regional Health Authority has authority over the territory "Region 4 of Alberta" (play) in matters of health.|21.69991869918701|26.609230769230777|13.627804878048781|12.7774358974359|12.822944444444445|11.008583333333334|13.621463414634146|10.852307692307694|14.102666666666671|9.964166666666667|86.63808689023553|80.79043260188672|27.90569105691057|25.71282051282051
Teaching a client a specific, in-residence, meditation technique to gain deep relaxation and eliminate his or her stress. Service is billed per course.|Teaching client a specific, in-residence, meditation technique to gain deep relaxation and eliminate his or her stress. Service is billed per course.|44.56637681159424|41.72803030303032|8.947826086956521|9.260909090909092|10.15295|11.270383333333335|-5.62956521739131|-5.885454545454543|8.905000000000001|6.905000000000001|57.127462747788826|57.127462747788826|20.457971014492756|21.115151515151517
Pathological processes of the URINARY BLADDER.|Pathology processes of the URINARY BLADDER.|-21.809999999999945|-7.7099999999999795|17.04666666666667|15.080000000000002|14.460766666666668|15.08867142857143|-58.48666666666666|-60.44666666666666|12.970000000000006|5.8885714285714315|44.250742366654144|44.250742366654144|27.866666666666664|27.866666666666664
The cellular synthesis of RNA on a template of DNA. [GOC:jl, GOC:txnOH]|The cell synthesis of RNA on a template of DNA. [GOC:jl, GOC:txnOH]|73.84500000000001|87.94500000000002|4.450000000000003|2.4833333333333343|14.134414285714287|13.4825|-19.93333333333333|-21.40333333333333|0.23714285714285666|-1.6660000000000004|44.250742366654144|38.32226702584281|15.733333333333333|12.4
A non-invasive serous neoplasm that arises from the ovary and shows greater cellular proliferation and cytologic atypia as compared to benign ovarian serous tumors, but less as compared to low-grade ovarian serous carcinoma.|A non-invasive serous tumor that arises from the ovary and shows greater cellular proliferation and cytologic atypia as compared to benign tumors of the vaginal mucusosal tissue type, but less as opposed to low-grade ovaries.|15.760227272727292|22.289642857142866|15.160151515151515|14.497857142857146|12.590785714285715|12.058373684210528|16.271515151515153|15.34171428571429|21.36942857142857|11.372105263157898|98.94766798666859|96.44225707644962|30.842424242424244|28.71428571428571
The reemergence of medulloblastoma after a period of remission.|The reemergence of medulloblastoma after a period of seizure disorder.|4.867500000000007|7.180000000000035|13.698333333333334|13.5|11.100677777777777|12.522027272727273|-29.84444444444444|-22.743999999999993|11.329999999999998|7.439090909090911|49.473833993334296|54.195869768830164|24.022222222222226|26.0
A position, site, or point on the body where electrocardiogram leads are attached.|A position, site, or point on the body where ECG leads are attached.|57.06826923076926|89.6067307692308|6.91423076923077|2.375769230769233|9.139761538461538|9.622985714285715|-13.876923076923077|-19.75692307692308|9.344615384615388|0.23714285714285666|44.250742366654144|38.32226702584281|14.90769230769231|11.830769230769231
Catalysis of the reaction: acetyl-CoA + formate = CoA + pyruvate. [EC:2.3.1.54]|Starting of the reaction: acetate molecule + formate = CoA + pyruvate. [EC:2.3.1.54]|70.44900000000001|87.05753846153847|4.029333333333334|1.7624615384615403|17.12622923076923|16.216528571428572|-90.01333333333335|-80.8276923076923|2.695384615384615|3.533571428571431|31.29|31.29|17.62666666666667|16.42461538461539
An oral formulation containing a small-molecule receptor tyrosine kinase inhibitor of both vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) with potential antineoplastic activity. TAK-593 selectively binds to and inhibits VEGFR and PDGFR, which may result in the inhibition of angiogenesis and tumor cell proliferation.|An oral formulation containing a small-molecule receptor tyrosine kinase inhibitor of both angiogenesis and tumor cell proliferation.|2.0648299319728096|-15.780735294117619|17.028979591836734|17.572058823529414|15.11835882352941|14.080331578947368|20.997551020408164|5.990588235294119|20.59588235294118|12.07578947368421|90.32644961471695|73.38155456243756|26.94149659863946|29.28235294117647
The determination of the amount of neurotensin present in a sample.|The determination of the amount of renin present in a sample.|39.7434090909091|55.12522727272727|9.08227272727273|6.936818181818182|8.488463636363637|9.197433333333334|-23.349090909090915|-26.021818181818183|8.048181818181817|1.5874999999999986|49.473833993334296|49.473833993334296|20.381818181818183|20.381818181818183
A pericentric chromosomal inversion that involves chromosome 16. It is associated with CBFA2T3/GLIS2 fusions and pediatric acute megakaryoblastic leukemia.|A pericentric DNA inversion that involves chromosome 16 It is associated with CBFA2T3/GLIS2 fusions and pediatric acute megakaryoblastic leukemia.|8.943508771929856|19.087236842105284|13.585263157894737|12.957105263157896|15.185500000000001|15.262271428571431|-4.338947368421053|8.764210526315786|15.127000000000002|10.554285714285715|59.91578840339164|69.96656701596841|25.69122807017544|24.852631578947367
The material exuded from a wound, either surgical or traumatic.|The material exuded from a wound, either surgical or trauma.|32.56000000000003|41.02000000000004|9.96|8.780000000000001|10.448500000000001|11.086572727272728|-27.447999999999993|-28.624|8.062000000000001|2.7290909090909103|49.473833993334296|49.473833993334296|22.0|22.0
Increased level of IgE antibody against animal proteins, such as albumins that are present in animal hair, dander, shed skin, saliva and urine. [PMID:8543754]|Increased level of IgE antibody against animal proteins, such as proteins that are present in animal hair, dander, shed skin, saliva and urine. [PMID:8543754]|50.130000000000024|53.655|9.248333333333335|8.756666666666668|10.15295|10.572500000000002|8.408333333333331|8.653333333333336|9.689999999999998|9.1236|76.64453405168562|76.64453405168562|24.8|24.8
Protein factors that inhibit the dissociation of GDP from GTP-BINDING PROTEINS.|Protein factors that inhibit the separation of GDP from GTP-BINDING PROTEINS.|47.434318181818185|47.434318181818185|8.009545454545457|8.009545454545457|14.758366666666669|14.890438461538462|-16.934545454545457|-17.46909090909091|10.8675|5.7323076923076925|54.195869768830164|54.195869768830164|24.018181818181816|24.018181818181816
Receptors that bind and internalize GRANULOCYTE COLONY-STIMULATING FACTOR. Their MW is believed to be 150 kD. These receptors are found mainly on a subset of myelomonocytic cells.|Receptors that bind and internalize GOC protein. Their MW is believed to be 150 kilodaltons. These receptors are found mainly on a subset of myelomonocytic cells.|40.18375000000003|57.06826923076926|9.331388888888892|6.91423076923077|11.66197142857143|10.989077777777778|-10.531851851851847|-14.329230769230772|10.802142857142854|5.495000000000001|49.473833993334296|46.934999999999995|17.514814814814816|16.446153846153845
An abscess located in the abdominal cavity, i.e., the cavity between the diaphragm above and the pelvis below. (From Dorland, 27th ed)|An abscess located in the abdominal cavity, i.e., the cavity between the diaphragm above and below. (From Dorland, 27th ed)|58.970681818181816|57.940000000000026|6.400454545454547|6.420000000000002|12.0771|12.428252380952381|-23.616363636363634|-28.33|6.977727272727272|6.024285714285714|51.88859484511023|49.473833993334296|22.200000000000003|22.0
An argon gas analyzer is a device intended to measure the concentration of argon in a gas mixture to aid in determining the patient's ventilatory status. The device may use techniques such as mass spectrometry or thermal conductivity.|An argon gas analyzer is a device intended to measure the concentration of atomic atoms to aid in determining the patient's ventilatory status. The device may use techniques such as mass spectrometry or thermal conductivity.|35.909912280701775|28.210476190476186|11.397368421052636|12.222857142857148|11.22732105263158|11.688088888888888|7.114736842105263|6.716571428571427|12.239736842105266|9.2975|74.48509850970193|74.48509850970193|22.96140350877193|24.095238095238095
Homogenous consistency which does not hold its shape after serving. Smooth and moist, but does not hold its shape on a plate or when scooped. Can be poured. Runny. No chewing required. No lumps. Spreads out if spilled.|Homogenous consistency which does not hold its shape after serving. Smooth and moist, but doesn't hold their shape on a plate or when scooped. Can be poured. Runny. No chewing required. Spread out if dropped.|86.24532894736844|85.73714285714289|2.409868421052632|2.5428571428571445|6.814441353383459|7.400474603174603|-34.30842105263157|-29.799999999999997|2.7271804511278184|3.1214285714285737|34.983283507984204|35.47952508137615|12.426315789473684|12.285714285714285
A syndrome of ichthyosis, spastic paralysis, and mental deficiency and other disorders with variable degree of severity.|A syndrome of ichthyosis, spasm, and mental deficit/other disorders with variable degree of severity.|9.101617647058845|12.401428571428596|14.101470588235298|13.26857142857143|13.767935294117647|13.902050000000001|1.1482352941176472|-4.905714285714289|15.05294117647059|7.591875000000002|73.38155456243756|62.58|29.28235294117647|25.65714285714286
Tissue component of lamellar bone, each instance of which is made up of some thin intersecting lamellae, usually internal to some compact bone.|Tissue component of a bone, each instance of which is made up of some thin intersecting lamellae, usually internal to some compact bone.|55.38858695652178|62.74510869565219|8.390652173913043|7.364565217391306|10.955995652173913|10.15295|5.194782608695654|3.6608695652173893|14.234347826086953|6.550000000000001|66.37611354998121|62.58|20.252173913043478|18.51304347826087
A new infection by the hepatitis E virus, which is usually spread by the fecal-oral route. Signs and symptoms may include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, jaundice, dark urine, clay-colored stools and joint pain. There is no specific anti-viral treatment, the infection resolves on its own.|A new infection by a virus called hepatitis E virus, which is usually spread by the fecal-oral route. Signs and symptoms may include fever, fatigue, loss of appetite, nausea, vomiting, body pain, and joint pain. There is no specific anti-viral|45.25150000000002|51.59666666666669|10.053|9.375|11.365030817610062|11.324410077519381|8.7776|7.935000000000002|10.508993710691826|6.986434108527135|71.69439674758411|72.26115969177356|21.8|21.333333333333336
International units per milliliter (concentration), divided by meters squared (surface area).|International units per milliliter (concentration) divided by meters squared (surface area).|-21.783863636363606|-21.783863636363606|17.664090909090913|17.664090909090913|15.665736363636366|15.7766|-9.450909090909093|-9.450909090909093|17.04|12.184999999999995|66.37611354998121|66.37611354998121|34.92727272727273|34.92727272727273
Gallbladder cancer with distant metastasis. (from AJCC 8th Ed.)|gallbladder cancer with distant metastasis. (from AJCC 8th Ed.)|62.79000000000002|62.79000000000002|5.246666666666666|5.246666666666666|16.140811111111113|16.5165|-62.73333333333333|-62.07999999999999|7.510000000000002|5.562000000000001|36.13057984588678|36.13057984588678|18.977777777777778|18.977777777777778
A condition in which a person has reduced protein production from two of the four alpha-globin alleles.|A condition in which a person has reduced protein production from two of the four beta-globin genes.|53.889852941176486|63.84279411764709|7.854411764705883|6.466176470588238|10.669855555555555|10.75612105263158|-4.731764705882352|-5.423529411764704|9.811666666666667|3.8952631578947354|58.53822981607831|54.195869768830164|19.870588235294118|17.51764705882353
A measure of the quality of health care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series.|A measure of the quality of care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series.|34.20153846153849|31.71550000000002|11.71846153846154|11.940999999999999|10.999176923076924|10.961684615384616|8.666153846153843|7.8368|16.388076923076923|8.982307692307693|76.64453405168562|76.64453405168562|23.661538461538463|24.200000000000003
Human EGR2 wild-type allele is located in the vicinity of 10q21.1 and is approximately 108 kb in length. This allele, which encodes E3 SUMO-protein ligase EGR2 protein, is involved in the regulation of both gene transcription and protein modification. Mutation of the gene is associated with Charcot-Marie-Tooth disease type 1D (CMT1D), Charcot-Marie-Tooth disease type 4E (CMT4E), and with Dejerine-Sottas syndrome (DSS).|Normal human EGR2 gene is located in the vicinity of chromosome location, 10q21.1, and is approximately 108 kilobases in length. This gene, which encodes SUMO-protein ligase protein, is regulated by both gene transcription and protein modification|51.60281967213115|37.20500000000001|9.092590163934428|11.051111111111112|14.745619607843139|14.551531578947367|10.632131147540989|10.123333333333335|13.591862745098041|13.727105263157895|68.55295529734659|72.26115969177356|20.617704918032786|22.57777777777778
Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not being able to pay attention.|Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month. Being able to pay attention.|67.03295454545456|71.75208333333336|8.008636363636366|5.901250000000001|7.6908875|7.126191666666667|10.74787878787879|1.4662500000000023|17.53125|6.570208333333333|73.38155456243756|59.91578840339164|19.933333333333334|18.016666666666666
A group of genetic disorders in which there is an abnormal increase in the size of the body or a body part that is often noted at birth. Examples of overgrowth syndromes include neurofibromatosis, Sotos syndrome, Beckwith-Wiedemann syndrome, Simpson-Golabi-Behmel syndrome, Weaver syndrome, Proteus syndrome, Sturge-Weber syndrome, and fragile X syndrome. Many of these syndromes increase the risk of cancer.|A group of genetic disorders in which there is an abnormal increase in the size of the body or part that is often noted at birth. Examples of overgrowth syndromes include neurofibromatosis, Sotos syndrome, Beckwith-Wiedemann Syndrome, Simpson-Golabi-Beh|31.267139830508484|23.43047297297298|12.562500000000004|14.587162162162166|12.69841746031746|11.58549512195122|14.8135593220339|18.64432432432433|14.189999999999998|13.059268292682923|87.10767345647568|91.22524239485473|26.916949152542372|25.77837837837838
The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte.|The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4 cell.|48.244637681159446|50.66500000000002|8.434782608695652|8.180000000000003|12.1267|11.629033333333332|-7.419130434782613|-8.580000000000005|7.923749999999998|4.214266666666667|51.09635603445709|51.09635603445709|16.979710144927534|16.53333333333333
Any process that stops, prevents or reduces the frequency, rate or extent of anterograde synaptic vesicle transport. [GO_REF:0000058, GOC:kmv, GOC:TermGenie, pmid:25329901]|Any process that stops, prevents or reduces the frequency, rate or extent of vesicle transport. [GO_REF:0000058, GOC:kmv, GroupGenie, pmid:25329901]|47.12035714285716|68.0661842105263|9.29547619047619|6.125526315789475|14.504726086956522|13.932061904761905|14.369523809523805|9.38315789473684|13.399130434782613|11.182857142857138|73.38155456243756|66.37611354998121|25.152380952380955|22.74736842105263
A question associated with the PGI Generic Modification Version questionnaire.|A question associated with the PGI Generic Modification Version questionnaire.|7.180000000000035|7.180000000000035|13.5|13.5|13.6065|13.957481818181819|-18.627999999999993|-18.04|15.597999999999999|10.864545454545457|54.195869768830164|54.195869768830164|26.0|26.0
A cluster of specialized cells located in the upper area of the right atrium. These cells generate the electrical impulses that result in the normal sinus rhythm.|A cluster of special cells located in the upper area of the right atrium. These cells generate the electrical impulses that result in a normal sinus rhythm.|50.433333333333366|56.70000000000002|8.460740740740743|7.58666666666667|11.323877777777778|11.430504761904762|-3.271111111111111|-4.359999999999999|8.695555555555554|4.936309523809523|62.58|62.58|21.37777777777778|21.37777777777778
Terminology associated with the tuberculosis findings about test code codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).|Terminology associated with the tuberculosis findings about test code codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).|3.8929347826087337|3.8929347826087337|15.573260869565217|15.573260869565217|15.761647826086957|15.416283333333334|13.631304347826088|13.88695652173913|20.582608695652176|14.0075|85.69119412168324|85.69119412168324|30.686956521739134|30.686956521739134
Catalysis of the reaction: 8-oxo-7,8-dihydrodeoxyguanosine-triphosphate + H2O = 8-oxo-7,8-dihydrodeoxyguanosine phosphate + diphosphate. 8-oxo-7,8-dihydrodeoxyguanosine-triphosphate, or 8-oxo-dGTP, is the oxidised form of the free guanine nucleotide and can act as a potent mutagenic substrate for DNA synthesis causing transversion mutations. 8-oxo-dGTPase hydrolyses 8-oxo-dGTP to its monophosphate form to prevent the misincorporation of 8-oxo-dGTP into cellular DNA. [PMID:17804481, PMID:7782328, PMID:7859359]|A process that increases the rate of the reaction: 8-oxo-7,8-dihydrodeoxyguanosine molecule is the oxidised form of guanine nucleotide and can act as a potent mutagenic substrate for DNA|67.6975657894737|42.4507142857143|7.356973684210526|14.294285714285717|15.356768493150687|12.814422580645163|26.47438596491228|23.028571428571432|15.567876712328761|17.923870967741934|69.96656701596841|98.94766798666859|19.735087719298246|25.485714285714288
A monoclonal antibody directed against human hepatocyte growth factor receptor (HGFR or c-Met), with potential antineoplastic activity. Telisotuzumab binds to c-Met, thereby preventing both c-Met binding to its ligand, HGF and the subsequent activation of the HGF/c-Met signaling pathway. This may cause cell death in c-Met-expressing tumor cells. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays a key role in cancer cell growth, survival, angiogenesis, invasion, and metastasis.|A monoclonal antibody directed against human hepatocyte growth factor receptor, with potential anti-cancer activity. Telisotuzumab binds to c-Met, a protein molecule that is overexpressed or mutated in many tumor types, plays|24.899486486486524|-2.6587903225806144|13.463081081081082|17.48080645161291|12.933421951219513|13.767935294117647|15.677297297297294|18.08|13.289024390243902|13.390588235294118|81.59433730351635|93.86999999999999|24.29837837837838|29.425806451612903
An indication that an individual lives with their sibling.|An indication that an individual lives with a sibling.|42.46750000000003|42.46750000000003|8.45388888888889|8.45388888888889|9.346233333333334|10.200500000000002|-33.11111111111111|-35.07111111111111|8.713333333333335|2.735999999999997|38.32226702584281|38.32226702584281|15.133333333333333|15.133333333333333
An adenocarcinoma cell line established from a 72 year old female patient with breast carcinoma.|An cancer cell line established from a 72 year old female patient with breast cancer.|46.942499999999995|86.42250000000001|8.575000000000003|3.068333333333335|10.6965|10.941425|-7.32266666666667|-11.242666666666668|11.503999999999998|3.470625000000002|49.473833993334296|49.473833993334296|16.333333333333332|16.333333333333332
The covalent alteration of one or more amino acid residues within the CAAX box region of CAAX box proteins. [GOC:mah]|The covalent alteration of one or more protein building blocks within the CAAX box region of proteins. [GOC:mah]|52.86500000000001|61.400000000000034|8.370000000000001|6.9311111111111146|13.180157142857144|12.0275|-0.7880000000000003|-1.5288888888888863|4.902857142857144|5.235999999999997|66.37611354998121|62.58|22.0|21.37777777777778
Functional Assessment of Multiple Sclerosis - Mobility: I have to limit my social activity because of my condition.|Muscular Dys - Mobility: I have to limit my social activity because of my condition.|28.50000000000003|46.942499999999995|11.520000000000003|8.575000000000003|12.839111764705882|12.429833333333335|-0.8755555555555503|-11.634666666666668|13.390588235294118|3.6720000000000006|69.96656701596841|58.53822981607831|25.822222222222223|21.666666666666668
Human ZRSR2 wild-type allele is located in the vicinity of Xp22.1 and is approximately 33 kb in length. This allele, which encodes U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2, plays a role in the regulation of RNA splicing.|Normal human ZRSR2 gene is located in the vicinity of Xp22.1 and is about 33 kilobases in length. This gene, which encodes a protein complex, U2 small nuclear ribonucleoprotein auxiliary factor 35 kilodaltons|53.163214285714304|49.54272727272729|8.452619047619049|9.081818181818182|14.417018181818184|14.23234705882353|3.029523809523809|4.629090909090905|12.798863636363635|11.174117647058821|62.58|67.59412548439398|19.43809523809524|21.36969696969697
cooperation among hospitals or other medical practices for the purpose of sharing various departmental services, e.g., pharmacy, laundry, data processing, etc.|cooperation among hospitals or other medical practices for the purpose of sharing various departmental services, e.g., pharmacy, laundry, data processing, etc.|12.163392857142895|12.163392857142895|12.867023809523811|12.867023809523811|12.949052380952383|13.340427272727274|-17.460952380952385|-17.180952380952377|18.9|18.258181818181818|60.592824451415034|60.592824451415034|30.671428571428574|30.671428571428574
A head and neck squamous cell carcinoma which has spread from the original site of growth to another anatomic site.|A head and neck cancer which has spread from the original site of growth to another body site.|61.32500000000002|80.20000000000003|7.190000000000001|4.308888888888891|10.155000000000001|9.094015789473683|-1.3759999999999977|-7.408888888888889|10.942500000000003|2.4078947368421026|49.473833993334296|44.250742366654144|14.0|12.488888888888889
Terminology associated with the genus and species response codelist of the Clinical Data Interchange Standards Consortium (CDISC) Standard for the Exchange of Non-clinical Data (SEND).|Terminology associated with the genus and species response codelist of the Clinical Data Interchange Standards Consortium (CDISC) Standard for the Exchange of Non-clinical Data.|21.563500000000005|18.405|13.357000000000003|13.673333333333336|14.643023076923077|14.60553076923077|13.951999999999998|13.30833333333333|19.46769230769231|12.424230769230768|85.69119412168324|85.69119412168324|29.0|29.8
An increased susceptibility to viral upper respiratory tract infections as manifested by a history of recurrent viral upper respiratory tract infections (otitis, sinusitis, pharyngitis, tonsillitis). [PMID:30422556]|An increased susceptibility to viral upper respiratory tract infections as manifested by a history of recurrent viral infection causing lung disease. [PMID:30422556]|-17.859999999999985|14.933636363636396|18.98|13.90909090909091|14.60553076923077|13.818204347826088|20.199999999999992|11.84545454545454|18.04|13.399130434782613|91.22524239485473|79.77416029015912|31.353846153846156|28.03636363636364
Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)|Oral intervention indicated (e.g., antibiotic, antifungal, or viral)|-49.67166666666665|-28.521666666666647|20.850000000000005|17.900000000000002|17.84955|18.118455555555556|-63.22499999999999|-65.42999999999998|17.895000000000003|12.899999999999999|44.250742366654144|44.250742366654144|31.06666666666667|31.06666666666667
Being unable to focus one's attention or mental effort on a particular object or activity. []|Being unable to focus one's attention or mental effort on a certain object or activity. []|34.80250000000001|45.377500000000026|10.392500000000002|8.917500000000004|11.377166666666668|10.941425|-8.334999999999997|-9.07|5.870000000000001|4.059374999999999|69.96656701596841|69.96656701596841|28.200000000000003|28.200000000000003
Molecular assay reagents intended to identify mutations in the filaggrin (FLG) gene, located at chromosome 1q21.3, which encodes the protein filaggrin. Genetic variants at this locus have been associated with atopic dermatitis and ichthyosis vulgaris.|Molecular assay reagents intended to identify mutations in a gene, located at chromosome location, 1q21.3, which encodes the protein complex. Genetic variants at this locus have been associated with dermatitis and ichthyosis.|21.502321428571435|26.871250000000003|12.433928571428577|11.498750000000001|14.429642857142857|13.75179696969697|2.627428571428581|-1.1687500000000028|15.714571428571425|11.188181818181818|69.96656701596841|66.37611354998121|26.357142857142858|25.700000000000003
A regimen based on the principles of a leukemia-type regimen that is used for the treatment of disseminated childhood anaplastic large cell lymphoma (ALCL). The treatment plan consists of an induction phase, a consolidation phase and a final maintenance phase; the duration of the entire regimen is 24 months, regardless of the initial stage.|A regimen based on the principles of a leukemia-type regimen that is used for the treatment of disseminated childhood cancer|42.86500000000001|34.255000000000024|11.752222222222223|13.450000000000003|12.177772727272727|11.187245454545454|15.024444444444448|16.363999999999997|16.383818181818178|12.049545454545452|80.79043260188672|88.50148473330829|22.014814814814816|24.0
A drug used to treat urinary problems caused by an enlarged prostate. It is also used to treat high blood pressure and is being studied in the treatment of other conditions. Terazosin hydrochloride relaxes muscle tissue in blood vessels and in the prostate. It is a type of alpha blocker.|A drug used to treat urinary problems caused by an enlarged prostate. It is also used as a blood pressure drug and is being studied in the treatment of other conditions.|63.016999999999996|70.81118279569893|6.954000000000004|5.949677419354842|9.6251|9.099941666666666|-1.4936000000000007|-2.090322580645161|6.957000000000001|4.215208333333333|62.58|59.91578840339164|20.0|18.32688172043011
Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL|Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing homeization indicated; limiting self care ADLs.|-48.43947368421047|-29.891710526315762|24.73578947368421|19.788684210526316|14.102500000000001|13.932061904761905|29.294736842105262|13.40631578947368|22.010999999999996|15.220000000000006|103.77718969022045|73.38155456243756|30.757894736842104|26.957894736842107
Death|Sudden death|121.22000000000003|77.90500000000002|-3.3999999999999986|2.890000000000004|0.0496|9.048633333333335|-266.6|-112.72|2.620000000000001|-1.0899999999999999|0.0|31.29|0.4|20.8
Brief Pain Inventory (BPI) Medications not prescribed by my doctor that I take for pain are.|Brief Pain Inventory) Medications not prescribed by my doctor that I take for pain are.|66.5275|63.86250000000001|5.967500000000001|6.215000000000003|9.364474999999999|9.364474999999999|-8.7025|-10.45866666666667|8.353750000000002|7.765000000000001|44.250742366654144|44.250742366654144|13.200000000000001|13.66666666666667
Human BDNF wild-type allele is located in the vicinity of 11p14.1 and is approximately 67 kb in length. This allele, which encodes brain-derived neurotrophic factor protein, is involved in both stress response regulation and in the survival of striatal neurons. Expression of the allele is decreased in both Alzheimer's and Huntington disease.|Normal human BDNF gene is located in the vicinity of 11p14.1 and is about 67 kilobases in length. This gene, which encodes brain-derived neurotrophic factor protein, is involved in both stress response and the survival of striatal neurons. Expression of the gene|48.22900000000001|57.19178571428574|9.116000000000003|7.890714285714285|13.009114814814815|12.97669393939394|4.556923076923077|2.8895238095238085|12.428333333333335|9.132196969696967|68.55295529734659|64.5059875127883|22.621538461538464|20.390476190476193
The chemical reactions and pathways involving (-)-secologanin. [GOC:TermGenie, GOC:yaf, UniPathway:UPA00328]|The chemical reactions and pathways involving (-)-secologanin. [GOC:Genie, GOC:yaf, UniPathway:UPA00328]|15.640000000000015|24.100000000000023|12.320000000000004|11.14|17.31966923076923|17.517985714285714|-0.9879999999999995|-2.7519999999999953|14.427692307692311|11.339285714285715|58.53822981607831|58.53822981607831|30.0|30.0
An antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Methotrexate also exhibits potent immunosuppressant activity although the mechanism(s) of actions is unclear. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C642" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C642" NCI Thesaurus)|An antimetabolite and anti-cancer drug and immunosuppressant. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate|8.429314456035797|-16.845|13.46125186289121|18.59|14.336865901639344|13.998223076923077|2.723934426229505|17.22833333333333|28.52704918032787|15.503846153846155|55.0108909878101|79.77416029015912|24.513263785394933|26.466666666666665
An intestinal HERNIA.|intestinal hernia|7.912499999999994|-48.994999999999976|12.528333333333336|20.590000000000007|14.311966666666669|19.5753|-160.0933333333333|-98.02000000000001|8.329999999999998|6.760000000000002|31.29|44.250742366654144|27.266666666666666|40.800000000000004
The upper limit in time of a planned period of time between planned trial disease assessments.|The upper limit in time of a planned period of time between planned trial disease assessment.|66.5275|66.5275|5.967500000000001|5.967500000000001|9.364474999999999|9.631041176470589|-7.967500000000001|-7.967500000000001|9.53125|4.430588235294117|58.53822981607831|58.53822981607831|20.700000000000003|20.700000000000003
<p>Policy for handling psychotherapy note information, which is afforded heightened confidentiality.</p><i>Usage Note:</i>In some jurisdiction, disclosure of psychotherapy notes requires patient consent.<p>If there is a jurisdictional mandate, then use the applicable ActPrivacyLaw code system, and specify the law rather than or in addition to this more generic code.</p>|Policy for handling psychotherapy note information, which is afforded heightened confidentiality.|2.3087500000000034|-29.474772727272693|15.856329787234046|18.736818181818183|12.930843859649123|13.144933333333334|15.5931914893617|-6.778181818181821|12.302368421052627|15.325000000000003|76.64453405168562|58.53822981607831|25.125531914893617|27.654545454545453
Catalysis of the reaction: diphosphate + nicotinate D-ribonucleotide = 5-phospho-alpha-D-ribose 1-diphosphate + H(+) + nicotinate. [EC:6.3.4.21, RHEA:13393]|Starting of the reaction: diphosphate + nicotinate D-ribose = 5 phosphorylation of a molecule of DNA. [EC:6.3.4.21, RHEA:13393]|73.99576470588238|76.28100000000002|3.7830588235294123|3.514000000000003|18.62385652173913|15.185500000000001|-38.63529411764707|-45.96222222222222|10.53217391304348|8.2975|34.27647764867329|34.27647764867329|15.47764705882353|14.773333333333333
Combining with interleukin-8 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. [GOC:jl, GOC:signaling]|Combining with interleukin-8 and sending the signal from one side of the membrane to the other to initiate a change in cell activity. [GOC:jl, GOC:signaling]|58.78750000000002|62.17150000000001|8.165000000000003|7.693000000000001|10.739062962962963|10.534114285714285|8.7776|7.8368|8.346666666666668|7.1014285714285705|62.58|62.58|17.8|17.8
A severe form of myelosuppression. Myelosuppression is a condition in which bone marrow activity is decreased, resulting in fewer red blood cells, white blood cells, and platelets. It is a side effect of some cancer treatments.|A severe form of myelosuppression is a condition in which bone marrow activity is decreased, resulting in fewer red blood cells, and platelets. It is an side effect of some cancer treatments.|54.35000000000002|55.88958333333338|7.914444444444449|8.113750000000003|9.495033333333335|10.196718181818182|-1.5288888888888863|1.833750000000002|8.905000000000001|9.22818181818182|56.4088497046341|62.58|18.044444444444444|19.266666666666666
A limb orthosis (brace) is a device intended for medical purposes that is worn on the upper or lower extremities to support, to correct, or to prevent deformities or to align body structures for functional improvement. Examples of limb orthoses include the following: A whole limb and joint brace, a hand splint, an elastic stocking, a knee cage, and a corrective shoe.|A leg orthosis (brace) is a device intended for medical purposes that is worn on the upper or lower extremities to support, to correct, or to prevent deformities or for functional improvement. Examples of limb orthoses include the following: A whole leg and joint brace,|46.67768817204302|41.11750000000001|11.882903225806455|13.11388888888889|10.522325806451612|10.612734782608696|14.887741935483868|16.50577777777778|16.63241935483871|12.596086956521738|88.50148473330829|93.86999999999999|23.7505376344086|25.0
A subtype with pulmonary ventricular septal defect.|A subtype with pulmonary ventral defect.|9.91107142857146|34.59000000000003|12.74642857142857|9.180000000000003|15.262271428571431|15.08867142857143|-46.77142857142857|-63.386666666666656|11.675714285714285|3.870000000000001|49.473833993334296|44.250742366654144|29.971428571428575|27.866666666666664
A plant genus of the family POACEAE.|A plant genus of the family POACEAE.|82.42535714285715|82.42535714285715|2.6321428571428562|2.6321428571428562|8.495128571428573|9.756150000000002|-59.37142857142857|-58.53142857142856|1.5828571428571436|-1.7674999999999983|31.29|31.29|12.82857142857143|12.82857142857143
high level of calcium in the blood|high level of calcium in the blood.|90.95857142857145|94.51107142857143|2.3114285714285714|0.946428571428573|6.239414285714286|7.7824|-18.765714285714285|-59.37142857142857|0.9100000000000001|-2.3562499999999993|44.250742366654144|31.29|14.228571428571428|12.82857142857143
A class of devices combining electrical and mechanical components that have at least one of the dimensions in the micrometer range (between 1 micron and 1 millimeter). They include sensors, actuators, microducts, and micropumps.|A class of devices combining electric and mechanical components that have at least one of the dimensions in the micrometer range (between 1 micron and 1 millimeter). They include sensors, actuators, and micropumps.|41.06107843137258|46.97909090909093|10.347647058823533|9.439393939393941|12.3747|11.910288235294118|7.60588235294118|5.698181818181819|13.11352941176471|11.589705882352938|69.96656701596841|67.59412548439398|22.180392156862748|21.36969696969697
A subjective score of 6 on an anxiety scale that ranges from 0: No Anxiety to 10: Worst Possible Anxiety.|A subjective score of 6 on a anxiety scale that ranges from 0: No Anxiety to 10: Worst Possible Angry.|65.555|74.01500000000001|6.600000000000005|5.419999999999998|11.734|11.445242857142857|-4.3160000000000025|-4.903999999999996|8.116500000000002|7.237142857142857|54.195869768830164|54.195869768830164|16.0|16.0
The fifth of the five long bones located in the mid-foot, which articulates proximally with the cuboid bone at the tarsometatarsal joint and distally with the metatarsophalangeal joint.|The fifth of the five long bones located in the mid-foot, which articulates proximally with the cuboid bone at the tarsometatarsal joint and distal to the joint.|32.48928571428573|52.13250000000002|12.205714285714286|9.341666666666669|10.519727586206898|9.800527586206897|12.037142857142864|7.691851851851851|18.24413793103448|7.421034482758621|66.37611354998121|62.58|18.45714285714286|17.25185185185185
<p>A relationship in which the source act is covered by or is under the authority of a target act. A financial instrument such as an Invoice Element is covered by one or more specific instances of an Insurance Policy.</p>|A relationship in which the source act is covered by or is under the authority of a target act. A financial instrument such as an Invoice Element has one or more specific instances of an Insurance Policy.|54.809230769230794|54.840990990991|8.844102564102567|8.674054054054057|10.222782170542636|9.666608771929825|4.821538461538459|2.85729729729729|5.672015503875972|5.602543859649121|67.59412548439398|65.13532912329528|19.55897435897436|18.98738738738739
An electronic or hard copy mechanism used to collect and assemble clinical information.|An electronic or hard copy mechanism used to collect and assemble clinical data.|24.529807692307713|37.54519230769233|11.45269230769231|9.637307692307694|11.568992307692309|11.8787|-11.61538461538462|-14.329230769230772|11.880769230769232|4.947142857142854|58.53822981607831|58.53822981607831|24.13846153846154|24.13846153846154
The CD40 receptor was first associated with expression in B cells and the role it plays through its ligand CD40L (CD154) in moderating T cell activation. Broader expression may indicate a broader role for CD40 and CD40L in immune function and disease states such as transplant rejection and HIV infection. Disruption and modulation of CD40 interaction with CD40L may prove therapeutic in the treatment of autoimmune disorders, heart disease, and cancer. As a member of the TNF receptor family, CD40 relies on interaction with TRAF proteins to mediate an intracellular signal in response to CD40L binding. The pathway downstream of TRAFs activates the transcription factor NF-kappaB through a kinase pathway involving map kinases, NIK (NF-kappaB inducing kinase) and I-kappa B kinases. Some CD40 responses like regulation of immunoglobulin expression might be mediated by NF-kappaB transcriptional activation. (This definition may be outdated - see the DesignNote.)|The TNF receptor was first associated with expression in B cells and the role it plays through its ligand CD40L (CD154) in modulating T cell activation. Broader expression may indicate a broader role for TRAFs in immune function and disease states such as transplant rejection and HIV|43.15950431034483|55.18250000000002|11.742198275862073|11.400531914893623|13.32701003861004|12.392941666666667|16.921379310344832|17.30468085106383|14.537239382239385|13.7275|87.10767345647568|85.69119412168324|24.35344827586207|22.165957446808513
A question about how often a person thought about learning to accept themselves as they are.|A question about how often a person thought about learning to accept them as they are.|71.81500000000001|77.1025|5.230000000000004|4.492500000000003|5.416975|4.986923529411765|-8.7025|-10.54|8.942499999999999|2.491176470588236|62.58|58.53822981607831|23.200000000000003|20.700000000000003
The essential oil extracted from Tanacetum vulgare plants. Tansy oil can be toxic but has been used in a dilute form as a treatment for expelling internal roundworms.|The essential oil extracted from Tanacetum vulgare plants. Tansy oil can be toxic but has been used in a dilute form to treat internal roundworms.|61.397380952380956|66.40066666666667|7.014285714285716|6.068000000000001|10.534114285714285|10.139443589743589|-2.524285714285714|-6.590399999999995|8.615357142857146|4.822948717948719|59.91578840339164|54.195869768830164|19.44761904761905|17.733333333333334
Any selective and non-covalent interaction with a nucleic acid involved in the initiation, activation, perpetuation, repression or termination of polypeptide synthesis at the ribosome. [GOC:dph, GOC:tb, GOC:vw]|Any selective and non-covalent interaction with a DNA base involved in the initiation, activation, perpetuation or termination of polypeptide synthesis at the cell's surface. [GOC:dph, GOC:tb, GroupW]|5.132500000000022|20.79916666666668|15.897222222222226|13.712037037037042|15.101751612903225|13.573687096774194|18.14518518518519|16.18518518518519|12.452903225806452|11.389354838709671|85.69119412168324|76.64453405168562|27.622222222222224|23.177777777777777
World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place?|Learning A New Task, for example, learning how to get to a new place?|66.87371621621622|83.85357142857143|8.527702702702705|5.041428571428572|9.056422222222224|6.485833333333334|11.969729729729732|2.7971428571428554|6.550000000000001|3.026|66.37611354998121|54.195869768830164|17.12972972972973|14.171428571428573
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding. [GOC:jl]|Interacting selectively and not binding with DNA of a specific chemical composition, e.g. GC-rich DNA binding, or with specific sequence motif or type of DNA. [GOC:jl]|45.44041666666669|50.56057692307695|8.24625|7.821923076923078|14.880785714285715|14.156389655172415|-22.241249999999994|-13.198461538461544|10.600857142857144|7.908275862068965|46.05763291789971|49.473833993334296|18.383333333333336|17.984615384615388
Any process in which an organism activates or increases the frequency, rate or extent of cytolysis by that organism of cells in its host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction. [GOC:add, GOC:dph, GOC:tb]|Any process in which an organism activates or increases the frequency, rate or extent of cytolysis by that organism of cells in its host organism. The host is defined as the larger of the organisms involved in an beneficial interaction. [GOC:add, GOC:dph, GroupB]|50.630852713178314|48.66341085271321|9.758139534883725|10.032558139534885|10.918989855072464|10.918989855072464|9.295813953488373|9.706046511627907|7.63644927536232|8.046014492753624|72.26115969177356|72.26115969177356|20.617054263565894|20.617054263565894
Catalysis of an oxidation-reduction (redox) reaction in which X-H and Y-H form X-Y and the acceptor is disulfide. [GOC:ai]|Increasing the rate of an oxidation-reduction reaction in which a molecule of hydrogen peroxide is formed. [GOC:ai]|36.89776315789476|29.00750000000002|10.472894736842104|11.325000000000003|14.10045|12.0275|1.0273684210526355|-0.235294117647058|3.0174999999999983|5.942499999999999|58.53822981607831|58.53822981607831|18.53684210526316|19.870588235294118
Any process that modulates the frequency, rate or extent of smooth muscle hypertrophy. [GO_REF:0000058, GOC:bc, GOC:BHF, GOC:BHF_miRNA, GOC:TermGenie, PMID:22161164]|Any process that modulates the frequency, rate or extent of smooth muscle hypertrophy. [GO_REF:0000058, GroupGenie, PMID:22161164]|50.25565789473683|55.952500000000015|8.609736842105267|7.442500000000003|15.191247826086956|13.346335294117647|14.334736842105258|5.630000000000003|11.76086956521739|13.296470588235294|66.37611354998121|62.58|22.74736842105263|23.200000000000003
Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed)|Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; and|-19.497368421052585|-20.99928571428569|20.69894736842105|23.14428571428572|15.940110256410257|14.875589655172414|25.426315789473687|27.64857142857143|18.995384615384616|21.817241379310346|112.8176994092682|136.38994794338765|34.96842105263158|38.34285714285715
Death|Sudden death|121.22000000000003|77.90500000000002|-3.3999999999999986|2.890000000000004|0.0496|9.048633333333335|-266.6|-112.72|2.620000000000001|-1.0899999999999999|0.0|31.29|0.4|20.8
A white patch or plaque on the oral mucosa that cannot be characterized clinically or pathologically as any other disease. The diagnosis of leukoplakia is one of exclusion; other conditions such as candidiasis, lichen planus, leukoedema, etc., must be ruled out before a diagnosis of leukoplakia can be made. Leukoplakia may be a premalignant condition.|A white patch or plaque on the oral mucous that cannot be characterized clinically or pathologically as any other disease. The diagnosis of leukoplakia is one of exclusion; other conditions such as candidiasis, lichen planus, leukoedema|28.00818181818184|17.015000000000015|12.085454545454546|15.357777777777777|10.483616666666666|11.22732105263158|5.056727272727276|16.54888888888889|12.294404761904765|12.611578947368422|69.96656701596841|93.86999999999999|22.581818181818182|27.200000000000003
A unique symbol that establishes the identity of an image.|A unique symbol that establishs the identity of an image.|41.02000000000004|49.48000000000002|8.780000000000001|7.600000000000001|12.0275|12.522027272727273|-30.387999999999998|-30.387999999999998|6.178000000000001|1.8727272727272712|49.473833993334296|49.473833993334296|22.0|22.0
Symptomatic but not limiting ADL|Symptomatic but not limiting ADL|32.56000000000003|32.56000000000003|9.96|9.96|13.3585|14.460766666666668|-26.272|-25.096000000000004|7.445999999999998|4.334999999999997|44.250742366654144|44.250742366654144|18.0|18.0
A benign or malignant thyroid tumor arising from follicular cells.|A benign or abnormal thyroid tumor arising from follicular cells.|32.56000000000003|32.56000000000003|9.96|9.96|12.0275|12.522027272727273|-25.683999999999997|-25.683999999999997|9.945999999999998|5.298181818181817|54.195869768830164|54.195869768830164|26.0|26.0
An orally available, ATP-competitive inhibitor of the receptor tyrosine kinases, anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (Ros1), with potential antineoplastic activity. Upon administration, lorlatinib binds to and inhibits both ALK and ROS1 kinases. The kinase inhibition leads to disruption of ALK- and ROS1-mediated signaling and eventually inhibits tumor cell growth in ALK- and ROS1-overexpressing tumor cells. In addition, lorlatinib is able to cross the blood brain barrier. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development; ALK dysregulation and gene rearrangements are associated with a series of tumors. ROS1, overexpressed in certain cancer cells, plays a key role in cell growth and survival of cancer cells. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C113655" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C113655" NCI Thesaurus)|An orally available, ATP-competitive inhibitor of the protein chemical receptors, anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (Ros1), with potential anti-cancer activity.|42.41647637795276|-3.4635869565217092|9.596676040494941|16.59934782608696|13.368241984732826|17.17202592592593|9.59496062992126|14.909565217391304|18.505057251908397|11.137777777777778|60.88067796928677|82.78555852321104|20.3214848143982|28.947826086956525
A small molecule and orally available inhibitor of colony-stimulating factor-1 receptor (CSF1R; cFMS) with potential antineoplastic activity. cFMS tyrosine kinase inhibitor ARRY-382 binds to and inhibits the activity of cFMS. By preventing colony-stimulating factor-1 (CSF-1)-cFMS signaling, this agent may inhibit tumor cell proliferation in cFMS-overexpressing tumor cells. cFMS, a tyrosine kinase receptor, is overexpressed in certain tumor cell types and plays an essential role in macrophage differentiation and regulation of cell proliferation.|A small molecule and orally available inhibitor of colony-stimulating factor-1 receptor is overexpressed in certain tumor types and plays an essential role in cell differentiation and regulation of cell proliferation.|11.269000000000005|5.490000000000009|15.26488888888889|16.220000000000006|14.461566666666666|12.8185375|18.562777777777775|17.310666666666663|17.147|14.0940625|81.59433730351635|79.77416029015912|24.64888888888889|23.333333333333336
An abnormality of the philtrum. [HPO:probinson]|An abnormality of the thetrum. [HPO:probinson]|6.390000000000015|6.390000000000015|13.113333333333333|13.113333333333333|12.832957142857145|13.70365|-57.50666666666666|-57.50666666666666|5.8885714285714315|2.942499999999999|38.32226702584281|38.32226702584281|21.200000000000003|21.200000000000003
An orally available small molecule and platelet thrombopoietin (TPO) receptor (TPOR; MPL) agonist with potential megakaryopoiesis stimulating activity. Upon administration, TPOR agonist ONO-7746 binds to and stimulates TPOR, which may lead to the proliferation and differentiation of megakaryocytes. In turn, this may increase the production of blood platelets and may prevent chemotherapy induced thrombocytopenia (CIT). TPOR is a cytokine receptor and member of the hematopoietin receptor superfamily.|An orally available small molecule and platelet factor with potential megakaryopoiesis stimulating activity. Upon administration, TPOR is a cytokine receptor and member of the hematopoietin superfamily.|5.093701492537349|-19.969358974358954|15.87779104477612|18.19769230769231|13.187150746268657|13.439937037037039|16.26208955223881|6.101538461538446|16.68126865671642|13.597777777777779|77.91147168421348|72.26115969177356|23.867462686567166|28.08205128205128
Created as a republic in 1918 by Czechs and Slovaks from territories formerly part of the Austro-Hungarian Empire. The country split into the Czech Republic and Slovakia 1 January 1993.|Created as a republic in 1918 by Czechs and Slovaks from territories formerly part of the Austro-Hungarian Empire. The country split into the Czech Republic and Slovakia 1 January 1993.|52.86500000000001|52.86500000000001|8.370000000000001|8.370000000000001|13.064332258064518|13.047441666666668|0.9759999999999991|1.1720000000000006|9.566129032258065|6.570208333333333|62.58|62.58|20.0|20.0
A class of polyunsaturated fatty acids with 24 carbons and 6 double bonds.|A class of fatty acids with 24 carbons and 6 double bonds.|70.08365384615385|102.045|5.098846153846157|0.5166666666666693|12.783607692307694|12.461207692307694|-17.49538461538462|-25.81333333333333|7.170769230769231|-1.1515384615384612|49.473833993334296|44.250742366654144|17.984615384615388|15.733333333333333
refers to one of two subdivisions of lobule VII of the cerebellar vermis; the other is the folium ( Madigan-1971 ).|refers to one of two subdivisions of lobule VII of the cerebellar vermis; the other is the folium.|79.34892857142859|61.400000000000034|4.800238095238097|6.9311111111111146|11.22732105263158|10.75612105263158|-1.5904761904761955|-6.10222222222222|10.62842105263158|3.151578947368421|58.53822981607831|58.53822981607831|17.53333333333333|19.15555555555556
a chemical substance|a substance that is soluble in fat.|34.59000000000003|82.42535714285715|9.180000000000003|2.6321428571428562|14.311966666666669|9.756150000000002|-63.386666666666656|-59.37142857142857|8.329999999999998|-2.3562499999999993|44.250742366654144|31.29|27.866666666666664|12.82857142857143
An inhibitor of protein tyrosine phosphatase (PTP) non-receptor type 11 (SHP2; src homology region 2 domain phosphatase; PTPN11), with potential antineoplastic activity. Upon oral administration, SHP2 inhibitor TNO155 binds to and inhibits SHP2. This prevents SHP2-mediated signaling, inhibits MAPK signaling and prevents growth of SHP2-expressing tumor cells. SHP2, an oncoprotein overexpressed in a variety of cancer cell types, regulates cell survival, differentiation and proliferation through activation of the RAS-RAF-ERK signaling pathway. SHP2 also regulates programmed cell death 1 (PD-1)-mediated signal transduction and is involved in immune checkpoint modulation.|An inhibitor of protein tyrosine phosphatase (PTP) non-receptor type 11 (SHP2), an oncoprotein that is overexpressed in a variety of cancer cell types, regulates cell survival, differentiation and proliferation through activation of the RAS|29.477878787878808|-1.8514705882352587|12.791363636363638|21.964117647058824|15.764866451612905|15.071544444444447|19.10727272727273|27.265882352941176|16.484516129032258|22.736666666666665|84.73372056035305|117.07645963215661|25.86666666666667|30.070588235294117
A specimen that has a gelatinous consistency.|A specimen that has a solid consistency.|21.99678571428572|46.1682142857143|11.060714285714287|7.689285714285713|10.750842857142857|11.7299|-51.81142857142857|-55.17142857142857|7.6385714285714315|0.5874999999999986|38.32226702584281|38.32226702584281|18.54285714285714|18.54285714285714
Failure of a patient to follow medical advice, take medication as directed, or adhere to a prescribed course of treatment.|Failure to follow medical advice, take medication as directed, or adhere to a prescribed course of treatment.|48.63500000000002|43.93691176470591|8.960000000000004|9.242647058823533|10.944500000000001|11.100677777777777|0.6820000000000057|-2.3105882352941123|12.119999999999997|6.881666666666664|69.96656701596841|66.37611354998121|24.0|24.576470588235296
A mixture composed of curcuminoid phenols extracted from the plant Curcuma longa (turmeric root) with potent antioxidant and anti-inflammatory properties. Curcumin/demethoxycurcumin/bisdemethoxycurcumin-containing supplement is a unique combination of three phenols: curcumin, demethoxycurcumin and bisdemethoxycurcumin. This agent may both prevent the formation of free radicals and neutralize free radicals. Curcuminoids may have chemopreventive and antiproliferative properties. (NCI04)|A mixture composed of curcuminoid phenols extracted from the plant Curcuma longa (turmeric root) with potent antioxidant and anti-inflammatory properties. This agent may both prevent the formation of free radicals and neutralize superoxide anisotropy, chemopre|-28.904545454545456|5.369642857142907|20.023636363636367|16.857857142857146|13.588729152542372|13.94274864864865|19.596363636363638|21.221714285714285|18.07864406779661|16.08|76.64453405168562|98.94766798666859|26.218181818181815|29.857142857142858
A measurement of the distribution of the hemoglobin concentration in red blood cells.|A measurement of the hemoglobin concentration in red blood cells.|44.05288461538464|49.48000000000002|8.729615384615386|7.600000000000001|9.139761538461538|9.651118181818184|-12.520000000000003|-25.683999999999997|11.156153846153849|5.298181818181817|44.250742366654144|38.32226702584281|14.90769230769231|14.0
National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have a good appetite.|CancerNet/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have a good appetite.|28.50000000000003|41.30250000000001|11.520000000000003|9.361666666666668|16.213636842105267|15.203982352941178|6.311111111111117|-1.8346666666666707|16.82578947368421|8.309411764705885|69.96656701596841|58.53822981607831|25.822222222222223|21.666666666666668
OBSOLETE. Catalysis of the formation of endothelin 1 by cleavage of the Trp21-Val22 bond in the precursor. [EC:3.4.24.71]|OBSOLETE. Catalysis of the formation of endothelin 1 by cleavage of a Trp21-Val22 bond in the precursor. [EC:3.4.24.71]|72.19000000000003|72.19000000000003|3.935555555555556|3.935555555555556|13.092212280701753|13.441166666666666|-64.69333333333333|-65.02|6.2782456140350895|4.982333333333333|31.29|31.29|14.533333333333331|14.533333333333331
A digoxin test system is a device intended to measure digoxin, a cardiovascular drug, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of digoxin overdose and in monitoring levels of digoxin to ensure appropriate therapy.|A drug test system is a device intended to measure digoxin, an inflammatory drug, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of drug overdose and to ensure appropriate therapy.|27.021550387596932|40.36254385964915|13.051162790697674|10.776315789473689|12.047086046511629|11.973864102564102|10.526511627906974|6.805263157894736|13.855813953488372|8.136923076923079|84.73372056035305|74.48509850970193|26.198449612403103|22.96140350877193
The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)|A substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)|53.814423076923106|57.54657608695652|7.368076923076924|6.661195652173912|11.908692592592592|12.4673|-14.329230769230772|-19.010434782608698|8.346666666666668|7.616399999999999|49.473833993334296|46.934999999999995|17.984615384615388|17.952173913043477
Emotional tension or energy characterized by unexplained feelings of apprehension, uneasiness or dread associated to an anticipated, actual or imagined stressor.|Emotional tension or energy characterized by unexplained feelings of apprehension, uneasiness or dread associated to an expected, real or imagined stressor.|-21.365357142857135|-5.251071428571407|18.847857142857148|16.6002380952381|15.20476666666667|13.512554545454547|11.289523809523807|10.16952380952381|20.021428571428565|12.758181818181818|79.77416029015912|79.77416029015912|28.961904761904762|28.961904761904762
An abnormality of the integument, which consists of the skin and the superficial fascia. [HPO:probinson]|An abnormality of the integument, which consists of a skin and the superficial fascia. [HPO:probinson]|30.022500000000008|30.022500000000008|10.935000000000002|10.935000000000002|10.941425|11.488688235294118|-4.186666666666667|-4.578666666666663|7.591875000000002|6.092941176470589|54.195869768830164|54.195869768830164|19.0|19.0
A reduction in diameter of the distal phalanx of finger towards the distal end. [HPO:probinson]|A reduction in diameter of the bone's end. [HPO:probinson]|41.30250000000001|33.067500000000024|9.361666666666668|9.765|10.941425|11.086572727272728|-7.714666666666666|-32.45777777777777|5.236875000000001|1.4445454545454552|62.58|44.250742366654144|24.333333333333336|19.57777777777778
Bronchoconstriction involves narrowing of air passage lumina, typically due to bronchial smooth muscle contraction, and leads to decreased air flow.|Brench obstruction involves narrowing of air passage lumina, typically due to bronchial smooth muscle contraction, and leads to decreased air flow.|31.715000000000003|43.09178571428572|11.320000000000004|9.857380952380954|12.5235|12.0771|8.326000000000004|7.6495238095238065|18.243000000000002|10.83136363636364|69.96656701596841|69.96656701596841|24.0|23.247619047619047
<p>An aqueous solution which is most often used for its deodorant, refreshing, or antiseptic effect.</p>|Aqueous solution which is most often used for its smell, refreshing, or antiseptic effect.|46.942499999999995|54.70142857142861|8.575000000000003|7.368571428571428|12.889426315789473|10.3245|-4.186666666666667|-9.525714285714287|9.884736842105266|5.870000000000001|58.53822981607831|54.195869768830164|21.666666666666668|19.942857142857143
Any process that modulates the frequency, rate or extent of ubiquitin protein ligase activity. [GO_REF:0000059, GOC:dph, GOC:TermGenie, GOC:vw, PMID:10921876, PMID:26216882]|Any process that modulates the frequency, rate or extent of protein ligase activity. [GO_REF:0000059, GOC:dph, GroupGenie, PMID:26216882]|48.63500000000002|53.889852941176486|8.960000000000004|7.854411764705883|15.877769565217392|14.911384210526316|15.675999999999998|7.374117647058824|13.399130434782613|11.579999999999998|69.96656701596841|66.37611354998121|24.0|24.576470588235296
Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Seeming to be in a daze.|Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month. Seeming to be in a daze.|75.12117647058825|82.87000000000003|7.004705882352944|4.433333333333334|8.144209090909092|7.053009090909091|8.875294117647062|-0.7163636363636421|16.050909090909094|4.337272727272726|66.37611354998121|51.09635603445709|17.388235294117646|14.096969696969698
The cell cycle process by which a cell commits to entering the next meiotic cell cycle phase. [GOC:mtg_cell_cycle]|The cell cycle process by which a cell commits to entering the next cycle phase. [GOC:mtg_cell_cycle]|66.10000000000002|66.5275|6.2755555555555596|5.967500000000001|10.75612105263158|11.100677777777777|-1.2022222222222183|-5.027500000000003|6.374210526315789|4.78833333333333|58.53822981607831|54.195869768830164|19.15555555555556|18.2
Any process that activates or increases the frequency, rate or extent of potassium ion export across the plasma membrane. [GO_REF:0000058, GOC:BHF, GOC:mtg_cardiac_conduct_nov11, GOC:rl, GOC:TermGenie, PMID:19646991]|Any process that activates or increases the rate or helps ion export across the plasma membrane. [GO_REF:0000058, GOC:BHF, GroupGenie, PMID:19646991]|58.78750000000002|69.78500000000001|8.165000000000003|6.010000000000002|15.245355172413795|13.512554545454547|21.4784|8.913999999999998|14.892068965517247|10.617272727272727|76.64453405168562|66.37611354998121|24.200000000000003|22.0
Medical intervention indicated; IV fluids indicated <24 hrs|Medical intervention indicated; fluids indicated 24 hrs.|8.365000000000009|-2.1746428571428282|14.080000000000002|14.432142857142857|19.8729|19.6249|1.2199999999999989|-41.731428571428566|9.760000000000002|9.41875|62.58|44.250742366654144|23.200000000000003|24.257142857142856
The elasticity of the pulmonary walls.|The elasticity of the lungs.|20.490000000000038|52.01750000000001|11.146666666666665|6.6250000000000036|9.197433333333334|11.6803|-66.32666666666665|-89.0|6.689999999999998|-1.0899999999999999|31.29|22.125371183327072|14.533333333333331|9.0
Severity of signs and symptoms of increased serum potassium|Severity of signs and symptoms of increased serum potassium|37.900000000000034|37.900000000000034|10.208888888888893|10.208888888888893|12.855122222222224|13.6065|0.43111111111111455|1.0844444444444505|9.760000000000002|8.062000000000001|69.96656701596841|69.96656701596841|25.822222222222223|25.822222222222223
A measurement of an individual's weight in relationship to age, in comparison to a reference percentile curve.|A measurement an individual's weight in relation to age, in comparison to a reference percentile curve.|38.960441176470624|40.09|9.936764705882357|9.655000000000001|10.981464705882354|11.488688235294118|-2.3105882352941123|-4.292499999999997|12.559411764705885|6.9241176470588215|54.195869768830164|54.195869768830164|17.51764705882353|18.2
This gene may be involved in the regulation of gene expression.|This gene is involved in the regulation of gene expression.|70.50704545454548|66.40000000000003|4.791363636363638|5.240000000000002|11.359372727272728|12.522027272727273|-25.48727272727273|-29.211999999999996|6.335454545454546|2.7290909090909103|38.32226702584281|38.32226702584281|13.109090909090908|14.0
The process in which a cell becomes capable of differentiating autonomously into a neuroblast in an environment that is neutral with respect to the developmental pathway. Upon specification, the cell fate can be reversed. [GOC:ef, ISBN:0878932585]|A cell becomes capable of turning into a neuroblast in an environment neutral with respect to the developmental pathway. Upon specification, the cell fate can be reversed. [GOC:ef, ISBN:0878932585]|34.85500000000002|42.40954022988507|11.378888888888891|9.745517241379314|11.076341441441443|11.280001075268817|9.96|3.8482758620689665|10.832612612612614|8.50215053763441|72.26115969177356|67.59412548439398|22.57777777777778|23.177011494252874
A drug used alone or with other drugs to treat colon cancer or rectal cancer that has spread to other parts of the body or has come back after treatment with fluorouracil. It is also being studied in the treatment of other types of cancer. Camptosar blocks certain enzymes needed for cell division and DNA repair, and it may kill cancer cells. It is a type of topoisomerase inhibitor and a type of camptothecin analog.|A drug used alone or with other drugs to treat colon cancer or rectal cancer that has spread to other parts of the body or has come back after treatment with fluorouracil. It is also being studied in the treatment of other types of cancer.|60.76200000000003|71.29000000000002|8.510666666666669|7.042222222222225|9.198233333333334|8.516163768115941|7.2362666666666655|5.877333333333329|9.234199999999998|6.1005797101449275|74.04565456527479|74.48509850970193|20.933333333333337|21.111111111111114
Monitors designed for continuous and simultaneous measure and display data on respiratory and administered anesthetic gases and also on several additional physiologic parameters during general peri-operative and anesthesia surgical procedures (intraoperative). These monitors consist of a computerized unit as well as a display that shows the numerical values, waveforms, and trends of the concentrations of the gases and other measured parameters, attached sensors, and alarms. They can sample, measure, and display simultaneously data on inspired and expired concentrations of respiratory (e.g., oxygen, carbon dioxide) and anesthetic gases (nitrogen oxide, enflurane, isoflurane) and several other physiologic parameters such as invasive pressure, electrocardiography, pulse oximetry, and temperature.|Monitors designed for continuous and simultaneous measure and display data on respiratory and administered anesthetic gases and also on several additional physiologic parameters such as pressure, heart rhythm, and temperature.|-9.133214285714274|-5.789999999999992|18.880714285714287|17.793333333333333|13.581957861635221|12.55497741935484|22.285714285714292|19.074666666666666|26.318459119496858|15.947419354838708|103.77718969022045|93.86999999999999|32.142857142857146|30.0
Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: Li+(in) + H+(out) = Li+(out) + H+(in). [PMID:17270011]|Enables the transfer from one side of a membrane to another according to the reaction: Li+(in) + hydrogen ion). [PMID:17270011]|78.34508620689657|65.555|5.933965517241379|6.600000000000005|12.091421379310345|12.428252380952381|7.566896551724138|2.4460000000000015|2.583793103448272|6.921428571428574|69.96656701596841|62.58|19.593103448275865|20.0
Nanometer-sized tubes composed of various substances including carbon (CARBON NANOTUBES), boron nitride, or nickel vanadate.|Nanometer-sized tubes composed of various substances including carbon (CARBON NANOTUBES), boron nitride, or nickel vanadate.|-9.45750000000001|-9.45750000000001|16.441666666666666|16.441666666666666|17.259475000000002|17.061629411764706|3.653333333333329|4.045333333333332|17.184999999999995|11.911176470588238|79.77416029015912|79.77416029015912|37.66666666666667|37.66666666666667
Ligature passers designed to carry and manipulate ligatures through tissue and cartilage and/or around bones. These passers are typically manual, handheld instruments including a rod with a straight or curved distal end and an appropriate configuration (e.g., U-shaped, loop) to hold the ligature. Bone ligature passers are used mainly to fix ligatures around bones during orthopedic procedures.|Ligature passers designed to carry and manipulate ligatures through tissue and cartilage and/or around bones. They are typically manual, handheld instruments including a rod with an elongated distal end and an appropriate configuration (e.g., U-shaped, loop) to hold the|32.44513157894738|32.07721153846154|11.093947368421052|11.207371794871793|11.945950574712644|12.740860975609756|3.812631578947368|4.770256410256412|15.034942528735627|14.782439024390243|71.12311754978124|69.96656701596841|25.554385964912285|24.412820512820513
An adenocarcinoma of unknown primary that is amenable to surgical resection.|An cancer of unknown primary that is amenable to surgical resection.|-6.402045454545458|32.05250000000001|15.518636363636364|10.155000000000001|11.359372727272728|11.8291|-18.53818181818182|-22.280000000000005|11.901818181818179|4.334999999999997|54.195869768830164|54.195869768830164|24.018181818181816|24.018181818181816
Catalysis of the reaction: pyridoxine + acceptor = isopyridoxal + reduced acceptor. [EC:1.1.99.9, MetaCyc:PYRIDOXINE-5-DEHYDROGENASE-RXN]|Starting of the reaction: pyridoxine + acceptor = a new molecule of calcium. [EC:1.1.99.9, MetaCyc:PYRIDOXINE-5-DEHYDROGENASE-RXN]|40.83585714285715|85.35000000000004|8.259142857142859|2.099999999999998|17.849919607843137|14.911384210526316|-53.63428571428572|-52.80266666666666|13.542156862745102|10.340526315789472|37.022827282637394|31.29|21.12|14.533333333333331
The process whose specific outcome is the progression of a mesonephric glomerular epithelial cell over time, from its formation to the mature structure. Mesonephric glomerular epithelial cells are specialized epithelial cells that form part of the mesonephric glomerulus; there are two types, mesonephric glomerular parietal epithelial cells and mesonephric glomerular visceral epithelial cells. [GOC:mtg_kidney_jan10]|The process whose specific outcome is the progression of a mesonephric glomerular epithelial cell over time, from its formation to its maturation to the mature structure. MSCs are specialized skin cells that form part of the middle germ-cell layer; there are two|6.831666666666649|42.505714285714305|16.77814814814815|12.547619047619047|12.584378787878787|10.469518181818183|23.299999999999997|16.984761904761903|18.308848484848482|12.905909090909084|92.11526583579942|88.50148473330829|26.459259259259262|23.63809523809524
Enables the transmembrane transfer of a solute by a channel that opens in response to dephosphorylation of one of its constituent parts. [GOC:mtg_transport, ISBN:0815340729]|Enables the transmembrane transfer of a solute between two body parts. [GOC:mtg_transport, ISBN:0815340729]|50.130000000000024|57.06826923076926|9.248333333333335|6.91423076923077|11.2041|12.429833333333335|12.083333333333336|-2.1169230769230793|12.137999999999998|10.893999999999998|69.96656701596841|58.53822981607831|21.46666666666667|24.13846153846154
This gene plays a role in cellular adhesion and mediates immune and endothelial cell interactions.|This gene plays a role in cell adhesion and mediates immune cell interactions.|41.30250000000001|63.57596153846157|9.361666666666668|6.006538461538462|12.801833333333335|12.225900000000001|-6.538666666666671|-15.233846153846155|12.131999999999998|7.774285714285714|54.195869768830164|44.250742366654144|19.0|14.90769230769231
A subspecies of Staphylococcus cohnii that is positive for urease, beta-glucuronidase, and beta-galactosidase activities, with delayed alkaline phosphatase activity and the ability to produce acid aerobically from alpha-lactose. This subspecies is most frequently isolated in homes and is only rarely encountered in the hospital setting.|A subspecies of Staphylococcus cohnii that is positive for urease, beta-glucuronidase, and beta glucane activities, with delayed alkaline phosphatase activity and the ability to produce acid aerobically from alpha-|-5.789999999999992|-20.972413793103414|17.793333333333333|23.388965517241378|13.050858333333334|15.361196774193548|18.552|27.70896551724138|18.535625000000003|21.874193548387098|90.32644961471695|132.75222709996243|28.222222222222225|36.42758620689656
A plant genus of the family FABACEAE that is a source of prosopis gum.|A plant genus of the family FABACEAE that is a source of gum.|78.87285714285717|89.6067307692308|3.997142857142858|2.375769230769233|8.842328571428572|8.495128571428573|-18.345714285714287|-22.923076923076927|4.41|-1.4450000000000003|44.250742366654144|38.32226702584281|14.228571428571428|11.830769230769231
A measurement of the prolactin hormone in a biological specimen.|A measurement of the growth hormone in a biological specimen.|24.100000000000023|41.02000000000004|11.14|8.780000000000001|12.0275|12.522027272727273|-26.86|-28.035999999999998|9.004000000000001|3.585454545454546|49.473833993334296|44.250742366654144|22.0|18.0
Serous membrane, which has as its parts a parietal serous membrane and a visceral serous membrane that together forms a serous sac that encloses a serous cavity. Examples: pleura, serous pericardium, peritoneum|Serous membrane, which has as its parts a left part of the brain pleura, serous pericardium, cytomegalosis, or more recently, has been shown to have an effect on the ovarian cancer|31.97|44.37645161290325|12.775000000000002|14.770967741935486|13.311975|10.6515125|14.39125|19.09290322580645|12.180625|16.059374999999996|93.86999999999999|98.94766798666859|28.900000000000002|25.303225806451614
Deletion of the short arm of chromosome 12. The syndrome is relatively rare and has a variable phenotype, consisting of growth and mental retardation and various craniofacial, neurological, and other abnormalities.|The syndrome is relatively rare and has a variable phenotype, consisting of growth and mental retardation and various brain abnormalities.|24.41763440860217|23.255000000000024|12.420645161290324|12.499999999999996|12.55497741935484|13.180157142857144|6.2554838709677405|5.680000000000003|13.516451612903225|10.285714285714285|67.59412548439398|66.37611354998121|22.197849462365593|22.0
The process in which a virus increases the frequency, rate or extent of the breakdown of host messenger RNA (mRNA). [GOC:bf, UniProtKB-KW:KW-1132]|A virus increases the frequency, rate or extent of the breakdown of host messenger RNA. [GOC:bf, UniProtKB-KW-1132]|76.46090909090911|73.79573529411766|5.327272727272728|5.077941176470592|13.0989|13.6065|6.4999999999999964|-0.235294117647058|6.485999999999997|5.4715000000000025|58.53822981607831|54.195869768830164|17.127272727272725|17.51764705882353
One of three layers of the endocardium comprising a layer of loose connective tissue continuous with the myocardium. The impulse-conducting system (Purkinje fibers) is located within this layer.|One of three layers of the endocardium comprising a layer of loose connective tissue continuous with the heart rhythm. The impulse-conducting system is located within this layer.|31.183095238095262|41.03333333333336|11.228571428571431|9.771851851851856|13.067424137931035|12.283208045977013|3.3557142857142885|0.43111111111111455|12.131034482758622|7.765402298850574|69.96656701596841|62.58|25.161904761904765|21.37777777777778
Subcallosal nuclei that form an integral part of the limbic system. These nuclei contribute to the medial forebrain bundle and have processes synapsing in the hippocampus.|These nuclei contribute to the medial forebrain bundle and have processes synapsing in the hippocampus.|41.853717948717986|35.662499999999994|9.574615384615385|10.148333333333337|11.568992307692309|11.9283|-1.1353846153846234|-4.186666666666667|11.156153846153849|8.769375|65.13532912329528|62.58|23.46666666666667|24.333333333333336
Microcephaly with calcification of the white matter, quadriplegia, and mental deficiency.|Microcephaly with calcification of the white matter, quadriplegia, and mental defect.|-6.402045454545458|8.979772727272717|15.518636363636364|13.373181818181823|11.359372727272728|11.8291|-11.589090909090913|-13.192727272727275|16.61181818181818|10.2225|54.195869768830164|54.195869768830164|24.018181818181816|24.018181818181816
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (1044 aa, ~119 kDa) is encoded by the human PIK3CD gene. This protein plays a role in both signal transduction and cell-mediated immunity.|This protein plays a role in both signal transduction and cell-mediated immunity.|47.22500000000002|45.64500000000001|9.15666666666667|8.383333333333333|15.460051515151518|11.8787|7.248000000000001|-14.54333333333333|12.510909090909088|5.283571428571431|62.58|49.473833993334296|20.0|19.06666666666667
This gene may play a role in calcium channel regulation and G protein-coupled receptor activity.|This gene may play a role in calcium channel regulation and protein-coupled receptor activity.|41.30250000000001|36.572857142857174|9.361666666666668|9.89714285714286|14.29885|13.902050000000001|-7.32266666666667|-7.845714285714287|10.120000000000001|6.120000000000001|54.195869768830164|54.195869768830164|19.0|19.942857142857143
Human SCTR wild-type allele is located in the vicinity of 2q14.1 and is approximately 85 kb in length. This allele, which encodes secretin receptor protein plays a role in the regulation of pancreatic bicarbonate, electrolyte and volume secretion. Dysfunction of the gene may be involved in pancreatic cancer and autism.|Normal human SCTR gene is located in the vicinity of chromosome location, 2q14.1, and is about 85 kilobases in length. This gene, which encodes a protein complex that regulates pancreatic bicarbonate, electrolyte and volume secretion|47.789000000000016|35.461904761904776|9.078|11.211428571428574|13.148719607843137|14.178744444444446|2.2696000000000005|8.228571428571428|11.543529411764702|13.082500000000003|65.6344577184881|74.48509850970193|21.6|24.095238095238095
Emotion Recognition - Number of stimuli defined as portraying fear.|Emotion Recognition - Number of stimuli defined as depicting fear.|41.02000000000004|32.56000000000003|8.780000000000001|9.96|12.855122222222224|13.3585|-25.096000000000004|-25.096000000000004|12.376666666666672|7.445999999999998|54.195869768830164|54.195869768830164|26.0|26.0
A benign or malignant neoplasm that affects the genitourinary system.|A benign or malignant tumor that affects the genital system.|24.100000000000023|49.48000000000002|11.14|7.600000000000001|13.6065|13.957481818181819|-23.919999999999995|-28.624|11.359000000000002|3.15727272727273|54.195869768830164|54.195869768830164|26.0|26.0
Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses.|Infections produced by viruses that are less numerous but more diverse than those caused by the RNA viruses.|46.096666666666664|66.10000000000002|8.900000000000002|6.2755555555555596|11.8357|10.75612105263158|-3.2975999999999956|-2.8355555555555547|10.254000000000001|5.87842105263158|57.127462747788826|54.195869768830164|19.333333333333336|16.933333333333334
This gene is involved in the regulation of gene expression and plays a role in the development of medulloblastoma.|This gene is involved in the regulation of gene expression and plays a role in developing medulloblastoma.|50.25565789473683|43.93691176470591|8.609736842105267|9.242647058823533|11.22732105263158|11.9779|-1.448421052631577|-3.3482352941176465|11.619999999999997|6.620000000000001|49.473833993334296|49.473833993334296|14.326315789473682|15.164705882352942
<b>Description:</b>Types of observations which describe characteristics of the immunization material.|Acute flaccid myelitis|-43.579999999999956|6.390000000000015|20.580000000000002|13.113333333333333|14.907166666666669|19.6249|-5.104000000000006|-57.50666666666666|14.643999999999998|5.297499999999999|54.195869768830164|54.195869768830164|26.0|41.2
A form of the anticancer drug doxorubicin that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than doxorubicin. Doxil is used to treat ovarian cancer, AIDS-related Kaposi sarcoma, and multiple myeloma in patients whose disease has not gotten better after treatment with other anticancer drugs. It may be used together with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Doxil is a type of anthracycline antitumor antibiotic.|A form of the anticancer drug that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than doxorubicin. Doxil is used to treat ovarian cancer, AIDS-related Kaposi sarcoma, and|41.90843373493976|46.60500000000002|10.359586919104995|9.740000000000002|10.097872549019609|9.949505128205129|5.782168674698799|5.386666666666667|9.092509803921569|6.446153846153845|74.79740637214636|72.26115969177356|24.019965576592085|22.57777777777778
The chemical reactions and pathways resulting in the formation of ergosteryl 3-beta-D-glucoside. [GO_REF:0000068, GOC:TermGenie, PMID:26116408]|The chemical reactions and pathways resulting in the formation of ergosteryl alcohol. [GO_REF:0000068, GOC:TermGenie, PMID:26116408]|58.2225|41.30250000000001|7.001666666666669|9.361666666666668|15.742436842105265|15.203982352941178|11.101333333333322|7.181333333333335|13.067368421052628|14.127647058823534|58.53822981607831|62.58|21.666666666666668|24.333333333333336
The process in which proteins required for 3'-end transcript processing become associated with the RNA polymerase II holoenzyme complex and the 3' end of a transcript. [PMID:18195044]|The process in which proteins required for 3'-end transcript processing become associated with RNA polymerase II holoenzyme complex and the 3 end of a transcript. [PMID:18195044]|67.79916666666671|66.74000000000002|7.156481481481482|7.180000000000003|12.783607692307694|13.390915384615385|12.265185185185189|12.284615384615382|12.786538461538463|12.605384615384615|73.38155456243756|73.38155456243756|21.696296296296296|22.123076923076923
Any viral process that inhibits the splicing of host mRNA, thus reducing host protein production. [ISBN:0781718325, PMID:19729513]|Any viral process that inhibits the splicing of host mRNA, so reducing host protein production. [ISBN:0781718325, PMID:19729513]|68.81926470588238|68.81926470588238|5.772058823529413|5.772058823529413|14.275158823529411|13.732344444444447|4.607058823529414|4.261176470588239|13.019411764705886|11.329999999999998|62.58|62.58|22.223529411764705|22.223529411764705
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-12 stimulus. [GOC:mah]|Any process that results in a change in state or activity of eukaryotic cell or an organism (in terms of movement, secretion, enzyme production, etc.). [GOC:mah]|64.46761904761905|54.869102564102604|7.165714285714287|7.7592307692307685|11.547077777777778|11.66197142857143|4.364571428571423|-3.170769230769235|9.28833333333333|6.9332142857142856|65.13532912329528|59.91578840339164|19.523809523809526|20.38974358974359
Material physical anatomical entity which has inherent 3D shape; is generated by coordinated expression of the organism's own structural genes; consists of parts that are anatomical structures; spatially related to one another in patterns determined by coordinated gene expression. Examples: heart, right ventricle, mitral valve, myocardium, endothelium, lymphocyte, fibroblast, thorax, cardiovascular system, hemoglobin, gene.|Material physical entity which has inherent 3D shape; is generated by coordinated expression of the organism's own structural genes; consists of parts that are anatomical structures; spatially related to one another through coordinated gene expression. Examples: heart, right ventricle, mitral valve, thorax|-2.5683333333332996|12.291428571428611|18.08925925925926|16.761904761904763|15.209959259259259|13.883132558139534|24.28|23.2847619047619|23.29555555555556|17.68953488372093|100.58327743715651|101.39118822659097|30.162962962962965|28.400000000000002
A contagious disease of horses that can be transmitted to humans. It is caused by BURKHOLDERIA MALLEI and characterized by ulceration of the respiratory mucosa and an eruption of nodules on the skin.|A viral disease of horses that can be transmitted to humans. It is caused by BURKHOLDERIA MALLEI and characterized by ulceration of the respiratory mucusosal area and an eruption of nodules on the skin.|39.28818181818184|36.08460784313729|10.512121212121212|11.041764705882358|10.196718181818182|10.531166666666667|2.8472727272727276|3.2823529411764696|10.370000000000001|7.011333333333333|65.13532912329528|67.59412548439398|20.157575757575756|21.00392156862745
<p>Mandibular right second molar abutment</p>|Mandibular right second molar abutment/p>|-1.2799999999999727|-1.2799999999999727|14.68|14.68|16.36401111111111|15.875800000000002|-10.984000000000002|-14.512|4.526666666666667|4.353750000000002|62.58|62.58|34.0|34.0
International Physical Activity Questionnaire (August 2002) Long Last 7 Days Self-Administered Format (IPAQ Long Last 7 Days Self-Administered Format Version) How much time did you usually spend on one of those days doing vigorous physical activities as part of your work?: minutes per day.|International Physical Activity Questionnaire (August 2002) Long Last 7 Days Self-Administered Format) How much time did you usual spend on one of those days doing vigorous physical activities as part of your work?: minutes per day.|32.60954545454547|38.16500000000002|14.176363636363636|12.407777777777778|10.918989855072464|10.246354736842106|19.553636363636357|15.895555555555553|10.605797101449276|6.043947368421051|91.22524239485473|79.77416029015912|24.254545454545454|21.644444444444446
Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported Version (PODCI Adolescent Parent-Reported Version) If you answered "no" to Question 36 above, was your child's activity limited by: Dislike of recreational outdoor activities?|If you answered "no" to Question 36 above, was your child's activity limited by: Dislike of recreational outdoor activities?|-23.849354838709672|31.70789473684212|24.287096774193547|13.556842105263158|12.110657575757577|10.155000000000001|31.990967741935485|17.534736842105264|16.65|12.591000000000001|143.38879349516822|93.86999999999999|39.49677419354839|26.54736842105263
The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION.|The residual portion of blood that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior blood loss.|45.80302631578948|59.16092105263158|9.230789473684215|7.367631578947371|10.396268421052632|9.659|1.0273684210526355|-0.8294736842105266|13.603157894736846|6.413499999999999|62.58|58.53822981607831|20.642105263157895|18.53684210526316
Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of deprivation of glucose. [GOC:dph]|Any process that increases the frequency, rate or extent of transcription from RNA polymerase II promoter as a result of deprivation of glucose. [GOC:dph]|45.25150000000002|43.08000000000001|10.053|10.23166666666667|12.783607692307694|13.390915384615385|7.601599999999998|7.673333333333332|8.25769230769231|8.076538461538462|73.38155456243756|73.38155456243756|22.6|23.133333333333333
Tributary of pterygoid plexus, each instance of which passes through the pterygoid canal.|Tributary of cutaneous nerves, each instance of which passes through the pterygoid canal.|44.05288461538464|44.05288461538464|8.729615384615386|8.729615384615386|10.354376923076924|9.622985714285715|-10.71076923076923|-10.258461538461539|12.24307692307692|7.6385714285714315|58.53822981607831|58.53822981607831|24.13846153846154|24.13846153846154
The standard character or string for representation and reporting of tumor findings data.|The standard character or string for representation and reporting tumor findings data.|44.05288461538464|38.595|8.729615384615386|9.366666666666667|12.783607692307694|12.461207692307694|-10.71076923076923|-12.093333333333334|12.605384615384615|8.993076923076924|58.53822981607831|58.53822981607831|24.13846153846154|25.733333333333338
This gene is involved in both endocytosis and protein sorting.|This gene is involved in both endocytosis and protein sorting.|57.940000000000026|57.940000000000026|6.420000000000002|6.420000000000002|12.0275|12.522027272727273|-28.035999999999998|-27.447999999999993|8.062000000000001|4.0136363636363654|44.250742366654144|44.250742366654144|18.0|18.0
<p>WHO Adverse Drug Reaction Terminology (WHOART). German Translation. Uppsala (Sweden): WHO Collaborating Centre for International Drug Monitoring, 1997. For more information, see http://www.umc-products.com/graphics/3149.pdf</p>|WHO Adverse Drug Reaction Terminology. German Translation. Uppsala (Sweden): WHO Collaborating Centre for International Drug Monitoring, 1997. For more information, see http://www.umc-products.com/graphics/3149.pdf/p>|23.26521739130436|19.063181818181846|10.830559006211182|11.381168831168832|16.25241111111111|15.7766|-36.9113043478261|-41.5290909090909|16.485|18.661250000000003|40.9682267129052|40.9682267129052|22.183850931677018|23.075324675324676
European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 (EORTC QLQ-C30 Version 3) How would you rate your overall quality of life during the past week?|European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Version 3.0 (EORTC QLQ-C30 Version 3) How would you rate your overall quality of life during the past week?|65.79821428571432|62.68000000000002|8.429285714285715|8.740000000000002|12.62507142857143|13.755711111111113|12.65371428571429|13.025882352941178|10.331714285714288|19.07333333333333|76.64453405168562|76.64453405168562|20.714285714285715|20.917647058823533
A partial or complete breakage of the orbit of skull. []|A partial or complete breakage of the orbital bone. []|93.57977272727274|83.32000000000004|1.5731818181818191|2.879999999999999|11.7795|11.7795|-29.229090909090914|-32.152|1.3230000000000004|1.3230000000000004|44.250742366654144|44.250742366654144|16.745454545454546|18.0
Terminology associated with the diabetic kidney disease findings about test name codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).|Terminology associated with the kidney disease findings about test name codes of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).|11.411500000000018|21.930000000000035|14.773000000000003|13.181666666666665|15.613700000000001|14.9937|14.657599999999995|12.818333333333335|20.837200000000003|12.703200000000002|91.22524239485473|85.69119412168324|32.2|29.8
Continuum in which events or experiences are expressed in terms of the past, the present, and the future. For effects of time-of-day or season consider also SEASONAL VARIATIONS and BIOLOGICAL RHYTHMS or their associated terms.|Continuum in which events or experiences are expressed in terms of the past, the present, and the future. For effects of time-of-day or day consider also SEASONAL VARIATIONS and BIOLOGICAL RHYTHMS or their associated terms.|37.87904761904764|40.2961904761905|10.874285714285715|10.537142857142857|9.675181081081082|9.980742105263158|6.884571428571427|6.5485714285714245|11.497297297297301|10.876315789473686|69.96656701596841|67.59412548439398|21.80952380952381|20.666666666666668
The process whose specific outcome is the progression of the facial nucleus over time, from its formation to the mature structure. [GO_REF:0000021, GOC:cls, GOC:curators, GOC:dgh, GOC:dph, GOC:jid]|The process whose specific outcome is the progression of the facial nucleus over time, from its formation to its maturation to the mature structure. [GO_REF:0000021, GOC:cls, Grouped Opinions|58.3991666666667|53.639285714285734|8.467592592592595|9.255714285714287|14.29885|12.801833333333335|15.314074074074071|13.507142857142863|9.678437500000001|11.032999999999994|76.64453405168562|79.77416029015912|23.177777777777777|24.171428571428574
A question about how bothered an individual is by tingling sensation in their breast or chest area.|A question about how bothered an individual is by tingling sensation in their breast area.|48.9133823529412|41.30250000000001|8.548529411764708|9.361666666666668|8.19499411764706|8.967675|-6.115294117647053|-9.282666666666668|9.788823529411765|4.942499999999999|58.53822981607831|58.53822981607831|19.870588235294118|21.666666666666668
A multinodular intermediate fibroblastic neoplasm arising from the stomach. It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes and plasma cells.|A multinodular intermediate fibrous tumor arising from the stomach. It is characterized by the presence of spindle-shaped cells, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes and plasma cells.|-2.272916666666646|10.564999999999998|16.22625|14.270000000000007|12.589142424242425|12.060566666666666|13.226250000000004|8.228000000000005|17.934545454545457|11.574583333333337|76.64453405168562|72.26115969177356|26.76666666666667|25.333333333333336
The development of female secondary sexual characteristics (such as breast enlargement, female body habitus) in boys.|The development of female secondary sexual characteristics (such as breast enlargement, body habitus) in boys.|8.365000000000009|7.462500000000006|14.080000000000002|14.081666666666667|12.3251|11.9283|0.48499999999999943|-1.4426666666666677|15.418749999999996|9.946874999999999|66.37611354998121|62.58|25.700000000000003|24.333333333333336
An individual that lives at a healthcare facility that provides rehabilitative, restorative, and/or ongoing skilled nursing care to patients or residents in need of assistance with activities of daily living.|An individual that lives at a health facility that provides rehabilitative, restorative and/or ongoing skilled nursing care to patients or residents in need of assistance with activities of daily living.|19.590000000000032|22.410000000000025|14.253333333333334|13.860000000000003|12.493166666666667|11.536267741935484|15.350666666666662|14.566666666666663|21.201999999999998|12.604838709677416|82.78555852321104|79.77416029015912|24.666666666666668|23.333333333333336
A country in Eastern Asia, bordering the South China Sea and China. (NCI)|A country in Eastern Asia, bordering the Red Sea and China. (NCI)|70.08365384615385|73.84500000000001|5.098846153846157|4.450000000000003|7.602746153846153|8.817361538461538|-17.94769230769231|-22.383333333333333|2.471538461538465|0.2976923076923086|54.195869768830164|49.473833993334296|21.06153846153846|19.06666666666667
Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other.|Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale Aids or devices that you usually use for any of these activities.|32.504999999999995|26.470000000000027|11.706666666666667|12.3|12.329039130434783|12.445160869565218|7.9183333333333366|7.034545454545448|16.691739130434783|10.122608695652175|76.64453405168562|73.38155456243756|24.8|24.400000000000002
A pain management technique based on improvement of functional ability, strengthening, and maintenance of range of motion. It is believed that endorphin release during exercise minimizes pain and improves effectiveness of analgesics.|A pain management technique based on improvement of functional ability, strengthening, and maintenance of range of motion. It is believed that endorphin release during exercise minimizes pain and helps effectiveness of opioids.|26.808333333333366|37.383333333333354|12.170000000000002|10.695|11.8316625|11.837857575757576|9.367500000000003|8.44875|15.713124999999998|11.616363636363637|74.48509850970193|72.26115969177356|25.516666666666666|24.266666666666666
The chemical reactions and pathways in which mannose, the aldohexose manno-hexose, is converted to fructose-6-phosphate. [GOC:dph, ISBN:0201090910, ISBN:0879010479]|The chemical reactions and pathways in which mannose, the aldohexoses, is converted to fructose-6-phosphate. [GOC:dph, ISBN:0201090910,0879010479]|66.10000000000002|66.5275|6.2755555555555596|5.967500000000001|14.683966666666668|14.080331578947368|15.13111111111111|11.509999999999998|14.547142857142852|14.058947368421052|58.53822981607831|54.195869768830164|19.15555555555556|18.2
A molecular genetic abnormality indicating deregulation of the ERG oncogene.|A genetic abnormality indicating deregulation of an oncogene.|-35.11999999999995|-40.44999999999999|19.400000000000002|19.895000000000007|15.185500000000001|14.38636666666667|-19.803999999999995|-33.575|14.655999999999999|9.079999999999998|54.195869768830164|49.473833993334296|26.0|26.6
The chemical reactions and pathways resulting in the formation of (S)-reticuline. [GOC:TermGenie, GOC:yaf, UniPathway:UPA00306]|The chemical reactions and pathways resulting in the formation of (S)-reticuline. [GOC:Genie, GOC:yaf, UniPathway:UPA00306]|36.572857142857174|42.61571428571432|9.89714285714286|9.054285714285715|15.203982352941178|15.486788888888892|5.594285714285711|4.334285714285713|11.911176470588238|9.760000000000002|62.58|62.58|25.65714285714286|25.65714285714286
Any process that stops, prevents or reduces the frequency, rate or extent of high voltage-gated calcium channel activity. [GOC:BHF, GOC:rl, GOC:TermGenie, PMID:12754254]|Any process that stops, prevents or reduces calcium channel activity. [GOC:BHF, GOC:rl, GroupGenie, PMID:12754254]|41.8518181818182|54.70142857142861|10.154545454545456|7.368571428571428|13.998223076923077|16.13280588235294|12.647272727272725|0.5542857142857187|9.706923076923076|8.586470588235294|73.38155456243756|62.58|24.400000000000002|25.65714285714286
Inducible T-cell costimulator (199 aa, ~23 kDa) is encoded by the human ICOS gene. This protein is involved in the regulation of T-cell antigen-mediated responses.|Inducible T-cell costimulator (199 amino acids, 23 kilodaltons) is encoded by a human gene ICOS. This protein is involved in the regulation of antigen-mediated responses.|42.71266666666668|22.408666666666676|9.372000000000003|12.204000000000004|14.481614285714286|14.814076190476193|-2.827200000000005|-0.9455999999999989|7.606071428571429|6.786666666666669|57.127462747788826|65.13532912329528|19.333333333333336|24.133333333333336
This gene plays a role in both cell cycle checkpoint control and DNA repair.|This gene has a role in both cell cycle checkpoint control and DNA repair.|90.95857142857145|90.95857142857145|2.3114285714285714|2.3114285714285714|11.098042857142858|11.377166666666668|-15.825714285714284|-16.245714285714282|6.428571428571431|1.4740000000000002|44.250742366654144|44.250742366654144|14.228571428571428|14.228571428571428
a drug that stimulates the immune system|drug that stimulates the immune system.|54.70142857142861|48.690000000000026|7.368571428571428|7.213333333333335|13.006557142857146|15.08867142857143|-13.72571428571429|-64.36666666666666|4.947142857142854|3.197142857142854|54.195869768830164|38.32226702584281|19.942857142857143|21.200000000000003
A myogenic regulatory factor that controls myogenesis. Though it is not clear how its function differs from the other myogenic regulatory factors, MyoD appears to be related to fusion and terminal differentiation of the muscle cell.|A myogenic regulatory factor that controls myogenesis. Though it is not clear how its function differs from the other factors, MyoD appears to be related to fusion and terminal differentiation of the muscle cell.|44.255000000000024|51.01401960784315|10.067777777777778|8.959411764705884|11.547077777777778|10.982309523809523|7.509999999999998|5.011764705882349|12.951666666666668|8.22247619047619|74.48509850970193|69.96656701596841|23.68888888888889|22.180392156862748
Any process that activates or increases the frequency, rate or extent of isotype switching. [GOC:go_curators]|Any process that activate or increases the frequency, rate or extent of isotype switching. [GOC:go_curators]|18.742500000000007|24.382499999999993|12.508333333333336|11.721666666666671|12.915175000000001|13.346335294117647|-2.2266666666666737|-2.2266666666666737|9.063749999999999|7.755294117647058|66.37611354998121|66.37611354998121|27.0|27.0
The controlled release of proteins or DNA by a cell, via the type IV secretion system. [GOC:pamgo_curators]|The controlled release of proteins or DNA by a cell, via the type IV secretion system. [GOC:pamgo_curator]|53.889852941176486|53.889852941176486|7.854411764705883|7.854411764705883|13.732344444444447|14.080331578947368|-3.3482352941176465|-3.3482352941176465|5.573333333333334|4.638947368421054|58.53822981607831|58.53822981607831|19.870588235294118|19.870588235294118
The chemical reactions and pathways resulting in the formation of D-ribose 5-phosphate. [GOC:TermGenie, GOC:yaf, UniPathway:UPA00293]|The chemical reactions and pathways resulting in the formation of cellular energy molecule. [GOC:TermGenie, GOC:yaf, UniPathway:UPA00293]|58.2225|29.515000000000015|7.001666666666669|11.130000000000003|15.975000000000001|15.975000000000001|7.181333333333335|8.2025|9.2395|10.652499999999996|62.58|69.96656701596841|24.333333333333336|28.200000000000003
A surgical lamp (including a fixture) is a device intended to be used to provide visible illumination of the surgical field or the patient.|A surgical lamp is a device intended to provide visible illumination of the surgical field or the patient.|50.130000000000024|42.60000000000002|9.248333333333335|9.553333333333335|10.74815|10.75612105263158|3.7533333333333303|-3.488888888888887|12.746249999999996|5.382631578947368|69.96656701596841|62.58|21.46666666666667|21.37777777777778
hereditary condition clinically resembling hypoparathyroidism, but caused by failure of response to rather than deficiency of parathyroid hormones; characterized by hypocalcemia and hyperphosphatemia, and commonly associated with short stature, obesity, short metacarpals, and ectopic calcification.|hereditary condition clinically resembling hypoparathyroidism, but caused by failure of response to rather than deficit of a thyroid hormone, characterized by hypocalcemia and hyperphosphatemia, and commonly associated with short stature, obesity, short metacarpals,|-38.13892857142852|-36.878181818181815|22.92642857142857|26.601212121212125|14.395357142857145|14.146723529411764|27.605714285714285|32.903030303030306|30.789428571428573|27.293235294117643|101.39118822659097|136.38994794338765|31.0|36.230303030303034
Colorectal adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.|colon cancer that has spread extensively to other body sites or is not responding to treatment.|14.07808823529416|55.952500000000015|13.407352941176473|7.442500000000003|10.981464705882354|10.559864705882354|0.4564705882352982|-7.232500000000002|15.05294117647059|4.984705882352941|58.53822981607831|58.53822981607831|19.870588235294118|20.700000000000003
The data of tumor progression after initial treatment.|The data of tumor progress after initial treatment.|33.57500000000002|44.150000000000006|9.57|8.094999999999999|13.902050000000001|14.38636666666667|-39.455000000000005|-40.925000000000004|9.6525|3.8466666666666676|54.195869768830164|54.195869768830164|31.6|31.6
An increased concentration of valine in the blood. [HPO:gcarletti]|An increased concentration of valine in the blood. [HPO:gcarletti]|42.46750000000003|42.46750000000003|8.45388888888889|8.45388888888889|11.7795|12.522027272727273|-27.88444444444444|-27.23111111111111|6.504000000000001|4.870000000000001|44.250742366654144|44.250742366654144|19.57777777777778|19.57777777777778
The chemical reactions and pathways involving poly(hydroxyvalerate). [GO_REF:0000068, GOC:mengo_curators, GOC:TermGenie, PMID:21705209]|The chemical reactions and pathways involving poly(hydroxyvalerate). [GO_REF:0000068, GOC:mengo_curators, GrupGenie, PMID:21705209]|-21.783863636363606|-14.092954545454518|17.664090909090913|16.591363636363642|17.31966923076923|17.31966923076923|12.999999999999993|11.396363636363638|23.847692307692306|23.12307692307693|58.53822981607831|58.53822981607831|27.654545454545453|27.654545454545453
The chemical reactions and pathways involving (R)-mevalonic acid. [GOC:TermGenie, GOC:yaf, UniPathway:UPA00058]|The chemical reactions and pathways involving (R)-mevalonate. [GOC:TermGenie, GOC:yaf, UniPathway:UPA00058]|24.36159090909092|24.100000000000023|11.227727272727272|11.14|17.517985714285714|17.517985714285714|0.1709090909090918|-0.9879999999999995|13.021428571428565|12.348571428571425|62.58|58.53822981607831|31.290909090909096|30.0
Hair on the neck extends less inferiorly than usual. [UToronto:htrang]|Hair on the neck extends less inferiorly than usual. [UToronto:htr]|32.56000000000003|41.02000000000004|9.96|8.780000000000001|11.086572727272728|11.8291|-23.332|-24.507999999999996|5.7263636363636365|3.157499999999999|44.250742366654144|44.250742366654144|18.0|18.0
A species of ORTHOREOVIRUS infecting birds, with outcomes ranging from inapparent to lethal depending on the virus strain and age of the host bird. This species does not infect mammals.|A species of virus infection birds, with outcomes ranging from inapparent to lethal depending on the virus strain and age of the host bird. This species does not infect mammals.|58.505000000000024|66.965|7.583333333333332|6.4033333333333395|10.6965|10.770646236559141|0.9759999999999991|-0.39599999999999724|10.090999999999998|5.919247311827959|62.58|62.58|20.0|20.0
Stylets designed for use in the lumen of catheters or cannulae intended for insertion into arteries; the stylet is usually withdrawn after cannula or catheter insertion. These stylets typically are thin metallic wires or flexible rods that provide a rigid or semirigid structure during insertion. The cannula or catheter can be connected to a tube or connector for the injection or withdrawal of intravenous solutions and/or blood. Dedicated arterial stylets are available according to the artery (e.g., aorta, coronary) to be punctured and/or the catheter used.|Stylets designed for use in the lumen of catheters or cannulae intended for insertion into arteries; the stylet is usually withdrawn after catheterization and/or the catheter used. Dedicated arterial styles are available according to the artery (e.g., a|32.05104651162793|30.218815789473695|11.840963455149506|11.404473684210526|12.781504651162791|13.106007692307694|8.520465116279066|2.4200000000000017|14.951162790697673|14.043846153846154|79.33462989136584|69.96656701596841|25.84451827242525|24.852631578947367
Defibrillator-pacemakers that generate electric impulses outside the body and deliver them to the heart through the chest wall using paddles (or electrodes). These devices typically include an electrocardiographic monitor and two large-surface, conductive, disposable adhesive electrodes that conduct the electrical stimuli through the skin and skeletal muscle to the heart. External defibrillator-pacemakers allow defibrillators to be used in the emergency temporary treatment of asystole, severe bradycardia, implantable pacemaker failure, certain types of tachycardia, and sick sinus syndrome.|Defibrillator-pacemakers that generate electric impulses outside of the body and deliver them to the heart through the chest wall using paddles. These devices typically include an electrocardiographic monitor and two large-surface, conductive electrodes that conduct the electrical stimuli from the skin and|-4.976477272727266|8.262857142857143|18.73568181818182|17.323809523809526|12.459416666666668|10.717611111111111|24.332467532467525|23.2847619047619|21.69408333333333|17.34733333333333|100.1768786946369|96.44225707644962|28.9987012987013|26.495238095238097
The sodium salt form of cefamandole, a beta-lactam, second-generation cephalosporin antibiotic with bactericidal activity. Cefamandole binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis.|The sodium salt form of cefamandole, a beta-lactam, second-generation cephalosporin antibiotic with bactericidal activity. It binds to and inactivates proteins necessary for bacterial cell wall strength and rigidity. This results in the weak|11.424250000000029|5.9609090909091265|14.845750000000002|15.16060606060606|11.678082352941177|11.688088888888888|13.9925|10.509090909090904|14.221764705882357|11.259999999999998|74.04565456527479|67.59412548439398|22.62|21.36969696969697
A measurement of the round cells (round shaped cells mainly comprised of white blood cells and immature spermatogenic cells) in a biological specimen.|A measurement of the round cells (round shaped cells mainly comprised of white blood cells and immature spermatid cells) in a biological specimen.|44.35380434782613|51.71032608695654|9.929782608695653|8.903695652173912|10.269473913043479|10.15295|6.984347826086953|6.217391304347824|15.667826086956524|8.5125|62.58|62.58|18.51304347826087|18.51304347826087
Any physical or mental impairment that interferes with an individual's ability to perform desired activities.|Any mental impairment that interferes with an individual's ability to perform desired activities.|1.822499999999991|-1.5009615384615245|14.868333333333336|15.083461538461542|12.801833333333335|13.006557142857146|-2.2266666666666737|-6.640000000000001|15.585999999999999|10.666428571428575|69.96656701596841|66.37611354998121|29.666666666666664|30.29230769230769
The brief report prepared by biostatisticians summarizing primary (and secondary) efficacy results and key demographic information.|The brief report prepared by biostatisticians summarizing primary (and second) efficacy results and key demographic information.|-12.784999999999997|-2.2099999999999795|17.029999999999998|15.555000000000003|13.311975|12.417511764705882|5.630000000000003|4.894999999999996|19.834375|13.573529411764703|69.96656701596841|69.96656701596841|28.200000000000003|28.200000000000003
Columbia-Suicide Severity Rating Scale Baseline - Has there been a time when you started to do something to try to end your life but someone or something stopped you before you actually did anything?|Columbia Suicide Severity Rating Scale Baseline - Has there been a time when you started to do something to try to end your life but someone or something stopped you before you actually did anything?|40.448529411764724|38.36714285714288|16.064117647058826|16.602857142857143|8.573782352941176|8.981642857142857|20.002352941176476|19.430857142857146|18.150294117647057|18.139714285714284|103.77718969022045|108.39173953766033|26.541176470588233|27.71428571428571
<p>Bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones. It contains <a href="https://medlineplus.gov/stemcells.html">stem cells</a>. The stem cells can develop into the red blood cells that carry oxygen through your body, the white blood cells that fight infections, and the platelets that help with blood clotting.</p> <p>With bone marrow disease, there are problems with the stem cells or how they develop:</p> <ul> <li>In <a href="https://medlineplus.gov/leukemia.html">leukemia</a>, a cancer of the blood, the bone marrow makes abnormal white blood cells</li> <li>In <a href="https://medlineplus.gov/aplasticanemia.html">aplastic anemia</a>, the bone marrow doesn't make red blood cells</li> <li>In myeloproliferative disorders, the bone marrow makes too many white blood cells</li> <li>Other diseases, such as <a href="https://medlineplus.gov/lymphoma.html">lymphoma</a>, can spread into the bone marrow and affect the production of blood cells</li> </ul> <p>Causes of bone marrow diseases include genetics and environmental factors. Tests for bone marrow diseases include <a href="https://medlineplus.gov/bloodcounttests.html">blood</a> and bone marrow tests. Treatments depend on the disorder and how severe it is. They might involve medicines, <a href="https://medlineplus.gov/bloodtransfusionanddonation.html">blood transfusions</a> or a <a href="https://medlineplus.gov/bonemarrowtransplantation.html">bone marrow transplant</a>.</p>|Bone marrow is the soft tissue surrounding some of your bones, such as your hip and thigh bones. It contains a href="https://medlineplus.gov/blood transfusions/a>, and the platelets that help with blood clo|30.044564935064983|62.62408602150538|11.044844155844157|7.091612903225808|12.156749045521293|9.46707142857143|6.804571428571428|4.927741935483869|14.732165932452276|10.466285714285714|55.4139065660335|54.195869768830164|18.953246753246756|15.746236559139787
A coded value specifying patients with a surname or origin associated with a particular ethnicity.|A coded value specifying patients witha surname or origin associated with a particular ethnicity.|18.742500000000007|6.35857142857148|12.508333333333336|14.111428571428572|12.801833333333335|14.535166666666669|-6.538666666666671|-6.585714285714289|12.131999999999998|8.695999999999998|66.37611354998121|69.96656701596841|27.0|31.371428571428574
Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial mRNA catabolic process. [GO_REF:0000058, GOC:TermGenie, PMID:27122350]|Any process that stops, prevents or reduces the frequency, rate or extent of a metabolic process. [GO_REF:0000058, GOC:TermGenie, PMID:27122350]|48.63500000000002|59.16092105263158|8.960000000000004|7.367631578947371|13.932061904761905|13.180157142857144|12.148|8.145263157894739|13.874285714285712|10.510000000000002|69.96656701596841|66.37611354998121|24.0|22.74736842105263
A monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed cell death 1 (PD-1, PCD-1; PDCD1) protein, with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, anti-PD-1 monoclonal antibody AGEN2034 binds to PD-1, and thereby blocks its binding to the PD-1 ligand programmed cell death-1 ligand 1 (PD-L1), and prevents the activation of its downstream signaling pathways. This may restore immune function through the activation of cytotoxic T cells. PD-1, a transmembrane protein in the immunoglobulin superfamily expressed on activated T cells, negatively regulates T-cell activation and effector function when activated by its ligand; it plays an important role in tumor evasion from host immunity. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C136455" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C136455" NCI Thesaurus)|A monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed cell death 1 (PD-1, PCD-1; PDCD1) protein, with potential immune checkpoint inhibitory and anti-cancer activities. This may restore immune function through the activation of a|36.48967286501377|11.67105263157896|10.674731404958678|16.351578947368424|13.938193087557604|13.771833333333333|15.10909090909091|22.641052631578948|21.15682027649769|13.496666666666663|68.19497397169383|101.39118822659097|22.876308539944905|29.70526315789474
Unified Huntington's Disease Rating Scale '99 - Delusions: Severity: When you feel suspicious (insert delusion here), are you able to convince yourself that it is not rational? [Severity should reflect the behavior's impact on the individual's ability to carry out daily activities as indicated by response choices.].|Unified Huntington's Disease Rating Scale '99 - Delusions: Severity: When you feel suspicious (insert delusion here), are you able to convince yourself that it is not rational?)|30.73333333333335|35.29666666666668|12.86468085106383|15.043703703703706|12.329039130434783|12.493507407407408|15.010212765957444|22.139259259259262|16.589347826086957|10.265555555555558|90.32644961471695|112.8176994092682|27.54326241134752|30.059259259259264
The chemical reactions and pathways resulting in the breakdown of glycosaminoglycans, any one of a group of polysaccharides that contain amino sugars. [ISBN:0192800981]|The chemical reactions and pathways resulting in the breakdown of a group of proteins that contain amino sugars. [ISBN:0192800981]|29.64076086956524|63.613552631578955|11.981956521739132|6.746578947368423|11.07211739130435|12.0275|11.586086956521733|3.812631578947368|13.399130434782613|9.475000000000001|73.38155456243756|66.37611354998121|23.730434782608697|22.74736842105263
Liquid preparation consisting of a suspension intended for rectal use or for diagnostic purposes. Rectal suspension are usually presented in containers with a volume in the range of 2.5 mL to 2000 mL. The container is fitted with an applicator or an applicator is provided separately.|Liquid preparation consisting of a suspension intended for rectal use or for diagnostic purposes. Rectal suspension are usually presented in containers with volumes in the range of 2.5 mL to 2000 mules. The container is fitted with an applicator or two different methods are used.|43.01004347826091|49.180000000000035|9.545826086956524|8.635555555555559|11.948772463768117|11.07211739130435|-1.623478260869561|-1.9208888888888858|10.50340579710145|8.279565217391305|62.58|62.58|21.07130434782609|21.37777777777778
A progressive advance or delay of bedtime until the desired bedtime is achieved.|A progressive advance or delay of bedtime until the desired Bedtime is achieved.|57.06826923076926|57.06826923076926|6.91423076923077|6.91423076923077|9.139761538461538|9.622985714285715|-14.781538461538464|-14.329230769230772|9.344615384615388|4.947142857142854|62.58|62.58|27.21538461538462|27.21538461538462
A change in the nucleotide sequence of the ERBB3 gene that that results in constitutive activation of receptor tyrosine-protein kinase erbB-3 and its downstream signaling pathways.|A change in the DNA of a gene that results in constitutive activation of receptor tyrosine-protein kinase erbB-3 and its downstream signaling pathways.|43.963076923076954|44.35380434782613|10.356923076923078|9.929782608695653|13.747922222222224|13.0989|12.284615384615382|7.495652173913044|18.759999999999998|8.935200000000002|73.38155456243756|66.37611354998121|22.123076923076923|20.252173913043478
Bladder cancer in which there is no regional lymph node metastasis. (from AJCC 6th and 7th Eds.)|cancer in which there is no regional lymph node metastasis. (from AJCC 6th and 7th Eds.)|91.60098039215687|95.67166666666668|1.8905882352941177|1.2399999999999984|13.346335294117647|12.915175000000001|-24.56470588235294|-28.672499999999996|3.8764705882352963|2.881875000000001|36.13057984588678|31.29|11.67843137254902|9.633333333333333
